| Ident. | Authors (with country if any) | Title |
|---|
| 001400 |
Jan Zijlmans [Royaume-Uni, Pays-Bas] ; Andrew Evans [Royaume-Uni] ; Flavia Fontes [Royaume-Uni] ; Regina Katzenschlager [Royaume-Uni, Autriche] ; Svetoslav Gacinovic [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Durval Costa [Royaume-Uni, Portugal] | [123I] FP-CIT spect study in vascular parkinsonism and Parkinson's disease |
| 001403 |
Harold L. Newmark [États-Unis] ; Jonathan Newmark [États-Unis] | Vitamin D and Parkinson's disease- : A hypothesis |
| 001405 |
Birgit Frauscher [Autriche] ; Viola Gschliesser [Autriche] ; Elisabeth Brandauer [Autriche] ; Hanno Ulmer [Autriche] ; Cecilia M. Peralta [Autriche, Argentine] ; Jorg Müller [Autriche] ; Werner Poewe [Autriche] ; Birgit Högl [Autriche] | Video analysis of motor events in REM sleep behavior disorder |
| 001407 |
Susann Junghanns [Allemagne] ; Joerg T. Fuhrmann [Allemagne] ; Gregor Simonis [Allemagne] ; Christian Oelwein [Allemagne] ; Rainer Koch [Allemagne] ; Ruth H. Strasser [Allemagne] ; Heinz Reichmann [Allemagne] ; Alexander Storch [Allemagne] | Valvular heart disease in parkinson's disease patients treated with dopamine agonists : A reader-blinded monocenter echocardiography study |
| 001409 |
Nadeeka N. W. Dissanayaka [Australie] ; Anna Sellbach [Australie] ; Sally Matheson [Australie] ; Rodney Marsh [Australie] ; Peter A. Silburn [Australie] ; John D. O'Sullivan [Australie] ; Gerard J. Byrne [Australie] ; George D. Mellick [Australie] | Validity of hamilton depression inventory in Parkinson's disease |
| 001411 |
Santiago Perez Lloret [Argentine] ; Gabriel Piran Arce [Argentine] ; Malco Rossi [Argentine] ; Maria Laura Caivano Nemet [Argentine] ; Paz Salsamendi [Argentine] ; Marcelo Merello [Argentine] | Validation of a new scale for the evaluation of sialorrhea in patients with Parkinson's disease |
| 001415 |
Asha Kishore [Canada] ; Alberto J. Espay [Canada] ; Connie Marras [Canada] ; Thamer Al-Khairalla [Canada] ; Tamara Arenovich [Canada] ; Abena Asante [Canada] ; Janis Miyasaki [Canada] ; Anthony E. Lang [Canada] | Unilateral versus bilateral tasks in early asymmetric Parkinson's disease : Differential effects on bradykinesia |
| 001417 |
J Rgen H. Olsen [Danemark] ; Karina Tangerud [Danemark] ; Lene Wermuth [Danemark] ; Kirsten Frederiksen [Danemark] ; S Ren Friis [Danemark] | Treatment with levodopa and risk for malignant melanoma |
| 001420 |
Yu-Wen Huang [Taïwan] ; Jiann-Shing Jeng [Taïwan] ; Chung-Fen Tsai [Taïwan] ; Li-Ling Chen [Taïwan] ; Ruey-Meei Wu [Taïwan] | Transcranial imaging of substantia nigra hyperechogenicity in a Taiwanese cohort of Parkinson's disease |
| 001421 |
Uwe Walter [Allemagne] ; Dirk Dressler [Allemagne] ; Alexander Wolters [Allemagne] ; Matthias Wittstock [Allemagne] ; Reiner Benecke [Allemagne] | Transcranial brain sonography findings in clinical subgroups of idiopathic Parkinson's disease |
| 001424 |
Brenda L. Den Oudsten [Pays-Bas] ; Guus L. Van Heck [Pays-Bas] ; Jolanda De Vries [Pays-Bas] | The suitability of patient-based measures in the field of Parkinson's disease : A systematic review |
| 001429 |
Tanya Gurevich [Israël] ; Chava Peretz [Israël] ; Orna Moore [Israël] ; Nina Weizmann [Israël] ; Nir Giladi [Israël] | The effect of injecting botulinum toxin type a into the calf muscles on freezing of gait in Parkinson's disease : A double blind placebo-controlled pilot study |
| 001438 |
Kelvin L. Chou [États-Unis] ; Maria L. Moro-De-Casillas [États-Unis] ; Melissa M. Amick [États-Unis] ; Leora L. Borek [États-Unis] ; Joseph H. Friedman [États-Unis] | Testosterone not associated with violent dreams or REM sleep behavior disorder in men with Parkinson's |
| 001441 |
Ville Pursiainen [Finlande] ; Tarja H. Haapaniemi [Finlande] ; Juha T. Korpelainen [Finlande] ; Kyösti A. Sotaniemi [Finlande] ; Vilho V. Myllyl [Finlande] | Sweating in parkinsonian patients with wearing-off |
| 001443 |
Paolo Barone [Italie] ; Janice Lamb [Royaume-Uni] ; Amanda Ellis [Royaume-Uni] ; Zoe Clarke [Royaume-Uni] | Sumanirole versus placebo or ropinirole for the adjunctive treatment of patients with advanced Parkinson's disease |
| 001446 |
Michael Schüpbach [France] ; Ebba Lohmann [France] ; Mathieu Anheim [France] ; Suzanne Lesage [France] ; Virginie Czernecki [France] ; Sadek Yaici [France] ; Yulia Worbe [France] ; Perrine Charles [France] ; Marie-Laure Welter [France] ; Pierre Pollak [France] ; Alexandra Dürr [France] ; Yves Agid [France] ; Alexis Brice [France] | Subthalamic nucleus stimulation is efficacious in patients with parkinsonism and LRRK2 mutations |
| 001451 |
Penelope J. Hallett [États-Unis] ; J. M. Brotchie [Canada] | Striatal delta opioid receptor binding in experimental models of Parkinson's disease and dyskinesia |
| 001452 |
Christopher D. Herzog [États-Unis] ; Biplob Dass [États-Unis] ; James E. Holden [États-Unis] ; James Iii Stansell [États-Unis] ; Mehdi Gasmi [États-Unis] ; Mark H. Tuszynski [États-Unis] ; Raymond T. Bartus [États-Unis] ; Jeffrey H. Kordower [États-Unis] | Striatal delivery of CERE-120, an AAV2 vector encoding human neurturin, enhances activity of the dopaminergic nigrostriatal system in aged monkeys |
| 001455 |
Ali Samii [États-Unis] ; Valerie E. Kelly [États-Unis] ; Jefferson C. Slimp [États-Unis] ; Anne Shumway-Cook [États-Unis] ; Robert Goodkin [États-Unis] | Staged unilateral versus bilateral subthalamic nucleus stimulator implantation in Parkinson disease |
| 001459 |
Marc G. Weisskopf [États-Unis] ; Francine Grodstein [États-Unis] ; Alberto Ascherio [États-Unis] | Smoking and cognitive function in Parkinson's disease |
| 001463 |
Joaquim Ferreira [Portugal] ; Joao Maia Silva [Portugal] ; Rita Freire [Portugal] ; Joao Pignatelli [Portugal] ; Leonor Correia Guedes [Portugal] ; Alexandra Feijo [Portugal] ; Mario Miguel Rosa [Portugal] ; Miguel Coelho [Portugal] ; Joao Costa [Portugal] ; Ana Noronha [Portugal] ; Russell Hewett [Portugal] ; A. Marques Gomes [Portugal] ; J. L. Cime De Castro [Portugal] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] | Skin cancers and precancerous lesions in Parkinson's disease patients |
| 001465 |
Kuen Lam [Hong Kong] ; Florence Kwai Yi Lam [Hong Kong] ; KWOK KWONG LAU [Hong Kong] ; YIU KAY CHAN [Hong Kong] ; Elaine Yee Ling Kan [Hong Kong] ; Jean Woo [Hong Kong] ; FAT KEE WONG [Hong Kong] ; Andrew Ko [Hong Kong] | Simple clinical tests may predict severe oropharyngeal dysphagia in Parkinson's disease |
| 001472 |
Jordan J. Elm [États-Unis] ; Cornelia Kamp [États-Unis] ; Barbara C. Tilley [États-Unis] ; Paulo Guimaraes [États-Unis] ; Debbie Fraser [États-Unis] ; Patricia Deppen [États-Unis] ; Alicia Brocht [États-Unis] ; Chris Weaver [États-Unis] ; Susan Bennett [États-Unis] | Self-reported adherence versus pill count in Parkinson's disease : The NET-PD experience |
| 001473 |
Angelika Nebe [Allemagne] ; Georg Ebersbach [Allemagne] | Selective diplopia in Parkinson's disease : A special subtype of visual hallucination? |
| 001474 |
Lianna Ishihara [Royaume-Uni] ; Rachel A. Gibson [Royaume-Uni] ; Liling Warren [États-Unis] ; Rim Amouri [Tunisie] ; Kelly Lyons [États-Unis] ; Catherine Wielinski [États-Unis] ; Christine Hunter [États-Unis] ; Jina E. Swartz [Royaume-Uni] ; Ramu Elango [Royaume-Uni] ; P. Anthony Akkari [États-Unis] ; David Leppert [Royaume-Uni] ; Linda Surh [Royaume-Uni] ; Kevin H. Reeves [États-Unis] ; Siwan Thomas [Royaume-Uni] ; Leigh Ragone [États-Unis] ; Nobutaka Hattori [Japon] ; Rajesh Pahwa [États-Unis] ; Joseph Jankovic [États-Unis] ; Martha Nance [États-Unis] ; Alan Freeman [États-Unis] ; Neziha Gouider-Khouja [Tunisie] ; Mounir Kefi [Tunisie] ; Mourad Zouari [Tunisie] ; Samia Ben Sassi [Tunisie] ; Samia Ben Yahmed [Tunisie] ; Ghada El Euch-Fayeche [Tunisie] ; Lefkos Middleton [Royaume-Uni] ; David J. Burn [Royaume-Uni] ; Ray L. Watts [États-Unis] ; Faycal Hentati [Tunisie] | Screening for Lrrk2 G2019S and clinical comparison of tunisian and North American caucasian Parkinson's disease families |
| 001475 |
Christopher G. Goetz [États-Unis] ; Philippe Damier [France] ; Christine Hicking [Allemagne] ; Eugene Laska [États-Unis] ; Thomas Müller [Allemagne] ; C. Warren Olanow [États-Unis] ; Olivier Rascol [France] ; Hermann Russ [Allemagne] | Sarizotan as a treatment for dyskinesias in Parkinson's disease : A double-blind placebo-controlled trial |
| 001479 |
Christoph Scherfler [Autriche] ; Johannes Schwarz [Allemagne] ; Angelo Antonini [Italie] ; Donald Grosset [Royaume-Uni] ; Francesc Valldeoriola [Espagne] ; Kenneth Marek [États-Unis] ; Wolfgang Oertel [Allemagne] ; Eduardo Tolosa [Espagne] ; Andrew Lees (neurologue) [Royaume-Uni] ; Werner Poewe [Autriche] | Role of DAT-SPECT in the diagnostic work up of parkinsonism |
| 001490 |
Thomas Eckert [États-Unis, Allemagne] ; Andrew Feigin [États-Unis] ; Daniel E. Lewis [États-Unis] ; Vijay Dhawan [États-Unis] ; Steven Frucht [États-Unis] ; David Eidelberg [États-Unis] | Regional metabolic changes in Parkinsonian patients with normal dopaminergic imaging |
| 001492 |
Anette Schrag [Royaume-Uni] ; Richard Dodel [Allemagne] ; Annika Spottke [Allemagne] ; Bemhard Bornschein [Autriche] ; Uwe Siebert [Autriche, États-Unis] ; Niall P. Quinn [Royaume-Uni] | Rate of clinical progression in parkinson's disease. A prospective study |
| 001493 |
Vincent Paille [France] ; Vincent Henry [France] ; Laurent Lescaudron [France] ; Philippe Brachet [France] ; Philippe Damier [France] | Rat model of Parkinson's disease with bilateral motor abnormalities, reversible with levodopa, and dyskinesias |
| 001494 |
Ana Djarmati [Allemagne] ; Miodrag Guzvic [Allemagne, Serbie] ; Anne Grünewald [Allemagne] ; Anthony E. Lang [Canada] ; Peter P. Pramstaller [Italie] ; David K. Simon [États-Unis] ; Angela M. Kaindl [Allemagne] ; Peter Vieregge [Allemagne] ; Anders O. H. Nygren [Pays-Bas] ; Christian Beetz [Allemagne] ; Katja Hedrich [Allemagne] ; Christine Klein [Allemagne] | Rapid and reliable detection of exon rearrangements in various movement disorders genes by multiplex ligation-dependent probe amplification |
| 001495 |
Robert A. Hauser [États-Unis] ; Laurence Salin [France] ; Nolwenn Juhel [France] ; Victor L. Konyago [États-Unis] | Randomized trial of the triple monoamine reuptake inhibitor NS 2330 (Tesofensine) in early parkinson's disease |
| 001497 |
Doris Broetz [Allemagne] ; Martin Eichner [Allemagne] ; Thomas Gasser [Allemagne] ; Michael Weller [Allemagne] ; Joachim P. Steinbach [Allemagne] | Radicular and nonradicular back pain in Parkinson's disease : A controlled study |
| 001502 |
Brenda L. Den Oudsten [Pays-Bas] ; Guus L. Van Heck [Pays-Bas] ; Jolanda De Vries [Pays-Bas] | Quality of life and related concepts in parkinson's disease : A systematic review |
| 001506 |
Janis M. Miyasaki [Canada] ; Khalid Al Hassan [Canada] ; Anthony E. Lang [Canada] ; Valerie Voon [Canada] | Punding prevalence in Parkinson's disease |
| 001510 |
Anne M. Landau [Canada] ; Edouard Kouassi [Canada] ; Rosmarie Siegrist-Johnstone [Canada] ; Julie Desbarats [Canada] | Proteasome inhibitor model of Parkinson's disease in mice is confounded by neurotoxicity of the ethanol vehicle |
| 001518 |
Anna Modoni [Italie] ; Maria Fiorella Contarino [Italie] ; Anna Rita Bentivoglio [Italie] ; Elisabetta Tabolacci [Italie] ; Massimo Santoro [Italie] ; Maria Lucia Calcagni [Italie] ; Pietro A. Tonali [Italie] ; Giovanni Neri [Italie] ; Gabriella Silvestri [Italie] | Prevalence of spinocerebellar ataxia type 2 mutation among italian parkinsonian patients |
| 001519 |
Pablo Martinez-Martin [Espagne] ; Anthony H. V. Schapira [Royaume-Uni] ; Fabrizio Stocchi [Italie] ; Kapil Sethi [États-Unis] ; Per Odin [Allemagne] ; Graeme Macphee [Royaume-Uni] ; Richard G. Brown [Royaume-Uni] ; Yogini Naidu [Royaume-Uni] ; Lisa Clayton [Royaume-Uni] ; Kazuo Abe [Japon] ; Yoshio Tsuboi [Japon] ; Dough Macmahon [Royaume-Uni] ; Paolo Barone [Italie] ; Martin Rabey [Israël] ; Ubaldo Bonuccelli [Italie] ; Alison Forbes [Royaume-Uni] ; Kieran Breen [Royaume-Uni] ; Susanne Tluk [Royaume-Uni] ; C. Warren Olanow [États-Unis] ; Sue Thomas [Royaume-Uni] ; David Rye [États-Unis] ; Annette Hand [Royaume-Uni] ; Adrian J. Williams [Royaume-Uni] ; William Ondo [États-Unis] ; K. Ray Chaudhuri [Royaume-Uni] | Prevalence of nonmotor symptoms in parkinson's disease in an international setting; Study using nonmotor symptoms questionnaire in 545 patients |
| 001521 |
Elan D. Louis [États-Unis] ; Steven J. Frucht [États-Unis] | Prevalence of essential tremor in patients with Parkinson's disease vs. parkinson-plus syndromes |
| 001522 |
YUE HUANG [Australie] ; Glenda M. Halliday [Australie] ; Himesha Vandebona [Australie] ; George D. Mellick [Australie] ; Frank Mastaglia [Australie] ; Julia Stevens [Australie] ; John Kwok [Australie] ; Michael Garlepp [Australie] ; Peter A. Silburn [Australie] ; Malcolm K. Horne [Australie] ; Katya Kotschet [Australie] ; Alison Venn [Australie] ; Dominic B. Rowe [Australie] ; Justin P. Rubio [Australie] ; Carolyn M. Sue [Australie] | Prevalence and clinical features of common LRRK2 mutations in australians with Parkinson's disease |
| 001524 |
Birgit Herting [Allemagne] ; Bettina Beuthien-Baumann [Allemagne] ; Katrin Pottrich [Allemagne] ; Markus Donix [Allemagne] ; Antje Triemer [Allemagne] ; Johannes B. Lampe [Allemagne] ; Rüdiger Von Kummer [Allemagne] ; Karl Herholz [Royaume-Uni] ; Heinz Reichmann [Allemagne] ; Vjera A. Holthoff [Allemagne] | Prefrontal cortex dysfunction and depression in atypical parkinsonian syndromes |
| 001526 |
Michael Macht [Allemagne] ; Yvonne Kaussner [Allemagne] ; Jens Carsten Möller [Allemagne] ; Karin Stiasny-Kolster [Allemagne] ; Karla Maria Eggert [Allemagne] ; Hans-Peter Krüger [Allemagne] ; Heiner Ellgring [Allemagne] | Predictors of freezing in Parkinson's disease: A survey of 6,620 patients |
| 001528 |
Paul Mccrone [Royaume-Uni] ; Liesl M. Allcock [Royaume-Uni] ; David J. Burn [Royaume-Uni] | Predicting the cost of Parkinson's disease |
| 001529 |
WEIDONG PAN [Japon] ; Kyoko Ohashi [Japon, États-Unis] ; Yoshiharu Yamamoto [Japon] ; Shin Kwak [Japon] | Power-law temporal autocorrelation of activity reflects severity of parkinsonism |
| 001533 |
Yoshikuni Mizuno [Japon] ; Ichiro Kanazawa [Japon] ; Sadako Kuno [Japon] ; Nobuo Yanagisawa [Japon] ; Mitsutoshi Yamamoto [Japon] ; Tomoyoshi Kondo [Japon] | Placebo-controlled, double-blind dose-finding study of entacapone in fluctuating Parkinsonian patients |
| 001537 |
Leora L. Borek [États-Unis] ; Robert Kohn [États-Unis] ; Joseph H. Friedman [États-Unis] | Phenomenology of dreams in Parkinson's disease |
| 001541 |
PRAMOD KUMAR PAL [Inde] ; Talakad N. Sathyaprabha [Inde] ; Prasad Tuhina [Inde] ; Kandavel Thennarasu [Inde] | Pattern of subclinical pulmonary dysfunctions in Parkinson's disease and the effect of levodopa |
| 001545 |
David A. Gallagher [Royaume-Uni] ; Sean S. O'Sullivan [Royaume-Uni] ; Andrew H. Evans [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Anette Schrag [Royaume-Uni] | Pathological gambling in parkinson's disease : Risk factors and differences from dopamine dysregulation. An analysis of published case series |
| 001546 |
Lars Wojtecki [Allemagne] ; Janpeter Nickel [Allemagne] ; Lars Timmermann [Allemagne] ; Mohammad Maarouf [Allemagne] ; Martin Südmeyer [Allemagne] ; Frank Schneider [Allemagne] ; Rüdiger J. Seitz [Allemagne] ; Jürgen Voges [Allemagne] ; Volker Sturm [Allemagne] ; Alfons Schnitzler [Allemagne] | Pathological crying induced by deep brain stimulation |
| 001547 |
Mathias Toft [États-Unis, Norvège] ; Ignacio F. Mata [États-Unis, Espagne] ; Owen A. Ross [États-Unis] ; Jennifer Kachergus [États-Unis] ; Mary M. Hulihan [États-Unis] ; Kristoffer Haugarvoll [États-Unis, Norvège] ; Jeremy T. Stone [États-Unis] ; Marta Blazquez [Espagne] ; J. Mark Gibson [Irlande (pays)] ; Jan O. Aasly [Norvège] ; Linda R. White [Norvège] ; Timothy Lynch [Irlande (pays)] ; Charles H. Adler [États-Unis] ; Katrina Gwinn-Hardy [États-Unis] ; Matthew J. Farrer [États-Unis] | Pathogenicity of the Lrrk2 R1514Q substitution in Parkinson's disease |
| 001558 |
Caroline Moreau [France] ; Canan Ozsancak [France] ; Jean-Louis Blatt [France] ; Philippe Derambure [France] ; Alain Destée [France] ; Luc Defebvre [France] | Oral festination in Parkinson's disease : Biomechanical analysis and correlation with festination and freezing of gait |
| 001560 |
Antje Haehner [Allemagne] ; Thomas Hummel [Allemagne] ; Cornelia Hummel [Allemagne] ; Ulrike Sommer [Allemagne] ; Susann Junghanns [Allemagne] ; Heinz Reichmann [Allemagne] | Olfactory loss may be a first sign of idiopathic Parkinson's disease |
| 001561 |
Roberta Frigerio [États-Unis] ; Monique M. B. Breteler [Pays-Bas] ; Lonneke M. L. De Lau [Pays-Bas] ; Kevin R. Sanft [États-Unis] ; James H. Bower [États-Unis] ; J. Eric Ahlskog [États-Unis] ; Brandon R. Grossardt [États-Unis] ; Mariza De Andrade [États-Unis] ; Demetrius M. Maraganore [États-Unis] ; Walter A. Rocca [États-Unis] | Number of children and risk of Parkinson's disease |
| 001563 |
Kari Swarztrauber [États-Unis] ; Eric Graf [États-Unis] | Nonphysicians' and physicians' knowledge and care preferences for Parkinson's disease |
| 001564 |
Kerrie L. Schoffer [Australie] ; Robert D. Henderson [Australie] ; Karen O'Maley [Australie] ; John D. O'Sullivan [Australie] | Nonpharmacological treatment, fludrocortisone, and domperidone for orthostatic hypotension in Parkinson's disease |
| 001568 |
Maria Teresa Giordana [Italie] ; Carla D'Agostino [Italie] ; Giovanni Albani [Italie] ; Alessandro Mauro [Italie] ; Alessio Di Fonzo [Pays-Bas, Italie] ; Angelo Antonini [Italie] ; Vincenzo Bonifati [Pays-Bas] | Neuropathology of Parkinson's disease associated with the LRRK2 Ile1371val mutation |
| 001569 |
Katie Kompoliti [États-Unis] ; YAPING CHU [États-Unis] ; Kathleen M. Shannon [États-Unis] ; Jeffrey H. Kordower [États-Unis] | Neuropathological study 16 years after autologous adrenal medullary transplantation in a Parkinson's disease patient |
| 001576 |
Jörg Spiegel [Allemagne] ; Dirk Hellwig [Allemagne] ; Georgios Farmakis [Allemagne] ; Wolfgang H. Jost [Allemagne] ; Samuel Samnick [Allemagne] ; Klaus Fassbender [Allemagne] ; Carl-Martin Kirsch [Allemagne] ; Ulrich Dillmann [Allemagne] | Myocardial sympathetic degeneration correlates with clinical phenotype of Parkinson's disease |
| 001579 |
Christopher G. Goetz [États-Unis] ; Stanley Fahn [États-Unis] ; Pablo Martinez-Martin [Espagne] ; Werner Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Glenn T. Stebbins [États-Unis] ; Matthew B. Stern [États-Unis] ; Barbara C. Tilley [États-Unis] ; Richard Dodel [Allemagne] ; Bruno Dubois [France] ; Robert Holloway [États-Unis] ; Joseph Jankovic [États-Unis] ; Jaime Kulisevsky [Espagne] ; Anthony E. Lang [Canada] ; Andrew Lees (neurologue) [Royaume-Uni] ; Sue Leurgans [États-Unis] ; Peter A. Lewitt [États-Unis] ; David Nyenhuis [États-Unis] ; C. Warren Olanow [États-Unis] ; Olivier Rascol [France] ; Anette Schrag [Royaume-Uni] ; Jeanne A. Teresi [États-Unis] ; Jacobus J. Van Hilten [Pays-Bas] ; Nancy Lapelle [États-Unis] | Movement disorder society-sponsored revision of the unified Parkinson's disease rating scale (MDS-UPDRS) : Process, format, and clinimetric testing plan |
| 001581 |
Michael W. M. Schupbach [France] ; Marie Laure Welter [France] ; Anne Marie Bonnet [France] ; Alexis Elbaz [France] ; Brandon R. Grossardt [États-Unis] ; Valerie Mesnage [France] ; Jean Luc Houeto [France] ; David Maltete [France] ; Luc Mallet [France] ; Walter A. Rocca [États-Unis] ; Alain Mallet [France] ; Yves Agid [France] | Mortality in patients with Parkinson's disease treated by stimulation of the subthalamic nucleus |
| 001583 |
Alexandre Berney [Canada, Suisse] ; Michel Panisset [Canada] ; Abbas F. Sadikot [Canada] ; Alain Ptito [Canada] ; Alain Dagher [Canada] ; Maria Fraraccio [Canada] ; Ghislaine Savard [Canada] ; Marc Pell [Canada] ; Chawki Benkelfat [Canada] | Mood Stability during Acute Stimulator Challenge in Parkinson's Disease Patients Under Long-Term Treatment with Subthalamic Deep Brain Stimulation |
| 001586 |
Elan D. Louis [États-Unis] ; David A. Bennett [États-Unis] | Mild parkinsonian signs : An overview of an emerging concept |
| 001588 |
Heike Stockner [Autriche] ; Martin Sojer [Autriche] ; Klaus Seppi K [Autriche] ; Joerg Mueller [Autriche] ; Gregor K. Wenning [Autriche] ; Christoph Schmidauer [Autriche] ; Werner Poewe [Autriche] | Midbrain sonography in patients with essential tremor |
| 001600 |
Radu Constantinescu [États-Unis] ; Megan Romer [États-Unis] ; Karl Kieburtz [États-Unis] | Malignant melanoma in early Parkinson's disease : The DATATOP trial |
| 001601 |
Richard M. Camicioli [Canada] ; Christopher C. Hanstock [Canada] ; Thomas P. Bouchard [Canada] ; Myrlene Gee [Canada] ; Nancy J. Fisher [Canada] ; W. R. Wayne Martin [Canada] | Magnetic resonance spectroscopic evidence for presupplementary motor area neuronal dysfunction in Parkinson's disease |
| 001602 |
Roberta Zangaglia [Italie] ; Emilia Martignoni [Italie] ; Margaret Glorioso [Italie] ; Maria Ossola [Italie] ; Giulio Riboldazzi [Italie] ; Daniela Calandrella [Italie] ; Gabriele Brunetti [Italie] ; Claudio Pacchetti [Italie] | Macrogol for the treatment of constipation in Parkinson's disease. A randomized placebo-controlled study |
| 001603 |
Chiara Balducci [Italie] ; Laura Pierguidi [Italie] ; Emanuele Persichetti [Italie] ; Lucilla Parnetti [Italie] ; Michele Sbaragli [Italie] ; Carmelo Tassi [Italie] ; Aldo Orlacchio [Italie] ; Paolo Calabresi [Italie] ; Tommaso Beccari [Italie] ; Aroldo Rossi [Italie] | Lysosomal hydrolases in cerebrospinal fluid from subjects with Parkinson's disease |
| 001604 |
Kristian Winge [Danemark] ; Kurt Kr Yer Nielsen [Danemark] ; Hans Stimpel [Danemark] ; Annemette Lokkegaard [Danemark] ; Steen Rusborg Jensen [Danemark] ; Lene Werdelin [Danemark] | Lower urinary tract symptoms and bladder control in advanced Parkinson's disease : Effects of deep brain stimulation in the subthalamic nucleus |
| 001606 |
XUEMEI HUANG [États-Unis] ; HONGLEI CHEN [États-Unis] ; William C. Miller [États-Unis] ; Richard B. Mailman [États-Unis] ; Jennifer L. Woodard [États-Unis] ; Peter C. Chen [États-Unis] ; DONG XIANG [États-Unis] ; Richard W. Murrow [États-Unis] ; Yi-Zhe Wang [États-Unis] ; Charles Poole [États-Unis] | Lower low-density lipoprotein cholesterol levels are associated with Parkinson's disease |
| 001607 |
Tua Annanmaki [Finlande] ; Antti Muuronen [Finlande] ; Kari Murros [Finlande] | Low plasma uric acid level in parkinson's disease |
| 001610 |
Selma Aybek [Suisse] ; Aline Gronchi-Perrin [Suisse] ; Alexandre Berney [Suisse] ; Sabina Catalano Chiuve [Suisse] ; Jean-Guy Villemure [Suisse] ; Pierre R. Burkhard [Suisse] ; Francois J. G. Vingerhoets [Suisse] | Long-term cognitive profile and incidence of dementia after STN-DBS in Parkinson's disease |
| 001614 |
Anthony P. Nicholas [États-Unis] | Levodopa-induced hyperactivity in mice treated with 1 -methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
| 001616 |
Panida Piboolnurak [Canada, Thaïlande] ; Anthony E. Lang [Canada] ; Andres M. Lozano [Canada] ; Janis M. Miyasaki [Canada] ; Jean A. Saint-Cyr [Canada] ; Yu-Yan W. Poon [Canada] ; William D. Hutchison [Canada] ; Jonathan O. Dostrovsky [Canada] ; Elena Moro [Canada] | Levodopa response in long-term bilateral Subthalamic stimulation for Parkinson's disease |
| 001617 |
Robert A. Wilcox [Australie] ; Andrew Churchyard [Australie] ; Henrik H. Dahl [Australie] ; Wendy M. Hutchison [Australie] ; Denise M. Kirby [Australie] ; Dominic Thyagarajan [Australie] | Levodopa response in Parkinsonism with multiple mitochondrial DNA deletions |
| 001620 |
Dariusz Koziorowski [Pologne] ; Andrzej Friedman [Pologne] | Levodopa "drug holiday" with amantadine infusions as a treatment of complications in Parkinson's disease |
| 001621 |
Lindsy N. Williams [États-Unis] ; Paul Seignourel [États-Unis] ; Gregory P. Crucian [États-Unis] ; Michael S. Okun [États-Unis] ; Ramon L. Rodriguez [États-Unis] ; Frank M. Skidmore [États-Unis] ; Paul S. Foster [États-Unis] ; Charles E. Iv Jacobson [États-Unis] ; Janet Romrell [États-Unis] ; Dawn Bowers [États-Unis] ; Hubert H. Fernandez [États-Unis] | Laterality, region, and type of motor dysfunction correlate with cognitive impairment in Parkinson's disease |
| 001627 |
Ronald B. Postuma [Canada] ; Christina Wolfson [Canada] ; Ali Rajput [Canada] ; A. Jon Stoessl [Canada] ; W. R. Wayne Martin [Canada] ; Oksana Suchowersky [Canada] ; Sylvain Chouinard [Canada] ; Michel Panisset [Canada] ; Mandar S. Jog [Royaume-Uni] ; David A. Grimes [Canada] ; Connie Marras [Canada] ; Anthony E. Lang [Canada] | Is there seasonal variation in risk of Parkinson's disease? |
| 001631 |
Jie-Yuan Li [Canada, Taïwan] ; Alberto J. Espay [Canada] ; Carolyn A. Gunraj [Canada] ; Pramod K. Pal [Canada] ; Danny I. Cunic [Canada] ; Anthony E. Lang [Canada] ; Robert Chen [Canada] | Interhemispheric and ipsilateral connections in Parkinson's disease : Relation to mirror movements |
| 001633 |
Caroline Gurvich [Australie] ; Nellie Georgiou Karistianis [Australie] ; Paul B. Fitzgerald [Australie] ; Lyn Millist [Australie] ; Owen B. White [Australie] | Inhibitory control and spatial working memory in Parkinson's disease |
| 001635 |
Francisco Javier Carod-Artal [Brésil] ; Pablo Martinez-Martin [Espagne] ; Antonio Pedro Vargas [Brésil] | Independent validation of SCOPA-psychosocial and metric properties of the PDQ-39 Brazilian version |
| 001636 |
Walter A. Rocca [États-Unis] ; James H. Bower [États-Unis] ; J. Eric Ahlskog [États-Unis] ; Alexis Elbaz [États-Unis, France] ; Brandon R. Grossardt [États-Unis] ; Shannon K. Mcdonnell [États-Unis] ; Daniel J. Schaid [États-Unis] ; Demetrius M. Maraganore [États-Unis] | Increased risk of essential tremor in first-degree relatives of patients with Parkinson's disease |
| 001640 |
Hisayoshi Oka [Japon] ; Masayuki Yoshioka [Japon] ; Kenji Onouchi [Japon] ; Masayo Morita [Japon] ; Soichiro Mochio [Japon] ; Masahiko Suzuki [Japon] ; Toshiaki Hirai [Japon] ; Mitsuyoshi Urashima [Japon] ; Kiyoharu Inoue [Japon] | Impaired cardiovascular autonomic function in Parkinson's disease with visual hallucinations |
| 001642 |
Donna White [États-Unis] ; Suzanne Moore [États-Unis] ; Stephen Waring [États-Unis] ; Karon Cook [États-Unis] ; Eugene Lai [États-Unis] | Identifying incident cases of parkinsonism among veterans using a tertiary medical center |
| 001648 |
Ming Chi Shih [Brésil] ; Luiz Augusto Franco De Andrade [Brésil] ; Edson Jr Amaro [Brésil] ; Andre Carvalho Felicio [Brésil] ; Henrique Ballalai Ferraz [Brésil] ; Jairo Wagner [Brésil] ; Marcelo Queiroz Hoexter [Brésil] ; LI FU LIN [Taïwan] ; YING KAI FU [Taïwan] ; Jair Jesus Mari [Brésil] ; Sergio Tufik [Brésil] ; Rodrigo Affonseca Bressan [Brésil] | Higher nigrostriatal dopamine neuron loss in early than late onset Parkinson's disease?-A [99mTc]-TRODAT-1 SPECT study |
| 001649 |
Joaquim J. Ferreira [Portugal] ; Leonor Correia Guedes [Portugal] ; Mario Miguel Rosa [Portugal] ; Miguel Coelho [Portugal] ; Marina Van Doeselaar [Pays-Bas] ; Dorothea Schweiger [Pays-Bas] ; Alessio Di Fonzo [Pays-Bas] ; Ben A. Oostra [Pays-Bas] ; Cristina Sampaio [Portugal] ; Vincenzo Bonifati [Pays-Bas] | High prevalence of LRRK2 mutations in familial and sporadic parkinson's disease in portugal |
| 001660 |
Andrew Feigin [États-Unis] ; David Eidelberg [États-Unis] | Gene transfer therapy for neurodegenerative disorders |
| 001662 |
Ettore Accolla [Italie] ; Elena Caputo [Italie] ; Filippo Cogiamanian [Italie] ; Filippo Tamma [Italie] ; Simona Mrakic-Sposta [Italie] ; Sara Marceglia [Italie] ; Marcello Egidi [Italie] ; Paolo Rampini [Italie] ; Marco Locatelli [Italie] ; Alberto Priori [Italie] | Gender differences in patients with Parkinson's disease treated with subthalamic deep brain stimulation |
| 001673 |
Joseph H. Friedman [États-Unis] ; Richard G. Brown [Royaume-Uni] ; Cynthia Comella [États-Unis] ; Carol E. Garber [États-Unis] ; Lauren B. Krupp [États-Unis] ; Jau-Shin Lou [États-Unis] ; Laura Marsh [États-Unis] ; Lillian Nail [États-Unis] ; Lisa Shulman [États-Unis] ; C. Barr Taylor [États-Unis] | Fatigue in parkinson's disease : A review |
| 001676 |
Roberto Cilia [Italie] ; Andrea Landi [Italie] ; Francesco Vergani [Italie] ; Erik Sganzerla [Italie] ; Gianni Pezzoli [Italie] ; Angelo Antonini [Italie] | Extradural motor cortex stimulation in Parkinson's disease |
| 001677 |
Siegfried Muhlack [Allemagne] ; Jacub Welnic [Allemagne] ; Dirk Woitalla [Allemagne] ; Thomas Müller [Allemagne] | Exercise improves efficacy of levodopa in patients with Parkinson's disease |
| 001679 |
Samyra H. J. Keus [Pays-Bas] ; Bastiaan R. Bloem [Pays-Bas] ; Erik J. M. Hendriks [Pays-Bas] ; Alexandra B. Bredero-Cohen [Pays-Bas] ; Marten Munneke [Pays-Bas] | Evidence-based analysis of physical therapy in Parkinson's disease with recommendations for practice and research |
| 001685 |
| Entacapone to tolcapone switch : Multicenter double-blind, randomized, active-controlled trial in advanced Parkinson's disease |
| 001686 |
MINNA HONG [États-Unis] ; Joel S. Perlmutter [États-Unis] ; Gammon M. Earhart [États-Unis] | Enhancement of rigidity in Parkinson's disease with activation |
| 001689 |
Günther Deuschl [Allemagne] ; Antanas Vaitkus [Lituanie] ; Gabriele-Cornelia Fox [Allemagne] ; Torsten Roscher [Allemagne] ; Dieter Schremmer [Allemagne] ; Ariel Gordin [Allemagne] | Efficacy and tolerability of entacapone versus cabergoline in parkinsonian patients suffering from wearing-off |
| 001691 |
Ken Nakamura [États-Unis] ; Chadwick W. Christine [États-Unis] ; Philip A. Starr [États-Unis] ; William J. Jr Marks [États-Unis] | Effects of unilateral subthalamic and pallidal deep brain stimulation on fine motor functions in Parkinson's disease |
| 001692 |
Neeraja Sadagopan [États-Unis] ; Jessica E. Huber [États-Unis] | Effects of loudness cues on respiration in individuals with Parkinson's disease |
| 001693 |
Tatiana Witjas [France] ; Elsa Kaphan [France] ; Jean Regis [France] ; Elisabeth Jouve [France] ; André Ali Cherif [France] ; Jean-Claude Peragut [France] ; Jean Philippe Azulay [France] | Effects of chronic subthalamic stimulation on nonmotor fluctuations in parkinson's disease |
| 001694 |
Mayumi Kitagawa [Japon] ; Hideki Houzen [Japon] ; Kunio Tashiro [Japon] | Effects of caffeine on the freezing of gait in Parkinson's disease |
| 001695 |
Jose M. Rabey [Israël] ; Tatiana Prokhorov ; Ala Miniovitz ; Eugenia Dobronevsky ; Colin Klein | Effect of quetiapine in psychotic parkinson's disease patients : A double-blind labeled study of 3 months' duration |
| 001696 |
Pablo Martinez-Martin [Espagne] ; Günther Deuschl [Allemagne] | Effect of medical and surgical interventions on health-related quality of life in Parkinson's disease |
| 001697 |
Daniel Weintraub [États-Unis] ; Kirsten Saboe [États-Unis] ; Matthew B. Stern [États-Unis] | Effect of age on geriatric depression scale performance in parkinson's disease |
| 001699 |
Kristoffer Haugarvoll [États-Unis, Norvège] ; Mathias Toft [États-Unis, Norvège] ; Owen A. Ross [États-Unis] ; Jeremy T. Stone [États-Unis] ; Michael G. Heckman [États-Unis] ; Linda R. White [Norvège] ; Timothy Lynch [Irlande (pays)] ; John Mark Gibson [Irlande (pays)] ; Zbigniew K. Wszolek [États-Unis] ; Ryan J. Uitti [États-Unis] ; Jan O. Aasly [Norvège] ; Matthew J. Farrer [États-Unis] | ELAVL4, PARK10, and the celts |
| 001702 |
Angelo Antonini [Italie] ; Ioannis U. Isaias [Italie] ; Margherita Canesi [Italie] ; Maurizio Zibetti [Italie] ; Francesca Mancini [Italie] ; Luigi Manfredi [Italie] ; Marco Dal Fante [Italie] ; Leonardo Lopiano [Italie] ; Gianni Pezzoli [Italie] | Duodenal levodopa infusion for advanced Parkinson's disease : 12-month treatment outcome |
| 001704 |
Quincy J. Almeida [Canada] ; James S. Frank [Canada] ; Eric A. Roy [Canada] ; Aftab E. Patla [Canada] ; Mandar S. Jog [Canada] | Dopaminergic modulation of timing control and variability in the gait of parkinson's disease |
| 001705 |
Eman M. Khedr [Égypte] ; John C. Rothwell [Royaume-Uni] ; Ola A. Shawky [Égypte] ; Mohammed A. Ahmed [Égypte] ; Nageh Foly [Égypte] ; Ahmed Hamdy [Égypte] | Dopamine levels after repetitive transcranial magnetic stimulation of motor cortex in patients with Parkinson's disease: Preliminary results |
| 001706 |
Astrid Thomas [Italie] ; Laura Bonanni [Italie] ; Angelo Antonini [Italie] ; Paolo Barone [Italie] ; Marco Onofrj [Italie] | Dopa-responsive pseudo-orthostatic tremor in parkinsonism |
| 001707 |
Fabienne Ory-Magne [France] ; Christine Brefel-Courbon [France] ; Marion Simonetta-Moreau [France] ; Nelly Fabre [France] ; Jean Albert Lotterie [France] ; Patrick Chaynes [France] ; Isabelle Berry [France] ; Yves Lazorthes [France] ; Olivier Rascol [France] | Does ageing influence deep brain stimulation outcomes in Parkinson's disease? |
| 001709 |
Dominic C. Paviour [Royaume-Uni] ; John S. Thornton [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; H. Rolf J Ger [Royaume-Uni] | Diffusion-weighted magnetic resonance imaging differentiates parkinsonian variant of multiple-system atrophy from progressive supranuclear palsy |
| 001711 |
Martin Köllensperger [Autriche] ; Klaus Seppi [Autriche] ; Claudia Liener [Autriche] ; Sylvia Boesch [Autriche] ; Dirk Heute [Autriche] ; Katherina J. Mair [Autriche] ; Joerg Mueller [Autriche] ; Martin Sawires [Autriche] ; Christoph Scherfler [Autriche] ; Michael F. Schocke [Autriche] ; Eveline Donnemiller [Autriche] ; Irene Virgolini [Autriche] ; Gregor K. Wenning [Autriche] ; Werner Poewe [Autriche] | Diffusion weighted imaging best discriminates PD from MSA-P : A comparison with tilt table testing and heart MIBG scintigraphy |
| 001713 |
Daniel G. Healy [Royaume-Uni] | Did géricault's "madwoman obsessed with gambling" have parkinson's disease? |
| 001715 |
Bernard Ravina [États-Unis] ; Karen Marder [États-Unis] ; Hubert H. Fernandez [États-Unis] ; Joseph H. Friedman [États-Unis] ; William Mcdonald [États-Unis] ; Diane Murphy [États-Unis] ; Dag Aarsland [États-Unis] ; Debra Babcock [États-Unis] ; Jefferey Cummings [États-Unis] ; Jean Endicott [États-Unis] ; Stewart Factor [États-Unis] ; Wendy Galpern [États-Unis] ; Andrew Lees (neurologue) [Royaume-Uni] ; Laura Marsh [États-Unis] ; Mark Stacy [États-Unis] ; Katrina Gwinn-Hardy [États-Unis] ; Valerie Voon [États-Unis] ; Christopher Goetz [États-Unis] | Diagnostic criteria for psychosis in Parkinson's disease : Report of an NINDS, NIMH work group |
| 001716 |
Francisco Javier Carod-Artal [Brésil] ; Antonio Pedro Vargas [Brésil] ; Pablo Martinez-Martin [Espagne] | Determinants of quality of life in Brazilian patients with Parkinson's disease |
| 001717 |
Kimberly M. Miller [États-Unis] ; Michael S. Okun [États-Unis] ; Hubert F. Fernandez [États-Unis] ; Charles E. Iv Jacobson [États-Unis] ; Ramon L. Rodriguez [États-Unis] ; Dawn Bowers [États-Unis] | Depression symptoms in movement disorders : Comparing Parkinson's disease, dystonia, and essential tremor |
| 001718 |
Anette Schrag [Royaume-Uni] ; Paolo Barone [Italie] ; Richard G. Brown [Royaume-Uni] ; Albert F. G. Leentjens [Pays-Bas] ; William M. Mcdonald [États-Unis] ; Sergio Starkstein [Australie] ; Daniel Weintraub [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis] | Depression rating scales in Parkinson's disease : Critique and recommendations |
| 001721 |
John N. Caviness [États-Unis] ; Erika Driver-Dunckley [États-Unis] ; Donald J. Connor [États-Unis] ; Marwan N. Sabbagh [États-Unis] ; Joseph G. Hentz [États-Unis] ; Brie Noble [États-Unis] ; Virgilio Gerald H. Evidente [États-Unis] ; Holly A. Shill [États-Unis] ; Charles H. Adler [États-Unis] | Defining mild cognitive impairment in Parkinson's disease |
| 001723 |
Molly M. Sturman [États-Unis] ; David E. Vaillancourt [États-Unis] ; Leo Verhagen Metman [États-Unis] ; Diane K. Sierens [États-Unis] ; Roy A. E. Bakay [États-Unis] ; Daniel M. Corcos [États-Unis] | Deep brain stimulation and medication for parkinsonian tremor during secondary tasks |
| 001726 |
Karla Eggert [Allemagne] ; Ullrich Wüllner [Allemagne] ; Gisela Antony [Allemagne] ; Thomas Gasser [Allemagne] ; Bernd Janetzky [Allemagne] ; Christine Klein [Allemagne] ; Ludger Schöls [Allemagne] ; Wolfgang Oertel [Allemagne] | Data protection in biomaterial banks for parkinson's disease research : The model of GEPARD (Gene bank parkinson's disease Germany) |
| 001729 |
Javier Pagonabarraga [Espagne] ; Carmen Garcia-Sanchez [Espagne] ; Gisela Llebaria [Espagne] ; Berta Pascual-Sedano [Espagne] ; Alexandre Gironell [Espagne] ; Jaime Kulisevsky [Espagne] | Controlled study of decision-making and cognitive impairment in Parkinson's disease |
| 001730 |
Emmanuel Broussolle [France] ; Paul Krack [France] ; Stéphane Thobois [France] ; Jing Xie-Brustolin [France] ; Pierre Pollak [France] ; Christopher G. Goetz [États-Unis] | Contribution of jules Froment to the study of parkinsonian Rigidity |
| 001731 |
Paul Sauleau [France] ; Pierre Pollak [France] ; Paul Krack [France] ; Denis Pelisson [France] ; Alain Vighetto [France] ; Alim-Louis Benabid [France] ; Caroline Tilikete [France] | Contraversive eye deviation during stimulation of the subthalamic region |
| 001734 |
Lorraine N. Clark [États-Unis] ; Eneli Haamer [Estonie] ; Helen Mejia-Santana [États-Unis] ; Juliette Harris [États-Unis] ; Suzanne Lesage [France] ; Alexandra Durr [France] ; Sabine Janin Bs [France] ; Katja Hedrich [Allemagne] ; Elan D. Louis [États-Unis] ; Lucien J. Cote [États-Unis] ; Howard Andrews [États-Unis] ; Stanley Fahn [États-Unis] ; Cheryl Waters [États-Unis] ; Blair Ford [États-Unis] ; Steven Frucht [États-Unis] ; William Scott [États-Unis] ; Christine Klein [Allemagne] ; Alexis Brice [France] ; Hanno Roomere [Estonie] ; Ruth Ottman [États-Unis] ; Karen Marder [États-Unis] | Construction and validation of a Parkinson's disease mutation genotyping array for the Parkin gene |
| 001739 |
Roseanne Defronzo Dobkin [États-Unis] ; Lesley A. Alien [États-Unis] ; Matthew Menza [États-Unis] | Cognitive-behavioral therapy for depression in Parkinson's disease: A pilot study |
| 001743 |
Murat Emre [Turquie] ; Dag Aarsland [Norvège] ; Richard Brown [Royaume-Uni] ; David J. Burn [Royaume-Uni] ; Charles Duyckaerts [France] ; Yoshikino Mizuno [Japon] ; Gerald Anthony Broe [Australie] ; Jeffrey Cummings [États-Unis] ; Dennis W. Dickson [États-Unis] ; Serge Gauthier [Canada] ; Jennifer Goldman [États-Unis] ; Christopher Goetz [États-Unis] ; Amos Korczyn [Israël] ; Andrew Lees (neurologue) [Royaume-Uni] ; Richard Levy [France] ; Irene Litvan [États-Unis] ; Ian Mckeith [Royaume-Uni] ; Warren Olanow [États-Unis] ; Werner Poewe [Autriche] ; Niall Quinn [Royaume-Uni] ; Christina Sampaio [Portugal] ; Eduardo Tolosa [Espagne] ; Bruno Dubois [France] | Clinical diagnostic criteria for dementia associated with parkinson's disease |
| 001752 |
Keisuke Suzuki [Japon] ; Yasuyuki Okuma [Japon] ; Nobutaka Hattori [Japon] ; Satoshi Kamei [Japon] ; Fumihito Yoshii [Japon] ; Hiroya Utsumi [Japon] ; Yasuo Iwasaki [Japon] ; Mutsumi Iijima [Japon] ; Tomoyuki Miyamoto [Japon] ; Masayuki Miyamoto [Japon] ; Koichi Hirata [Japon] | Characteristics of sleep disturbances in japanese patients with parkinson's disease. A study using Parkinson's disease sleep scale |
| 001754 |
Kathy Dujardin [France] ; Pascal Sockeel [France] ; David Devos [France] ; Marie Delliaux [France] ; Pierre Krystkowiak [France] ; Alain Destée [France] ; Luc Defebvre [France] | Characteristics of apathy in Parkinson's disease |
| 001760 |
Pablo Martinez-Martin [Espagne] ; Maria Joao Forjaz [Espagne] ; Belén Frades-Payo [Espagne] ; Angels Bayés Rusinol [Espagne] ; José Manuel Fernandez-Garcia [Espagne] ; Julian Benito-Leon [Espagne] ; Victor Campos Arillo [Espagne] ; Miquel Aguilar Barbera [Espagne] ; Margarita Pondal Sordo [Espagne] ; Maria José Catalan [Espagne] | Caregiver burden in Parkinson's disease |
| 001764 |
Sebastian Paus [Allemagne] ; Tanja Schmitz-Hübsch [Allemagne] ; Ullrich Wüllner [Allemagne] ; Antje Vogel [Allemagne] ; Thomas Klockgether [Allemagne] ; Michael Abele [Allemagne] | Bright light therapy in Parkinson's disease : A pilot study |
| 001766 |
Robert D. Abbott [États-Unis, Japon] ; G. Webster Ross [États-Unis] ; Helen Petrovitch [États-Unis] ; Caroline M. Tanner [États-Unis] ; Daron G. Davis [États-Unis] ; Kamal H. Masaki [États-Unis] ; Lenore J. Launer [États-Unis] ; J. David Curb [États-Unis] ; Lon R. White [États-Unis] | Bowel movement frequency in late-life and incidental lewy bodies |
| 001782 |
XUEMEI HUANG [États-Unis] ; Yueh Z. Lee [États-Unis] ; Martin Mckeown [Canada] ; Guido Gerig [États-Unis] ; HONGBIN GU [États-Unis] ; WEILI LIN [États-Unis] ; Mechelle M. Lewis [États-Unis] ; Sutapa Ford [États-Unis] ; Alexander I. Troster [États-Unis] ; Daniel R. Weinberger [États-Unis] ; Martin Styner [États-Unis] | Asymmetrical ventricular enlargement in Parkinson's disease |
| 001784 |
Allan D. Wu [États-Unis] ; Giselle M. Petzinger [États-Unis] ; Chien-Ho J. Lin [États-Unis] ; Myron Kung [États-Unis] ; Beth Fisher [États-Unis] | Asymmetric corticomotor excitability correlations in early Parkinson's disease |
| 001785 |
Eric M. Cheng [États-Unis] ; Kari Swarztrauber [États-Unis] ; Andrew D. Siderowf [États-Unis] ; Mahmood S. Eisa [États-Unis] ; Martin Lee [États-Unis] ; Stefanie Vassar [États-Unis] ; Erin Jacob [États-Unis] ; Barbara G. Vickrey [États-Unis] | Association of specialist involvement and quality of care for Parkinson's disease |
| 001787 |
Shalom Michaeli [États-Unis] ; Gulin Öz [États-Unis] ; Dennis J. Sorce [États-Unis] ; Michael Garwood [États-Unis] ; Kamil Ugurbil [États-Unis] ; Stacv Majestic [États-Unis] ; Paul Tuite [États-Unis] | Assessment of brain iron and neuronal integrity in patients with Parkinson's disease using novel MRI contrasts |
| 001792 |
Marisol Lopez [Mexique] ; Jorge Guerrero [Mexique] ; Petra Yescas [Mexique] ; Marie-Catherine Boll [Mexique] ; Itziar Familiar [Mexique] ; Adriana Ochoa [Mexique] ; Astrid Rasmussen [Mexique] ; Maria Elisa Alonso [Mexique] | Apolipoprotein E ε4 allele is associated with parkinson disease risk in a mexican mestizo population |
| 001793 |
Connie Marras [Canada] ; Alexander Kopp [Canada] ; FENG QIU [Canada] ; Anthony E. Lang [Canada] ; Kathy Sykora [Canada] ; Kenneth I. Shulman [Canada] ; Paula A. Rochon [Canada] | Antipsychotic use in older adults with parkinson's disease |
| 001794 |
Regina Katzenschlager [Royaume-Uni, Autriche] ; Michael J. Jackson [Royaume-Uni] ; Sarah Rose [Royaume-Uni] ; Kim Stockwell [Royaume-Uni] ; Kayhan A. Tayarani-Binazir [Royaume-Uni] ; Mohammed Zubair [Royaume-Uni] ; Lance A. Smith [Royaume-Uni] ; Peter Jenner [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Antiparkinsonian activity of L-propyl-L-leucyl-glycinamide or melanocyte-inhibiting factor in MPTP-treated common marmosets |
| 001799 |
JI YOUN KIM [Corée du Sud] ; WON YONG LEE [Corée du Sud] ; EUN JOO CHUNG [Corée du Sud] ; Hun-Jong Dhong [Corée du Sud] | Analysis of olfactory function and the depth of olfactory sulcus in patients with Parkinson's disease |
| 001800 |
Eng-King Tan [Singapour] ; YI ZHAO [Singapour] ; Louis Tan [Singapour] ; Hui-Qin Lim [Singapour] ; Jasinda Lee [Singapour] ; Yih Yuen [Singapour] ; Ratnagopal Pavanni [Singapour] ; Meng-Cheong Wong [Singapour] ; Stephanie Fook-Chong [Singapour] ; Jian-Jun Liu [Singapour] | Analysis of LRRK2 Gly2385Arg genetic variant in Non-Chinese asians |
| 001806 |
Jaime Kulisevsky [Espagne] ; Berta Pascual-Sedano [Espagne] ; Manel Barbanoj [Espagne] ; Alexandre Gironell [Espagne] ; Javier Pagonabarraga [Espagne] ; Carmen Garcia-Sanchez [Espagne] | Acute effects of immediate and controlled-release levodopa on mood in Parkinson's disease : A double-blind study |
| 001807 |
Marie-Laure Mille [États-Unis] ; Marjorie Johnson Hilliard [États-Unis] ; Katherine M. Martinez [États-Unis] ; Tanya Simuni [États-Unis] ; Mark W. Rogers [États-Unis] | Acute effects of a lateral postural assist on voluntary step initiation in patients with Parkinson's disease |
| 001810 |
Katia Noyes [États-Unis] ; HANGSHENG LIU [États-Unis] ; Robert Holloway [États-Unis] ; Andrew W. Dick [États-Unis] | Accuracy of medicare claims data in identifying parkinsonism cases : Comparison with the medicare current beneficiary survey |
| 001823 |
Dietrich Haubenberger [Autriche] ; Silvia Bonelli [Autriche] ; Christoph Hotzy [Autriche] ; Petra Leitner [Allemagne] ; Peter Lichtner [Allemagne] ; Doris Samal [Autriche] ; Regina Katzenschlager [Autriche] ; Atbin Djamshidian [Autriche] ; Thomas Brücke [Autriche] ; Michaela Steffelbauer [Autriche] ; Christian Bancher [Autriche] ; Josef Grossmann [Allemagne] ; Gerhard Ransmayr [Autriche] ; Tim M. Strom [Allemagne] ; Thomas Meitinger [Allemagne] ; Thomas Gasser [Allemagne] ; Eduard Auff [Autriche] ; Alexander Zimprich [Autriche] | A novel LRRK2 mutation in an austrian cohort of patients with parkinson's disease |
| 001825 |
Imad Ghorayeb [France] ; Anderson Loundou [France] ; Pascal Auquier [France] ; Yves Dauvilliers [France] ; Bernard Bioulac [France] ; Francois Tison [France] | A nationwide survey of excessive daytime sleepiness in Parkinson's disease in France |
| 001829 |
Carlos Singer [États-Unis] ; Janice Lamb [Royaume-Uni] ; Amanda Ellis [Royaume-Uni] ; Gary Layton [Royaume-Uni] | A comparison of sumanirole versus placebo or ropinirole for the treatment of patients with early Parkinson's disease |
| 001838 |
| Annual Symposia on Etiology, Pathogenesis, and Treatment of Parkinson's Disease and Other Movement Disorders |
| 001841 |
Mordechai Lorberboym [Israël] ; Therese A. Treves [Israël] ; Eldad Melamed [Israël] ; Yair Lampl [Israël] ; Mark Hellmann [Israël] ; Ruth Djaldetti [Israël] | [123I]-FP/CIT SPECT imaging for distinguishing drug-induced parkinsonism from parkinson's disease |
| 001843 |
Lianna Ishihara [Royaume-Uni] ; Carol Brayne [Royaume-Uni] | What is the evidence for a premorbid parkinsonian personality : A systematic review |
| 001844 |
Till-Karsten Hauser [Allemagne] ; Andreas Luft [Allemagne] ; Martin Skalej [Allemagne] ; Thomas N Gele [Allemagne] ; Tilo T. J. Kircher [Allemagne] ; Dirk T. Leube [Allemagne] ; Jörg B. Schulz [Allemagne] | Visualization and quantification of disease progression in multiple system atrophy |
| 001845 |
Mona K. Beyer [Norvège] ; Dag Aarsland [Norvège] ; Ole Jacob Greve [Norvège] ; Jan P. Larsen [Norvège] | Visual rating of white matter hyperintensities in Parkinson's disease |
| 001846 |
Cecilia Peralta [Autriche] ; Elisabeth Wolf [Autriche] ; Hannes Alber [Autriche] ; Klaus Seppi [Autriche] ; Silvana Müller [Autriche] ; Sylvia Bosch [Autriche] ; Gregor K. Wenning [Autriche] ; Otmar Pachinger [Autriche] ; Werner Poewe [Autriche] | Valvular heart disease in Parkinson's disease vs. Controls : An echocardiographic study |
| 001847 |
Ji-Youn Kim [Corée du Sud] ; EUN JOO CHUNG [Corée du Sud] ; SEUNG WOO PARK [Corée du Sud] ; WON YONG LEE [Corée du Sud] | Valvular heart disease in Parkinson's disease treated with ergot derivative dopamine agonists |
| 001848 |
William M. Mcdonald [États-Unis] ; Paul E. Holtzheimer [États-Unis] ; Michael Haber [États-Unis] ; Jerrold L. Vitek [États-Unis] ; Kimberly Mcwhorter [États-Unis] ; Mahlon Delong [États-Unis] | Validity of the 30-item geriatric depression scale in patients with Parkinson's disease |
| 001850 |
Summer C. Wolfrath [États-Unis] ; Amy R. Borenstein [États-Unis] ; Skai Schwartz [États-Unis] ; Robert A. Hauser [États-Unis] ; Kelly L. Sullivan [États-Unis] ; Theresa A. Zesiewicz [États-Unis] | Use of nutritional supplements in Parkinson's disease patients |
| 001851 |
Louis C. S. Tan [Singapour] ; Puay-Ngoh Lau [Singapour] ; Roland Dominic G. Jamora [Singapour] ; Edwin S. Y. Chan [Singapour] | Use of complementary therapies in patients with Parkinson's disease in singapore |
| 001852 |
Mette Brandt-Christensen [Danemark] ; Kajsa Kvist [Danemark] ; Flemming M Rkeberg Nilsson [Danemark] ; Per Kragh Andersen [Danemark] ; Lars Vedel Kessing [Danemark] | Use of antiparkinsonian drugs in Denmark : Results from a nationwide pharmacoepidemiological study |
| 001853 |
Christoph Scherfler [Royaume-Uni] ; Naheed L. Khan [Royaume-Uni] ; Nicola Pavese [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; David J. Brooks [Royaume-Uni] ; Paola P. Piccini [Royaume-Uni] | Upregulation of dopamine D2 receptors in dopaminergic drugnaive patients with Parkin gene mutations |
| 001860 |
C. Warren Olanow [États-Unis] ; Kevin St. P. Mcnaught [États-Unis] | Ubiquitin-proteasome system and Parkinson's disease |
| 001861 |
Kevin E. Novak [États-Unis] ; Emmanuel K. Nenonene [États-Unis] ; Lawrence P. Bernstein [États-Unis] ; Sandra Vergenz [États-Unis] ; Gina Medalle [États-Unis] ; Jordan M. Prager [États-Unis] ; Theodore W. Eller [États-Unis] ; Jeffrey W. Cozzens [États-Unis] ; Michael Rezak [États-Unis] | Two cases of ischemia associated with subthalamic nucleus stimulator implantation for advanced parkinson's disease |
| 001863 |
Susan H. Fox [Canada] ; Anthony E. Lang [Canada] ; Jonathan M. Brotchie [Canada] | Translation of nondopaminergic treatments for levodopa-induced dyskinesia from MPTP-lesioned nonhuman primates to phase IIa clinical studies : Keys to success and roads to failure |
| 001864 |
David A. Grimes [Canada] ; FABIN HAN [Canada] ; Michel Panisset [Canada] ; Lemuel Racacho [Canada] ; FENGXIA XIAO [Canada] ; RUOBING ZOU [Canada] ; Kelly Westaff [Canada] ; Dennis E. Bulman [Canada] | Translated mutation in the Nurr1 gene as a cause for Parkinson's disease |
| 001866 |
Anette Schrag [Royaume-Uni] ; Pauline Banks [Royaume-Uni] | Time of loss of employment in Parkinson's disease |
| 001867 |
Robert Iansek [Australie] ; Frances Huxham [Australie] ; Jennifer Mcginley [Australie] | The sequence effect and gait festination in parkinson disease : Contributors to freezing of gait? |
| 001868 |
Ann L. Hunt [États-Unis] ; Kapil D. Sethi [États-Unis] | The pull test : A history |
| 001869 |
Alexandre Castro-Caldas [Portugal] ; Paul Delwaide [Belgique] ; Wolfgang Jost [Allemagne] ; Marcelo Merello [Argentine] ; Adrian Williams [Royaume-Uni] ; Paolo Lamberti [Italie] ; Miguel Aguilar [Espagne] ; Susanna Del Signore [France] ; Pierre Cesaro [France] | The parkinson-control study : A 1-year randomized, double- blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in parkinson's disease |
| 001873 |
Kelly L. Sullivan [États-Unis] ; Joseph F. Staffetti [États-Unis] ; Robert A. Hauser [États-Unis] ; Peter B. Dunne [États-Unis] ; Theresa A. Zesiewicz [États-Unis] | Tegaserod (Zelnorm) for the treatment of constipation in Parkinson's disease |
| 001878 |
HONGLEI CHEN [États-Unis] ; Shumin M. Zhang [États-Unis] ; Michael A. Schwarzschild [États-Unis] ; Miguel A. Hernan [États-Unis] ; Alberto Ascherio [États-Unis] | Survival of Parkinson's disease patients in a large prospective cohort of male health professionals |
| 001879 |
Massimo Cincotta [Italie] ; Fabio Giovannelli [Italie] ; Alessandra Borgheresi [Italie] ; Fabrizio Balestrieri [Italie] ; Paola Vanni [Italie] ; Aldo Ragazzoni [Italie] ; Gaetano Zaccara [Italie] ; Ulf Ziemann [Allemagne] | Surface electromyography shows increased mirroring in parkinson's disease patients without overt mirror movements |
| 001881 |
Vicky L. Marshall [Royaume-Uni] ; Jim Patterson [Royaume-Uni] ; Donald M. Hadley [Royaume-Uni] ; Katherine A. Grosset [Royaume-Uni] ; Donald G. Grosset [Royaume-Uni] | Successful antiparkinsonian medication withdrawal in patients with parkinsonism and normal FP-CIT SPECT |
| 001882 |
Carmen Cristea Janvin [Norvège] ; Jan Petter Larsen [Norvège] ; Dag Aarsland [Norvège] ; Kenneth Hugdahl [Norvège] | Subtypes of mild cognitive impairment in parkinson's disease : Progression to dementia |
| 001884 |
Galit Kleiner-Fisman [États-Unis] ; Jan Herzog [Allemagne] ; David N. Fisman [États-Unis] ; Filippo Tamma [Italie] ; Kelly E. Lyons [États-Unis] ; Rajesh Pahwa [États-Unis] ; Anthony E. Lang [Canada] ; Günther Deuschl [Allemagne] | Subthalamic nucleus deep brain stimulation : Summary and meta-analysis of outcomes |
| 001885 |
William G. Ondo [États-Unis] ; Yavuz Silay [États-Unis] ; Mike Almaguer [États-Unis] ; Joseph Jankovic [États-Unis] | Subthalamic deep brain stimulation in patients with a previous pallidotomy |
| 001886 |
Katherine J. Schweitzer [Allemagne] ; Rüdiger Hilker [Allemagne] ; Uwe Walter [Allemagne] ; Lothar Burghaus [Allemagne] ; Daniela Berg [Allemagne] | Substantia nigra hyperechogenicity as a marker of predisposition and slower progression in Parkinson's disease |
| 001887 |
Lisa M. Shulman [États-Unis] ; Ingrid Pretzer-Aboff [États-Unis] ; Karen E. Anderson [États-Unis] ; Rashida Stevenson [États-Unis] ; Christopher G. Vaughan [États-Unis] ; Ann L. Gruber-Baldini [États-Unis] ; Stephen G. Reich [États-Unis] ; William J. Weiner [États-Unis] | Subjective report versus objective measurement of activities of daily living in parkinson's disease |
| 001889 |
Anna Brück [Finlande] ; Sargo Aalto [Finlande] ; Elina Nurmi [Finlande] ; Tero Vahlberg [Finlande] ; Jorgen Bergman [Finlande] ; Juha O. Rinne [Finlande] | Striatal subregional 6-[18F]fluoro-L-dopa uptake in early Parkinson's disease : A two-year follow-up study |
| 001890 |
Michelle J. Porritt [Australie] ; Ann E. Kingsbury [Royaume-Uni] ; Andrew J. Hughes [Australie] ; David W. Howells [Australie] | Striatal dopaminergic neurons are lost with Parkinson's disease progression |
| 001891 |
Ioannis U. Isaias [Italie] ; Riccardo Benti [Italie] ; Stefano Goldwurm [Italie] ; Michela Zini [Italie] ; Roberto Cilia [Italie] ; Paolo Gerundini [Italie] ; Alessio Di Fonzo [Pays-Bas, Italie] ; Vincenzo Bonifati [Pays-Bas, Italie] ; Gianni Pezzoli [Italie] ; Angelo Antonini [Italie] | Striatal dopamine transporter binding in Parkinson's disease associated with the LRRK2 Gly2019Ser mutation |
| 001892 |
Anna L. Bartels [Pays-Bas] ; Bauke M. De Jong [Pays-Bas] ; Nir Giladi [Israël] ; Joanna D. Schaafsma [Pays-Bas] ; R. Paul Maguire [Pays-Bas] ; Lammy Veenma [Pays-Bas] ; Jan Pruim [Pays-Bas] ; Yacov Balash [Israël] ; Moussa B. H. Youdim [Israël] ; Klaus L. Leenders [Pays-Bas] | Striatal dopa and glucose metabolism in PD patients with freezing of gait |
| 001895 |
Heiko Braak [Allemagne] ; Jürgen R. Bohl [Allemagne] ; Christian M. Müller [Allemagne] ; Udo Rüb [Allemagne] ; Rob A. I. De Vos [Pays-Bas] ; Kelly Del Tredici [Allemagne] | Stanley fahn lecture 2005 : The staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered |
| 001897 |
Daan J. Kamphuis [Pays-Bas] ; Hans Koelman [Pays-Bas] ; Andrew Lees (neurologue) [Royaume-Uni] ; Marina A. J. Tijssen [Pays-Bas] | Sporadic rapid-onset dystonia-parkinsonism presenting as Parkinson's disease |
| 001901 |
Michela Barichella [Italie] ; Agnieszka Marczewska [Italie] ; Roberta De Notaris [Italie] ; Antonella Vairo [Italie] ; Cinzia Baldo [Italie] ; Andrea Mauri [Italie] ; Chiara Savardi [Italie] ; Gianni Pezzoli [Italie] | Special low-protein foods ameliorate postprandial off in patients with advanced Parkinson's disease |
| 001903 |
Juan Carlos Gomez-Esteban [Espagne] ; Juan Jose Zarranz ; Elena Lezcano ; Fernando Velasco ; Roberto Ciordia ; Idoia Rouco ; Jose Losada ; Iker Bilbao | Sleep complaints and their relation with drug treatment in patients suffering from Parkinson's disease |
| 001904 |
Heather L. Katzen [États-Unis] ; Bonnie E. Levin [États-Unis] ; William Weiner [États-Unis] | Side and type of motor symptom influence cognition in Parkinson's disease |
| 001905 |
Dennis A. Nowak [Royaume-Uni, Allemagne] ; Stephen Tisch [Royaume-Uni] ; Marwan Hariz [Royaume-Uni] ; Patricia Limousin [Royaume-Uni] ; Helge Topka [Allemagne] ; John C. Rothwell [Royaume-Uni] | Sensory timing cues improve akinesia of grasping movements in Parkinson's disease : A comparison to the effects of subthalamic nucleus stimulation |
| 001913 |
Erika Driver-Dunckley [États-Unis] ; Virgilio Gerald H. Evidente [États-Unis] ; Charles H. Adler [États-Unis] ; Renee Hillman [États-Unis] ; Jose Hernandez [États-Unis] ; Geoffrey Fletcher [États-Unis] ; Mark K. Lyons [États-Unis] | Restless legs syndrome in Parkinson's disease patients may improve with subthalamic stimulation |
| 001917 |
Martine Visser [Pays-Bas] ; Albert F. G. Leentjens [Pays-Bas] ; Johan Marinus [Pays-Bas] ; Anne M. Stiggelbout [Pays-Bas] ; Jacobus J. Van Hilten [Pays-Bas] | Reliability and validity of the beck depression inventory in patients with Parkinson's disease |
| 001919 |
Christiane Reitz [Allemagne] ; Claudia Trenkwalder [Allemagne] ; Konrad Kretzschmar [Allemagne] ; Andreas Roesler [Allemagne] ; Arnold V. Eckardstein [Allemagne] ; Klaus Berger [Allemagne] | Relation of cerebral small-vessel disease and brain atrophy to mild parkinsonism in the elderly |
| 001923 |
Katja Hedrich [Allemagne] ; Susen Winkler [Allemagne] ; Johann Hagenah [Allemagne] ; Kemal Kabakci [Allemagne] ; Meike Kasten [Allemagne] ; Eberhard Schwinger [Allemagne] ; Jens Volkmann [Allemagne] ; Peter P. Pramstaller [Italie] ; Vladimir Kostic [Serbie] ; Peter Vieregge [Allemagne] ; Christine Klein [Allemagne] | Recurrent LRRK2 (Park8) mutations in early-onset parkinson's disease |
| 001924 |
Shin-Ichiro Kubo [Japon] ; Nobutaka Hattori [Japon] ; Yoshikuni Mizuno [Japon] | Recessive Parkinson's disease |
| 001925 |
Anan Moran [Israël] ; Izhar Bar-Gad [Israël] ; Hagai Bergman [Israël] ; Zvi Israel [Israël] | Real-time refinement of subthalamic nucleus targeting using bayesian decision-making on the root mean square measure |
| 001926 |
Kevin M. Biglan [États-Unis] ; Steven Schwid [États-Unis] ; Shirley Eberly [États-Unis] ; Karen Blindauer [États-Unis] ; Stanley Fahn [États-Unis] ; Tamar Goren [Israël] ; Karl Kieburtz [États-Unis] ; David Oakes [États-Unis] ; Sandra Plumb [États-Unis] ; Andrew Siderowf [États-Unis] ; Matthew Stern [États-Unis] ; Ira Shoulson [États-Unis] | Rasagiline improves quality of life in patients with early Parkinson's disease |
| 001928 |
Angelo Antonini [Italie] ; Silvana Tesei [Italie] ; Anna Zecchinelli [Italie] ; Paolo Barone [Italie] ; Danilo De Gaspari [Italie] ; Margherita Canesi [Italie] ; Giorgio Sacilotto [Italie] ; Nicoletta Meucci [Italie] ; Claudio Mariani [Italie] ; Gianni Pezzoli [Italie] | Randomized study of sertraline and low-dose amitriptyline in patients with Parkinson's disease and depression : Effect on quality of life |
| 001929 |
Elena Sinforiani [Italie] ; Roberta Zangaglia [Italie] ; Raffaele Manni [Italie] ; Silvano Cristina [Italie] ; Enrico Marchioni [Italie] ; Giuseppe Nappi [Italie] ; Francesca Mancini [Italie] ; Claudio Pacchetti [Italie] | REM sleep behavior disorder, hallucinations, and cognitive impairment in parkinson's disease |
| 001930 |
Omar R. Tumilasci [Argentine] ; Juan E. Belforte [Argentine] ; Federico E. Micheli [Argentine] ; Eduardo E. Benarroch [États-Unis] ; Jorge H. Pazo [Argentine] | Quantitative study of salivary secretion in Parkinson's disease |
| 001932 |
Tanja Schmitz-Hübsch [Allemagne] ; Derek Pyfer [Allemagne] ; Karin Kielwein [Allemagne] ; Rolf Fimmers [Allemagne] ; Thomas Klockgether [Allemagne] ; Ullrich Wüllner [Allemagne] | Qigong exercise for the symptoms of parkinson's disease : A randomized, controlled pilot study |
| 001933 |
Laura Silveira-Moriyama [Royaume-Uni] ; Andrew H. Evans [Royaume-Uni] ; Regina Katzenschlager [Royaume-Uni, Autriche] ; Andrew Lees (neurologue) [Royaume-Uni] | Punding and dyskinesias |
| 001934 |
Alfonso Fasano [Italie] ; Antonio E. Elia [Italie] ; Francesco Soleti [Italie] ; Arianna Guidubaldi [Italie] ; Anna Rita Bentivoglio [Italie] | Punding and computer addiction in Parkinson's disease |
| 001935 |
Yoshimi Suzukamo [Japon] ; Sadayoshi Ohbu [Japon] ; Tomoyoshi Kondo [Japon] ; Junko Kohmoto [Japon] ; Shunichi Fukuhara [Japon] | Psychological adjustment has a greater effect on health- related quality of life than on severity of disease in parkinson's disease |
| 001936 |
Sandrine Benaderette [France] ; Paolo Zanotti Fregonara [France] ; Emmanuelle Apartis [France] ; Charles Nguyen [France] ; Jean-Marc Trocello [France] ; Philippe Remy [France] ; Jean-Yves Devaux [France] ; Serge Askienazy [France] ; Marie Vidailhet [France] | Psychogenic parkinsonism : A combination of clinical, electrophysiological, and [123I]-FP-CIT SPECT scan explorations improves diagnostic accuracy |
| 001939 |
Laura Marsh [États-Unis] ; William M. Mcdonald [États-Unis] ; Jeffrey Cummings [États-Unis] ; Bernard Ravina [États-Unis] | Provisional diagnostic criteria for depression in Parkinson's disease : Report of an NINDS/NIMH work group |
| 001940 |
Agnieszka Marczewska [Italie] ; Roberta De Notaris [Italie] ; Sabina Sieri [Italie] ; Michela Barichella [Italie] ; Elisabetta Fusconi [Italie] ; Gianni Pezzoli [Italie] | Protein intake in parkinsonian patients using the EPIC food frequency questionnaire |
| 001944 |
Kenichi Sato [Japon] ; Taku Hatano [Japon] ; Kazuo Yamashiro [Japon] ; Maki Kagohashi [Japon] ; Kenya Nishioka [Japon] ; Nana Izawa [Japon] ; Hideki Mochizuki [Japon] ; Nobutaka Hattori [Japon] ; Hideo Mori [Japon] ; Yoshikuni Mizuno [Japon] | Prognosis of parkinson's disease : Time to stage III, IV, V, and to motor fluctuations |
| 001945 |
Katherine A. Grosset [Royaume-Uni] ; Graeme Macphee [Royaume-Uni] ; Guru Pal [Royaume-Uni] ; David Stewart [Royaume-Uni] ; Andrew Watt [Royaume-Uni] ; Jim Davie [Royaume-Uni] ; D. G. Grosset [Royaume-Uni] | Problematic gambling on dopamine agonists : Not such a rarity |
| 001946 |
Marc Morissette [Canada] ; Mehdi Dridi [Canada] ; Frédéric Calon [Canada] ; Abdallah Hadj Tahar [Canada] ; Leonard T. Meltzer [États-Unis] ; Paul J. Bedard [Canada] ; Thérèse Di Paolo [Canada] | Prevention of levodopa-induced dyskinesias by a selective NR1A/2B N-methyl-D-aspartate receptor antagonist in Parkinsonian monkeys : Implication of preproenkephalin |
| 001950 |
Maurizio Avanzi [Italie] ; Mario Baratti [Italie] ; Silvia Cabrini [Italie] ; Elena Uber [Italie] ; Gianni Brighetti [Italie] ; Flavio Bonfa [Italie] | Prevalence of pathological gambling in patients with Parkinson's disease |
| 001952 |
Takashi Nomura [Japon] ; Yuichi Inoue [Japon] ; Masahiro Miyake [Japon] ; Kenichi Yasui [Japon] ; Kenji Nakashima [Japon] | Prevalence and clinical characteristics of restless legs syndrome in Japanese patients with Parkinson's disease |
| 001953 |
Nathan Pankratz [États-Unis] ; Lisa Byder [États-Unis] ; Cheryl Halter [États-Unis] ; Alice Rudolph [États-Unis] ; Clifford W. Shults [États-Unis] ; P. Michael Conneally [États-Unis] ; Tatiana Foroud [États-Unis] ; William C. Nichols [États-Unis] | Presence of an APOE4 allele results in significantly earlier onset of Parkinson's disease and a higher risk with dementia |
| 001955 |
Ergun Y. Uc [États-Unis] ; Lynn K. Struck [États-Unis] ; Robert L. Rodnitzky [États-Unis] ; Bridget Zimmerman [États-Unis] ; Judith Dobson [États-Unis] ; William J. Evans [États-Unis] | Predictors of weight loss in Parkinson's disease |
| 001956 |
Charles J. Worringham [Australie] ; Joanne M. Wood [Australie] ; Graham K. Kerr [Australie] ; Peter A. Silburn [Australie] | Predictors of driving assessment outcome in Parkinson's disease |
| 001957 |
Jürgen Prestel [Allemagne] ; Katherine J. Schweitzer [Allemagne] ; Anne Hofer [Allemagne] ; Thomas Gasser [Allemagne] ; Daniela Berg [Allemagne] | Predictive value of transcranial sonography in the diagnosis of Parkinson's disease |
| 001960 |
Peter Valkovic [Allemagne, Slovaquie] ; Siegbert Krafczyk [Allemagne] ; Marian Saling [Slovaquie] ; Jan Benetin [Slovaquie] ; Kai Botzel [Allemagne] | Postural reactions to neck vibration in Parkinson's disease |
| 001962 |
Sergio Bagnato [Italie] ; Rocco Agostino [Italie] ; Nicola Modugno [Italie] ; Angelo Quartarone [Italie] ; Alfredo Berardelli [Italie] | Plasticity of the motor cortex in Parkinson's disease patients On and Off therapy |
| 001963 |
Mikhail P. Lomarev [États-Unis] ; Sulada Kanchana [États-Unis] ; William Bara-Jimenez [États-Unis] ; Meena Iyer [États-Unis] ; Eric M. Wassermann [États-Unis] ; Mark Hallett [États-Unis] | Placebo-controlled study of rTMS for the treatment of Parkinson's disease |
| 001964 |
Mattia Gambarin [Italie] ; Angelo Antonini [Italie] ; Giuseppe Moretto [Italie] ; Paolo Bovi [Italie] ; Silvia Romito [Italie] ; Antonio Fiaschi [Italie] ; Michele Tinazzi [Italie] | Pisa syndrome without neuroleptic exposure in a patient with Parkinson's disease : Case report |
| 001965 |
Kate S. M. Taylor [Royaume-Uni] ; Carl E. Counsell [Royaume-Uni] ; Clare E. Harris [Royaume-Uni] ; Joanna C. Gordon [Royaume-Uni] ; W. Cairns S. Smith [Royaume-Uni] | Pilot study of the incidence and prognosis of degenerative parkinsonian disorders in Aberdeen, United Kingdom : Methods and preliminary results |
| 001966 |
Naomi P. Visanji [Canada] ; Jordi Gomez-Ramirez [Canada] ; Tom H. Johnston [Canada] ; Donna Pires [Canada] ; Valerie Voon [Canada] ; Jonathan M. Brotchie [Canada] ; Susan H. Fox [Canada] | Pharmacological characterization of psychosis-like behavior in the MPTP-lesioned nonhuman primate model of Parkinson's disease |
| 001967 |
Wolfgang H. Oertel [Allemagne] ; Erik Wolters [Pays-Bas] ; Cristina Sampaio [Portugal] ; Santiago Gimenez-Roldan [Espagne] ; Bruno Bergamasco [Italie] ; Max Dujardin [France] ; Donald G. Grosset [Royaume-Uni] ; Guy Arnold [Allemagne] ; Klaus L. Leenders [Pays-Bas] ; Hans-Peter Hundemer [États-Unis] ; Alberto Lledo [États-Unis] ; Andrew Wood [États-Unis] ; Paul Frewer [États-Unis] ; Johannes Schwarz [Allemagne] | Pergolide versus levodopa monotherapy in early Parkinson's disease patients : The PELMOPET study |
| 001968 |
Paula R. Arantes [Brésil] ; Ellison F. Cardoso [Brésil] ; Maria A. Barreiros [Brésil] ; Manoel J. Teixeira [Brésil] ; Marcia R. Goncalves [Brésil] ; Egberto R. Barbosa [Brésil] ; Sukhi Shergill Sukwinder [Royaume-Uni] ; Claudia C. Leite [Brésil] ; Edson Jr Amaro [Brésil, Royaume-Uni] | Performing functional magnetic resonance imaging in patients with Parkinson's disease treated with deep brain stimulation |
| 001969 |
Matthias Maschke [États-Unis, Allemagne] ; Paul J. Tuite [États-Unis] ; Kim Krawczewski [États-Unis] ; Kristen Pickett [États-Unis] ; Jurgen Konczak [Allemagne] | Perception of heaviness in Parkinson's disease |
| 001970 |
Christine Schroder [Allemagne] ; Janine Mobes [Allemagne] ; Martin Schütze [Allemagne] ; Friedemann Szymanowski [Allemagne] ; Wido Nager [Allemagne] ; Marc Bangert [Allemagne] ; Thomas Frank Münte [Allemagne] ; Reinhard Dengler [Allemagne] | Perception of emotional speech in Parkinson's disease |
| 001972 |
Claire Ardouin [France] ; Valerie Voon [Canada] ; Yulia Worbe [France] ; Nehman Abouazar [France] ; Virginie Czernecki [France] ; Hassan Hosseini [France] ; Antoine Pelissolo [France] ; Elena Moro [Canada] ; Eugénie Lhommee [France] ; Anthony E. Lang [Canada] ; Yves Agid [France] ; Alim-Louis Benabid [France] ; Pierre Pollak [France] ; Luc Mallet [France] ; Paul Krack [France] | Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation |
| 001976 |
Maira Tonidandel Barbosa [Brésil] ; Paulo Caramelli [Brésil] ; Débora Palma Maia [Brésil] ; Mauro César Quintao Cunningham [Brésil] ; Henrique Leonardo Guerra [Brésil] ; Maria Fernanda Lima-Costa [Brésil] ; Francisco Cardoso [Brésil] | Parkinsonism and parkinson's disease in the elderly : A community-based survey in Brazil (the Bambuí Study) |
| 001977 |
Susanne Buechner [Italie] ; Maria Teresa Rosaria De Cristofaro [Italie] ; Silvia Ramat [Italie] ; Walter Borsini [Italie] | Parkinsonism and Anderson Fabry's disease : A case report |
| 001978 |
Njideka U. Okubadejo [États-Unis, Nigeria] ; James H. Bower [États-Unis] ; Walter A. Rocca [États-Unis] ; Demetrius M. Maraganore [États-Unis] | Parkinson's disease in Africa : A systematic review of epidemiologic and genetic studies |
| 001979 |
Javier Simon-Sanchez [Espagne] ; José-Félix Marti-Masso [Espagne] ; José Vicente Sanchez-Mut [Espagne] ; Coro Paisan-Ruiz [États-Unis] ; Angel Martinez-Gil [Espagne] ; Javier Ruiz-Martinez [Espagne] ; Amets Saenz [Espagne] ; Andrew B. Singleton [États-Unis] ; Adolfo Lopez De Munain [Espagne] ; Jordi Perez-Tur [Espagne] | Parkinson's disease due to the R1441G mutation in dardarin : A founder effect in the basques |
| 001980 |
Kirsti K. Martikainen [Finlande] ; Tiina H. Luukkaala [Finlande] ; Reijo J. Marttila [Finlande] | Parkinson's disease and working capacity |
| 001981 |
Denise M. Kay [États-Unis] ; Cyrus P. Zabetian [États-Unis] ; Stewart A. Factor [États-Unis] ; John G. Nutt [États-Unis] ; Ali Samii [États-Unis] ; Alida Griffith [États-Unis] ; Tom D. Bird [États-Unis] ; Patricia Kramer [États-Unis] ; Donald S. Higgins [États-Unis] ; Haydeh Payami [États-Unis] | Parkinson's disease and LRRK2 : Frequency of a common mutation in U.S. movement disorder clinics |
| 001983 |
Eng-King Tan [Singapour] ; Kenneth Yew [Singapour] ; Eva Chua [Singapour] ; K. Puvan [Singapour] ; HUI SHEN [Singapour] ; Esther Lee [Singapour] ; Kim-Yoong Puong [Singapour] ; YI ZHAO [Singapour] ; Ratnagopal Pavanni [Singapour] ; Meng-Cheong Wong [Singapour] ; Dominic Jamora [Singapour] ; Deidre De Silva [Singapour] ; Kyaw-Thu Moe [Singapour] ; Fung-Peng Woon [Singapour] ; YIH YUEN [Singapour] ; Louis Tan [Singapour] | PINK1 mutations in sporadic early-onset parkinson's disease |
| 001985 |
Plamen Gatev [États-Unis] ; Olivier Darbin [États-Unis] ; Thomas Wichmann [États-Unis] | Oscillations in the basal ganglia under normal conditions and in movement disorders |
| 001987 |
Kaveh M. Koochesfahani [Canada] ; Raul De La Fuente-Fernandez [Canada, Espagne] ; Vesna Sossi [Canada] ; Michael Schulzer [Canada] ; Lakshmi N. Yatham [Canada] ; Thomas J. Ruth [Canada] ; Stephan Blinder [Canada] ; A. Jon Stoessl [Canada] | Oral methylphenidate fails to elicit significant changes in extracellular putaminal dopamine levels in Parkinson's disease patients : Positron emission tomographic studies |
| 001989 |
Joseph H. Friedman [États-Unis] ; Robert M. Berman [États-Unis] ; Christopher G. Goetz [États-Unis] ; Stewart A. Factor [États-Unis] ; William G. Ondo [États-Unis] ; Joanne Wojcieszek [États-Unis] ; William H. Carson [États-Unis] ; Ronald N. Marcus [États-Unis] | Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease |
| 001993 |
Matthew A. Brodsky [États-Unis] ; Penelope Hogarth [États-Unis] ; John G. Nutt [États-Unis] | OFF-off rebound dyskinesia in subthalamic nucleus deep brain stimulation of parkinson's disease |
| 001997 |
Thanh G. Ton [États-Unis] ; Susan R. Heckbert [États-Unis] ; W. T. Jr Longstreth [États-Unis] ; Mary Anne Rossing [États-Unis] ; Walter A. Kukull [États-Unis] ; Gary M. Franklin [États-Unis] ; Phillip D. Swanson [États-Unis] ; Terri Smith-Weller [États-Unis] ; Harvey Checkoway [États-Unis] | Nonsteroidal anti-inflammatory drugs and risk of Parkinson's disease |
| 001998 |
Felipe Fregni [États-Unis] ; Paulo S. Boggio [Brésil] ; Marcelo C. Santos [Brésil] ; Moises Lima [Brésil] ; Adriana L. Vieira [Brésil] ; Sergio P. Rigonatti [Brésil] ; M. Teresa A. Silva [Brésil] ; Egberto R. Barbosa [Brésil] ; Michael A. Nitsche [Allemagne] ; Alvaro Pascual-Leone [États-Unis] | Noninvasive cortical stimulation with transcranial direct current stimulation in Parkinson's disease |
| 001A00 |
Michele T. M. Hu [Royaume-Uni] ; Christoph Scherfler [Royaume-Uni] ; Naheed L. Khan [Royaume-Uni] ; Jo V. Hajnal [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Niall Quinn [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni] ; David J. Brooks [Royaume-Uni] | Nigral degeneration and striatal dopaminergic dysfunction in idiopathic and Parkin-linked Parkinson's disease |
| 001A02 |
Paola Piccini [Royaume-Uni] ; David J. Brooks [Royaume-Uni] | New developments of brain imaging for Parkinson's disease and related disorders |
| 001A03 |
Eus J. W. Van Someren [Pays-Bas] ; Myrthe D. Pticek [Pays-Bas] ; Johannes D. Speelman [Pays-Bas] ; Peter R. Schuurman [Pays-Bas] ; Rianne Esselink [Pays-Bas] ; Dick F. Swaab [Pays-Bas] | New actigraph for long-term tremor recording |
| 001A06 |
Blanca Ramirez-Ruiz [Espagne] ; Carme Junque [Espagne] ; Maria-Jose Martf [Espagne] ; Francesc Valldeoriola [Espagne] ; Eduardo Tolosa [Espagne] | Neuropsychological deficits in parkinson's disease patients with visual hallucinations |
| 001A07 |
Marcelo Merello [Argentine] ; Eduardo Tenca [Argentine] ; Daniel Cerquetti [Argentine] | Neuronal activity of the zona incerta in Parkinson's disease patients |
| 001A10 |
Johannes Brettschneider [Allemagne] ; Axel Petzold [Royaume-Uni] ; Sigurd D. Süssmuth [Allemagne] ; Georg B. Landwehrmeyer [Allemagne] ; Albert C. Ludolph [Allemagne] ; Jan Kassubek [Allemagne] ; Hayrettin Tumani [Allemagne] | Neurofilament heavy-chain NfHSMI35 in cerebrospinal fluid supports the differential diagnosis of Parkinsonian syndromes |
| 001A11 |
Daniel G. Healy [Royaume-Uni] ; Patrick M. Abou-Sleiman [Royaume-Uni] ; Kourosh R. Ahmadi [Royaume-Uni] ; Sonia Gandhi [Royaume-Uni] ; Miratul M. Muqit [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Janice L. Holton [Royaume-Uni] ; Tamas Revesz [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni] | NR4A2 genetic variation in sporadic Parkinson's disease : A genewide approach |
| 001A15 |
Carlos Portera-Cailliau [États-Unis] ; Daryl Victor [États-Unis] ; Steven Frucht [États-Unis] ; Stanley Fahn [États-Unis] | Movement disorders fellowship training program at columbia university medical center in 2001-2002 |
| 001A17 |
Hideaki Matsui [Japon] ; Kazuto Nishinaka [Japon] ; Masaya Oda [Japon] ; Kenichi Komatsu [Japon] ; Tamotsu Kubori [Japon] ; Fukashi Udaka [Japon] | Minor depression and brain perfusion images in Parkinson's disease |
| 001A18 |
Anette Schrag [Royaume-Uni] ; Cristina Sampaio [Portugal] ; Nicholas Counsell [Royaume-Uni] ; Werner Poewe [Autriche] | Minimal clinically important change on the unified Parkinson's disease rating scale |
| 001A19 |
Maria Joao Forjaz [Espagne] ; Pablo Martinez-Martin [Espagne] | Metric attributes of the unified Parkinson's disease rating scale 3.0 battery: Part II, Construct and content validity |
| 001A20 |
Pablo Martinez-Martin [Espagne] ; Maria Joao Forjaz [Espagne] | Metric attributes of the unified Parkinson's disease rating scale 3.0 battery: Part I, Feasibility, scaling assumptions, reliability, and precision |
| 001A23 |
Massimo Cincotta [Italie] ; Alessandra Borgheresi [Italie] ; Fabrizio Balestrieri [Italie] ; Fabio Giovannelli [Italie] ; Aldo Ragazzoni [Italie] ; Paola Vanni [Italie] ; Francesco Benvenuti [Italie] ; Gaetano Zaccara [Italie] ; Ulf Ziemann [Allemagne] | Mechanisms underlying mirror movements in Parkinson's disease : A transcranial magnetic stimulation study |
| 001A24 |
Ute Hidding [Allemagne] ; Tobias B Umer [Allemagne] ; Hartwig Roman Siebner [Allemagne] ; Cüneyt Demiralay [Allemagne] ; Carsten Buhmann [Allemagne] ; Thomas Weyh [Allemagne] ; Christian Moll [Allemagne] ; Wolfgang Hamel [Allemagne] ; Alexander Münchau [Allemagne] | MEP latency shift after implantation of deep brain stimulation systems in the subthalamic nucleus in patients with advanced parkinson's disease |
| 001A25 |
Benjamin G. Clissold [Australie] ; Craig D. Mccoll [Australie] ; Katrina R. Reardon [Australie] ; Mark Shiff [Australie] ; Peter A. Kempster [Australie] | Longitudinal study of the motor response to levodopa in Parkinson's disease |
| 001A27 |
Andrew Siderowf [États-Unis] ; Jurg L. Jaggi [États-Unis] ; Sharon X. Xie [États-Unis] ; Catherine Loveland-Jones [États-Unis] ; Lewis Leng [États-Unis] ; Howard Hurtig [États-Unis] ; Amy Colcher [États-Unis] ; Matthew Stern [États-Unis] ; Kelvin L. Chou [États-Unis] ; Grace Liang [États-Unis] ; Heather Maccarone [États-Unis] ; Tanya Simuni [États-Unis] ; Gordon Baltuch [États-Unis] | Long-term effects of bilateral subthalamic nucleus stimulation on health-related quality of life in advanced parkinson's disease |
| 001A28 |
Werner Poewe [Autriche] ; Erik Wolters [Pays-Bas] ; Murat Emre [Turquie] ; Marco Onofrj [Italie] ; Chuanchieh Hsu [États-Unis] ; Sibel Tekin [États-Unis] ; Roger Lane [États-Unis] | Long-term benefits of rivastigmine in dementia associated with parkinson's disease : An active treatment extension study |
| 001A31 |
Klaus Seppi [Autriche] ; Birgit Högl [Autriche] ; Anja Diem [Autriche] ; Cecilia Peralta [Autriche] ; Gregor K. Wenning [Autriche] ; Werner Poewe [Autriche] | Levodopa-induced sleepiness in the parkinson variant of multiple system atrophy |
| 001A34 |
Omit Chiba-Falek [États-Unis] ; Grisel J. Lopez [États-Unis] ; Robert L. Nussbaum [États-Unis] | Levels of alpha-synuclein mRNA in sporadic parkinson disease patients |
| 001A35 |
Andrea Carmine Belin [Suède] ; Marie Westerlund [Suède] ; Olof Sydow [Suède] ; Karin Lundströmer [Suède] ; Anna Hakansson [Suède] ; Hans Nissbrandt [Suède] ; Lars Olson [Suède] ; Dagmar Gaiter [Suède] | Leucine-rich repeat kinase 2 (LRRK2) mutations in a Swedish parkinson cohort and a healthy nonagenarian |
| 001A36 |
Ann L. Smiley-Oyen [États-Unis] ; Kristin A. Lowry [États-Unis] ; Quinn R. Emerson [États-Unis] | Learning and retention of movement sequences in Parkinson's disease |
| 001A37 |
Hubertus J. A. Van Hedel [Suisse] ; Daniel Waldvogel [Suisse] ; Volker Dietz [Suisse] | Learning a high-precision locomotor task in patients with Parkinson's disease |
| 001A39 |
Hon-Chung Fung [États-Unis, Royaume-Uni, Taïwan] ; Chiung-Mei Chen [Taïwan] ; John Hardy [États-Unis, Royaume-Uni] ; Dena Hernandez [États-Unis] ; Andrew Singleton [États-Unis] ; Yih-Ru Wu [Taïwan] | Lack of G2019S LRRK2 mutation in a cohort of taiwanese with sporadic parkinson's disease |
| 001A40 |
Norman Putzki [Allemagne] ; Philipp Stude [Allemagne] ; Jürgen Konczak [États-Unis] ; Karoline Graf [Allemagne] ; Hans-Christoph Diener [Allemagne] ; Matthias Maschke [Allemagne] | Kinesthesia is impaired in focal dystonia |
| 001A41 |
Ramsey Ashour [États-Unis] ; Joseph Jankovic [États-Unis] | Joint and skeletal deformities in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy |
| 001A44 |
Daniela Berg [Allemagne] ; Helmine Hochstrasser [Allemagne] | Iron metabolism in Parkinsonian syndromes |
| 001A46 |
William G. Ondo [États-Unis] ; Yavuz S. Silay [États-Unis] | Intravenous flumazenil for Parkinson's disease : A single dose, double blind, placebo controlled, cross-over trial |
| 001A48 |
Kallol Ray Chaudhuri [Royaume-Uni] ; Pablo Martinez-Martin [Espagne] ; Anthony H. V. Schapira [Royaume-Uni] ; Fabrizio Stocchi [Italie] ; Kapil Sethi [États-Unis] ; Per Odin [Allemagne] ; Richard G. Brown [Royaume-Uni] ; William Koller [États-Unis] ; Paolo Barone [Italie] ; Graeme Macphee [Royaume-Uni] ; Linda Kelly [Royaume-Uni] ; Martin Rabey [Israël] ; Doug Macmahon [Royaume-Uni] ; Sue Thomas [Royaume-Uni] ; William Ondo [États-Unis] ; David Rye [États-Unis] ; Alison Forbes [Royaume-Uni] ; Susanne Tluk [Royaume-Uni] ; Vandana Dhawan [Royaume-Uni] ; Annette Bowron [Royaume-Uni] ; Adrian J. Williams [Royaume-Uni] ; Charles W. Olanow [États-Unis] | International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease : The NMSQuest study |
| 001A51 |
Thomas Müller [Allemagne] ; Christoph Erdmann [Allemagne] ; Siegfried Muhlack [Allemagne] ; Dirk Bremen [Allemagne] ; Horst Przuntek [Allemagne] ; Dirk Woitalla [Allemagne] | Inhibition of catechol-O-methyltransferase contributes to more stable levodopa plasma levels |
| 001A52 |
Mark A. Lee [Royaume-Uni] ; Richard W. Walker [Royaume-Uni] ; Anthony J. Hildreth [Royaume-Uni] ; Wendy M. Prentice [Royaume-Uni] | Individualized assessment of quality of life in idiopathic Parkinson's disease |
| 001A53 |
Hatice Kumru [Espagne] ; Joan Santamaria [Espagne] ; Francesc Valldeoriola [Espagne] ; Maria J. Marti [Espagne] ; Eduardo Tolosa [Espagne] | Increase in body weight after pramipexole treatment in Parkinson's disease |
| 001A56 |
Mandy Miller Koop [États-Unis] ; Amy Andrzejewski [États-Unis] ; Bruce C. Hill [États-Unis] ; Gary Heit [États-Unis] ; Helen M. Bronte-Stewart [États-Unis] | Improvement in a quantitative measure of bradykinesia after microelectrode recording in patients with Parkinson's disease during deep brain stimulation surgery |
| 001A58 |
Fortunato Battaglia [États-Unis] ; Maria Felice Ghilardi [États-Unis] ; Angelo Quartarone [Italie] ; Sergio Bagnato [Italie] ; Paolo Girlanda [Italie] ; Mark Hallett [États-Unis] | Impaired long-term potentiation-like plasticity of the trigeminal blink reflex circuit in Parkinson's disease |
| 001A59 |
Emma L. Stack [Royaume-Uni] ; Ann M. Ashburn [Royaume-Uni] | Impaired bed mobility and disordered sleep in parkinson's disease |
| 001A62 |
Fatima Rodrigues De Paula [Brésil] ; Luci Fuscaldi Teixeira-Salmela [Brésil] ; Christina Danielli Coelho De Morais Faria [Brésil] ; Patricia Rocha De Brito [Brésil] ; Francisco Cardoso [Brésil] | Impact of an exercise program on physical, emotional, and social aspects of quality of life of individuals with Parkinson's disease |
| 001A63 |
Hideaki Kobayashi [Japon] ; Hiroshi Ujike [Japon] ; Junko Hasegawa [Japon] ; Mitsutoshi Yamamoto [Japon] ; Akihiro Kanzaki [Japon] ; Ichiro Sora [Japon] | Identification of a risk haplotype of the α-synuclein gene in japanese with sporadic Parkinson's disease |
| 001A65 |
Hideaki Matsui [Japon] ; Kazuto Nishinaka [Japon] ; Masaya Oda [Japon] ; Narihiro Hara [Japon] ; Kenichi Komatsu [Japon] ; Tamotsu Kubori [Japon] ; Fukashi Udaka [Japon] | Hypoperfusion of the visual pathway in parkinsonian patients with visual hallucinations |
| 001A66 |
Hideaki Matsui [Japon] ; Kazuto Nishinaka [Japon] ; Masaya Oda [Japon] ; Narihiro Hara [Japon] ; Kenichi Komatsu [Japon] ; Tamotsu Kubori [Japon] ; Fukashi Udaka [Japon] | Hypoperfusion of the auditory and prefrontal cortices in Parkinsonian patients with verbal hallucinations |
| 001A67 |
Pedro Schestatsky [Brésil] ; Josep Valls-Sole [Espagne] ; Joao Arthur Ehlers [Brésil] ; Carlos R. M. Rieder [Brésil] ; Irenio Gomes [Brésil] | Hyperhidrosis in Parkinson's disease |
| 001A69 |
Cindy Zadikoff [Canada] ; Ekaterina Rogaeva [Canada] ; Ana Djarmati [Allemagne] ; Christine Sato [Canada] ; Shabnam Salehi-Rad [Canada] ; Peter St. George-Hyslop [Canada] ; Christine Klein [Canada, Allemagne] ; Anthony E. Lang [Canada] | Homozygous and heterozygous PINK1 mutations : Considerations for diagnosis and care of parkinson's disease patients |
| 001A72 |
Jordi Gomez-Ramirez [Canada] ; Tom H. Johnston [Canada] ; Naomi P. Visanji [Canada] ; Susan H. Fox [Canada] ; Jonathan M. Brotchie [Canada] | Histamine H3 receptor agonists reduce L-dopa-induced chorea, but not dystonia, in the MPTP-lesioned nonhuman primate model of parkinson's disease |
| 001A73 |
Leland E. Dibble [États-Unis] ; Tessa F. Hale [États-Unis] ; Robin L. Marcus [États-Unis] ; John Droge [États-Unis] ; J. Parry Gerber [États-Unis] ; Paul C. Lastayo [États-Unis] | High-intensity resistance training amplifies muscle hypertrophy and functional gains in persons with parkinson's disease |
| 001A74 |
Ana Djarmati [Allemagne, Serbie] ; Katja Hedrich [Allemagne] ; Marina Svetel [Serbie] ; Thora Lohnau [Allemagne] ; Eberhard Schwinger [Allemagne] ; Stanka Romac [Serbie] ; Peter P. Pramstaller [Italie] ; Vladimir Kostic [Serbie] ; Christine Klein [Allemagne] | Heterozygous PINK1 mutations : A susceptibility factor for parkinson disease? |
| 001A78 |
Emmanuel Roze [France] ; Maria Clara Coeho-Braga [France] ; Dominique Gayraud [France] ; Andre Pierre Legrand [France] ; Jean-Marc Trocello [France] ; Gilles Fenelon [France] ; Valérie Cochen [France] ; Nathalie Patte [France] ; Francois Viallet [France] ; Marie Vidailhet [France] ; Pierre Pollak [France] ; Emmanuelle Apartis [France] | Head tremor in Parkinson's disease |
| 001A80 |
Joseph J. Higgins [États-Unis] ; Roni Q. Lombardi [États-Unis] ; Joanna Pucilowska [États-Unis] ; Joseph Jankovic [États-Unis] ; Lawrence I. Golbe [États-Unis] ; Leo Verhagen [États-Unis] | HS1-BP3 gene variant is common in familial essential tremor |
| 001A81 |
William Bara-Jimenez [États-Unis] ; Tzvetelina D. Dimitrova [États-Unis] ; Abdullah Sherzai [États-Unis] ; Murat Aksu [États-Unis] ; Thomas N. Chase [États-Unis] | Glutamate release inhibition ineffective in levodopa-induced motor complications |
| 001A83 |
Pablo Martinez-Martin [Espagne] ; M. Joao Forjaz [Espagne] ; Esther Cubo [Espagne] ; Belén Frades [Espagne] ; Jesus De Pedro Cuesta [Espagne] | Global versus factor-related impression of severity in Parkinson's disease : A new clinimetric index (CISI-PD) |
| 001A86 |
Judith A. Strong [États-Unis] ; Arif Dalvi [États-Unis] ; Fredy J. Revilla [États-Unis] ; Alok Sahay [États-Unis] ; Frederick J. Samaha [États-Unis] ; Jeffrey A. Welge [États-Unis] ; JIANHUA GONG [États-Unis] ; Maureen Gartner [États-Unis] ; XIA YUE [États-Unis] ; LEI YU [États-Unis] | Genotype and smoking history affect risk of levodopa-induced dyskinesias in Parkinson's disease |
| 001A89 |
Sofya N. Pchelina [Russie] ; Andrei F. Yakimovskii [Russie] ; Olga N. Ivanova [Russie] ; Anton K. Emelianov [Russie] ; Andrei H. Zakharchuk [Russie] ; Alexander L. Schwarzman [Russie] | G2019S LRRK2 mutation in familial and sporadic Parkinson's disease in Russia |
| 001A90 |
Elan D. Louis [États-Unis] ; Nicole Schupf [États-Unis] ; Karen Marder [États-Unis] ; Ming X. Tang [États-Unis] | Functional correlates of mild parkinsonian signs in the community-dwelling elderly : Poor balance and inability to ambulate independently |
| 001A91 |
Isabelle Momjian-Mayor [Suisse] ; Gian Paolo Pizzolato [Suisse] ; Karim Burkhardt [Suisse] ; Theodor Landis [Suisse] ; Alessandra Coeytaux [Suisse] ; Pierre R. Burkhard [Suisse] | Fulminant lewy body disease |
| 001A92 |
Roberta Marongiu [Italie] ; Daniele Ghezzi [Italie] ; Tamara Ialongo [Italie] ; Francesco Soleti [Italie] ; Antonio Elia [Italie] ; Stefania Cavone [Italie] ; Alberto Albanese [Italie] ; Maria Concetta Altavista [Italie] ; Paolo Barone [Italie] ; Livia Brusa [Italie] ; Pietro Cortelli [Italie] ; Lucia Petrozzi [Italie] ; Cesa Scaglione [Italie] ; Paolo Stanzione [Italie] ; Michele Tinazzi [Italie] ; Massimo Zeviani [Italie] ; Bruno Dallapiccola [Italie] ; Anna Rita Bentivoglio [Italie] ; Enza Maria Valente [Italie] ; Barbara Garavaglia [Italie] | Frequency and phenotypes of LRRK2 G2019S mutation in italian patients with Parkinson's disease |
| 001A94 |
L. Joseph Iii Melton [États-Unis] ; Cynthia L. Leibson [États-Unis] ; Sara J. Achenbach [États-Unis] ; James H. Bower [États-Unis] ; Demetrius M. Maraganore [États-Unis] ; Ann L. Oberg [États-Unis] ; Walter A. Rocca [États-Unis] | Fracture risk after the diagnosis of parkinson's disease : Influence of concomitant dementia |
| 001A95 |
Sun J. Kang [États-Unis] ; William K. Scott [États-Unis] ; Yi-Ju Li [États-Unis] ; Michael A. Hauser [États-Unis] ; Joelle M. Van Der Walt [États-Unis] ; Kenichiro Fujiwara [États-Unis] ; Gregory M. Mayhew [États-Unis] ; Sandra G. West [États-Unis] ; Jeffery M. Vance [États-Unis] ; Eden R. Martin [États-Unis] | Family-based case-control study of MAOA and MAOB polymorphisms in parkinson disease |
| 001A98 |
Marko Korosec [Slovénie] ; Ignac Zidar [Slovénie] ; Dik Reits [Pays-Bas] ; Craig Evinger [États-Unis] ; Frans Vanderwerf [Pays-Bas] | Eyelid movements during blinking in patients with Parkinson's disease |
| 001B00 |
Rodrigo Mercado [Canada] ; Constantine Constantoyannis [Canada] ; Tomasz Mandat [Canada] ; Ajit Kumar [Canada] ; Michael Schulzer [Canada] ; A. Jon Stoessl [Canada] ; Christopher R. Honey [Canada] | Expectation and the placebo effect in parkinson's disease patients with subthalamic nucleus deep brain stimulation |
| 001B01 |
Isaac Shpirer [Israël] ; Ala Miniovitz [Israël] ; Colin Klein [Israël] ; Richard Goldstein [Israël] ; Tatiana Prokhorov [Israël] ; Jack Theitler [Israël] ; Lea Pollak [Israël] ; Jose Martin Rabey [Israël] | Excessive daytime sleepiness in patients with parkinson's disease : A polysomnography study |
| 001B02 |
Julie Kaye [Royaume-Uni] ; Heather Gage [Royaume-Uni] ; Alan Kimber [Royaume-Uni] ; Lesley Storey [Royaume-Uni] ; Patrick Trend [Royaume-Uni] | Excess burden of constipation in Parkinson's disease : A pilot study |
| 001B04 |
Karen Stergaard [Danemark] ; Niels Aa. Sunde [Danemark] | Evolution of Parkinson's disease during 4 years of bilateral deep brain stimulation of the subthalamic nucleus |
| 001B07 |
John M. Bertoni [États-Unis] ; Pamela M. Sprenkle [États-Unis] ; Daniel Strickland [États-Unis] ; Nancy Noedel [États-Unis] | Evaluation of Parkinson's disease in entrants on the nebraska state Parkinson's disease registry |
| 001B10 |
Diana Apetauerova [États-Unis] ; R. Kevin Ryan [États-Unis] ; Susie I. Ro [États-Unis] ; Jeffrey Arle [États-Unis] ; Jay Shils [États-Unis] ; Efstathios Papavassiliou [États-Unis] ; Daniel Tarsy [États-Unis] | End of day dyskinesia in advanced Parkinson's disease can be eliminated by bilateral subthalamic nucleus or globus pallidus deep brain stimulation |
| 001B11 |
Alexei Korchounov [Allemagne, Égypte] ; Gregory Bogomazov [Russie] | Employment, medical absenteeism, and disability perception in Parkinson's disease : A pilot double-blind, randomized, placebo-controlled study of entacapone adjunctive therapy |
| 001B12 |
Robert E. Gross [États-Unis] ; Paul Krack [France] ; Maria C. Rodriguez-Oroz [Espagne] ; Ali R. Rezai [États-Unis] ; Alim-Louis Benabid [France] | Electrophysiological mapping for the implantation of deep brain stimulators for Parkinson's disease and tremor |
| 001B15 |
Vincent Chung [Hong Kong] ; LIANG LIU [Hong Kong] ; ZHAOXIANG BIAN [Hong Kong] ; ZHONGZHEN ZHAO [Hong Kong] ; WAI LEUK FONG [Hong Kong] ; WAN FUNG KUM [Hong Kong] ; JING GAO [Hong Kong] ; MIN LI [Hong Kong] | Efficacy and safety of herbal medicines for idiopathic Parkinson's disease : A systematic review |
| 001B16 |
J. Antonelle Demarcaida [États-Unis] ; Steven R. Schwid [États-Unis] ; William B. White [États-Unis] ; Karen Blindauer [États-Unis] ; Stanley Fahn [États-Unis] ; Karl Kieburtz [États-Unis] ; Matthew Stern [États-Unis] ; Ira Shoulson [États-Unis] | Effects of tyramine administration in Parkinson's disease patients treated with selective MAO-B inhibitor rasagiline |
| 001B18 |
David Burn [Royaume-Uni] ; Murat Emre [Turquie] ; Ian Mckeith [Royaume-Uni] ; Peter Paul De Deyn [Belgique] ; Dag Aarsland [Norvège] ; Chuanchieh Hsu [États-Unis] ; Roger Lane [États-Unis] | Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease |
| 001B19 |
Aurélie Funkiewiez [France] ; Claire Ardouin [France] ; Roshan Cools [Royaume-Uni] ; Paul Krack [France] ; Valérie Fraix [France] ; Alina Batir [France] ; Stephan Chabardes [France] ; Alim-Louis Benabid [France] ; Trevor W. Robbins [Royaume-Uni] ; Pierre Pollak [France] | Effects of levodopa and subthalamic nucleus stimulation on cognitive and affective functioning in Parkinson's disease |
| 001B20 |
David E. Vaillancourt [États-Unis] ; Janey Prodoehl [États-Unis] ; Molly M. Sturman [États-Unis] ; Roy A. E. Bakay [États-Unis] ; Leo Verhagen Metman [États-Unis] ; Daniel M. Corcos [États-Unis] | Effects of deep brain stimulation and medication on strength, bradykinesia, and electromyographic patterns of the ankle joint in Parkinson's disease |
| 001B22 |
Tanya Y. Gurevich [Israël] ; Herzel Shabtai [Israël] ; Amos D. Korczyn [Israël] ; Ely S. Simon [États-Unis] ; Nir Giladi [Israël] | Effect of rivastigmine on tremor in patients with Parkinson's disease and dementia |
| 001B23 |
Lisa M. Muratori [États-Unis] ; Geraldine Dapul [États-Unis] ; Matthew N. Bartels [États-Unis] ; Andrew M. Gordon [États-Unis] | Effect of object transport on grasp coordination in multiple system atrophy |
| 001B24 |
Daniel Oved [Israël] ; Ilan Ziv [Israël] ; Therese A. Treves [Israël] ; Diana Paleacu [Israël] ; Eldad Melamed [Israël] ; Ruth Djaldetti [Israël] | Effect of dopamine agonists on fatigue and somnolence in Parkinson's disease |
| 001B25 |
Mark A. Hellmann [Israël] ; Ruth Djaldetti [Israël] ; Zvi Israel [Israël] ; Eldad Melamed [Israël] | Effect of deep brain subthalamic stimulation on camptocormia and postural abnormalities in idiopathic Parkinson's disease |
| 001B26 |
Eman M. Khedr [Égypte] ; John C. Rothwell [Royaume-Uni] ; Ola A. Shawky [Égypte] ; Mohamed A. Ahmed [Égypte] ; Ahmed Hamdy [Égypte] | Effect of daily repetitive transcranial magnetic stimulation on motor performance in Parkinson's disease |
| 001B28 |
Rene J. Stolwyk [Australie] ; Tom J. Triggs [Australie] ; Judith L. Charlton [Australie] ; Simon Moss [Australie] ; Robert Iansek [Australie] ; John L. Bradshaw [Australie] | Effect of a concurrent task on driving performance in people with Parkinson's disease |
| 001B29 |
GANG WANG [République populaire de Chine] ; QI CHENG [République populaire de Chine] ; RUI ZHENG [République populaire de Chine] ; Yu-Yan Tan [République populaire de Chine] ; Xiao-Kang Sun [République populaire de Chine] ; Hai-Yan Zhou [République populaire de Chine] ; Xiao-Lai Ye [République populaire de Chine] ; YING WANG [République populaire de Chine] ; ZENG WANG [République populaire de Chine] ; Bo-Min Sun [République populaire de Chine] ; Sheng-Di Chen [République populaire de Chine] | Economic burden of parkinson's disease in a developing country : A retrospective cost analysis in Shanghai, China |
| 001B30 |
Katia Noyes [États-Unis] ; HANGSHENG LIU [États-Unis] ; YUE LI [États-Unis] ; Robert Holloway [États-Unis] ; Andrew W. Dick [États-Unis] | Economic burden associated with Parkinson's disease on elderly medicare beneficiaries |
| 001B31 |
Olivier Rascol [France] ; Bruno Dubois [France] ; Alexandre Castro Caldas [Portugal] ; Stephen Senn [Royaume-Uni] ; Susanna Del Signore [France] ; Andrew Lees (neurologue) [Royaume-Uni] | Early piribedil monotherapy of Parkinson's disease : A planned seven-month report of the REGAIN study |
| 001B36 |
Kenichi Kashihara [Japon] ; Manabu Ohno [Japon] ; Susumu Tomita [Japon] | Dropped head syndrome in Parkinson's disease |
| 001B37 |
Stefanie Klaffke [Allemagne] ; Andrea A. Kuhn [Allemagne] ; Michail Plotkin [Allemagne] ; Holger Amthauer [Allemagne] ; Daniel Harnack [Allemagne] ; Roland Felix [Allemagne] ; Andreas Kupsch [Allemagne] | Dopamine transporters, D2 receptors, and glucose metabolism in corticobasal degeneration |
| 001B38 |
Lena Elisabeth Hjermind [Danemark] ; Lis Gitte Johannsen [Danemark] ; Nenad Blau [Suisse] ; Ron Allan Wevers [Pays-Bas] ; Christoph-Burkhard Lucking [Allemagne] ; Jens Michael Hertz [Danemark] ; Lars Friberg [Danemark] ; Lisbeth Regeur [Danemark] ; J Rgen Erik Nielsen [Danemark] ; Sven Asger S Rensen [Danemark] | Dopa-responsive dystonia and early-onset Parkinson's disease in a patient with GTP cyclohydrolase I deficiency? |
| 001B39 |
Aline Gronchi-Perrin [Suisse] ; Sarah Viollier [Suisse] ; Joseph Ghika [Suisse] ; Pierre Combremont [Suisse] ; Jean-Guy Villemure [Suisse] ; Julien Bogousslavsky [Suisse] ; Pierre R. Burkhard [Suisse] ; Francois Vingerhoets [Suisse] | Does subthalamic nucleus deep brain stimulation really improve quality of life in parkinson's disease? |
| 001B40 |
Christopher G. Goetz [États-Unis] ; John Michael Li [États-Unis] ; Joanne Wuu [États-Unis] ; Sue Leurgans [États-Unis] | Does seasonal variation affect hallucinations in PD? A longitudinal study |
| 001B43 |
Cynthia L. Leibson [États-Unis] ; Kirsten Hall Long [États-Unis] ; Demetrius M. Maraganore [États-Unis] ; James H. Bower [États-Unis] ; Jeanine E. Ransom [États-Unis] ; Peter C. O'Brien [États-Unis] ; Walter A. Rocca [États-Unis] | Direct medical costs associated with Parkinson's disease : A population-based study |
| 001B44 |
Mona Ragothaman [Inde] ; Shyla T. Govindappa [Inde] ; Rohini Rattihalli [Inde] ; Dodaballapur K. Subbakrishna [Inde] ; Uday B. Muthane [Inde] | Direct costs of managing Parkinson's disease in India : Concerns in a developing country |
| 001B50 |
Olivier Rascol [France] ; David J. Brooks [Royaume-Uni] ; Amos D. Korczyn [Israël] ; Peter P. De Deyn [Belgique] ; Carl E. Clarke [Royaume-Uni] ; Anthony E. Lang [Canada] ; Mona Abdalla [Royaume-Uni] | Development of dyskinesias in a 5-year trial of ropinirole and L-dopa |
| 001B53 |
Andre Machado [États-Unis] ; Ali R. Rezai [États-Unis] ; Brian H. Kopell [États-Unis] ; Robert E. Gross [États-Unis] ; Ashwini D. Sharan [États-Unis] ; Alim-Louis Benabid [France] | Deep brain stimulation for Parkinson's disease : Surgical technique and perioperative management |
| 001B54 |
Ali R. Rezai [États-Unis] ; Brian H. Kopell [États-Unis] ; Robert E. Gross [États-Unis] ; Jerrold L. Vitek [États-Unis] ; Ashwini D. Sharan [États-Unis] ; Patricia Limousin [Royaume-Uni] ; Alim-Louis Benabid [France] | Deep brain stimulation for Parkinson's disease : Surgical issues |
| 001B55 |
Anthony E. Lang [Canada] ; Jean-Luc Houeto [France] ; Paul Krack [France] ; Cynthia Kubu [États-Unis] ; Kelly E. Lyons [États-Unis] ; Elena Moro [Canada] ; William Ondo [États-Unis] ; Rajesh Pahwa [États-Unis] ; Werner Poewe [Autriche] ; Alexander I. Tröster [États-Unis] ; Ryan Uitti [États-Unis] ; Valerie Voon [Canada, États-Unis] | Deep brain stimulation : Preoperative issues |
| 001B56 |
Günther Deuschl [Allemagne] ; Jan Herzog [Allemagne] ; Galit Kleiner-Fisman [États-Unis] ; Cynthia Kubu [États-Unis] ; Andres M. Lozano [Canada] ; Kelly E. Lyons [États-Unis] ; Maria C. Rodriguez-Oroz [Espagne] ; Filippo Tamma [Italie] ; Alexander I. Tröster [États-Unis] ; Jerrold L. Vitek [États-Unis] ; Jens Volkmann [Allemagne] ; Valerie Voon [États-Unis] | Deep brain stimulation : Postoperative issues |
| 001B57 |
Valerie Voon [Canada, États-Unis] ; Cynthia Kubu [États-Unis] ; Paul Krack [France] ; Jean-Luc Houeto [France] ; Alexander I. Tröster [États-Unis] | Deep brain stimulation : Neuropsychological and neuropsychiatric issues |
| 001B58 |
Todd B. Sherer [États-Unis] ; Brian K. Fiske [États-Unis] ; Clive N. Svendsen [États-Unis] ; Anthony E. Lang [Canada] ; J. William Langston [États-Unis] | Crossroads in GDNF therapy for Parkinson's disease |
| 001B60 |
John N. Caviness [États-Unis] ; Holly A. Shill [États-Unis] ; Marwan N. Sabbagh [États-Unis] ; Virgilio G. H. Evidente [États-Unis] ; Jose L. Hernandez [États-Unis] ; Charles H. Adler [États-Unis] | Corticomuscular coherence is increased in the small postural tremor of parkinson's disease |
| 001B62 |
PHIL HYU LEE [Corée du Sud] ; SEUNG HYEON YEO [Corée du Sud] ; HYUN JOON KIM [Corée du Sud] ; HYO YOUNG YOUM [Corée du Sud] | Correlation between cardiac 123I-MIBG and odor identification in patients with Parkinson's disease and multiple system atrophy |
| 001B66 |
Lauren H. Craig [États-Unis] ; Anna Svircev [États-Unis] ; Michael Haber [États-Unis] ; Jorge L. Juncos [États-Unis] | Controlled pilot study of the effects of neuromuscular therapy in patients with Parkinson's disease |
| 001B68 |
William G. Ondo [États-Unis] ; Mike Almaguer [États-Unis] ; Helen Cohen [États-Unis] | Computerized posturography balance assessment of patients with bilateral ventralis intermedius nuclei deep brain stimulation |
| 001B69 |
Melissa J. Nirenberg [États-Unis] ; Cheryl Waters [États-Unis] | Compulsive eating and weight gain related to dopamine agonist use |
| 001B71 |
Nicholas J. Cordato [Australie] ; Glenda M. Halliday [Australie] ; Diana Caine [Australie] ; John G. L. Morris [Australie] | Comparison of motor, cognitive, and behavioral features in progressive supranuclear palsy and Parkinson's disease |
| 001B72 |
Cynthia L. Leibson [États-Unis] ; Demetrius M. Maraganore [États-Unis] ; James H. Bower [États-Unis] ; Jeanine E. Ransom [États-Unis] ; Peter C. O'Brien [États-Unis] ; Walter A. Rocca [États-Unis] | Comorbid conditions associated with parkinson's disease : A population-based study |
| 001B74 |
Carmen Cristea Janvin [Norvège] ; Jan Petter Larsen [Norvège] ; David P. Salmon [États-Unis] ; Douglas Galasko [États-Unis] ; Kenneth Hugdahl [Norvège] ; Dag Aarsland [Norvège] | Cognitive profiles of individual patients with Parkinson's disease and dementia : Comparison with dementia with lewy bodies and Alzheimer's disease |
| 001B76 |
Concepcio Marin [Espagne] ; Esther Aguilar [Espagne] ; José A. Obeso [Espagne] | Coadministration of entacapone with levodopa attenuates the severity of dyskinesias in hemiparkinsonian rats |
| 001B78 |
Hiroyuki Tomiyama [Japon] ; YUANZHE LI [Japon] ; Manabu Funayama [Japon] ; Kazuko Hasegawa [Japon] ; Hiroyo Yoshino [Japon] ; Shin-Ichiro Kubo [Japon] ; Kenichi Sato [Japon] ; Tatsuya Hattori [Japon] ; Chin-Song Lu [Taïwan] ; Rivka Inzelberg [Israël] ; Ruth Djaldetti [Israël] ; Eldad Melamed [Israël] ; Rim Amouri [Tunisie] ; Neziha Gouider-Khouja [Tunisie] ; Faycal Hentati [Tunisie] ; Yasuko Hatano [Japon] ; MEI WANG [Japon] ; Yoko Imamichi [Japon] ; Koichi Mizoguchi [Japon] ; Hiroaki Miyajima [Japon] ; Fumiya Obata [Japon] ; Tatsushi Toda [Japon] ; Matthew J. Farrer [États-Unis] ; Yoshikuni Mizuno [Japon] ; Nobutaka Hattori [Japon] | Clinicogenetic study of mutations in LRRK2 exon 41 in Parkinson's disease patients from 18 countries |
| 001B80 |
Liesl M. Allcock [Royaume-Uni] ; Rose Anne Kenny [Royaume-Uni] ; David J. Burn [Royaume-Uni] | Clinical phenotype of subjects with Parkinson's disease and orthostatic hypotension : Autonomic symptom and demographic comparison |
| 001B85 |
Roberta Frigerio [États-Unis] ; Kevin R. Sanft [États-Unis] ; Brandon R. Grossardt [États-Unis] ; Brett J. Peterson [États-Unis] ; Alexis Elbaz [France] ; James H. Bower [États-Unis] ; J. Eric Ahlskog [États-Unis] ; Mariza De Andrade [États-Unis] ; Demetrius M. Maraganore [États-Unis] ; Walter A. Rocca [États-Unis] | Chemical exposures and Parkinson's disease : A population-based case-control study |
| 001B88 |
Guido Alves [Norvège] ; Jan Petter Larsen [Norvège] ; Murat Emre [Turquie] ; Tore Wentzel-Larsen [Norvège] ; Dag Aarsland [Norvège] | Changes in motor subtype and risk for incident dementia in Parkinson's disease |
| 001B94 |
Eng-King Tan [Singapour] ; Kim-Yoong Puong [Singapour] ; Stephanie Fook-Chong [Singapour] ; Eva Chua [Singapour] ; HUI SHEN [Singapour] ; YIH YUEN [Singapour] ; Ratnagopal Pavanni [Singapour] ; Meng-Cheong Wong [Singapour] ; Kathiravelu Puvan [Singapour] ; YI ZHAO [Singapour] | Case-control study of UCHL1 S18Y variant in Parkinson's disease |
| 001B95 |
Joong-Seok Kim [Corée du Sud] ; Phil-Hyu Lee [Corée du Sud] ; Kwang-Soo Lee [Corée du Sud] ; Jeong-Wook Park [Corée du Sud] ; Yeong-In Kim [Corée du Sud] ; Yong-An Chung [Corée du Sud] ; Sung-Hoon Kim [Corée du Sud] ; Seung-Hyun Kim [Corée du Sud] ; Juhan Kim [Corée du Sud] ; Yun-Young Choi [Corée du Sud] ; Hee-Tae Kim [Corée du Sud] | Cardiac [123I]metaiodobenzylguanidine scintigraphy for vascular parkinsonism |
| 001B96 |
PHIL HYU LEE [Corée du Sud] ; JI WON KIM [Corée du Sud] ; OH YOUNG BANG [Corée du Sud] ; IN SOO JOO [Corée du Sud] ; Seok-Nam Yoon [Corée du Sud] ; Kyoon Huh [Corée du Sud] | Cardiac 123I-MIBG scintigraphy in patients with essential tremor |
| 001C04 |
Giovanni Lagalla [Italie] ; Marzia Millevolte [Italie] ; Marianna Capecci [Italie] ; Leandro Provinciali [Italie] ; Maria Gabriella Ceravolo [Italie] | Botulinum toxin type a for drooling in Parkinson's disease : A double-blind, randomized, placebo-controlled study |
| 001C09 |
Susanne A. Schneider [Royaume-Uni] ; Mark J. Edwards [Royaume-Uni] ; Carla Cordivari [Royaume-Uni] ; William N. Macleod [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Botulinum toxin A may be efficacious as treatment for jaw tremor in Parkinson's disease |
| 001C10 |
Cornelius G. Bachmann [Allemagne] ; Claudia Trenkwalder [Allemagne] | Body weight in patients with Parkinson's disease |
| 001C11 |
Giancarlo Logroscino [États-Unis] ; Honglei Chen [États-Unis] ; Al Wing [États-Unis] ; Alberto Ascherio [États-Unis] | Blood donations, iron stores, and risk of parkinson's disease |
| 001C14 |
Nicole Shivitz [États-Unis] ; Mandy Miller Koop [États-Unis] ; Jahan Fahimi [États-Unis] ; Gary Heit [États-Unis] ; Helen M. Bronte-Stewart [États-Unis] | Bilateral subthalamic nucleus deep brain stimulation improves certain aspects of postural control in Parkinson's disease, whereas medication does not |
| 001C18 |
Gloria E. Meredith [États-Unis] ; UN JUNG KANG [États-Unis] | Behavioral models of Parkinson's disease in rodents : A new look at an old problem |
| 001C19 |
Carl-Albrecht Haensch [Allemagne] ; Johannes Jörg [Allemagne] | Beat-to-beat blood pressure analysis after premature ventricular contraction indicates sensitive baroreceptor dysfunction in parkinson's disease |
| 001C20 |
Jens Volkmann [Allemagne] ; Elena Moro [Canada] ; Rajesh Pahwa [États-Unis] | Basic algorithms for the programming of deep brain stimulation in Parkinson's disease |
| 001C21 |
Antonio Nardone [Italie] ; Marco Schieppati [Italie] | Balance in parkinson's disease under static and dynamic conditions |
| 001C25 |
Martin Wilhelm Kurz [Allemagne, Norvège] ; Jan Petter Larsen [Norvège] ; Jan Terje Kvaloy [Norvège] ; Dag Aarsland [Norvège] | Associations between family history of Parkinson's disease and dementia and risk of dementia in Parkinson's disease : A community-based, longitudinal study |
| 001C26 |
Georgios M. Hadjigeorgiou [Grèce] ; Georgia Xiromerisiou [Grèce, États-Unis] ; Vanessa Gourbali [Grèce] ; Kostantinos Aggelakis [Grèce] ; Nikolaos Scarmeas [Grèce, États-Unis] ; Alexandros Papadimitriou [Grèce] ; Andrew Singleton [États-Unis] | Association of α-synuclein Rep1 polymorphism and parkinson's disease : Influence of Rep1 on age at onset |
| 001C27 |
Liana Fidani [Grèce] ; Kallirhoe Kalinderi [Grèce] ; Sevasti Bostantjopoulou [Grèce] ; Jordi Clarimon [États-Unis] ; Antonis Goulas [Grèce] ; Zoe Katsarou [Grèce] ; John Hardy [États-Unis, Royaume-Uni] ; Alexandros Kotsis [Grèce] | Association of the Tau haplotype with Parkinson's disease in the greek population |
| 001C28 |
G. Webster Ross [États-Unis] ; Robert D. Abbott [États-Unis] ; Helen Petrovitch [États-Unis] ; Caroline M. Tanner [États-Unis] ; Daron G. Davis [États-Unis] ; James Nelson [États-Unis] ; William R. Markesbery [États-Unis] ; John Hardman [États-Unis] ; Kamal Masaki [États-Unis] ; Lenore Launer [États-Unis] ; Lon R. White [États-Unis] | Association of olfactory dysfunction with incidental lewy bodies |
| 001C31 |
Rivka Inzelberg [Israël] ; Ubaldo Bonuccelli [Italie] ; Edna Schechtman [Israël] ; Ala Miniowich [Israël] ; Rosa Strugatsky [Israël] ; Roberto Ceravolo [Italie] ; Chiara Logi [Italie] ; Carlo Rossi [Italie] ; Colin Klein [Israël] ; J. Martin Rabey [Israël] | Association between amantadine and the onset of dementia in parkinson's disease |
| 001C33 |
Chava Peretz [Israël] ; Talia Herman [Israël] ; Jeffrey M. Hausdorff [Israël, États-Unis] ; Nir Giladi [Israël] | Assessing fear of falling : Can a short version of the activities-specific balance confidence scale be useful? |
| 001C35 |
Michael P. Hill [Royaume-Uni] ; Paula Ravenscroft [Royaume-Uni] ; Steven G. Mcguire [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] ; Catherine Rochat [France] ; Mark J. Millan [France] | Antiparkinsonian effects of the novel D3/D2 dopamine receptor agonist, S32504, in MPTP-lesioned marmosets : Mediation by D2, not D3, dopamine receptors |
| 001C36 |
Marc J. Mentis [États-Unis] ; Dominique Delalot [États-Unis] ; Hassan Naqvi [États-Unis] ; Mark F. Gordon [États-Unis] ; Mark Gudesblatt [États-Unis] ; Christine Edwards [États-Unis] ; Luke Donatelli [États-Unis] ; Vijay Dhawan [États-Unis] ; David Eidelberg [États-Unis] | Anticholinesterase effect on motor kinematic measures and brain activation in parkinson's disease |
| 001C38 |
Brian H. Kopell [États-Unis] ; Ali R. Rezai [États-Unis] ; JIN WOO CHANG [Corée du Sud] ; Jerrold L. Vitek [États-Unis] | Anatomy and physiology of the basal Ganglia : Implications for deep brain stimulation for Parkinson's disease |
| 001C40 |
E. K. Tan [Singapour] ; Lisa Skipper [Singapour] ; Eva Chua [Singapour] ; Meng-Cheong Wong [Singapour] ; Ratnagopal Pavanni [Singapour] ; Carine Bonnard [Singapour] ; Prasanna Kolatkar [Singapour] ; Jian-Jun Liu [Singapour] | Analysis of 14 LRRK2 mutations in Parkinson's plus syndromes and late-onset Parkinson's disease |
| 001C41 |
Noël L. W. Keijsers [Pays-Bas] ; Martin W. I. M. Horstink [Pays-Bas] ; Stan C. A. M. Gielen [Pays-Bas] | Ambulatory motor assessment in Parkinson's disease |
| 001C44 |
Yoshihiro Sato [Japon] ; Jun Iwamoto [Japon] ; Tomohiro Kanoko [Japon] ; Kei Satoh [Japon] | Alendronate and vitamin D2 for prevention of hip fracture in Parkinson's disease : A randomized controlled trial |
| 001C45 |
Christopher G. Goetz [États-Unis] ; Joanne Wuu [États-Unis] ; Linda Curgian [États-Unis] ; Sue Leurgans [États-Unis] | Age-related influences on the clinical characteristics of new-onset hallucinations in Parkinson's disease patients |
| 001C46 |
Paolo Ragonese [Italie] ; Marco D'Amelio [Italie] ; Graziella Callari [Italie] ; Giuseppe Salemi [Italie] ; Letterio Morgante [Italie] ; Giovanni Savettieri [Italie] | Age at menopause predicts age at onset of Parkinson's disease |
| 001C49 |
Matteo Signorini [Italie] ; Chiara Volpato [Italie] | Action fluency in parkinson's disease : A follow-up study |
| 001C56 |
Bénédicte Ballanger [France] ; Stéphane Thobois [France] ; Pierre Baraduc [France] ; Robert S. Turner [États-Unis] ; Emmanuel Broussolle [France] ; Michel Desmurget [France] | "Paradoxical kinesis" is not a hallmark of parkinson's disease but a general property of the motor system |
| 001C66 |
Brad A. Racette [États-Unis] ; Jo Ann Antenor [États-Unis] ; Lori Mcgee-Minnich [États-Unis] ; Stephen M. Moerlein [États-Unis] ; Tom O. Videen [États-Unis] ; Vikas Kotagal [États-Unis] ; Joel S. Perlmutter [États-Unis] | [18F]FDOPA PET and clinical features in parkinsonism due to manganism |
| 001C69 |
Martin Schubert [Allemagne] ; Thomas Prokop [Allemagne] ; Frank Brocke [Allemagne] ; Wiltrud Berger [Allemagne] | Visual kinesthesia and locomotion in Parkinson's disease |
| 001C71 |
Nagaraja Sarangmath [Inde] ; Rohini Rattihalli [Inde] ; Mona Ragothaman [Inde] ; Gururaj Gopalkrishna [Inde] ; Subbakrishna Doddaballapur [Inde] ; Elan D. Louis [États-Unis] ; Uday B. Muthane [Inde] | Validity of a modified parkinson's disease screening questionnaire in India : Effects of literacy of participants and medical training of screeners and implications for screening efforts in developing countries |
| 001C74 |
Bart Post [Pays-Bas] ; Maruschka P. Merkus [Pays-Bas] ; Rob M. A. De Bie [Pays-Bas] ; Rob J. De Haan [Pays-Bas] ; Johannes D. Speelman [Pays-Bas] | Unified Parkinson's disease rating scale motor examination : Are ratings of nurses, residents in neurology, and movement disorders specialists interchangeable? |
| 001C81 |
Werner Poewe [Autriche] | Treatment of dementia with lewy bodies and Parkinson's disease dementia |
| 001C82 |
Silvi Frenkel-Toledo [Israël] ; Nir Giladi [Israël] ; Chava Peretz [Israël] ; Talia Herman [Israël] ; Leor Gruendlinger [Israël] ; Jeffrey M. Hausdorff [Israël, États-Unis] | Treadmill walking as an external pacemaker to improve gait rhythm and stability in Parkinson's disease |
| 001C87 |
Monty A. Silverdale [Royaume-Uni] ; S. L. Nicholson [Royaume-Uni] ; A. R. Crossman [Royaume-Uni] ; J. M. Brotchie [Canada] | Topiramate reduces levodopa-induced dyskinesia in the MPTP-lesioned marmoset model of parkinson's disease |
| 001C88 |
Sanjay S. Iyer [États-Unis] ; John C. Morgan [États-Unis] ; Andrea L. Glover [États-Unis] ; Kapil D. Sethi [États-Unis] | Throat clicking as the initial symptom of Parkinson's disease |
| 001C89 |
Hideaki Matsui [Japon] ; Fukashi Udaka [Japon] ; Takafumi Miyoshi [Japon] ; Narihiro Hara [Japon] ; Akiko Tamaura [Japon] ; Masaya Oda [Japon] ; Tamotsu Kubori [Japon] ; Kazuto Nishinaka [Japon] ; Masakuni Kameyama [Japon] | Three-dimensional stereotactic surface projection study of freezing of gait and brain perfusion image in Parkinson's disease |
| 001C90 |
Yasushi Osaki [Japon] ; Yukari Morita [Japon] ; Mitsutaka Fukumoto [Japon] ; Naoki Akagi [Japon] ; Shoji Yoshida [Japon] ; Yoshinori Doi [Japon] | Three-dimensional stereotactic surface projection SPECT analysis in Parkinson's disease with and without dementia |
| 001C91 |
Meg Morris [Australie] ; Robert Iansek [Australie] ; Jennifer Mcginley [Australie] ; Thomas Matyas [Australie] ; Frances Huxham [Australie] | Three-dimensional gait biomechanics in Parkinson's disease: Evidence for a centrally mediated amplitude regulation disorder |
| 001C99 |
Mariese A. Hely [Australie] ; John G. L. Morris [Australie] ; Wayne G. J. Reid [Australie] ; Robert Trafficante [Australie] | Sydney multicenter study of Parkinson's disease : Non-L-dopa-responsive problems dominate at 15 years |
| 001D01 |
Francisca Sueli Monte [Brésil] ; Francisco Pereira Da Silva-Junior [Brésil] ; Pedro Braga-Neto [Brésil] ; Miguel Angelo Nobre E Souza [Brésil] ; Veralice Meireles Sales De Bruin [Brésil] | Swallowing abnormalities and dyskinesia in Parkinson's disease |
| 001D02 |
Francois Alesch [Autriche] | Sudden failure of dual channel pulse generators |
| 001D03 |
Katherine A. Grosset [Royaume-Uni] ; Ian Bone [Royaume-Uni] ; Donald G. Grosset [Royaume-Uni] | Suboptimal medication adherence in Parkinson's disease |
| 001D04 |
Antonio Pisani [Italie] ; Diego Centonze [Italie] ; Giorgio Bemardi [Italie] ; Paolo Calabresi [Italie] | Striatal synaptic plasticity : Implications for motor learning and Parkinson's disease |
| 001D13 |
Kirsten Hahn [Allemagne] ; Georg Ebersbach [Allemagne] | Sonographic assessment of urinary retention in multiple system atrophy and idiopathic Parkinson's disease |
| 001D14 |
Koichi Hiraoka [Japon] ; Yoshimi Matsuo [Japon] ; Kazuo Abe [Japon] | Soleus H-reflex inhibition during gait initiation in Parkinson's disease |
| 001D15 |
Eilis J. O'Reilly [États-Unis] ; Marji L. Mccullough [États-Unis] ; Ann Chao [États-Unis] ; S. Jane Henley [États-Unis] ; Eugenia E. Calle [États-Unis] ; Michael J. Thun [États-Unis] ; A. Ascherio [États-Unis] | Smokeless tobacco use and the risk of Parkinson's disease mortality |
| 001D16 |
Connie Marras [États-Unis] ; Samuel Goldman [États-Unis] ; Amanda Smith [États-Unis] ; Peter Barney [États-Unis] ; Diana Aston [États-Unis] ; Kathleen Comyns [États-Unis] ; Monica Korell [États-Unis] ; J. William Langston [États-Unis] ; G. Webster Ross [États-Unis] ; Caroline M. Tanner [États-Unis] | Smell identification ability in twin pairs discordant for Parkinson's disease |
| 001D17 |
Nico J. Diederich [Luxembourg (pays)] ; Michel Vaillant [Luxembourg (pays)] ; Mike Leischen [Luxembourg (pays)] ; Giovanna Mancuso [Luxembourg (pays)] ; Serge Golinval [Luxembourg (pays)] ; Romain Nati [Luxembourg (pays)] ; Marc Schlesser [Luxembourg (pays)] | Sleep apnea syndrome in Parkinson's disease. A case-control study in 49 patients |
| 001D21 |
Melisa Proulx [Canada] ; Francois P. De Courval [Canada] ; Michael A. Wiseman [Canada] ; Michel Panisset [Canada] | Salivary production in Parkinson's disease |
| 001D22 |
Leo Verhagen Metman [États-Unis] ; Shaun T. O'Leary [États-Unis] | Role of surgery in the treatment of motor complications |
| 001D23 |
Katherine L. Widnell [États-Unis] ; Cynthia Comella [États-Unis] | Role of COMT inhibitors and dopamine agonists in the treatment of motor fluctuations |
| 001D24 |
Alexis Elbaz [États-Unis, France] ; Brett J. Peterson [États-Unis] ; James H. Bower [États-Unis] ; PING YANG [États-Unis] ; Demetrius M. Maraganore [États-Unis] ; Shannon K. Mcdonnell [États-Unis] ; J. Eric Ahlskog [États-Unis] ; Walter A. Rocca [États-Unis] | Risk of cancer after the diagnosis of Parkinson's disease : A historical cohort study |
| 001D25 |
Carlos Singer [États-Unis] ; Spiridon Papapetropoulos [États-Unis] ; Manuel A. Gonzalez [États-Unis] ; Eugene L. Roberts [États-Unis] ; Abraham Lieberman [États-Unis] | Rimantadine in Parkinson's disease patients experiencing peripheral adverse effects from amantadine : Report of a case series |
| 001D28 |
Nico J. Diederich [Luxembourg (pays), États-Unis] ; Christopher G. Goetz [États-Unis] ; Glenn T. Stebbins [États-Unis] | Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions : Focused review and a new integrative model |
| 001D30 |
Claudio Pacchetti [Italie] ; Raffaele Manni [Italie] ; Roberta Zangaglia [Italie] ; Francesca Mancini [Italie] ; Enrico Marchioni [Italie] ; Cristina Tassorelli [Italie] ; Michele Terzaghi [Italie] ; Maria Ossola [Italie] ; Emilia Martignoni [Italie] ; Arrigo Moglia [Italie] ; Giuseppe Nappi [Italie] | Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson's disease |
| 001D33 |
Hubert H. Fernandez [États-Unis] ; Martha E. Trieschmann [États-Unis] ; Michael S. Okun [États-Unis] | Rebound psychosis: Effect of discontinuation of antipsychotics in Parkinson's disease |
| 001D35 |
Ana Lisa Taylor Tavares [États-Unis] ; Gregory S. X. E. Jefferis [États-Unis] ; Mandy Koop [États-Unis] ; Bruce C. Hill [États-Unis] ; Trevor Hastie [États-Unis] ; Gary Heit [États-Unis] ; Helen M. Bronte-Stewart [États-Unis] | Quantitative measurements of alternating finger tapping in Parkinson's disease correlate with UPDRS motor disability and reveal the improvement in fine motor control from medication and deep brain stimulation |
| 001D36 |
Pierre Champy [France] ; Alice Melot [France] ; Vincent Guerineau [France] ; Christophe Gleye [France] ; Djibril Fall [France, Sénégal] ; Gunter U. Höglinger [France] ; Merle Ruberg [France] ; Annie Lannuzel [France] ; Olivier Laprevote [France] ; Alain Laurens [France] ; Reynald Hocquemiller [France] | Quantification of acetogenins in Annona muricata linked to atypical parkinsonism in guadeloupe |
| 001D38 |
Panida Piboolnurak [États-Unis] ; Natalia Rothey [États-Unis] ; Anwar Ahmed [États-Unis] ; Blair Ford [États-Unis] ; QIPING YU [États-Unis] ; DONG XU [États-Unis] ; Seth L. Pullman [États-Unis] | Psychogenic tremor disorders identified using tree-based statistical algorithms and quantitative tremor analysis |
| 001D39 |
Allison Fleming [États-Unis] ; Karon F. Cook [États-Unis] ; Naomi D. Nelson [États-Unis] ; Eugene C. Lai [États-Unis] | Proxy reports in Parkinson's disease : Caregiver and patient self-reports of quality of life and physical activity |
| 001D45 |
Francesca Romana Pezzella [Italie] ; Carlo Colosimo [Italie] ; Nicola Vanacore [Italie] ; Simone Di Rezze [Italie] ; Melania Chianese [Italie] ; Giovanni Fabbrini [Italie] ; Giuseppe Meco [Italie] | Prevalence and clinical features of Hedonistic homeostatic dysregulation in Parkinson's disease |
| 001D46 |
Masahiko Suzuki [Japon] ; Nobutaka Hattori [Japon] ; Satoshi Orimo [Japon] ; Nobuyoshi Fukumitsu [Japon] ; M. Masahiro Abo [Japon] ; Yu Kono [Japon] ; Renpei Sengoku [Japon] ; Akira Kurita [Japon] ; Hidehiko Honda [Japon] ; Kiyoharu Inoue [Japon] | Preserved myocardial [123I]metaiodobenzylguanidine uptake in autosomal recessive juvenile parkinsonism : First case report |
| 001D47 |
Satoshi Orimo [Japon] ; Takeshi Amino [Japon] ; Masayuki Yokochi [Japon] ; Tohru Kojo [Japon] ; Toshiki Uchihara [Japon] ; Atsushi Takahashi [Japon] ; Koichi Wakabayashi [Japon] ; Hitoshi Takahashi [Japon] ; Nobutaka Hattori [Japon] ; Yoshikuni Mizuno [Japon] | Preserved cardiac sympathetic nerve accounts for normal cardiac uptake of MIBG in PARK2 |
| 001D48 |
Katja Hedrich [Allemagne] ; Peter P. Pramstaller [Italie] ; Katrin Stübke [Allemagne] ; Anja Hiller [Allemagne] ; Kemal Kabakci [Allemagne] ; Sabine Purmann [Allemagne] ; Meike Kasten [Allemagne] ; Cesa Scaglione [Italie] ; Eberhard Schwinger [Allemagne] ; Jens Volkmann [Allemagne] ; Vladimir Kostic [Serbie] ; Peter Vieregge [Allemagne] ; Paolo Martinelli [Italie] ; Giovanni Abbruzzese [Italie] ; Christine Klein [Allemagne] ; Christine Zühlke [Allemagne] | Premutations in the FMR1 gene as a modifying factor in Parkin-associated Parkinson's disease? |
| 001D51 |
Lorraine N. Clark [États-Unis] ; Angelique Nicolai [États-Unis] ; Shehla Afridi [États-Unis] ; Juliette Harris [États-Unis] ; Helen Mejia-Santana [États-Unis] ; Lisa Strug [États-Unis] ; Lucien J. Cote [États-Unis] ; Elan D. Louis [États-Unis] ; Howard Andrews [États-Unis] ; Cheryl Waters [États-Unis] ; Blair Ford [États-Unis] ; Steven Frucht [États-Unis] ; Stanley Fahn [États-Unis] ; Richard Mayeux [États-Unis] ; Ruth Ottman [États-Unis] ; K. Marder [États-Unis] | Pilot association study of the β-glucocerebrosidase N370S allele and Parkinson's disease in subjects of Jewish ethnicity |
| 001D53 |
Katherine A. Grosset [Royaume-Uni] ; Donald G. Grosset [Royaume-Uni] | Patient-perceived involvement and satisfaction in Parkinson's disease : Effect on therapy decisions and quality of life |
| 001D54 |
Katherine Widnell [États-Unis] | Pathophysiology of motor fluctuations in Parkinson's disease |
| 001D60 |
Andrew Nataraj [Canada] ; Ali H. Rajput [Canada] | Parkinson's disease, stroke, and related epidemiology |
| 001D61 |
Chava Peretz [Israël] ; Bruce H. Alexander [États-Unis] ; Sonia I. Nagahama [États-Unis] ; Karen B. Domino [États-Unis] ; Harvey Checkoway [États-Unis] | Parkinson's disease mortality among male anesthesiologists and internists |
| 001D62 |
John Hardy [États-Unis, Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Parkinson's disease : A broken nosology |
| 001D65 |
Chon-Haw Tsai [Taïwan] ; Fang-Chia Chang [Taïwan] ; Chin-Song Lu [Taïwan] ; Shih-Tseng Lee [Taïwan] ; Yu-Ting Huang [Taïwan] ; Ming-Kuei Lu [Taïwan] ; Rou-Shayn Chen [Taïwan] ; TONY WU [Taïwan] ; Jiann-Der Lee [Taïwan] ; Yi-Hsin Weng [Taïwan] ; Hsiu-Chen Chang [Taïwan] | Pallidotomy effect on the cortical excitability in patients with severe Parkinson's disease |
| 001D68 |
Cheryl Waters [États-Unis] | Other pharmacological treatments for motor complications and dyskinesias |
| 001D69 |
Brian Wood [Royaume-Uni] ; Richard Walker [Royaume-Uni] | Osteoporosis in Parkinson's disease |
| 001D70 |
Theresa A. Zesiewicz [États-Unis] ; Kelly L. Sullivan [États-Unis] ; John L. Maldonado [États-Unis] ; William O. Tatum [États-Unis] ; Robert A. Hauser [États-Unis] | Open-label pilot study of levetiracetam (Keppra) for the treatment of levodopa-induced dyskinesias in Parkinson's disease |
| 001D72 |
William G. Ondo [États-Unis] ; DEJIAN LAI [États-Unis] | Olfaction testing in patients with tremor-dominant Parkinson's disease : Is this a distinct condition? |
| 001D73 |
José L. Giroud-Benitez [Pays-Bas] ; Ali Akyol [Cuba] ; Egberto Barbosa [Turquie] ; Onno Schaap [Brésil] ; Herma C. Van Der Linde [Pays-Bas] ; Emilia Martignoni [Pays-Bas] ; Leonardo Lopiano [Italie] ; Paolo Lamberti [Italie] ; Emiliana Fincati [Italie] ; Angelo Antonini [Italie] ; Fabrizio Stocchi [Italie] ; Pasquale Montagna [Italie] ; Ferdinando Squitieri [Italie] ; Paolo Marini [Italie] ; Giovanni Abbruzzese [Italie] ; Giovanni Fabbrini [Italie] ; Roberto Marconi [Italie] ; Alessio Dalla Libera [Italie] ; Giorgio Trianni [Italie] ; Marco Guidi [Italie] ; Antonio De Gaetano [Italie] ; Gustavo Boff Maegawa [Italie] ; Antonino De Leo [Brésil] ; Virgilio Gallai [Italie] ; Giulia De Rosa [Italie] ; Nicola Vanacore [Italie] ; Giuseppe Meco [Italie] ; Cornelia M. Van Duijn [Italie] ; Ben A. Oostra [Pays-Bas] ; Peter Heutink [Pays-Bas] ; Vincenzo Bonifati | Novel parkin mutations detected in patients with early-onset Parkinson's disease |
| 001D78 |
Charles H. Adler [États-Unis] | Nonmotor complications in Parkinson's disease |
| 001D82 |
Kamilla M. Pedersen [Danemark] ; Lisbeth Marner [Danemark] ; Henning Pakkenberg [Danemark] ; Bente Pakkenberg [Danemark] | No global loss of neocortical neurons in Parkinson's disease : A quantitative stereological study |
| 001D83 |
C. Warren Olanow [États-Unis] ; Joseph Jankovic [États-Unis] | Neuroprotective therapy in Parkinson's disease and motor complications : A search for a pathogenesis-targeted, disease-modifying strategy |
| 001D88 |
Jordi Clarimon [États-Unis] ; Janel Johnson [États-Unis] ; Ruth Djaldetti [Israël] ; Dena Hernandez [États-Unis] ; Nobutaka Hattori [Japon] ; Hava Sroka [Israël] ; Yael Barhom [Israël] ; Andrew Singleton [États-Unis] | Mutation of the parkin gene in a persian family : Clinical progression over a 40-year period |
| 001D92 |
Joseph Jankovic [États-Unis] | Motor fluctuations and dyskinesias in Parkinson's disease : Clinical manifestations |
| 001D93 |
ZHI LIU [Japon] ; Ryuji Sakakibara [Japon] ; Takeo Odaka [Japon] ; Tomoyuki Uchiyama [Japon] ; Tomoyuki Uchiyama [Japon] ; Tatsuya Yamamoto [Japon] ; Takashi Ito [Japon] ; Masato Asahina [Japon] ; Kazuya Yamaguchi [Japon] ; Taketo Yamaguchi [Japon] ; Takamichi Hattori [Japon] | Mosapride citrate, a novel 5-HT4 agonist and partial 5-HT3 antagonist, ameliorates constipation in Parkinsonian patients |
| 001D94 |
Robert M. Silva [États-Unis] ; Chia-Yi Kuan [États-Unis] ; Pasko Rakic [États-Unis] ; Robert E. Burke [États-Unis] | Mixed lineage kinase-c-jun N-terminal kinase signaling pathway : A new therapeutic target in Parkinson's disease |
| 001D98 |
Katherine A. Grosset [Royaume-Uni] ; John L. Reid [Royaume-Uni] ; Donald G. Grosset [Royaume-Uni] | Medicine-taking behavior : Implications of suboptimal compliance in Parkinson's disease |
| 001E03 |
J. Carsten Möller [Allemagne] ; Wolfgang H. Oertel [Allemagne] ; Jürgen Koster [Allemagne] ; Gianni Pezzoli [Italie] ; Leandro Provinciali [Italie] | Long-term efficacy and safety of pramipexole in advanced Parkinson's disease : Results from a European multicenter trial |
| 001E14 |
Anna Hakansson [Suède] ; Lars Westberg [Suède] ; Staffan Nilsson [Suède] ; Silvia Buervenich [Suède] ; Andrea Carmine [Suède] ; Bjorn Holmberg [Suède] ; Olof Sydow [Suède] ; Lars Olson [Suède] ; Bo Johnels [Suède] ; Elias Eriksson [Suède] ; Hans Nissbrandt [Suède] | Investigation of genes coding for inflammatory components in Parkinson's disease |
| 001E22 |
Luigi Zecca [Italie] ; Daniela Berg [Allemagne] ; Thomas Arzberger [Allemagne] ; Petra Ruprecht [Allemagne] ; Wolf D. Rausch [Autriche] ; Massimo Musicco [Italie] ; Davide Tampellini [Italie] ; Peter Riederer [Allemagne] ; Manfred Gerlach [Allemagne] ; Georg Becker [Allemagne] | In vivo detection of iron and neuromelanin by transcranial sonography : A new approach for early detection of substantia nigra damage |
| 001E24 |
Stéphane Chapuis [France] ; Lemlih Ouchchane [France] ; Olivier Metz [France] ; Laurent Gerbaud [France] ; Franck Durif [France] | Impact of the motor complications of Parkinson's disease on the quality of life |
| 001E25 |
Rene J. Stolwyk [Australie] ; Tom J. Triggs [Australie] ; Judith L. Charlton [Australie] ; Robert Iansek [Australie] ; John L. Bradshaw [Australie] | Impact of internal versus external cueing on driving performance in people with Parkinson's disease |
| 001E26 |
Kari Swarztrauber [États-Unis] ; Jane Anau [États-Unis] ; Dawn Peters [États-Unis] | Identifying and distinguishing cases of parkinsonism and Parkinson's disease using ICD-9 CM codes and pharmacy data |
| 001E27 |
Mark Stacy [États-Unis] ; Annette Bowron [Royaume-Uni] ; Mark Guttman [Canada] ; Robert Hauser [États-Unis] ; Kim Hughes [Royaume-Uni] ; Jan Petter Larsen [Norvège] ; Peter Lewitt [États-Unis] ; Wolfgang Oertel [Allemagne] ; Niall Quinn [Royaume-Uni] ; Kapil Sethi [États-Unis] ; Fabrizio Stocchi [Italie] | Identification of motor and nonmotor wearing-off in Parkinson's disease : Comparison of a patient questionnaire versus a clinician assessment |
| 001E29 |
Felix Geser [Autriche] ; Gregor K. Wenning [Autriche] ; Werner Poewe [Autriche] ; Ian Mckeith [Royaume-Uni] | How to diagnose dementia with lewy bodies : State of the art |
| 001E33 |
Anne Doe De Maindreville [France] ; Gilles Fenelon [France] ; Florence Mahieux [France] | Hallucinations in Parkinson's disease : A follow-up study |
| 001E37 |
Masataka Nishimura [Japon] ; Sadako Kuno [Japon] ; Ryuji Kaji [Japon] ; Katsuhito Yasuno [Japon] ; Hideshi Kawakami [Japon] | Glutathione-S-transferase-1 and interleukin-1β gene polymorphisms in Japanese patients with Parkinson's disease |
| 001E38 |
Maher A. Noureddine [États-Unis] ; Yi-Ju Li [États-Unis] ; Joelle M. Van Der Walt [États-Unis] ; Robert Walters [États-Unis] ; Rita M. Jewett [États-Unis] ; HONG XU [États-Unis] ; TIANYUAN WANG [États-Unis] ; Jeffrey W. Waiter [États-Unis] ; Burton L. Scott [États-Unis] ; Christine Hulette [États-Unis] ; Don Schmechel [États-Unis] ; Judith E. Stenger [États-Unis] ; Fred Dietrich [États-Unis] ; Jeffery M. Vance [États-Unis] ; Michael A. Hauser [États-Unis] | Genomic convergence to identify candidate genes for parkinson disease : SAGE analysis of the substantia Nigra |
| 001E39 |
Aideen Mcinerney-Leo [États-Unis] ; Donald W. Hadley [États-Unis] ; Katrina Gwinn-Hardy [États-Unis] ; John Hardy [États-Unis] | Genetic testing in Parkinson's disease |
| 001E40 |
Manuela Contin [Italie] ; Paolo Martinelli [Italie] ; Mirella Mochi [Italie] ; Roberto Riva [Italie] ; Fiorenzo Albani [Italie] ; Agostino Baruzzi [Italie] | Genetic polymorphism of catechol-O-methyltransferase and levodopa pharmacokinetic-pharmacodynamic pattern in patients with Parkinson's disease |
| 001E43 |
Jose Miguel Bras [Portugal, États-Unis] ; Rita Joao Guerreiro [Portugal, États-Unis] ; Maria Helena Ribeiro [Portugal] ; Cristina Januario [Portugal] ; Ana Morgadinho [Portugal] ; Catarina Resende Oliveira [Portugal] ; Luis Cunha [Portugal] ; John Hardy [États-Unis] ; Andrew Singleton [États-Unis] | G2019S dardarin substitution is a common cause of parkinson's disease in a portuguese cohort |
| 001E46 |
Julie A. Robichaud [États-Unis] ; Kerstin D. Pfann [États-Unis] ; David E. Vaillancourt [États-Unis] ; Cynthia L. Comella [États-Unis] ; Daniel M. Corcos [États-Unis] | Force control and disease severity in Parkinson's disease |
| 001E51 |
Catherine L. Wielinski [États-Unis] ; Cordelia Erickson-Davis [États-Unis] ; Rose Wichmann [États-Unis] ; Maria Walde-Douglas [États-Unis] ; Sotirios A. Parashos [États-Unis] | Falls and injuries resulting from falls among patients with Parkinson's disease and other parkinsonian syndromes |
| 001E52 |
Jörg Spiegel [Allemagne] ; Marc-Oliver Mollers [Allemagne] ; Wolfgang H. Jost [Allemagne] ; Gerhard Fuss [Allemagne] ; Ulrich Dillmann [Allemagne] ; Georg Becker [Allemagne] ; Carl-Martin Kirsch [Allemagne] | FP-CIT and MIBG scintigraphy in early Parkinson's disease |
| 001E53 |
Christopher G. Goetz [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] | Evidence-based medical review update : Pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004 |
| 001E55 |
Adrian Cristian [États-Unis] ; Meredith Katz [États-Unis] ; Eileen Cutrone [États-Unis] ; Ruth H. Walker [États-Unis] | Evaluation of acupuncture in the treatment of Parkinson's disease : A double-blind pilot study |
| 001E58 |
Nicolas Simon [France] ; Joëlle Micallef [France] ; Jean-Charles Reynier [France] ; Monique Lesourd [France] ; Tatiana Witjas [France] ; André Alicherif [France] ; Jean-Philippe Azulay [France] ; Olivier Blin [France] | End-of-dose akinesia after a single intravenous infusion of the dopaminergic agonist piribedil in Parkinson's disease patients : A pharmacokinetic/pharmacodynamic, randomized, double-blind study |
| 001E59 |
Henry Woodford [Royaume-Uni] ; Richard Walker [Royaume-Uni] | Emergency hospital admissions in idiopathic Parkinson's disease |
| 001E63 |
William Bara-Jimenez [États-Unis] ; Francesco Bibbiani [États-Unis] ; Michael J. Morris [États-Unis] ; Tzvetelina Dimitrova [États-Unis] ; Abdullah Sherzai [États-Unis] ; Maral M. Mouradian [États-Unis] ; Thomas N. Chase [États-Unis] | Effects of serotonin 5-HT1A agonist in advanced Parkinson's disease |
| 001E65 |
Paolo Lamberti [Italie] ; Stefano Zoccolella [Italie] ; Giovanni Iliceto [Italie] ; Elio Armenise [Italie] ; Angela Fraddosio [Italie] ; Michele De Mari [Italie] ; Paolo Livrea [Italie] | Effects of levodopa and COMT inhibitors on plasma Homocysteine in Parkinson's disease patients |
| 001E66 |
Anna Lena Törnqvist [Suède] ; Lucyna Schalen [Suède] ; Stig Rehncrona [Suède] | Effects of different electrical parameter settings on the intelligibility of speech in patients with Parkinson's disease treated with subthalamic deep brain stimulation |
| 001E67 |
Paulo S. Boggio [Brésil] ; Felipe Fregni [États-Unis] ; Felix Bermpohl [États-Unis] ; Carlos G. Mansur [Brésil] ; Moacyr Rosa [Brésil] ; Demetrio O. Rumi [Brésil] ; Egberto R. Barbosa [Brésil] ; Marina Odebrecht Rosa [Brésil] ; Alvaro Pascual-Leone [États-Unis] ; Sélgio Paulo Rigonatti [Brésil] ; Marco A. Marcolin [Brésil] ; Maria Teresa Araujo Silva [Brésil] | Effect of repetitive TMS and fluoxetine on cognitive function in patients with parkinson's disease and concurrent depression |
| 001E68 |
Christine Brefel-Courbon [France] ; Pierre Payoux [France] ; Claire Thalamas [France] ; Fabienne Ory [France] ; Isabelle Quelven [France] ; Francois Chollet [France] ; Jean Louis Montastruc [France] ; Olivier Rascol [France] | Effect of levodopa on pain threshold in Parkinson's disease : A clinical and positron emission tomography study |
| 001E69 |
Pershia Samadi [Canada] ; Laurent Gregoire [Canada] ; Arash Rassoulpour [États-Unis] ; Paolo Guidetti [Canada] ; Emanuela Izzo [Italie] ; Robert Schwarcz [États-Unis] ; Paul J. Bedard [Canada] | Effect of kynurenine 3-hydroxylase inhibition on the dyskinetic and antiparkinsonian responses to levodopa in parkinsonian monkeys |
| 001E72 |
Charlotte Meindorfner [Allemagne] ; Yvonne Körner [Allemagne] ; Jens Carsten Möller [Allemagne] ; Karin Stiasny-Kolster [Allemagne] ; Wolfgang Hermann Oertel [Allemagne] ; Hans-Peter Krüger [Allemagne] | Driving in Parkinson's disease : Mobility, accidents, and sudden onset of sleep at the wheel |
| 001E73 |
William G. Ondo [États-Unis] ; Ron Tintner [États-Unis] ; Kevin Dat Voung [États-Unis] ; DEJIAN LAI [États-Unis] ; George Ringholz [États-Unis] | Double-blind, placebo-controlled, unforced titration parallel trial of quetiapine for dopaminergic-induced hallucinations in Parkinson's disease |
| 001E74 |
Michelle Porritt [Australie] ; Davor Stanic [Australie] ; David Finkelstein [Australie] ; Peter Batchelor [Australie] ; Sharon Lockhart [Australie] ; Andrew Hughes [Australie] ; Renate Kalnins [Australie] ; David Howells [Australie] | Dopaminergic innervation of the human striatum in Parkinson's disease |
| 001E75 |
Hae-Won Shin [Corée du Sud] ; Suk Y. Kang [Corée du Sud] ; Young H. Sohn [Corée du Sud] | Dopaminergic influence on disturbed spatial discrimination in Parkinson's disease |
| 001E76 |
Ronald B. Postuma [Canada] ; Tamara Arenovich [Canada] ; Anthony E. Lang [Canada] | Does severity of Parkinson's disease vary according to season? |
| 001E78 |
Reinoud C. Klein [Pays-Bas] ; Bauke M. De Jong [Pays-Bas] ; Joeke J. De Vries [Pays-Bas] ; Klaus L. Leenders [Pays-Bas] | Direct comparison between regional cerebral metabolism in progressive supranuclear palsy and Parkinson's disease |
| 001E79 |
Hansjorg B Zner [Allemagne] ; Jurik Schanz [Allemagne] ; Christian Blahak [Allemagne] ; Eva Grips [Allemagne] ; Johannes C. Wöhrle [Allemagne] ; Michael Hennerici [Allemagne] | Differential pattern of hand-tapping compromise in vascular versus idiopathic parkinsonism : A study based on computerized movement analysis |
| 001E84 |
J. Carsten Moller [Allemagne] ; Mira Rethfeldt [Allemagne] ; Yvonne Körner [Allemagne] ; Karin Stiasny-Kolster [Allemagne] ; Werner Cassel [Allemagne] ; Charlotte Meindorfner [Allemagne] ; Ida Rissling [Allemagne] ; Hans-Peter Krüger [Allemagne] ; Wolfgang H. Oertel [Allemagne] | Daytime sleep latency in medication-matched parkinsonian patients with and without sudden onset of sleep |
| 001E85 |
Peter Hobson [Royaume-Uni] ; John Gallacher [Royaume-Uni] ; Jolyon Meara [Royaume-Uni] | Cross-sectional survey of Parkinson's disease and parkinsonism in a rural area of the United Kingdom |
| 001E88 |
Alexandre Kreisler [France] ; Luc Defebvre [France] ; Pascal Lecouffe [France] ; Alain Duhamel [France] ; Pierre Charpentier [France] ; Marc Steinling [France] ; Alain Destée [France] | Corticobasal degeneration and Parkinson's disease assessed by HmPaO spect : The utility of factorial discriminant analysis |
| 001E89 |
Regina Katzenschlager [Royaume-Uni, Autriche] ; Andrew Hughes [Australie] ; Andrew Evans [Royaume-Uni] ; Alice J. Manson [Royaume-Uni] ; Marion Hoffman [Australie] ; Lesley Swinn [Royaume-Uni] ; Hilary Watt [Royaume-Uni] ; Kailash Bhatia [Royaume-Uni] ; Niall Quinn [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease : A prospective study using single-dose challenges |
| 001E90 |
Victor Lun [Canada] ; Nancy Pullan [Canada] ; Nancy Labelle [Canada] ; Corey Adams [Canada] ; Oksana Suchowersky [Canada] | Comparison of the effects of a self-supervised home exercise program with a physiotherapist-supervised exercise program on the motor symptoms of Parkinson's disease |
| 001E96 |
Gail A. Kang [États-Unis] ; Jeff M. Bronstein [États-Unis] ; Donna L. Masterman [États-Unis] ; Matthew Redelings [États-Unis] ; Jarrod A. Crum [États-Unis] ; Beate Ritz [États-Unis] | Clinical characteristics in early Parkinson's disease in a central California population-based study |
| 001F02 |
Jean-Philippe Galanaud [France] ; Alexis Elbaz [France] ; Jacqueline Clavel [France] ; Jean-Sébastien Vidal [France] ; Jean-René Correze [France] ; Annick Alperovitch [France] ; Christophe Tzourio [France] | Cigarette smoking and Parkinson's disease : A case-control study in a population characterized by a high prevalence of pesticide exposure |
| 001F06 |
Anne Beuter [France] ; Emilie Barbo [Canada] ; Robert Rigal [Canada] ; Pierre J. Blanchet [Canada] | Characterization of subclinical tremor in Parkinson's disease |
| 001F07 |
Serge Pinto [France] ; Michèle Gentil [France] ; Paul Krack [France] ; Paul Sauleau [France] ; Valérie Fraix [France] ; Alim-Louis Benabid [France] ; Pierre Pollak [France] | Changes induced by levodopa and subthalamic nucleus stimulation on parkinsonian speech |
| 001F11 |
Shateeq S. Ladha [États-Unis] ; Russell Walker [États-Unis] ; Holly A. Shill [États-Unis] | Case of neuroleptic malignant-like syndrome precipitated by abrupt fava bean discontinuance |
| 001F15 |
Daniel M. Huse [États-Unis] ; Kathy Schulman [États-Unis] ; Lucinda Orsini [États-Unis] ; Jane Castelli-Haley [États-Unis] ; Sean Kennedy [États-Unis] ; Gregory Lenhart [États-Unis] | Burden of illness in Parkinson's disease |
| 001F16 |
Esther Cubo [Espagne] ; Elena Alvarez [Espagne] ; Consuelo Morant [Espagne] ; Jesus De Pedro Cuesta [Espagne] ; Pablo Martinez Martin [Espagne] ; Ricard Genova [Espagne] ; José Manuel Freire [Espagne] | Burden of disease related to Parkinson's disease in Spain in the year 2000 |
| 001F17 |
Masataka Nishimura [Japon] ; Sadako Kuno [Japon] ; Ryuji Kaji [Japon] ; Hideshi Kawakami [Japon] | Brain-derived neurotrophic factor gene polymorphisms in Japanese patients with sporadic Alzheimer's disease, Parkinson's disease, and multiple system atrophy |
| 001F18 |
Emma J. Burton [Royaume-Uni] ; Ian G. Mckeith [Royaume-Uni] ; David J. Burn [Royaume-Uni] ; John T. O'Brien [Royaume-Uni] | Brain atrophy rates in Parkinson's disease with and without dementia using serial magnetic resonance imaging |
| 001F20 |
Bjorn Holmberg [Suède] ; Olle Corneliusson [Suède] ; Mikael Elam [Suède] | Bilateral stimulation of nucleus subthalamicus in advanced Parkinson's disease : No effects on, and of, autonomic dysfunction |
| 001F29 |
Richard Camicioli [Canada] ; Ali Rajput [Canada] ; Michelle Rajput [Canada] ; Christian Reece [Canada] ; Haydeh Payami [États-Unis] ; CHUNHAI HAO [Canada] ; Alex Rajput [Canada] | Apolipoprotein E ε4 and catechol-O-methyltransferase alleles in autopsy-proven Parkinson's disease : Relationship to dementia and hallucinations |
| 001F31 |
Valerie E. Kelly [États-Unis] ; Amy J. Bastian [États-Unis] | Antiparkinson medications improve agonist activation but not antagonist inhibition during sequential reaching movements |
| 001F32 |
Daniel Weintraub [États-Unis] ; Knashawn H. Morales [États-Unis] ; Paul J. Moberg [États-Unis] ; Warren B. Bilker [États-Unis] ; Catherine Balderston [États-Unis] ; John E. Duda [États-Unis] ; Ira R. Katz [États-Unis] ; Matthew B. Stern [États-Unis] | Antidepressant studies in Parkinson's disease : A review and meta-analysis |
| 001F33 |
Wilfred F. A. Den Dunnen [Pays-Bas] ; Michiel J. Staal [Pays-Bas] | Anatomical alterations of the subthalamic nucleus in relation to age : A postmortem study |
| 001F34 |
Kazumasa Shindo [Japon] ; Eri Kaneko [Japon] ; Harue Watanabe [Japon] ; Tetsuhiko Sugimoto [Japon] ; Emiko Ohta [Japon] ; Kenji Ohashi [Japon] ; Takamura Nagasaka [Japon] ; Zenji Shiozawa [Japon] | Analysis of the relationship between muscle sympathetic nerve activity and cardiac 123I -metaiodobenzylguanidine uptake in patients with Parkinson's disease |
| 001F35 |
Carme Junque [Espagne] ; Blanca Ramirez-Ruiz [Espagne] ; Eduardo Tolosa [Espagne] ; Christopher Summerfield [Espagne] ; Maria-José Marti [Espagne] ; Pau Pastor [Espagne] ; Beatriz Gomez-Anson [Espagne] ; José M. Mercader [Espagne] | Amygdalar and hippocampal MRI volumetric reductions in Parkinson's disease with dementia |
| 001F38 |
Eng-King Tan [Singapour] ; Van R. Chandran [Singapour] ; Stephanie Fook-Chong [Singapour] ; HUI SHEN [Singapour] ; F. Kenneth Yew [Singapour] ; Mei-Lin Teoh [Singapour] ; YI ZHAO [Singapour] | Alpha-synuclein mRNA expression in sporadic Parkinson's disease |
| 001F39 |
Kevin J. Klos [États-Unis] ; Keith A. Josephs [États-Unis] ; Joseph E. Parisi [États-Unis] ; Dennis W. Dickson [États-Unis] | Alpha-synuclein immunohistochemistry in two cases of co-occurring idiopathic Parkinson's disease and motor neuron disease |
| 001F40 |
Daniela Berg [Allemagne] ; Marc Niwar [Allemagne] ; Sylvia Maass [Allemagne] ; Alexander Zimprich [Autriche] ; J. Carsten Moller [Allemagne] ; Ullrich Wuellner [Allemagne] ; Tanja Schmitz-Hübsch [Allemagne] ; Christine Klein [Allemagne] ; Eng-King Tan [Singapour] ; Ludger Schöls [Allemagne] ; Laura Marsh [États-Unis] ; Ted M. Dawson [États-Unis] ; Bernd Janetzky [Allemagne] ; Thomas Müller [Allemagne] ; Dirk Woitalla [Allemagne] ; Vladimir Kostic [Serbie] ; Peter P. Pramstaller [Italie] ; Wolfgang H. Oertel [Allemagne] ; Peter Bauer [Allemagne] ; Rejko Krueger [Allemagne] ; Thomas Gasser [Allemagne] ; Olaf Riess [Allemagne] | Alpha-synuclein and Parkinson's disease : Implications from the screening of more than 1,900 patients |
| 001F41 |
George K. Tofaris [Royaume-Uni] ; Maria Grazia Spillantini | Alpha-synuclein Dysfunction in lewy body diseases |
| 001F45 |
Tatiana Witjas [France] ; Christelle Baunez [France] ; Jean Marc Henry [France] ; Marie Delfini [France] ; Jean Regis [France] ; André Ali Cherif [France] ; Jean Claude Peragut [France] ; Jean Philippe Azulay [France] | Addiction in Parkinson's disease : Impact of subthalamic nucleus deep brain stimulation |
| 001F48 |
Samer Karamohamed [États-Unis] ; L. I. Golbe [États-Unis] ; M. H. Mark [États-Unis] ; A. M. Lazzarini [États-Unis] ; O. Suchowersky [Canada] ; N. Labelle [Canada] ; Mark Guttman [Canada] ; L. J. Currie [États-Unis] ; G. F. Wooten [États-Unis] ; M. Stacy [États-Unis] ; M. Saint-Hilaire [États-Unis] ; R. G. Feldman [États-Unis] ; J. Liu [États-Unis] ; C. M. Shoemaker [États-Unis] ; J. B. Wilk [États-Unis] ; A. L. Destefano [États-Unis] ; J. C. Latourelle [États-Unis] ; G. Xu [États-Unis] ; R. Watts [États-Unis] ; J. Growdon [États-Unis] ; M. Lew [États-Unis] ; C. Waters [États-Unis] ; P. Vieregge [Allemagne] ; P. P. Pramstaller [Italie] ; C. Klein [Allemagne] ; B. A. Racette [États-Unis] ; J. S. Perlmutter [États-Unis] ; A. Parsian [États-Unis] ; Carlos Singer [États-Unis] ; E. Montgomery [États-Unis] ; K. Baker [États-Unis] ; J. F. Gusella [États-Unis] ; A. Herbert [États-Unis] ; R. H. Myers [États-Unis] | Absence of previously reported variants in the SCNA (G88c and G209A), NR4A2 (T291D and T245G) and the DJ-1 (T497C) genes in familial parkinson's disease from the GenePD study |
| 001F50 |
Yoshihiro Sato [Japon] ; Yoshiaki Honda [Japon] ; Jun Iwamoto [Japon] ; Tomohiro Kanoko [Japon] ; Kei Satoh [Japon] | Abnormal bone and calcium metabolism in immobilized Parkinson's disease patients |
| 001F51 |
Dag Aarsland [Norvège] ; Julia Zaccai [Royaume-Uni] ; Carol Brayne [Royaume-Uni] | A systematic review of prevalence studies of dementia in Parkinson's disease |
| 001F57 |
Cheryl H. Waters [États-Unis] ; Kapil D. Sethi [États-Unis] ; Robert A. Hauser [États-Unis] ; Eric Molho [États-Unis] ; John M. Bertoni [États-Unis] | Zydis selegiline reduces Off time in Parkinson's disease patients with motor fluctuations: A 3-month, randomized, placebo-controlled study |
| 001F59 |
Dag Nyholm [Suède] ; Jan Kowalski [Suède] ; Sten-Magnus Aquilonius [Suède] | Wireless real-time electronic data capture for self-assessment of motor function and quality of life in Parkinson's disease |
| 001F62 |
Atsuko Nagano-Saito [Japon] ; Yukihiko Washimi [Japon] ; Yutaka Arahata [Japon] ; Katsushige Iwai [Japon] ; Shoji Kawatsu [Japon] ; Kengo Ito [Japon] ; Akinori Nakamura [Japon] ; Yuji Abe [Japon] ; Takako Yamada [Japon] ; Takashi Kato [Japon] ; Teruhiko Kachi [Japon] | Visual hallucination in Parkinson's disease with FDG PET |
| 001F70 |
Marco D'Amelio [Italie] ; Paolo Ragonese [Italie] ; Letterio Morgante [Italie] ; Antonio Epifanio [Italie] ; Graziella Callari [Italie] ; Giuseppe Salemi [Italie] ; Giovanni Savettieri [Italie] | Tumor diagnosis preceding Parkinson's disease: A case-control study |
| 001F71 |
Katherine Grosset [Royaume-Uni] ; Donald Grosset [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Trial of subtherapeutic pergolide in de novo Parkinson's disease |
| 001F77 |
Lorenzo Priano [Italie] ; Gianni Albani [Italie] ; Andrea Brioschi [Italie] ; Sara Calderoni [Italie] ; Leonardo Lopiano [Italie] ; Mario Rizzone [Italie] ; Roberta Cavalli [Italie] ; Maria Rosa Gasco [Italie] ; Francesco Scaglione [Italie] ; Franco Fraschini [Italie] ; Bruno Bergamasco [Italie] ; Alessandro Mauro [Italie] | Transdermal apomorphine permeation from microemulsions: A new treatment in Parkinson's Disease |
| 001F80 |
Leo Verhagen Metman [États-Unis] ; Brian Myre [États-Unis] ; Niek Verwey [États-Unis] ; Sharon Hassin-Baer [Israël] ; Jean Arzbaecher [États-Unis] ; Diane Sierens [États-Unis] ; Roy Bakay [États-Unis] | Test-retest reliability of UPDRS-III, dyskinesia scales, and timed motor tests in patients with advanced Parkinson's disease: An argument against multiple baseline assessments |
| 001F81 |
Lars Timmermann [Allemagne] ; Lars Wojtecki [Allemagne] ; Joachim Gross [Allemagne] ; Ralph Lehrke [Allemagne] ; Jürgen Voges [Allemagne] ; Mohammed Maarouf [Allemagne] ; Harald Treuer [Allemagne] ; Volker Sturm [Allemagne] ; Alfons Schnitzler [Allemagne] | Ten-Hertz stimulation of subthalamic nucleus deteriorates motor symptoms in Parkinson's disease |
| 001F83 |
Katherine Grosset [Royaume-Uni] ; Fiona Needleman [Royaume-Uni] ; Graeme Macphee [Royaume-Uni] ; Donald Grosset [Royaume-Uni] | Switching from ergot to nonergot dopamine agonists in Parkinson's disease: A clinical series and five-drug dose conversion table |
| 001F85 |
Katerina Venderova [République tchèque] ; Evzen Ruzicka [République tchèque] ; Viktor Vorisek [République tchèque] ; Peter Visnovsky [République tchèque] | Survey on cannabis use in Parkinson's disease: Subjective improvement of motor symptoms |
| 001F87 |
Galit Kleiner-Fisman [Canada] ; David N. Fisman [Canada] ; Orit Zamir [Canada] ; Jonathan O. Dostrovsky [Canada] ; Elspeth Sime [Canada] ; Jean A. Saint-Cyr [Canada] ; Andres M. Lozano [Canada] ; Anthony E. Lang [Canada] | Subthalamic nucleus deep brain stimulation for Parkinson's disease after successful pallidotomy: Clinical and electrophysiological observations |
| 001F94 |
Naoki Hagiwara [Japon] ; Takao Hashimoto [Japon] ; Shu-Ichi Ikeda [Japon] | Static balance impairment and its change after pallidotomy in Parkinson's Disease |
| 001F99 |
MOHAMED FAROUK ALLAM [Espagne] ; Michael J. Campbell [Royaume-Uni] ; Albert Hofman [Pays-Bas] ; Amparo Serrano Del Castillo [Espagne] ; Rafael Fernandez-Crehuet Navajas [Espagne] | Smoking and Parkinson's disease: Systematic review of prospective studies |
| 002006 |
Jan C. M. Zijlmans [Royaume-Uni, Pays-Bas] ; Berengere Debilly [France] ; Olivier Rascol [France] ; Andrew Lees (neurologue) [Royaume-Uni] ; Franck Durif [France] | Safety of entacapone and apomorphine coadministration in levodopa-treated Parkinson's disease patients: Pharmacokinetic and pharmacodynamic results of a multicenter, double-blind, placebo-controlled, cross-over study |
| 002014 |
Peter Hobson [Royaume-Uni] ; Jolyon Meara [Royaume-Uni] | Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom |
| 002027 |
Gurutz Linazasoro [Espagne] | Recent failures of new potential symptomatic treatments for Parkinson's disease: Causes and solutions |
| 002030 |
Jorge L. Juncos [États-Unis] ; Vicki J. Roberts [États-Unis] ; Marian L. Evatt [États-Unis] ; Rita D. Jewart [États-Unis] ; Colleen D. Wood [États-Unis] ; Larry S. Potter [États-Unis] ; Hann-Chang Jou [États-Unis] ; Paul P. Yeung [États-Unis] | Quetiapine improves psychotic symptoms and cognition in Parkinson's disease |
| 002032 |
Connie Marras [Canada] ; Anthony Lang [Canada] ; Murray Krahn [Canada] ; George Tomlinson [Canada] ; Gary Naglie [Canada] | Quality of life in early Parkinson's disease: Impact of dyskinesias and motor fluctuations |
| 002033 |
Marcin Zach [Pologne] ; Andrzej Friedman [Pologne] ; Jarosław Sławek [Pologne] ; Mirosława Derejko [Pologne] | Quality of life in Polish patients with long-lasting Parkinson's disease |
| 002034 |
Andrew H. Evans [Royaume-Uni] ; Regina Katzenschlager [Royaume-Uni] ; Dominic Paviour [Royaume-Uni] ; John D. O'Sullivan [Australie] ; Silke Appel [Royaume-Uni] ; Andrew D. Lawrence [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Punding in Parkinson's disease: Its relation to the dopamine dysregulation syndrome |
| 002037 |
Rocco Agostino [Italie] ; Antonio Curra [Italie] ; Giampiero Soldati [Italie] ; Loredana Dinapoli [Italie] ; Luigi Chiacchiari [Italie] ; Nicola Modugno [Italie] ; Francesco Pierelli [Italie] ; Alfredo Berardelli [Italie] | Prolonged practice is of scarce benefit in improving motor performance in Parkinson's disease |
| 002045 |
Rainer Linke [Allemagne] ; Ilonka Eisensehr [Allemagne] ; Thomas-Christian Wetter [Allemagne] ; Franz-Josef Gildehaus [Allemagne] ; Gabriele Pöpperl [Allemagne] ; Claudia Trenkwalder [Allemagne] ; Soheyl Noachtar [Allemagne] ; Klaus Tatsch [Allemagne] | Presynaptic dopaminergic function in patients with restless legs syndrome: Are there common features with early Parkinson's disease? |
| 002047 |
Din-E. Shan [Taïwan] ; Ren-Shyan Liu [Taïwan] ; Chen-Ming Sun [Taïwan] ; Shwn-Jen Lee [Taïwan] ; Kwong-Kum Liao [Taïwan] ; Bing-Wen Soong [Taïwan] | Presence of spinocerebellar ataxia type 2 gene mutation in a patient with apparently sporadic Parkinson's disease: Clinical implications |
| 002049 |
Yvonne Körner [Allemagne] ; Charlotte Meindorfner [Allemagne] ; Jens Carsten Möller [Allemagne] ; Karin Stiasny-Kolster [Allemagne] ; Doris Haja [Allemagne] ; Werner Cassel [Allemagne] ; Wolfgang Hermann Oertel [Allemagne] ; Hans-Peter Krüger [Allemagne] | Predictors of sudden onset of sleep in Parkinson's disease |
| 002051 |
Marco Mucchiut [Italie] ; Enrico Belgrado [Italie] ; Daniela Cutuli [Italie] ; Angelo Antonini [Italie] ; Paolo Bergonzi [Italie] | Pramipexole-treated Parkinson's disease during pregnancy |
| 002053 |
Thomas Foltynie [Royaume-Uni] ; Terry E. Goldberg [États-Unis] ; Simon G. J. Lewis [Royaume-Uni] ; Andrew D. Blackwell [Royaume-Uni] ; Bhaskar S. Kolachana [États-Unis] ; Daniel R. Weinberger [États-Unis] ; Trevor W. Robbins [Royaume-Uni] ; Roger A. Barker [Royaume-Uni] | Planning ability in Parkinson's disease is influenced by the COMT Val158Met polymorphism |
| 002065 |
Elena Lezcano [Espagne] ; Juan C. Gomez-Esteban [Espagne] ; Juan J. Zarranz [Espagne] ; Rafael Alcaraz [Espagne] ; Begona Atares [Espagne] ; Gaizka Bilbao [Espagne] ; Jesus Garibi [Espagne] ; Imanol Lambarri [Espagne] | Parkinson's disease-like presentation of multiple system atrophy with poor response to STN stimulation: A clinicopathological case report |
| 002066 |
Frédéric Macia [France] ; Caroline Perlemoine [France] ; Irène Coman [France] ; Dominique Guehl [France] ; Pierre Burbaud [France] ; Emmanuel Cuny [France] ; Henri Gin [France] ; Vincent Rigalleau [France] ; Francois Tison [France] | Parkinson's disease patients with bilateral subthalamic deep brain stimulation gain weight |
| 002067 |
Joseph Wiley [Irlande (pays)] ; Timothy Lynch [Irlande (pays)] ; Sarah Lincoln [États-Unis] ; Lisa Skipper [États-Unis] ; Mary Hulihan [États-Unis] ; David Gosal [Irlande (pays)] ; Gina Bisceglio [États-Unis] ; Jennifer Kachergus [États-Unis] ; John Hardy [États-Unis] ; Matthew J. Farrer [États-Unis] | Parkinson's disease in Ireland: Clinical presentation and genetic heterogeneity in patients with Parkin mutations |
| 002068 |
Robert A. Hauser [États-Unis] ; Frieda Deckers [Belgique] ; Philippe Lehert [Belgique] | Parkinson's disease home diary: Further validation and implications for clinical trials |
| 002069 |
Pablo Martinez-Martin [Espagne] ; Carlos Salvador [Espagne] ; Luis Menendez-Guisasola [Espagne] ; Sonia Gonzalez [Espagne] ; Aurelio Tobias [Espagne] ; Javier Almazan [Espagne] ; K. Ray Chaudhuri [Royaume-Uni] | Parkinson's Disease Sleep scale: Validation study of a Spanish version |
| 002076 |
Eng-King Tan [Singapour] ; Henry Chung [Singapour] ; Vandana R. Chandran [Singapour] ; Chris Tan [Singapour] ; HUI SHEN [Singapour] ; Kenneth Yew [Singapour] ; Ratnagopal Pavanni [Singapour] ; Kathi-Avelu Puvan [Singapour] ; Meng-Cheong Wong [Singapour] ; Mei-Lin Teoh [Singapour] ; YUAN YIH [Singapour] ; YI ZHAO [Singapour] | Nurr1 mutational screen in Parkinson's disease |
| 002078 |
Susan Fox [Royaume-Uni] ; Montague Silverdale ; Mark Kellett ; Rhys Davies ; Malcolm Steiger [Royaume-Uni] ; Nicholas Fletcher [Royaume-Uni] ; Alan Crossman [Royaume-Uni] ; Jonathan Brotchie | Non-subtype-selective Opioid receptor antagonism in treatment of levodopa-induced motor complications in Parkinson's disease |
| 002096 |
Jan Herzog [Allemagne] ; Urban Fietzek [Allemagne] ; Wolfgang Hamel [Allemagne] ; Andre Morsnowski [Allemagne] ; Frank Steigerwald [Allemagne] ; Bettina Schrader [Allemagne] ; Dieter Weinert [Allemagne] ; Gerd Pfister [Allemagne] ; Dieter Müller [Allemagne] ; Hubertus M. Mehdorn [Allemagne] ; Günther Deuschl [Allemagne] ; Jens Volkmann [Allemagne] | Most effective stimulation site in subthalamic deep brain stimulation for Parkinson's disease |
| 002098 |
Padraig E. O'Suilleabhain [États-Unis] ; Teodoro Bottiglieri [États-Unis] ; Richard B. Jr Dewey [États-Unis] ; Shailja Sharma [États-Unis] ; Ramon Diaz-Arrastia [États-Unis] | Modest increase in plasma homocysteine follows levodopa initiation in Parkinson's disease |
| 002102 |
Peter A. Kempster [Australie] | Michael J. Fox and his Parkinson's disease |
| 002111 |
Neeraj Kumar [États-Unis] ; Jay A. Van Gerpen [États-Unis] ; James H. Bower [États-Unis] ; J. Eric Ahlskog [États-Unis] | Levodopa-dyskinesia incidence by age of Parkinson's disease onset |
| 002112 |
Svenja Happe [Allemagne] ; Tobias Tings [Allemagne] ; Kathrin Helmschmied [Allemagne] ; Karin Neubert [Allemagne] ; Wolfgang Wuttke [Allemagne] ; Walter Paulus [Allemagne] ; Claudia Trenkwalder [Allemagne] | Levodopa treatment does not affect low-dose apomorphine test in patients with Parkinson's disease |
| 002113 |
C. Warren Olanow [États-Unis] ; Yves Agid [France] ; Yoshi Mizuno [Japon] ; Alberto Albanese [Italie] ; U. Bonucelli [Italie] ; Philip Damier [France] ; Justo De Yebenes [Espagne] ; Oscar Gershanik [Argentine] ; Mark Guttman [Canada] ; F. Grandas [Espagne] ; Mark Hallett [États-Unis] ; Ole Hornykiewicz [Autriche] ; Peter Jenner [Royaume-Uni] ; R. Katzenschlager [Royaume-Uni] ; William J. Langston [États-Unis] ; Peter Lewitt [États-Unis] ; Eldad Melamed [Israël] ; M. A. Mena [Espagne] ; P. P. Michel [France] ; Catherine Mytilineou [États-Unis] ; Jose A. Obeso [Espagne] ; Werner Poewe [Autriche] ; Niall Quinn [Royaume-Uni] ; R. Raisman-Vozari [France] ; Ali H. Rajput [Canada] ; Olivier Rascol [France] ; Christina Sampaio ; Fabrizio Stocchi | Levodopa in the treatment of Parkinson's disease: Current controversies |
| 002114 |
Michael S. Okun [États-Unis] ; Jerrold L. Vitek [États-Unis] | Lesion therapy for Parkinson's disease and other movement disorders: Update and controversies |
| 002125 |
Valtteri Kaasinen [Finlande] ; Sargo Aalto [Finlande] ; Kjell Nagren [Finlande] ; Juha O. Rinne [Finlande] | Insular dopamine D2 receptors and Novelty seeking personality in Parkinson's disease |
| 002130 |
Niels Hjort [Danemark] ; Karen Stergaard [Danemark] ; Erik Dupont [Danemark] | Improvement of sleep quality in patients with advanced Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus |
| 002135 |
Ana M. Catafau [Espagne] ; Eduardo Tolosa [Espagne] | Impact of dopamine transporter SPECT using 123I-ioflupane on diagnosis and management of patients with clinically uncertain parkinsonian syndromes |
| 002142 |
Pablo Martinez-Martin [Espagne] ; Julian Benito-Leon [Espagne] ; Fernando Alonso [Espagne] ; Maria José Catalan [Espagne] ; Margarita Pondal [Espagne] ; Ivana Zamarbide [Espagne] | Health-related quality of life evaluation by proxy in Parkinson's disease: Approach using PDQ-8 and EuroQol-5D |
| 002144 |
Stuart J. Fellows [Allemagne] ; Johannes Noth [Allemagne] | Grip force abnormalities in de novo Parkinson's disease |
| 002151 |
Daniela Berg [Allemagne] ; Berthold Merz [Allemagne] ; Karlheinz Reiners [Allemagne] ; Markus Naumann [Allemagne] ; Georg Becker [Allemagne] | Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease |
| 002153 |
Bastiaan R. Bloem [Pays-Bas] ; Jeffrey M. Hausdorff [Israël, États-Unis] ; Jasper E. Visser [Pays-Bas] ; Nir Giladi [Israël] | Falls and freezing of gait in Parkinson's disease: A review of two interconnected, episodic phenomena |
| 002155 |
Michiko K. Bruno [États-Unis] ; Bernard Ravina [États-Unis] ; Gaetan Garraux [États-Unis] ; Mark Hallett [États-Unis] ; Louis Ptacek [États-Unis] ; Amanda Singleton [États-Unis] ; Janel Johnson [États-Unis] ; Andrew Singleton [États-Unis] ; Melissa Hanson [États-Unis] ; Elaine Considine [États-Unis] ; Katrina Gwinn-Hardy [États-Unis] | Exercise-induced dystonia as a preceding symptom of familial Parkinson's disease |
| 002157 |
William C. Nichols [États-Unis] ; Sean K. Uniacke [États-Unis] ; Nathan Pankratz [États-Unis] ; Terry Reed [États-Unis] ; David K. Simon [États-Unis] ; Cheryl Halter [États-Unis] ; Alice Rudolph [États-Unis] ; Clifford W. Shults [États-Unis] ; P. Michael Conneally [États-Unis] ; Tatiana Foroud [États-Unis] | Evaluation of the role of Nurr1 in a large sample of familial Parkinson's disease |
| 002161 |
Istvan Vermes [Pays-Bas] ; Ernst N. H. Jansen Steur [Pays-Bas] ; Gustav F. Jirikowski [Allemagne] ; Clemens Haanen [Pays-Bas] | Elevated concentration of cerebrospinal fluid Tissue transglutaminase in Parkinson's disease indicating apoptosis |
| 002162 |
Hatice Kumru [Espagne] ; Christopher Summerfield [Espagne] ; Francesc Valldeoriola [Espagne] ; Josep Valls-Sole [Espagne] | Effects of subthalamic nucleus stimulation on characteristics of EMG activity underlying reaction time in Parkinson's disease |
| 002163 |
Maaike Bakker [Pays-Bas] ; Rianne A. J. Esselink [Pays-Bas] ; Marten Munneke [Pays-Bas] ; Patricia Limousin-Dowsey [Royaume-Uni] ; Hans D. Speelman [Pays-Bas] ; Bastiaan R. Bloem [Pays-Bas] | Effects of stereotactic neurosurgery on postural instability and gait in Parkinson's disease |
| 002166 |
William Bara-Jimenez [États-Unis] ; Tzvetelina Dimitrova [États-Unis] ; Abdulah Sherzai [États-Unis] ; Antonella Favit [États-Unis] ; M. M. Mouradian [États-Unis] ; Thomas N. Chase [États-Unis] | Effect of monoamine reuptake inhibitor NS 2330 in advanced Parkinson's disease |
| 002169 |
Norman A. Leopold [États-Unis] ; Marcia Polansky [États-Unis] ; Marcia R. Hurka [États-Unis] | Drug adherence in Parkinson's disease |
| 002170 |
Matthew B. Stern [États-Unis] ; Kenneth L. Marek [États-Unis] ; Joseph Friedman [États-Unis] ; Robert A. Hauser [États-Unis] ; Peter A. Lewitt [États-Unis] ; Daniel Tarsy [États-Unis] ; C. Warren Olanow [États-Unis] | Double-blind, randomized, controlled trial of Rasagiline as monotherapy in early Parkinson's Disease patients |
| 002171 |
Ida Rissling [Allemagne] ; Frank Geller [Allemagne] ; Oliver Bandmann [Allemagne] ; Karim Stiasny-Kolster [Allemagne] ; Yvonne Körner [Allemagne] ; Charlotte Meindorfner [Allemagne] ; Hans-Peter Krüger [Allemagne] ; Wolfgang H. Oertel [Allemagne] ; J. Carsten Möller [Allemagne] | Dopamine receptor gene polymorphisms in Parkinson's disease patients reporting "sleep attacks" |
| 002176 |
Joyce C. Pressley [États-Unis] ; Ming-Xin Tang [États-Unis] ; Karen Marder [États-Unis] ; Lucien J. Cote [États-Unis] ; Richard Mayeux [États-Unis] | Disparities in the recording of Parkinson's disease on death certificates |
| 002177 |
Roger Kurlan [États-Unis] | Disabling repetitive behaviors in Parkinson's disease |
| 002179 |
Alexei Korchounov [Allemagne] ; Hayo I. Schipper [Allemagne] ; Irina S. Preobrazhenskaya [Russie] ; Kirn R. Kessler [Allemagne] ; Nikolay N. Yakhno [Russie] | Differences in age at onset and familial aggregation between clinical types of idiopathic Parkinson's disease |
| 002182 |
Eric M. Cheng [États-Unis] ; Andrew Siderowf [États-Unis] ; Kari Swarztrauber [États-Unis] ; Mahmood Eisa [États-Unis] ; Martin Lee [États-Unis] ; Barbara G. Vickrey [États-Unis] | Development of quality of care indicators for Parkinson's disease |
| 002183 |
Federico Micheli [Argentine] ; Maria Clara Scorticati [Argentine] ; Silvia Folgar [Argentine] ; Emilia Gatto [Argentine] ; MD [Argentine] | Development of Parkinson's disease in patients with blepharospasm |
| 002185 |
Ulrike Sommer [Allemagne] ; Thomas Hummel [Allemagne] ; Katja Cormann [Allemagne] ; Antje Mueller [Allemagne] ; Johannes Frasnelli [Allemagne] ; Joachim Kropp [Allemagne] ; Heinz Reichmann [Allemagne] | Detection of presymptomatic Parkinson's disease: Combining smell tests, transcranial sonography, and SPECT |
| 002187 |
Eugene Tunik [États-Unis] ; Sergei V. Adamovich [États-Unis] ; Howard Poizner [États-Unis] ; Anatol G. Feldman [Canada] | Deficits in rapid adjustments of movements according to task constraints in Parkinson's disease |
| 002191 |
Paola Costa-Mallen [États-Unis] ; Zahra Afsharinejad [États-Unis] ; Samir N. Kelada [États-Unis] ; Lucio G. Costa [États-Unis, Italie] ; Gary M. Franklin [États-Unis] ; Phillip D. Swanson [États-Unis] ; W. T. Jr Longstreth [États-Unis] ; Hannah-Malia A. Viernes [États-Unis] ; Federico M. Farin [États-Unis] ; Terri Smith-Weller [États-Unis] ; Harvey Checkoway [États-Unis] | DNA sequence analysis of monoamine oxidase B gene coding and promoter regions in Parkinson's disease cases and unrelated controls |
| 002197 |
Klaus Seppi [Autriche] ; Michael F. H. Schocke [Autriche] ; Eveline Donnemiller [Autriche] ; Regina Esterhammer [Autriche] ; Christian Kremser [Autriche] ; Christoph Scherfler [Autriche] ; Anja Diem [Autriche] ; Werner Jaschke [Autriche] ; Gregor K. Wenning [Autriche] ; Werner Poewe [Autriche] | Comparison of diffusion-weighted imaging and [123I]IBZM-SPECT for the differentiation of patients with the Parkinson variant of multiple system atrophy from those with Parkinson's disease |
| 002198 |
Enrique Noe [États-Unis, Espagne] ; Karen Marder [États-Unis] ; Karen L. Bell [États-Unis] ; Diane M. Jacobs [États-Unis] ; Jennifer J. Manly [États-Unis] ; Yaakov Stern [États-Unis] | Comparison of dementia with Lewy bodies to alzheimer's Disease and Parkinson's disease with dementia |
| 002199 |
Montse Alegret [Espagne] ; Francesc Valldeoriola [Espagne] ; Mjosé Marti [Espagne] ; Manuela Pilleri [Espagne] ; Carme Junque [Espagne] ; Jordi Rumia [Espagne] ; Eduardo Tolosa [Espagne] | Comparative cognitive effects of Bilateral subthalamic stimulation and subcutaneous continuous infusion of apomorphine in Parkinson's disease |
| 002207 |
Lene Wermuth [Danemark] ; Nick Bünger [Danemark] ; Paul Von Weitzel-Mudersback [Danemark] ; Henning Pakkenberg [Danemark] ; Bernard Jeune [Danemark] | Clinical characteristics of Parkinson's disease among inuit in Greenland and inhabitants of the Faroe Islands and Als (Denmark) |
| 002209 |
Guido Alves [Norvège] ; Martin Kurz [Norvège] ; Stein A. Lie [Norvège] ; Jan P. Larsen [Norvège] | Cigarette smoking in Parkinson's disease: Influence on disease progression |
| 002215 |
J. Eric Ahlskog [États-Unis] | Challenging conventional wisdom : The etiologic role of dopamine oxidative stress in Parkinson's disease |
| 002217 |
W. Farid Abdo [Pays-Bas] ; Daniëlle De Jong [Pays-Bas] ; Jan C. M. Hendriks [Pays-Bas] ; Martin W. I. M. Horstink [Pays-Bas] ; Berry P. H. Kremer [Pays-Bas] ; Bastiaan R. Bloem [Pays-Bas] ; Marcel M. Verbeek [Pays-Bas] | Cerebrospinal fluid analysis differentiates multiple system atrophy from Parkinson's disease |
| 002220 |
Nicola Pavese [Royaume-Uni] ; Ornella Rimoldi [Royaume-Uni] ; Alexander Gerhard [Royaume-Uni] ; David J. Brooks [Royaume-Uni] ; Panla Piccini [Royaume-Uni] | Cardiovascular effects of methamphetamine in Parkinson's disease patients |
| 002232 |
Ruth Djaldetti [Israël] ; Mark Hellmann ; Eldad Melamed | Bent knees and tiptoeing: Late manifestations of end-stage Parkinson's disease |
| 002235 |
Margaret K. Y. Mak [Hong Kong] ; Christina W. Y. Hui-Chan [Hong Kong] | Audiovisual cues can enhance sit-to-stand in patients with Parkinson's disease |
| 002239 |
Sebastian Paus [Allemagne] ; Gert Seeger [Allemagne] ; Hans M. Brecht [Allemagne] ; Jürgen Köster [Allemagne] ; Mahha El-Faddagh [Allemagne] ; Markus M. Nöthen [Belgique] ; Thomas Klockgether [Allemagne] ; Ullrich Wüllner [Allemagne] | Association study of dopamine D2, D3, D4 receptor and serotonin transporter gene polymorphisms with sleep attacks in Parkinson's disease |
| 002242 |
Martine Visser [Pays-Bas] ; Johan Marinus [Pays-Bas] ; Anne M. Stiggelbout [Pays-Bas] ; Jacobus J. Van Hilten [Pays-Bas] | Assessment of autonomic dysfunction in Parkinson's disease: The SCOPA-AUT |
| 002243 |
Zoe Katsarou [Grèce] ; Sevasti Bostantjopoulou [Grèce] ; Viv Peto [Royaume-Uni] ; Anna Kafantari [Grèce] ; Elizabeth Apostolidou [Grèce] ; Eleni Peitsidou [Grèce] | Assessing quality of life in Parkinson's disease: Can a short-form questionnaire be useful? |
| 002244 |
Martine Visser [Pays-Bas] ; Johan Marinus [Pays-Bas] ; Jacobus J. Van Hilten [Pays-Bas] ; Ruth G. B. Schipper [Pays-Bas] ; Anne M. Stiggelbout [Pays-Bas] | Assessing comorbidity in patients with Parkinson's disease |
| 002249 |
Christine Sato [Canada] ; Angharad Morgan [Canada] ; Anthony E. Lang [Canada] ; Shabnam Salehi-Rad [Canada] ; Toshitaka Kawarai [Canada] ; YAN MENG [États-Unis] ; Peter N. Ray [Canada] ; Lindsay A. Farrer [États-Unis] ; Peter St George-Hyslop [Canada] ; Ekaterina Rogaeva [Canada] | Analysis of the glucocerebrosidase gene in Parkinson's disease |
| 002250 |
Peter H. Kraus [Allemagne] ; Peter Klotz [Allemagne] ; Arndt Hoffmann [Allemagne] ; Johannes Lewe [Allemagne] ; Horst Przuntek [Allemagne] | Analysis of the course of Parkinson's disease under dopaminergic therapy : Performance of "fast tapping" is not a suitable parameter |
| 002251 |
Lorraine N. Clark [États-Unis] ; Shehla Afridi [États-Unis] ; Helen Mejia-Santana [États-Unis] ; Juliette Harris [États-Unis] ; Elan D. Louis [États-Unis] ; Lucien J. Cote [États-Unis] ; Howard Andrews [États-Unis] ; Andrew Singleton [États-Unis] ; Fabienne Wavrant De-Vrieze [États-Unis] ; John Hardy [États-Unis] ; Richard Mayeux [États-Unis] ; Stanley Fahn [États-Unis] ; Cheryl Waters [États-Unis] ; Blair Ford [États-Unis] ; Steven Frucht [États-Unis] ; Ruth Ottman [États-Unis] ; Karen Marder [États-Unis] | Analysis of an early-onset Parkinson's disease cohort for DJ-1 mutations |
| 002255 |
Ann E. Kingsbury [Royaume-Uni] ; Susan E. Daniel [Royaume-Uni] ; Hardev Sangha [Royaume-Uni] ; Sarah Eisen [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Oliver J. F. Foster [Royaume-Uni] | Alteration in α-synuclein mRNA expression in Parkinson's disease |
| 002261 |
Jerrold L. Vitek [États-Unis] ; Takao Hashimoto [Japon] ; John Peoples [États-Unis] ; Mahlon R. Delong [États-Unis] ; Roy A. E. Bakay [États-Unis] | Acute stimulation in the external segment of the globus pallidus improves Parkinsonian motor signs |
| 002266 |
Okan Dogu [Turquie, États-Unis] ; Janel Johnson [États-Unis] ; Dena Hernandez [États-Unis] ; Melissa Hanson [États-Unis] ; John Hardy [États-Unis] ; Hulya Apaydin [Turquie] ; Sibel Özekmekci [Turquie] ; Serhan Sevim [Turquie] ; Katrina Gwinn-Hardy [États-Unis] ; Andrew Singleton [États-Unis] | A consanguineous Turkish family with early-onset Parkinson's disease and an exon 4 parkin deletion |
| 002267 |
Evelien Huisman [Pays-Bas] ; Harry B. M. Uylings [Pays-Bas] ; Piet V. Hoogland [Pays-Bas, Afrique du Sud] | A 100% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson's disease |
| 002268 |
Carl E. Clarke [Royaume-Uni] | A "cure" for Parkinson's disease: Can neuroprotection be proven with Current trial designs? |
| 002271 |
| Parkinsonism and Dementia: Synucleinopathies, Tauopathies, and Beyond. Proceedings of the "Movement" Disorder Society-European Division-Sponsored Workshop, Istanbul, Turkey, 9-11 May 2002 |
| 002272 |
| Dopamine transporter imaging |
| 002273 |
Anette Schrag [Royaume-Uni] ; Anna Hovris [Royaume-Uni] ; David Morley [Royaume-Uni] ; Niall Quinn [Royaume-Uni] ; Marjan Jahanshahi [Royaume-Uni] | Young-versus older-onset Parkinson's disease: Impact of disease and psychosocial consequences |
| 002274 |
Murat Emre [Turquie] | What causes mental dysfunction in Parkinson's disease? |
| 002275 |
Christian Brenneis [Autriche] ; Klaus Seppi [Autriche] ; Michael F. Schocke [Autriche] ; Jörg Müller [Autriche] ; Elisabeth Luginger [Autriche] ; Sylvia Bosch [Autriche] ; Wolfgang N. Loscher [Autriche] ; Christian Büchel [Allemagne] ; Werner Poewe [Autriche] ; Gregor K. Wenning [Autriche] | Voxel-based morphometry detects cortical atrophy in the Parkinson variant of multiple system atrophy |
| 002276 |
Takashi Nomura [Japon] ; Yuichi Inoue [Japon] ; Hidetaka Mitani [Japon] ; Ryuzo Kawahara [Japon] ; Masahiro Miyake [Japon] ; Kenji Nakashima [Japon] | Visual hallucinations as REM sleep behavior disorders in patients with Parkinson's disease |
| 002279 |
David J. Burn [Royaume-Uni] ; John T. O'Brien [Royaume-Uni] | Use of functional imaging in parkinsonism and dementia |
| 002283 |
Gurutz Linazasoro [Espagne] ; Nadège Van Blercom [Espagne] ; Asier Lasa [Espagne] | Unilateral subthalamic deep brain stimulation in advanced Parkinson's disease |
| 002285 |
Jan Herzog [Allemagne] ; Jens Volkmann [Allemagne] ; Paul Krack [Allemagne] ; Florian Kopper [Allemagne] ; Monika Potter [Allemagne] ; Delia Lorenz [Allemagne] ; Meike Steinbach [Allemagne] ; Stefan Klebe [Allemagne] ; Wolfgang Hamel [Allemagne] ; Bettina Schrader [Allemagne] ; Dieter Weinert [Allemagne] ; Dieter Müller [Allemagne] ; Hubertus M. Mehdorn [Allemagne] ; Günther Deuschl [Allemagne] | Two-year follow-up of subthalamic deep brain stimulation in Parkinson's disease |
| 002288 |
Amy N. Hill [États-Unis] ; Joseph Jankovic [États-Unis] ; Kevin D. A. T. Vuong [États-Unis] ; Don Donovan [États-Unis] | Treatment of hypophonia with collagen vocal cord augmentation in patients with parkinsonism |
| 002290 |
Philip C. Su [Taïwan] ; Ham-Min Tseng [Taïwan] ; Hon-Man Liu [Taïwan] ; Ruoh-Fang Yen [Taïwan] ; Horng-Huei Liou [Taïwan] | Treatment of advanced Parkinson's Disease by subthalamotomy: One-year results |
| 002291 |
Francisco Grandas [Espagne] ; Jaime Kulisevsky [Espagne] | Treatment of Parkinson's disease in Spain |
| 002292 |
Valérie Cochen [France] ; Maria-Joao Ribeiro [France] ; Jean-Paul Nguyen [France] ; Jean-Marc Gurruchaga [France] ; Gabriel Villafane [France] ; Christian Loc'H [France] ; Gilles Defer [France] ; Yves Samson [France] ; Marc Peschanski [France] ; Philippe Hantraye [France] ; Pierre Cesaro [France] ; Philippe Remy [France] | Transplantation in Parkinson's disease: PET changes correlate with the amount of grafted tissue |
| 002296 |
| The unified Parkinson's Disease Rating Scale (UPDRS): Status and recommendations |
| 002299 |
Dominique Twelves [Royaume-Uni] ; Kate S. M. Perkins [Royaume-Uni] ; Carl Counsell [Royaume-Uni] | Systematic review of incidence studies of Parkinson's disease |
| 002300 |
Lesley Swinn [Royaume-Uni] ; Anette Schrag [Royaume-Uni] ; Ramchandran Viswanathan [Royaume-Uni] ; Bastiaan R. Bloem [Royaume-Uni, Pays-Bas] ; Andrew Lees (neurologue) [Royaume-Uni] ; Niall Quinn [Royaume-Uni] | Sweating dysfunction in Parkinson's disease |
| 002301 |
Per-Arne Fall [Suède] ; Avin Saleh [Suède] ; Mats Fredrickson [Suède] ; Jan-Edvin Olsson [Suède] ; Ann-Kathrine Granerus [Suède] | Survival time, mortality, and cause of death in elderly patients with Parkinson's disease: A 9-year follow-up |
| 002302 |
Aida M. Bertoli-Avella [Pays-Bas, Cuba] ; Jose L. Giroud-Benitez [Cuba] ; Vincenzo Bonifati [Pays-Bas, Italie] ; Eduardo Alvarez-Gonzalez [Cuba] ; Luis Heredero-Baute [Cuba] ; Cornelia M. Van Duijn [Pays-Bas] ; Peter Heutink [Pays-Bas] | Suggestive linkage to chromosome 19 in a large Cuban family with late-onset Parkinson's disease |
| 002304 |
Alessandra Pesenti [Italie] ; Alberto Priori [Italie] ; Marco Locatelli [Italie] ; Marcello Egidi [Italie] ; Paolo Rampini [Italie] ; Filippo Tamma [Italie] ; Elena Caputo [Italie] ; Valentina Chiesa [Italie] ; Sergio Barbieri [Italie] | Subthalamic somatosensory evoked potentials in Parkinson's disease |
| 002305 |
Roland Wenzelburger [Allemagne] ; Florian Kopper [Allemagne] ; Bao-Rong Zhang [Allemagne] ; Karsten Witt [Allemagne] ; Wolfgang Hamel [Allemagne] ; Dieter Weinert [Allemagne] ; Johann Kuhtz-Buschbeck [Allemagne] ; Mukaddes Gölge [Allemagne] ; Michael Illert [Allemagne] ; Günther Deuschl [Allemagne] ; Paul Krack [Allemagne] | Subthalamic nucleus stimulation for Parkinson's disease preferentially improves akinesia of proximal arm movements compared to finger movements |
| 002309 |
Christopher G. Goetz [États-Unis] ; Peter A. Lewitt [États-Unis] ; Meredith Weidenman [États-Unis] | Standardized training tools for the UPDRS Activities of Daily Living scale: Newly available teaching program |
| 002312 |
Anna Mura [Suisse] ; Joram Feldon [Suisse] | Spatial learning in rats is impaired after degeneration of the nigrostriatal dopaminergic system |
| 002315 |
Matthew A. Brodsky [États-Unis] ; James Godbold [États-Unis] ; Tom Roth [États-Unis] ; C. Warren Olanow [États-Unis] | Sleepiness in Parkinson's disease: A controlled study |
| 002316 |
Sebastian Paus [Allemagne] ; Hans Michael Brecht [Allemagne] ; Jürgen Köster [Allemagne] ; Gert Seeger [Allemagne] ; Thomas Klockgether [Allemagne] ; Ullrich Wüllner [Allemagne] | Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease |
| 002317 |
Klaus L. Leenders [Pays-Bas] | Significance of non-presynaptic SPECT tracer methods in Parkinson's disease |
| 002318 |
Tomoyuki Uchiyama [Japon] ; Ryuji Sakakibara [Japon] ; Takamichi Hattori [Japon] ; Tomonori Yamanishi [Japon] | Short-term effect of a single levodopa dose on micturition disturbance in Parkinson's disease patients with the wearing-off phenomenon |
| 002320 |
Wolf-Rüdiger Sch Bitz [Allemagne] ; Katharina Glatz [Allemagne] ; Christian Schuhan [Allemagne] ; Clemens Sommer [Allemagne] ; Christian Berger [Allemagne] ; Markus Schwaninger [Allemagne] ; Marius Hartmann [Allemagne] ; Hans Hilmar Goebel [Allemagne] ; Hans-Michael Meinck [Allemagne] | Severe forward flexion of the trunk in Parkinson's disease: Focal myopathy of the paraspinal muscles mimicking camptocormia |
| 002321 |
Oren Cohen [États-Unis] ; Stanley Fahn [États-Unis] ; Steven J. Frucht [États-Unis] | Severe cervical dystonia in pathologically proven Parkinson's disease and dementia |
| 002324 |
Giovanni Abbruzzese [Italie] ; Alfredo Berardelli [Italie] | Sensorimotor integration in movement disorders |
| 002327 |
Irene Litvan [États-Unis] ; Kailash P. Bhatia ; David J. Burn ; Christopher G. Goetz ; Anthony E. Lang ; Ian Mckeith ; Niall Quinn ; Kapil D. Sethi ; Cliff Shults ; Gregor K. Wenning | SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders |
| 002328 |
Haydeh Payami [États-Unis] ; John Nutt [États-Unis] ; Steven Gancher [États-Unis] ; Thomas Bird [États-Unis] ; Melissa Gonzales Mcneal [États-Unis] ; William K. Seltzer [États-Unis] ; Jennifer Hussey [États-Unis] ; Paul Lockhart [États-Unis] ; Katrina Gwinn-Hardy [États-Unis] ; Amanda A. Singleton [États-Unis] ; Andrew B. Singleton [États-Unis] ; John Hardy [États-Unis] ; Matthew Farrer [États-Unis] | SCA2 may present as levodopa-responsive parkinsonism |
| 002329 |
Alexis Elbaz [France] ; Clotilde Levecque [France] ; Jacqueline Clavel [France] ; Jean-Sébastien Vidal [France] ; Florence Richard [France] ; Jean-René Correze [France] ; Bernard Delemotte [France] ; Philippe Amouyel [France] ; Annick Alperovitch [France] ; Marie-Christine Chartier-Harlin [France] ; Christophe Tzourio [France] | S18Y polymorphism in the UCH-L1 gene and Parkinson's disease: Evidence for an age-dependent relationship |
| 002331 |
Vicky Marshall [Royaume-Uni] ; Donald G. Grosset [Royaume-Uni] | Role of dopamine transporter imaging in the diagnosis of atypical tremor disorders |
| 002332 |
Vicky Marshall [Royaume-Uni] ; Donald Grosset [Royaume-Uni] | Role of dopamine transporter imaging in routine clinical practice |
| 002337 |
Pudukode R. Krishnan [Inde] ; Manvir Bhatia [Inde] ; Madhuri Behari [Inde] | Restless legs syndrome in Parkinson's disease: A case-controlled study |
| 002338 |
Carson R. Reider [États-Unis] ; Cheryl A. Halter [États-Unis] ; Peter F. Castelluccio [États-Unis] ; David Oakes [États-Unis] ; William C. Nichols [États-Unis] ; Tatiana Foroud [États-Unis] | Reliability of reported age at onset for Parkinson's disease |
| 002342 |
Padraig O'Suilleabhain [États-Unis] ; Cole Giller [États-Unis] | Rapidly progressive parkinsonism in a self-reported user of ecstasy and other drugs |
| 002343 |
Prithiva Navan [Royaume-Uni] ; Leslie J. Findley [Royaume-Uni] ; Jim A. R. Jeffs [Royaume-Uni] ; Ronald K. B. Pearce [Royaume-Uni] ; Peter G. Bain [Royaume-Uni] | Randomized, double-blind, 3-month parallel study of the effects of pramipexole, pergolide, and placebo on parkinsonian tremor |
| 002344 |
Yoshikuni Mizuno [Japon] ; Nobuo Yanagisawa [Japon] ; Sadako Kuno [Japon] ; Mitsutoshi Yamamoto [Japon] ; Kazuko Hasegawa [Japon] ; Hideki Origasa [Japon] ; Hisayuki Kowa [Japon] | Randomized, double-blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease |
| 002345 |
Charles H. Adler [États-Unis] ; John N. Caviness [États-Unis] ; Joseph G. Hentz [États-Unis] ; Marlene Lind [États-Unis] ; Judy Tiede [États-Unis] | Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease |
| 002351 |
Noëlle G. A. Spliethoff-Kamminga [Pays-Bas] ; Aeilko H. Zwinderman [Pays-Bas] ; Machiel P. Springer [Pays-Bas] ; Raymund A. C. Roos [Pays-Bas] | Psychosocial problems in Parkinson's disease: Evaluation of a disease-specific questionnaire |
| 002352 |
Werner Poewe [Autriche] | Psychosis in Parkinson's disease |
| 002356 |
Marc G. Weisskopf [États-Unis] ; HONGLEI CHEN [États-Unis] ; Michael A. Schwarzschild [États-Unis] ; Ichiro Kawachi [États-Unis] ; Alberto Ascherio [États-Unis] | Prospective study of phobic anxiety and risk of Parkinson's disease |
| 002361 |
Frank L. Mastaglia [Australie] ; Russell D. Johnsen [Australie] ; Michelle L. Byrnes [Australie] ; Byron A. Kakulas [Australie] | Prevalence of amyloid-β deposition in the cerebral cortex in Parkinson's disease |
| 002362 |
Zhen-Xin Zhang [République populaire de Chine] ; Dallas W. Anderson [États-Unis] ; Jue-Bin Huang [République populaire de Chine] ; HUI LI [République populaire de Chine] ; XIA HONG [République populaire de Chine] ; JING WEI [République populaire de Chine] ; En-Li Yang [République populaire de Chine] ; Demetrius M. Maraganore [États-Unis] | Prevalence of Parkinson's disease and related disorders in the elderly population of Greater Beijing, China |
| 002363 |
Julian Benito-Leon [Espagne] ; Félix Bermejo-Pareja [Espagne] ; Javier Rodriguez [Espagne] ; José-Antonio Molina [Espagne] ; Rafael Gabriel [Espagne] ; José-Manuel Morales [Espagne] | Prevalence of PD and other types of parkinsonism in three elderly populations of central Spain |
| 002368 |
Edith Werber [Israël] ; Colin Klein [Israël] ; Jonathan Grünfeld [Israël] ; José Martin Rabey [Israël] | Phenotypic presentation of frontotemporal dementia with parkinsonism-chromosome 17 type p301s in a patient of jewish-algerian origin |
| 002374 |
Pablo Martinez-Martin [Espagne] ; Julian Benito-Leon [Espagne] ; Fernando Alonso [Espagne] ; M. José Catalan [Espagne] ; Margarita Pondal [Espagne] ; Aurelio Tobias [Espagne] ; Ivana Zamarbide [Espagne] | Patients', doctors', and caregivers' assessment of disability using the UPDRS-ADL section: Are these ratings interchangeable? |
| 002375 |
Peter Teismann [États-Unis] ; Kim Tieu [États-Unis] ; Oren Cohen [États-Unis] ; Dong-Kug Choi [États-Unis] ; DU CHU WU [États-Unis] ; Daniel Marks [États-Unis] ; Miquel Vila [États-Unis] ; Vernice Jackson-Lewis [États-Unis] ; Serge Przedborski [États-Unis] | Pathogenic role of glial cells in Parkinson's disease |
| 002376 |
Maria Bozi [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Paroxysmal exercise-induced dystonia as a presenting feature of young-onset Parkinson's disease |
| 002379 |
Andrew Lees (neurologue) [Royaume-Uni] | Parkinson's syndrome associated with neurofibrillary degeneration and tau pathologic findings |
| 002380 |
Bechir Jarraya [France] ; Anne-Marie Bonnet [France] ; Charles Duyckaerts [France] ; Jean-Luc Houetc [France] ; Philippe Cornu [France] ; Jean-Jacques Hauw [France] ; Yves Agid [France] | Parkinson's disease, subthalamic stimulation, and selection of candidates: A pathologic study |
| 002381 |
Richard Camicioli [États-Unis, Canada] ; M. Milar Moore [États-Unis] ; Anthony Kinney [États-Unis] ; Elizabeth Corbridge [États-Unis] ; Kathryn Glassberg [États-Unis] ; Jeffrey A. Kaye [États-Unis] | Parkinson's disease is associated with hippocampal atrophy |
| 002382 |
Sarah J. Lincoln [États-Unis] ; Demetrius M. Maraganore [États-Unis] ; Timothy G. Lesnick [États-Unis] ; Rebecca Bounds [États-Unis] ; Mariza De Andrade [États-Unis] ; James H. Bower [États-Unis] ; John A. Hardy [États-Unis] ; Matthew J. Farrer [États-Unis] | Parkin variants in North American Parkinson's disease: Cases and controls |
| 002384 |
Marcelo Merello [Argentine] ; Jorge Balej [Argentine] ; Ramon Leiguarda [Argentine] | Pallidotomy in Parkinson's disease improves single-joint, repetitive, ballistic movements, but fails to modify multijoint, repetitive, gestural movements |
| 002386 |
Peter Brown [Royaume-Uni] | Oscillatory nature of human basal ganglia activity: Relationship to the pathophysiology of Parkinson's disease |
| 002389 |
Christopher Hawkes [Royaume-Uni] | Olfaction in neurodegenerative disorder |
| 002391 |
Michael P. Hill [Royaume-Uni] ; Erwan Bezard [France] ; Steven G. Mcguire [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] ; Jonathan M. Brotchie [Canada] ; Ann Michel [Belgique] ; Renee Grimee [Belgique] ; Henrik Klitgaard [Belgique] | Novel antiepileptic drug levetiracetam decreases dyskinesia elicited by L-dopa and ropinirole in the MPTP-lesioned marmoset |
| 002393 |
Paul S. Fitzmaurice [Canada] ; LEE ANG [Canada] ; Mark Guttman [Canada] ; Ali H. Rajput [Canada] ; Yoshiaki Furukawa [Canada] ; Stephen J. Kish [Canada] | Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease |
| 002404 |
Thomas Gasser [Allemagne] ; Susan Bressman [États-Unis] ; Alexandra Dürr [France] ; Joseph Higgins [États-Unis] ; Thomas Klockgether [Allemagne] ; Richard H. Myers [États-Unis] | Molecular diagnosis of inherited movement disorders. Movement disorders Society Task Force on Molecular Diagnosis |
| 002405 |
Michael Orth [Royaume-Uni] ; Sarah J. Tabrizi [Royaume-Uni] | Models of Parkinson's disease |
| 002408 |
Walter Pirker [Autriche] ; Iris Holler [Autriche] ; Willibald Gerschlager [Autriche] ; Susanne Asenbaum [Autriche] ; Georg Zettinig [Autriche] ; Thomas Brücke [Autriche] | Measuring the rate of progression of Parkinson's disease over a 5-year period with β-CIT SPECT |
| 002410 |
Blanka Hejdukova [Suède, République tchèque] ; Nasser Hosseini [Suède] ; Bo Johnels [Suède] ; Pall E. Ingvarsson [Suède] ; Göran Steg [Suède] ; Torsten Olsson [Suède] | Manual transport in Parkinson's disease |
| 002411 |
Jan Herzog [Allemagne] ; Julia Reiff [Allemagne] ; Paul Krack [Allemagne] ; Karsten Witt [Allemagne] ; Bettina Schrader [Allemagne] ; Dieter Müller [Allemagne] ; Günther Deuschl [Allemagne] | Manic episode with psychotic symptoms induced by subthalamic nucleus stimulation in a patient with Parkinson's disease |
| 002413 |
Mona Ragothaman [Inde] ; Uday A. Murgod [Inde] ; Gopalkrishna Gururaj [Inde] ; Subbakrishna D. Kumaraswamy [Inde] ; Uday Muthane [Inde] | Lower risk of Parkinson's disease in an admixed population of European and Indian origins |
| 002414 |
Hubert H. Fernandez [États-Unis] ; Martha E. Trieschmann [États-Unis] ; Monica A. Burke [États-Unis] ; Carol Jacques [États-Unis] ; Joseph H. Friedman [États-Unis] | Long-term outcome of quetiapine use for psychosis among parkinsonian patients |
| 002416 |
Philip V. Theodosopoulos [États-Unis] ; William J. Jr Marks [États-Unis] ; Chadwick Christine [États-Unis] ; Philip A. Starr [États-Unis] | Locations of movement-related cells in the human subthalamic nucleus in Parkinson's disease |
| 002419 |
Jau-Shin Lou [États-Unis] ; Greg Kearns [États-Unis] ; Theodore Benice [États-Unis] ; Barry Oken [États-Unis] ; Gary Sexton [États-Unis] ; John Nutt [États-Unis] | Levodopa improves physical fatigue in Parkinson's disease: A double-blind, placebo-controlled, crossover study |
| 002420 |
Lisa M. Inkster [Canada] ; Janice J. Eng [Canada] ; Donna L. Macintyre [Canada] ; A. Jon Stoessl [Canada] | Leg muscle strength is reduced in Parkinson's disease and relates to the ability to rise from a chair |
| 002422 |
David R. Lynch [États-Unis] ; P. David Mozley [États-Unis] ; Set Sokol [États-Unis] ; Nicole M. C. Maas [États-Unis] ; Laura J. Balcer [États-Unis] ; Andrew D. Siderowf [États-Unis] | Lack of effect of polymorphisms in dopamine metabolism related genes on imaging of TRODAT-1 in striatum of asymptomatic volunteers and patients with Parkinson's disease |
| 002428 |
Masataka Nishimura [Japon] ; Sadako Kuno [Japon] ; Ikuko Mizuta [Japon] ; Mitsuhiro Ohta [Japon] ; Hirofumi Maruyama [Japon] ; Ryuji Kaji [Japon] ; Hideshi Kawakami [Japon] | Influence of monocyte chemoattractant protein 1 gene polymorphism on age at onset of sporadic Parkinson's disease |
| 002429 |
Birgit Hogl [Autriche] ; Klaus Seppi [Autriche] ; Elisabeth Brandauer [Autriche] ; Susanne Glatzl [Autriche] ; Birgit Frauscher [Autriche] ; Ulrike Niedermüller [Autriche] ; Gregor Wenning [Autriche] ; Werner Poewe [Autriche] | Increased daytime sleepiness in Parkinson's disease: A questionnaire survey |
| 002430 |
Rocco Agostino [Italie] ; Antonio Curra [Italie] ; Morena Giovannelli [Italie] ; Nicola Modugno [Italie] ; Mario Manfredi [Italie] ; Alfredo Berardelli [Italie] | Impairment of individual finger movements in Parkinson's disease |
| 002432 |
Takeshi Morimoto [Japon, États-Unis] ; Takuro Shimbo [Japon] ; John E. Orav [États-Unis] ; Kunihiko Matsui [Japon] ; Masashi Goto [Japon] ; Manabu Takemura [Japon] ; Kenji Hira [États-Unis] ; Tsuguya Fukui [Japon] | Impact of social functioning and vitality on preference for life in patients with Parkinson's disease |
| 002433 |
Christopher G. Goetz [États-Unis] ; Kimberly Janko [États-Unis] ; Lucy Blasucci [États-Unis] ; Jean A. Jaglin [États-Unis] | Impact of placebo assignment in clinical trials of Parkinson's disease |
| 002434 |
John Hardy [États-Unis, Royaume-Uni] | Impact of Genetic analysis on Parkinson's disease research |
| 002435 |
José M. Garcia-Moreno [Espagne] ; José Chacon-Pena [Espagne] | Hypothyroidism and Parkinson's disease and the issue of diagnostic confusion |
| 002436 |
Paul K. Morrish [Royaume-Uni] | How valid is dopamine transporter imaging as a surrogate marker in research trials in Parkinson's disease? |
| 002437 |
Albert F. G. Leentjens [Pays-Bas] ; Marjan Van Den Akker [Pays-Bas] ; Job F. M. Metsemakers [Pays-Bas] ; Richel Lousberg [Pays-Bas] ; Frans R. J. Verhey [Pays-Bas] | Higher incidence of depression preceding the onset of Parkinson's disease: A register study |
| 002440 |
Peter Hagell [Suède] ; Diane Whalley [Royaume-Uni] ; Stephen P. Mckenna [Royaume-Uni] ; Olle Lindvall [Suède] | Health status measurement in Parkinson's disease: Validity of the PDQ-39 and Nottingham Health profile |
| 002443 |
Marco Onofrj [Italie] ; Anna Lisa Luciano [Italie] ; Diego Iacono [Italie] ; Astrid Thomas [Italie] ; Fabrizio Stocchi [Italie] ; Franco Papola [Italie] ; Domenico Adorno [Italie] ; Rocco Di Mascio [Italie] | HLA typing does not predict REM sleep behaviour disorder and hallucinations in Parkinson's disease |
| 002446 |
Marwan I. Hariz [Suède, Royaume-Uni] | From functional neurosurgery to "interventional" neurology: Survey of publications on thalamotomy, pallidotomy, and deep brain stimulation for Parkinson's disease from 1966 to 2001 |
| 002449 |
William G. Ondo [États-Unis] ; Christine Hunter [États-Unis] | Flumazenil, a GABA antagonist, may improve features of Parkinson's Disease |
| 002450 |
Juha-Matti Savola [Finlande] ; Michael Hill [Royaume-Uni] ; Mia Engstrom [Finlande] ; Hannele Merivuori [Finlande] ; Siegfried Wurster [Finlande] ; Steven G. Mcguire [Royaume-Uni] ; Susan H. Fox [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni] | Fipamezole (JP-1730) is a potent α2 adrenergic receptor antagonist that reduces levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease |
| 002451 |
Allan L. Adkin [Canada] ; James S. Frank [Canada] ; Mandar S. Jog [Canada] | Fear of falling and postural control in Parkinson's disease |
| 002456 |
David J. Burn [Royaume-Uni] ; Elise N. Rowan [Royaume-Uni] ; Thais Minett [Royaume-Uni] ; Jonathon Sanders [Royaume-Uni] ; Pat Myint [Royaume-Uni] ; Jonathon Richardson [Royaume-Uni] ; Alan Thomas [Royaume-Uni] ; Jane Newby [Royaume-Uni] ; Jenny Reid [Royaume-Uni] ; John T. O'Brien [Royaume-Uni] ; Ian G. Mckeith [Royaume-Uni] | Extrapyramidal features in Parkinson's disease with and without dementia and dementia with Lewy bodies: A cross-sectional comparative study |
| 002459 |
Emma Mcintosh [Royaume-Uni] ; Alastair Gray [Royaume-Uni] ; Tipu Aziz [Royaume-Uni] | Estimating the costs of surgical innovations: The case for subthalamic nucleus stimulation in the treatment of advanced Parkinson's disease |
| 002464 |
James T. H. Yip [Hong Kong] ; Tatia M. C. Lee [Hong Kong] ; Shu-Leong Ho [Hong Kong] ; Kin-Lun Tsang [Hong Kong] ; Leonard S. W. Li [Hong Kong] | Emotion recognition in patients with idiopathic Parkinson's disease |
| 002465 |
Kathy Steece-Collier [États-Unis] ; Timothy J. Collier [États-Unis] ; Paul D. Danielson [États-Unis] ; Roger Kurlan [États-Unis] ; David M. Yurek [États-Unis] ; John R. Jr Sladek [États-Unis] | Embryonic mesencephalic grafts increase levodopa-induced forelimb hyperkinesia in Parkinsonian rats |
| 002467 |
Marc Ziegler [France] ; Alexandre Castro-Caldas [Portugal] ; Susanna Del Signore [France] ; Olivier Rascol [France] | Efficacy of Piribedil as early combination to levodopa in patients with stable Parkinson's disease: A 6-month, randomized, placebo-controlled study |
| 002468 |
Ryoichi Hayashi [Japon] ; Takao Hashimoto [Japon] ; Tsuyoshi Tada [Japon] ; Shu-Ichi Ikeda [Japon] | Effects of unilateral pallidotomy on voluntary movement, and simple and choice reaction times in Parkinson's disease |
| 002469 |
Amy J. Bastian [États-Unis] ; Valerie E. Kelly [États-Unis] ; Joel S. Perlmutter [États-Unis] ; Jonathan W. Mink [États-Unis] | Effects of pallidotomy and levodopa on walking and reaching movements in Parkinson's disease |
| 002470 |
Manuel Rodriguez Diaz [Espagne] ; Pedro Barroso-Chinea [Espagne] ; Abraham Acevedo [Espagne] ; Tomas Gonzalez-Hernandez [Espagne] | Effects of dopaminergic cell degeneration on electrophysiological characteristics and GAD65/GAD67 expression in the substantia nigra: Different action on GABA cell subpopulations |
| 002471 |
Gregorio Segovia [Royaume-Uni, Espagne] ; Francisco Mora [Espagne] ; Alan R. Crossman [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni] | Effects of CB1 cannabinoid receptor modulating compounds on the hyperkinesia induced by high-dose levodopa in the reserpine-treated rat model of Parkinson's disease |
| 002472 |
Lance A. Smith [Royaume-Uni] ; Michael J. Jackson ; Matthew J. Hansard ; Eleni Maratos ; Peter Jenner | Effect of pulsatile administration of Levodopa on dyskinesia induction in drug-naïve MPTP-treated common marmosets: Effect of dose, frequency of administration, and brain exposure |
| 002474 |
Roberta Marchese [Italie] ; Marco Bove [Italie] ; Giovanni Abbruzzese [Italie] | Effect of cognitive and motor tasks on postural stability in Parkinson's disease: A posturographic study |
| 002477 |
Prithiva Navan [Royaume-Uni] ; Leslie J. Findley [Royaume-Uni] ; Jim A. R. Jeffs [Royaume-Uni] ; Ronald K. B. Pearce [Royaume-Uni] ; Peter G. Bain [Royaume-Uni] | Double-blind, single-dose, cross-over study of the effects of pramipexole, pergolide, and placebo on rest Tremor and UPDRS part III in Parkinson's disease |
| 002478 |
Francesca Mancini [Italie] ; Roberta Zangaglia [Italie] ; Silvano Cristina [Italie] ; Maria Grazia Sommaruga [Italie] ; Emilia Martignoni [Italie] ; Giuseppe Nappi [Italie] ; Claudio Pacchetti [Italie] | Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of Drooling in parkinsonism |
| 002479 |
Carsten Buhmann [Allemagne] ; Alexandra Bussopulos [Allemagne] ; Matthias Oechsner [Allemagne] | Dopaminergic response in Parkinsonian phenotype of Machado-Joseph Disease |
| 002480 |
George R. Uhl [États-Unis] | Dopamine transporter: Basic science and human variation of a key molecule for dopaminergic function, locomotion, and parkinsonism |
| 002482 |
Richard C. Dodel [Allemagne] ; Helmut Höffken [Allemagne] ; J. Carsten Möller [Allemagne] ; Bernhard Bornschein [Allemagne] ; Thomas Klockgether [Allemagne] ; Thomas Behr [Allemagne] ; Wolfgang H. Oertel [Allemagne] ; Uwe Siebert [États-Unis, Allemagne] | Dopamine transporter imaging and SPECT in diagnostic work-up of Parkinson's disease: A decision-analytic approach |
| 002483 |
Eng-King Tan [Singapour] ; YANNI TAN [Singapour] ; Anthea Chai [Singapour] ; Christopher Tan [Singapour] ; HUI SHEN [Singapour] ; Sau-Ying Lum [Singapour] ; Stephanie M. C. Fook-Cheong [Singapour] ; Mei-Ling Teoh [Singapour] ; YUAN YIH [Singapour] ; Meng-Cheong Wong [Singapour] ; YI ZHAO [Singapour] | Dopamine D2 receptor TaqIA and TaqIB polymorphisms in Parkinson's disease |
| 002485 |
Gun-Marie Hariz [Suède] ; Margareta Lindberg [Suède] ; Marwan I. Hariz [Suède] ; A. Tommy Bergenheim [Suède] | Does the ADL Part of the Unified Parkinson's Disease Rating Scale Measure ADL? An evaluation in patients after pallidotomy and thalamic deep brain stimulation |
| 002487 |
Leslie Findley [Royaume-Uni] ; Manjit Aujla [Royaume-Uni] ; Peter G. Bain [Royaume-Uni] ; Mary Baker [Royaume-Uni] ; Catherine Beech [Royaume-Uni] ; Clive Bowman [Royaume-Uni] ; Jeremy Holmes [Royaume-Uni] ; Wendy K. Kingdom [Royaume-Uni] ; Douglas G. Macmahon [Royaume-Uni] ; Viv Peto [Royaume-Uni] ; Jeremy R. Playfer [Royaume-Uni] | Direct economic impact of Parkinson's disease: A research survey in the United Kingdom |
| 002488 |
Amy J. Bastian [États-Unis] ; Valerie E. Kelly [États-Unis] ; Fredy J. Revilla [États-Unis] ; Joel S. Perlmutter [États-Unis] ; Jonathan W. Mink [États-Unis] | Different effects of unilateral versus bilateral subthalamic nucleus stimulation on walking and reaching in Parkinson's Disease |
| 002492 |
Mickie Welsh [États-Unis] ; Michael P. Mcdermott [États-Unis] ; Robert G. Holloway [États-Unis] ; Sandy Plumb [États-Unis] ; Ronald Pfeiffer [États-Unis] ; Jean Hubble [États-Unis] | Development and testing of the Parkinson's disease quality of life scale |
| 002496 |
Patrice Peran [France] ; Olivier Rascol [France] ; Jean-Francois Demonet [France] ; Pierre Celsis [France] ; Jean-Luc Nespoulous [France] ; Bruno Dubois [France] ; Dominique Cardebat [France] | Deficit of verb generation in nondemented patients with Parkinson's disease |
| 002497 |
Ruediger Hilker [Allemagne] ; Juergen Voges [Allemagne] ; Mehran Ghaemi [Allemagne] ; Ralf Lehrke [Allemagne] ; Jobst Rudolf [Allemagne] ; Athanasios Koulousakis [Allemagne] ; Karl Herholz [Allemagne] ; Klaus Wienhard [Allemagne] ; Volker Sturm [Allemagne] ; Wolf-Dieter Heiss [Allemagne] | Deep brain stimulation of the subthalamic nucleus does not increase the striatal dopamine concentration in Parkinsonian humans |
| 002498 |
Taresa Stefurak [Canada] ; David Mikulis [Canada] ; Helen Mayberg [Canada] ; Anthony E. Lang [Canada] ; Stephanie Hevenor [Canada] ; Peter Pahapill [États-Unis] ; Jean Saint-Cyr [Canada] ; Andres Lozano [Canada] | Deep brain stimulation for Parkinson's disease dissociates mood and motor circuits: A functional MRI case study |
| 002501 |
David J. Burn [Royaume-Uni] ; Ian G. Mckeith [Royaume-Uni] | Current treatment of Dementia with lewy bodies and Dementia associated with Parkinson's disease |
| 002504 |
Walter Pirker [Autriche] | Correlation of dopamine transporter imaging with parkinsonian motor handicap: How close is it? |
| 002505 |
Nico J. Diederich [Luxembourg (pays), États-Unis] ; Vannina Pieri [Luxembourg (pays)] ; Christopher G. Goetz [États-Unis] | Coping strategies for visual hallucinations in Parkinson's disease |
| 002506 |
Demetrius M. Maraganore [États-Unis] ; Mariza De Andrade [États-Unis] ; Timothy G. Lesnick [États-Unis] ; Matthew J. Farrer [États-Unis] ; James H. Bower [États-Unis] ; John A. Hardy [États-Unis] ; Walter A. Rocca [États-Unis] | Complex interactions in Parkinson's disease: A two-phased approach |
| 002510 |
Montse Alegret [Espagne] ; Francesc Valldeoriola [Espagne] ; Eduardo Tolosa [Espagne] ; Pere Vendrell [Espagne] ; Carme Junque [Espagne] ; José Martinez [Espagne] ; Jordi Rumia [Espagne] | Cognitive effects of unilateral posteroventral pallidotomy: A 4-year follow-up study |
| 002511 |
Maria J. Marti [Espagne] ; Eduardo Tolosa [Espagne] ; Jaume Campdelacreu [Espagne] | Clinical overview of the synucleinopathies |
| 002513 |
Christine Brefel-Courbon [France] ; Karine Desboeuf [France] ; Claire Thalamas [France] ; Monique Galitzky [France] ; Jean-Michel Senard [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France] | Clinical and economic analysis of spa therapy in Parkinson's disease |
| 002514 |
Nancy Belanger [Canada] ; Laurent Gregoire [Canada] ; ABDALLAH HADJ TAHAR [Canada] ; Paul J. Bedard [Canada] | Chronic treatment with small doses of cabergoline prevents Dopa-induced dyskinesias in Parkinsonian monkeys |
| 002519 |
Frédéric Calon [Canada] ; Marc Morissette [Canada] ; Ali H. Rajput [Canada] ; Oleh Hornykiewicz [Canada, Autriche] ; Paul J. Bedard [Canada] ; Thérèse Di Paolo [Canada] | Changes of GABA receptors and dopamine turnover in the postmortem brains of parkinsonians with levodopa-induced motor complications |
| 002520 |
Björn Holmberg [Suède] ; Bo Johnels [Suède] ; Kaj Blennow [Suède] ; Lars Rosengren [Suède] | Cerebrospinal fluid Aβ42 is reduced in multiple system atrophy but normal in Parkinson's disease and progressive supranuclear palsy |
| 002522 |
Demetrius M. Maraganore [États-Unis] ; Matthew J. Farrer [États-Unis] ; Timothy G. Lesnick [États-Unis] ; Mariza De Andrade [États-Unis] ; James H. Bower [États-Unis] ; Dena Hernandez [États-Unis] ; John A. Hardy [États-Unis] ; Walter A. Rocca [États-Unis] | Case-control study of the α-synuclein interacting protein gene and Parkinson's disease |
| 002523 |
Frédéric Courbon [France] ; Christine Brefel-Courbon [France] ; Claire Thalamas [France] ; Marie Jeanne Alibelli [France] ; Isabelle Berry [France] ; Jean-Louis Montastruc [France] ; Olivier Rascol [France] ; Jean-Michel Senard [France] | Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease |
| 002524 |
Antje M. Smala [Allemagne] ; E. Annika Spottke [Allemagne] ; Olaf Machat [Allemagne] ; Uwe Siebert [États-Unis] ; Dieter Meyer [Allemagne] ; Rudolf Köhne-Volland [Allemagne] ; Martin Reuther [Allemagne] ; Janeen Duchane [États-Unis] ; Wolfgang H. Oertel [Allemagne] ; Karin B. Berger [Allemagne] ; Richard C. Dodel [Allemagne] | Cabergoline versus levodopa monotherapy: A decision analysis |
| 002529 |
Michela Barichella [Italie] ; Agnieszka M. Marczewska [Italie] ; Claudio Mariani [Italie] ; Andrea Landi [Italie] ; Antonella Vairo [Italie] ; Gianni Pezzoli [Italie] | Body weight gain rate in patients with Parkinson's disease and deep brain stimulation |
| 002530 |
George J. Counelis [États-Unis] ; Tanya Simuni [États-Unis] ; Mark S. Forman [États-Unis] ; Jurg L. Jaggi [États-Unis] ; John Q. Trojanowski [États-Unis] ; Gordon H. Baltuch [États-Unis] | Bilateral subthalamic nucleus deep brain stimulation for advanced PD: Correlation of intraoperative MER and postoperative MRI with neuropathological findings |
| 002532 |
Noël L. W. Keijsers [Pays-Bas] ; Martin W. I. M. Horstink [Pays-Bas] ; Stan C. A. M. Gielen [Pays-Bas] | Automatic assessment of levodopa-induced dyskinesias in daily life by neural networks |
| 002539 |
Georg Ebersbach [Allemagne] | An artist's view of drug-induced hallucinosis |
| 002541 |
Florian A. Kagerer [Australie] ; Jeff J. Summers [Australie] ; Winston D. Byblow [Nouvelle-Zélande] ; Bruce Taylor [Australie] | Altered corticomotor representation in patients with Parkinson's disease |
| 002543 |
Christian Prueter [Allemagne] ; Benedikt Habermeyer [Allemagne] ; Christine Norra [Allemagne] ; Christoph M. Kosinski [Allemagne] | Akathisia as a side effect of antipsychotic treatment with quetiapine in a patient with Parkinson's disease |
| 002545 |
Aurélie Funkiewiez [France] ; Claire Ardouin [France] ; Paul Krack [France] ; Valérie Fraix [France] ; Nadège Van Blercom [France] ; JING XIE [France] ; Elena Moro [France] ; Alim-Louis Benabid [France] ; Pierre Pollak [France] | Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease |
| 002547 |
Stefano Tamburin [Italie] ; Antonio Fiaschi [Italie] ; Domenico Idone [Italie] ; Piergiorgio Lochner [Italie] ; Paolo Manganotti [Italie] ; Giampietro Zanette [Italie] | Abnormal sensorimotor integration is related to disease severity in Parkinson's disease: A TMS study |
| 002548 |
John N. Caviness [États-Unis] ; Charles H. Adler [États-Unis] ; Marwan N. Sabbagh [États-Unis] ; Donald J. Connor [États-Unis] ; Jose L. Hernandez [États-Unis] ; Terrence D. Lagerlund [États-Unis] | Abnormal corticomuscular coherence is associated with the small amplitude cortical myoclonus in Parkinson's disease |
| 002550 |
Philippe Le Cavorzin [France] ; Guy Carrault [France] ; Francis Chagneau [France] ; Pierre Rochcongar [France] ; Hervé Allain [France] | A computer model of rigidity and related motor dysfunction in Parkinson's disease |
| 002551 |
Shingo Okabe [Japon] ; Yoshikazu Ugawa [Japon] ; Ichiro Kanazawa [Japon] | 0.2-Hz repetitive transcranial magnetic stimulation has no add-on effects as compared to a realistic sham stimulation in Parkinson's Disease |
| 002553 |
| Management of Parkinson's disease: an evidence-based review |
| 002555 |
| Abstracts of the Seventh International Congress of Parkinson's Disease and "Movement" Disorders, November 10-14, 2002, Miami, Florida, USA |
| 002558 |
Willibald Gerschlager [Autriche, Royaume-Uni] ; Gerhard Bencsits [Autriche] ; Walter Pirker [Autriche] ; Bastiaan R. Bloem [Royaume-Uni, Pays-Bas] ; Susanne Asenbaum [Autriche] ; Daniella Prayer [Autriche] ; Jan C. M. Zijlmans [Royaume-Uni] ; Martha Hoffmann [Autriche] ; Thomas Brücke [Autriche] | [123I]β-CIT SPECT distinguishes vascular parkinsonism from Parkinson's disease |
| 002564 |
Simon G. Parkin [Royaume-Uni] ; Ralph P. Gregory [Royaume-Uni] ; Richard Scott [Royaume-Uni] ; Peter Bain [Royaume-Uni] ; Peter Silbum [Australie] ; Bruce Hall [Australie] ; Richard Boyle [Australie] ; Carole Joint [Royaume-Uni] ; Tipu Z. Aziz [Royaume-Uni] | Unilateral and bilateral pallidotomy for idiopathic Parkinson's disease: A case series of 115 patients |
| 002566 |
Esmaeil Nikfekr [Royaume-Uni] ; Kathleen Kerr [Royaume-Uni] ; Steve Attfield [Royaume-Uni] ; Diane E. Playford [Royaume-Uni] | Trunk movement in Parkinson's disease during rising from seated position |
| 002571 |
Pierre Pollak [France] ; Valérie Fraix [France] ; Paul Krack [France] ; Elena Moro [France] ; Alexandre Mendes [France] ; Stephan Chabardes [France] ; Adnan Koudsie [France] ; Alim-Louis Benabid [France] | Treatment results: Parkinson's disease |
| 002572 |
Michael S. Okun [États-Unis] ; Kenneth M. Heilman [États-Unis] ; Jerrold L. Vitek [États-Unis] | Treatment of pseudobulbar laughter after gamma knife thalamotomy |
| 002574 |
| Treatment of depression in idiopathic Parkinson's disease |
| 002575 |
Kin-Lun Tsang [Hong Kong] ; Iris Chi [Hong Kong] ; Shu-Leong Ho [Hong Kong] ; Vivian Weiqun Lou [Hong Kong] ; Tatia M. C. Lee [Hong Kong] ; Leung-Wing Chu [Hong Kong] | Translation and validation of the standard Chinese version of PQD-39: A quality-of-life measure for patients with Parkinson's disease |
| 002576 |
Luigi Michele Romito [Italie] ; Michele Raja [Italie] ; Antonio Daniele [Italie] ; Maria Fiorella Contarino [Italie] ; Anna Rita Bentivoglio [Italie] ; Annalisa Barbier [Italie] ; Massimo Scerrati [Italie] ; Alberto Albanese [Italie] | Transient mania with hypersexuality after surgery for high-frequency stimulation of the subthalamic nucleus in Parkinson's disease |
| 002579 |
Natasa Dragasevic [Serbie] ; Aleksandra Potrebic [Serbie] ; Aleksandar Damjanovic [Serbie] ; Elka Stefanova [Serbie] ; Vladimir S. Kostic [Serbie] | Therapeutic efficacy of bilateral prefrontal slow repetitive transcranial magnetic stimulation in depressed patients with Parkinson's disease: An open study |
| 002581 |
Tamar C. Rubinstein [Israël] ; Nir Giladi [Israël] ; Jeffrey M. Hausdorff [Israël, États-Unis] | The power of cueing to circumvent dopamine deficits: A review of physical therapy treatment of gait disturbances in Parkinson's disease |
| 002582 |
Ronald K. B. Pearce [Royaume-Uni] ; Lance A. Smith [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Tara Banerji [Royaume-Uni] ; Jorgen Scheel-Krüger [Danemark] ; Peter Jenner [Royaume-Uni] | The monoamine reuptake blocker brasofensine reverses akinesia without dyskinesia in MPTP-treated and levodopa-primed common marmosets |
| 002584 |
Sujana Reddy [États-Unis] ; Stewart A. Factor [États-Unis] ; Eric S. Molho [États-Unis] ; Paul J. Feustel [États-Unis] | The effect of quetiapine on psychosis and motor function in Parkinsonian patients with and without dementia |
| 002587 |
Andrew Siderowf [États-Unis] ; Michael Mcdermott [États-Unis] ; Karl Kieburtz [États-Unis] ; Karen Blindauer [États-Unis] ; Sandra Plumb [États-Unis] ; Ira Shoulson [États-Unis] | Test-retest reliability of the Unified Parkinson's Disease Rating Scale in patients with early Parkinson's disease: Results from a multicenter clinical trial |
| 002588 |
Andrew Feigin [États-Unis] ; Angelo Antonini [Italie] ; Masafumi Fukuda [États-Unis] ; Roberta De Notaris [Italie] ; Riccardo Benti [Italie] ; Gianni Pezzoli [Italie] ; Marc J. Mentis [États-Unis] ; James R. Moeller [États-Unis] ; David Eidelberg [États-Unis] | Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of Parkinsonism |
| 002591 |
Katherine H. O. Deane [Royaume-Uni] ; Caroline Ellis-Hill [Royaume-Uni] ; Diana Jones [Royaume-Uni] ; Renata Whurr [Royaume-Uni] ; Yoav Ben-Shlomo [Royaume-Uni] ; E. Diane Playford [Royaume-Uni] ; Carl E. Clarke [Royaume-Uni] | Systematic review of paramedical therapies for Parkinson's disease |
| 002592 |
Claudia Ramaker [Pays-Bas] ; Johan Marinus [Pays-Bas] ; Anne Margarethe Stiggelbout [Pays-Bas] ; Bob Johannes Van Hilten [Pays-Bas] | Systematic evaluation of rating scales for impairment and disability in Parkinson's disease |
| 002593 |
Margaret K. Y. Mak [Hong Kong] ; Christina W. Y. Hui-Chan [Hong Kong] | Switching of movement direction is central to parkinsonian bradykinesia in sit-to-stand |
| 002595 |
| Surgical treatment for Parkinson's disease: Neural transplantation |
| 002596 |
| Surgical treatment for Parkinson's disease: Deep brain surgery |
| 002599 |
Kenneth B. Baker [États-Unis] ; Erwin B. Jr Montgomery [États-Unis] ; Ali R. Rezai [États-Unis] ; Richard Burgess [États-Unis] ; Hans O. Lüders [États-Unis] | Subthalamic nucleus deep brain stimulus evoked potentials: Physiological and therapeutic implications |
| 002600 |
H. Christopher Hyson [Canada] ; Andrew M. Johnson [Canada] ; Mandar S. Jog [Canada] | Sublingual atropine for sialorrhea secondary to parkinsonism: A pilot study |
| 002601 |
Susan H. Fox [Royaume-Uni] ; Brian Henry [Royaume-Uni] ; Michael Hill [Royaume-Uni] ; Alan Crossman [Royaume-Uni] ; Jonathan Brotchie [Royaume-Uni] | Stimulation of cannabinoid receptors reduces levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate model of Parkinson's disease |
| 002603 |
Johannes D. Speelman [Pays-Bas] ; Richard Schuurman [Pays-Bas] ; Rob M. A. De Bie [Pays-Bas] ; Rianne A. J. Esselink [Pays-Bas] ; D. Andries Bosch [Pays-Bas] | Stereotactic neurosurgery for tremor |
| 002604 |
Hidehiro Hirabayashi [Japon] ; Magnus Tengvar [Suède] ; Marwan I. Hariz [Suède] | Stereotactic imaging of the pallidal target |
| 002608 |
| Speech therapy in Parkinson's disease |
| 002609 |
John N. Caviness [États-Unis] ; Charles H. Adler [États-Unis] ; Thomas G. Beach [États-Unis] ; Kristi L. Wetjen [États-Unis] ; Richard J. Caselli [États-Unis] | Small-amplitude cortical myoclonus in Parkinson's disease: Physiology and clinical observations |
| 002610 |
Suresh Kumar [Inde] ; Manvir Bhatia [Inde] ; Madhuri Behari [Inde] | Sleep disorders in Parkinson's disease |
| 002615 |
Virginia Macdonald [Australie] ; Glenda M. Halliday [Australie] | Selective loss of pyramidal neurons in the pre-supplementary motor cortex in Parkinson's disease |
| 002624 |
Peter Hagell [Suède] ; Sara Nordling [Suède] ; Jan Reimer [Suède] ; Martin Grabowski [Suède] ; Ulf Persson [Suède] | Resource use and costs in a Swedish cohort of patients with Parkinson's disease |
| 002625 |
F. Gilio [Italie] ; A. Curra [Italie] ; M. Inghilleri [Italie] ; C. Lorenzano [Italie] ; M. Manfredi [Italie] ; Alfredo Berardelli [Italie] | Repetitive magnetic stimulation of cortical motor areas in Parkinson's disease: Implications for the pathophysiology of cortical function |
| 002626 |
Lance A. Smith [Royaume-Uni] ; Banu C. Tel [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Matthew J. Hansard [Royaume-Uni] ; Rogelio Braceras [Royaume-Uni] ; Céline Bonhomme [France] ; Claire Chezaubernard [France] ; Susanna Del Signore [France] ; Sarah Rose [Royaume-Uni] ; Peter Jenner [Royaume-Uni] | Repeated administration of Piribedil induces less dyskinesia than L-dopa in MPTP-treated common marmosets: A behavioural and biochemical investigation |
| 002627 |
Roger A. Barker [Royaume-Uni] | Repairing the brain in Parkinson's disease: Where next? |
| 002628 |
Didier Flament [États-Unis] ; Mark B. Shapiro [États-Unis] ; Kerstin D. Pfann [États-Unis] ; Charity G. Moore [États-Unis] ; Richard D. Penn [États-Unis] ; Daniel M. Corcos [États-Unis] | Reaction time is not impaired by stimulation of the ventral-intermediate nucleus of the thalamus (Vim) in patients with tremor |
| 002631 |
Robert A. Hauser [États-Unis] ; Nicholas H. G. Holford [Nouvelle-Zélande] | Quantitative description of loss of clinical benefit following withdrawal of levodopa-carbidopa and bromocriptine in early Parkinson's Disease |
| 002632 |
Joseph O'Neill [États-Unis] ; Norbert Schuff [États-Unis] ; William J. Jr Marks [États-Unis] ; Robert Feiwell [États-Unis] ; Michael J. Aminoff [États-Unis] ; Michael W. Weiner [États-Unis] | Quantitative 1H magnetic resonance spectroscopy and MRI of Parkinson's disease |
| 002633 |
Alastair Gray [Royaume-Uni] ; Lain Mcnamara [Royaume-Uni] ; Tipu Aziz [Royaume-Uni] ; Ralph Gregory [Royaume-Uni] ; Peter Bain [Royaume-Uni] ; Joanna Wilson [Royaume-Uni] ; Richard Scott [Royaume-Uni] | Quality of life outcomes following surgical treatment of Parkinson's disease |
| 002635 |
| Psychosocial counseling in Parkinson's disease |
| 002638 |
Walter Pirker [Autriche] ; Schiva Djamshidian [Autriche] ; Susanne Asenbaum [Autriche] ; Willibald Gerschlager [Autriche] ; Gotthard Tribl [Autriche] ; Martha Hoffmann [Autriche] ; Thomas Brücke [Autriche] | Progression of dopaminergic degeneration in Parkinson's disease and atypical parkinsonism: A longitudinal β-CIT SPECT study |
| 002639 |
Marie Sarazin [France] ; Bernard Deweer [France] ; Angela Merkl [France] ; Natalia Von Poser [France] ; Bernard Pillon [France] ; Bruno Dubois [France] | Procedural learning and striatofrontal dysfunction in Parkinson's disease |
| 002640 |
Frank L. Mastaglia [Australie] ; Russell D. Johnsen [Australie] ; Byron A. Kakulas [Australie] | Prevalence of stroke in Parkinson's disease: A postmortem study |
| 002641 |
Luis Erik Claveria [Espagne] ; Jacinto Duarte [Espagne] ; Maria Dolores Sevillano [Espagne] ; Angel Perez-Sempere [Espagne] ; Carmen Cabezas [Espagne] ; Fernanda Rodriguez [Espagne] ; Jesus De Pedro-Cuesta [Espagne, Suède] | Prevalence of Parkinson's disease in Cantalejo, Spain: A door-to-door survey |
| 002642 |
José Berciano [Espagne] ; Francesc Valldeoriola [Espagne] ; Isidre Ferrer [Espagne] ; Jordi Rumia [Espagne] ; Julio Pascual [Espagne] ; Concepcion Marin [Espagne] ; Maria J. Rey [Espagne] ; Eduardo Tolosa [Espagne] | Presynaptic parkinsonism in multiple system atrophy mimicking Parkinson's disease: A clinicopathological case study |
| 002644 |
Ann L. Smiley-Oyen [États-Unis] ; Charles J. Worringham [Australie] ; Carol L. Cross [États-Unis] | Practice effects in three-dimensional sequential rapid aiming in Parkinson's disease |
| 002645 |
Philip C. Su [Taïwan] ; Ham-Min Tseng [Taïwan] ; Horng-Huei Liou [Taïwan] | Postural asymmetries following unilateral subthalamotomy for advanced Parkinson's disease |
| 002647 |
Paul Krack [France] ; Valérie Fraix [France] ; Alexandre Mendes [France] ; Alim-Louis Benabid [France] ; Pierre Pollak [France] | Postoperative management of subthalamic nucleus stimulation for Parkinson's disease |
| 002649 |
Jasmine M. Henderson [Australie] ; Malcolm Pell [Australie] ; Dudley J. O'Sullivan [Australie] ; Elizabeth A. Mccusker [Australie] ; Victor S. C. Fung [Australie] ; Philippa Hedges [Australie] ; Glenda M. Halliday [Australie] | Postmortem analysis of bilateral subthalamic electrode implants in Parkinson's disease |
| 002652 |
Pauline L. Lee [États-Unis] ; Terri Gelbart [États-Unis] ; Carol West [États-Unis] ; Carol Halloran [États-Unis] ; Jack C. Sipe [États-Unis] ; Ernest Beutler [États-Unis] | Polymorphisms in iron-responsive binding protein 2 and lack of association with sporadic Parkinson's disease |
| 002653 |
Christopher G. Goetz [États-Unis] ; Sue Leurgans [États-Unis] ; Rema Raman [États-Unis] | Placebo-associated improvements in motor function: Comparison of subjective and objective sections of the UPDRS in early Parkinson's disease |
| 002656 |
| Physical and occupational therapy in Parkinson's disease |
| 002658 |
Virgilio Gerald H. Evidente [États-Unis, Philippines] ; Joel Advincula [Philippines] ; Raymund Esteban [Philippines] ; Paul Pasco [Philippines] ; Jhoe Anthony Alfon [Philippines] ; Filipinas F. Natividad [Philippines] ; Joven Cuanang [Philippines] ; Amado San Luis [Philippines] ; Katrina Gwinn-Hardy [États-Unis] ; John Hardy [États-Unis] ; Dena Hernandez [États-Unis] ; Andrew Singleton [États-Unis] | Phenomenology of "Lubag" or X-linked dystonia-parkinsonism |
| 002661 |
Hagai Bergman [Israël] ; Günther Deuschl [Allemagne] | Pathophysiology of Parkinson's disease: From clinical neurology to basic neuroscience and back |
| 002663 |
Francois Tison [France] ; Farid Yekhlef [France] ; Virginie Chrysostome [France] ; Eric Balestre [France] ; Niall P. Quinn [Royaume-Uni] ; Werner Poewe [Autriche] ; Gregor K. Wenning [Autriche] | Parkinsonism in multiple system atrophy: Natural history, severity (UPDRS-III), and disability assessment compared with Parkinson's disease |
| 002665 |
Irene Hegeman Richard [États-Unis] ; Michelle Papka [États-Unis] ; Ana Rubio [États-Unis] ; Roger Kurlan [États-Unis] | Parkinson's disease and dementia with Lewy bodies: One disease or two? |
| 002671 |
Ruth Djaldetti [Israël] ; Rivkah Inzelberg [Israël] ; Nir Giladi [Israël] ; Amos D. Korczyn [Israël] ; Yehudit Peretz-Aharon [Israël] ; Martin J. Rahey [Israël] ; Yuval Herishano [Israël] ; Silvia Honigman [Israël] ; Sami Badarny [Israël] ; Eldad Melamed [Israël] | Oral solution of levodopa ethylester for treatment of response fluctuations in patients with advanced Parkinson's disease |
| 002672 |
William G. Ondo [États-Unis] ; Joel K. Levy [États-Unis] ; Kevin Dat Vuong [États-Unis] ; Christine Hunter [États-Unis] ; Joseph Jankovic [États-Unis] | Olanzapine treatment for dopaminergic-induced hallucinations |
| 002678 |
J. D. Speelman [Pays-Bas] ; D. A. Bosch [Pays-Bas] | Neurosurgical treatment modalities in Parkinson's disease |
| 002679 |
Bernard Pillon [France] | Neuropsychological assessment for management of patients with deep brain stimulation |
| 002680 |
Maria C. Obinu [France] ; Michel Reibaud [France] ; Véronique Blanchard [France] ; Saliha Moussaoui [France] ; Assunta Imperato [France] | Neuroprotective effect of riluzole in a primate model of Parkinson's disease: Behavioral and histological evidence |
| 002686 |
Craig D. Mccoll [Australie] ; Katrina A. Reardon [Australie] ; Mark Shiff [Australie] ; Peter A. Kempster [Australie] | Motor response to levodopa and the evolution of motor fluctuations in the first decade of treatment of Parkinson's disease |
| 002687 |
Mehran Ghaemi [Allemagne] ; Jan Raethjen [Allemagne] ; Rüdiger Hilker [Allemagne] ; Jobst Rudolf [Allemagne] ; Jan Sobesky [Allemagne] ; Günther Deuschl [Allemagne] ; Wolf-Dieter Heiss [Allemagne] | Monosymptomatic resting tremor and Parkinson's disease: A multitracer positron emission tomographic study |
| 002688 |
Hans Brunner [Allemagne] ; Thomas C. Wetter [Allemagne] ; Birgit Hoegl [Allemagne] ; Alexander Yassouridis [Allemagne] ; Claudia Trenkwalder [Allemagne] ; Elisabeth Friess [Allemagne] ; MD [Allemagne] | Microstructure of the non-rapid eye movement sleep electroencephalogram in patients with newly diagnosed Parkinson's disease: Effects of dopaminergic treatment |
| 002691 |
Jong-Hoon Kim [Corée du Sud] ; HEE YEON JUNG [Corée du Sud] ; UNG GU KANG [Corée du Sud] ; SEONG HOON JEONG [Corée du Sud] ; YONG MIN AHN [Corée du Sud] ; Hee-Jung Byun [Corée du Sud] ; Kyoo-Seob Ha [Corée du Sud] ; YONG SIK KIM [Corée du Sud] | Metric characteristics of the Drug-Induced extrapyramidal Symptoms Scale (DIEPSS): A practical combined rating Scale for drug-induced movement disorders |
| 002692 |
Rajeev Kumar [États-Unis] | Methods for programming and patient management with deep brain stimulation of the globus pallidus for the treatment of advanced Parkinson's disease and dystonia |
| 002693 |
Gilberto Levy [États-Unis] ; Diane M. Jacobs [États-Unis] ; Ming-Xin Tang [États-Unis] ; Lucien J. Cote [États-Unis] ; Elan D. Louis [États-Unis] ; Brenda Alfaro [États-Unis] ; Helen Mejia [États-Unis] ; Yaakov Stern [États-Unis] ; Karen Marder [États-Unis] | Memory and executive function impairment predict dementia in Parkinson's disease |
| 002700 |
| MAO-B inhibitors for the treatment of Parkinson's disease |
| 002701 |
Franck Durif [France] ; Jean-Jacques Lemaire [France] ; Bérengère Debilly [France] ; Gérard Dordain [France] | Long-term follow-up of globus pallidus chronic stimulation in advanced Parkinson's Disease |
| 002705 |
| Levodopa |
| 002707 |
Gurutz Linazasoro [Espagne] ; Nadege Van Blercom [Espagne] ; Asier Lasa [Espagne] | Levodopa-induced ocular dyskinesias in Parkinson's disease |
| 002708 |
Petr Kanovsky [République tchèque] ; Dagmar Kubova [République tchèque] ; Martin Bares [République tchèque] ; Hana Hortova [République tchèque] ; Hana Streitova [République tchèque] ; Ivan Rektor [République tchèque] ; Vladimir Znojil [République tchèque] | Levodopa-induced dyskinesias and continuous subcutaneous infusions of apomorphine: Results of a two-year, prospective follow-up |
| 002710 |
Marie-Paule Muriel [France] ; Gaël Orieux [France] ; Etienne C. Hirsch [France] | Levodopa but not ropinirole induces an internalization of D1 dopamine receptors in Parkinsonian rats |
| 002713 |
David A. Grimes [Canada] ; J. David Grimes [Canada] ; Lem Racacho [Canada] ; Kylie A. Scoggan [Canada] ; Fabin Han [Canada] ; Betty Anne Schwarz [Canada] ; John Woulfe [Canada] ; Dennise Bulman [Canada] | Large French-Canadian family with Lewy body parkinsonism: Exclusion of known loci |
| 002714 |
José Manuel Garcia-Moreno [Espagne] ; José Chacon [Espagne] | Juvenile parkinsonism as a manifestation of systemic lupus erythematosus: Case report and review of the literature |
| 002719 |
Jens Volkmann [Allemagne] ; Jan Herzog [Allemagne] ; Florian Kopper [Allemagne] ; Güntner Deuschl [Allemagne] | Introduction to the programming of deep brain stimulators |
| 002721 |
Abdelhamid Benazzouz [France] ; Sorin Breit [France] ; Adnan Koudsie [France] ; Pierre Pollak [France] ; Paul Krack [France] ; Alim-Louis Benabid [France] | Intraoperative microrecordings of the subthalamic nucleus in Parkinson's disease |
| 002723 |
Pierre Pollak [France] ; Paul Krack [France] ; Valérie Fraix [France] ; Alexandre Mendes [France] ; Elena Moro [France] ; Stephan Chabardes [France] ; Alim-Louis Benabid [France] | Intraoperative micro- and macrostimulation of the subthalamic nucleus in Parkinson's disease |
| 002727 |
Valerie E. Kelly [États-Unis] ; Allie S. Hyngstrom [États-Unis] ; Melissa M. Rundle [États-Unis] ; Amy J. Bastian [États-Unis] | Interaction of levodopa and cues on voluntary reaching in Parkinson's disease |
| 002728 |
Luc J. P. Defebvre [France] ; Pierre Krystkowiak [France] ; Jean-Louis Blatt [France] ; Alain Duhamel [France] ; Jean-Louis Bourriez [France] ; Myriame Perina [France] ; Serge Blond [France] ; Jean-Daniel Guieu [France] ; Alain Destée [France] | Influence of pallidal stimulation and levodopa on gait and preparatory postural adjustments in Parkinson's disease |
| 002729 |
ZAODUNG LING [États-Unis] ; Dave A. Gayle [États-Unis] ; SHANG YONG MA [États-Unis] ; Jack W. Lipton [États-Unis] ; CHONG WAI TONG [États-Unis] ; Jau-Shyong Hong [États-Unis] ; Paul M. Carvey [États-Unis] | In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain |
| 002731 |
Laura Camfield [Royaume-Uni] ; Yoav Ben-Shlomo [Royaume-Uni] ; Thomas T. Warner [Royaume-Uni] | Impact of cervical dystonia on quality of life |
| 002738 |
Chiung-Chu Chen [Taïwan] ; Shih-Tseng Lee [Taïwan] ; Tony Wu [Taïwan] ; Chi-Jen Chen [Taïwan] ; Chin-Chang Huang [Taïwan] ; Chin-Song Lu [Taïwan] | Hemiballism after subthalamotomy in patients with Parkinson's disease: Report of 2 cases |
| 002739 |
Helle Just [Danemark] ; Karen Ostergaard [Danemark] | Health-related quality of life in patients with advanced Parkinson's Disease treated with deep brain stimulation of the subthalamic nuclei |
| 002742 |
Katrina Gwinn-Hardy [États-Unis] | Genetics of parkinsonism |
| 002746 |
Andrea Carmine [Suède] ; Silvia Buervenich [Suède] ; Olof Sydow [Suède] ; Maria Anvret [Suède] ; Lars Olson [Suède] | Further evidence for an association of the paraoxonase 1 (PON1) Met-54 allele with Parkinson's disease |
| 002756 |
Maria Dolores Sevillano [Espagne] ; Jesus De Pedro-Cuesta [Espagne, Suède] ; Jacinto Duarte [Espagne] ; Luis Erik Claveria [Espagne] | Field validation of a method for population screening of parkinsonism |
| 002760 |
| Factors impacting on quality of life in Parkinson's disease: Results from an international survey |
| 002765 |
J. Carsten Moller [Allemagne] ; Karin Stiasny [Allemagne] ; Volker Hargutt [Allemagne] ; Werner Cassel [Allemagne] ; Heiko Tietze [Allemagne] ; J. Hermann Peter [Allemagne] ; H.-Peter Krüger [Allemagne] ; Wolfgang H. Oertel [Allemagne] | Evaluation of sleep and driving performance in six patients with Parkinson's disease reporting sudden onset of sleep under dopaminergic medication: A pilot study |
| 002770 |
Alexander Fisher [Australie] ; James Croft-Baker [Australie] ; Michael Davis [Australie] ; Patrick Purcell [Australie] ; Allan J. Mclean [Australie] | Entacapone-induced hepatotoxicity and hepatic dysfunction |
| 002774 |
Cumhur Ertekin [Turquie] ; Sultan Tarlaci [Turquie] ; Ibrahim Aydogdu [Turquie] ; Nefati Kiylioglu [Turquie] ; Nur Yuceyar [Turquie] ; A. Bulent Turman [Australie] ; Yaprak Secil [Turquie] ; Figen Esmeli [Turquie] | Electrophysiological evaluation of pharyngeal phase of swallowing in patients with Parkinson's disease |
| 002776 |
Karen Stergaard [Danemark] ; Niels Sunde [Danemark] ; Erik Dupont [Danemark] | Effects of bilateral stimulation of the subthalamic nucleus in patients with severe Parkinson's disease and motor fluctuations |
| 002780 |
Julie A. Robichaud [États-Unis] ; Kerstin D. Pfann [États-Unis] ; Cynthia L. Comella [États-Unis] ; Daniel M. Corcos [États-Unis] | Effect of medication on EMG patterns in individuals with Parkinson's disease |
| 002787 |
| Drugs to treat urinary frequency, urgency, and/or urge incontinence |
| 002788 |
| Drugs to treat gastrointestinal motility problems |
| 002789 |
| Drugs to treat dementia and psychosis |
| 002790 |
| Drugs to treat autonomic dysfunction in Parkinson's disease |
| 002791 |
Y. Kim [Corée du Sud] ; J.-M. Kim [Corée du Sud] ; J.-W. Kim [Corée du Sud] ; C.-I. Yoo [Corée du Sud] ; C. R. Lee [Corée du Sud] ; J. H. Lee [Corée du Sud] ; H. K. Kim [Corée du Sud] ; S. O. Yang [Corée du Sud] ; H. K. Chung [Corée du Sud] ; D. S. Lee [Corée du Sud] ; B. Jeon [Corée du Sud] | Dopamine transporter density is decreased in parkinsonian patients with a history of Manganese exposure: What does it mean? |
| 002792 |
Oleh Hornykiewicz [Autriche] | Dopamine miracle: From brain homogenate to dopamine replacement |
| 002794 |
Chin-Song Lu [Taïwan] ; Yah-Huei Wu Chou [Taïwan] ; Tzu-Chen Yen [Taïwan] ; Chon-Haw Tsai [Taïwan] ; Rou-Shayn Chen [Taïwan] ; Hsiu-Chen Chang [Taïwan] | Dopa-responsive parkinsonism phenotype of spinocerebellar ataxia type 2 |
| 002796 |
Gilberto Levy [États-Unis] ; Ming-Xin Tang [États-Unis] ; Lucien J. Cote [États-Unis] ; Elan D. Louis [États-Unis] ; Brenda Alfaro [États-Unis] ; Helen Mejia [États-Unis] ; Yaakov Stern [États-Unis] ; Karen Marder [États-Unis] | Do risk factors for Alzheimer's Disease predict dementia in Parkinson's disease? An exploratory study |
| 002797 |
J. E. Rice [Australie] ; R. Antic [Australie] ; Philip D. Thompson [Australie] | Disordered respiration as a levodopa-induced dyskinesia in Parkinson's disease |
| 002800 |
Elan D. Louis [États-Unis] ; Gilberto Levy [États-Unis] ; Lucien J. Cote [États-Unis] ; Helen Mejia [États-Unis] ; Stanley Fahn [États-Unis] ; Karen Marder [États-Unis] | Diagnosing Parkinson's disease using videotaped neurological examinations: Validity and factors that contribute to incorrect diagnoses |
| 002802 |
Paresh K. Doshi [Inde] ; Niraj Chhaya [Inde] ; Mohit H. Bhatt [Inde] | Depression leading to attempted suicide after bilateral Subthalamic nucleus stimulation for Parkinson's disease |
| 002806 |
Anthony E. Lang [Canada] ; Hakan Widner [Suède] | Deep brain stimulation for Parkinson's disease: Patient selection and evaluation |
| 002807 |
Diego Garcia-Borreguero [Espagne] ; Ana B. Caminero [Espagne] ; Yolanda De La Llave [Espagne] ; Oscar Larrosa [Espagne] ; Soledad Barrio [Espagne] ; Juan J. Granizo [Espagne] ; Juan A. Pareja [Espagne] | Decreased phasic EMG activity during Rapid eye movement sleep in treatment-naïve Parkinson's disease: Effects of treatment with levodopa and progression of illness |
| 002808 |
| DA agonists: ergot derivatives: Bromocriptine |
| 002809 |
| DA agonists: Non-Ergot derivatives: Ropinirole |
| 002810 |
| DA agonists: Non-Ergot derivatives: Pramipexole |
| 002811 |
| DA agonists: Non-Ergot derivatives: Piribedil |
| 002812 |
| DA agonists: Non-Ergot derivatives: Apomorphine |
| 002813 |
| DA agonists: Ergot derivatives: Pergolide |
| 002814 |
| DA agonists: Ergot derivatives: Lisuride |
| 002815 |
| DA agonists: Ergot derivatives: Dihydroergocryptine (DHEC) |
| 002816 |
| DA agonists: Ergot derivatives: Cabergoline |
| 002821 |
Marwan I. Hariz [Suède] | Complications of deep brain stimulation surgery |
| 002822 |
Yun J. Kim [Canada] ; Masanori Ichise [Canada] ; James R. Ballinger [Canada] ; Douglas Vines [Canada] ; Sean S. Erami [Canada] ; Tatsuro Tatschida [Canada] ; Anthony E. Lang [Canada] | Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP |
| 002825 |
Theresa A. Zesiewicz [États-Unis] ; Sujatha Borra [États-Unis] ; Robert A. Hauser [États-Unis] | Clozapine withdrawal symptoms in a Parkinson's disease patient |
| 002826 |
Azi H. Rajput [Canada] ; Mark E. Fenton [Canada] ; Sam Birdi [Canada] ; Rob Macaulay [Canada] ; David George [Canada] ; Bohdar Rozdilsky [Canada] ; Lee C. Ang [Canada] ; Ambikaipakan Senthilselvan [Canada] ; Oleh Hornykiewicz [Autriche] | Clinical-pathological study of levodopa complications |
| 002827 |
Valeria Isella [Italie] ; Paola Melzi [Italie] ; Marco Grimaldi [Italie] ; Simona Iurlaro [Italie] ; Roberto Piolti [Italie] ; Carlo Ferrarese [Italie] ; Lodovico Frattola [Italie] ; Ildebrando Appollonio [Italie] | Clinical, neuropsychological, and morphometric correlates of apathy in Parkinson's disease |
| 002828 |
Ruey-Meei Wu [Taïwan] ; Din-E Shan [Taïwan] ; Chen-Ming Sun [Taïwan] ; Ren-Shyan Liu [Taïwan] ; Wuh-Liang Hwu [Taïwan] ; Chun-Hwei Tai [Taïwan] ; Jennifer Hussey [États-Unis] ; Andrew West [États-Unis] ; Katrina Gwinn-Hardy [États-Unis] ; John Hardy [États-Unis] ; Judy Chen [États-Unis] ; Matt Farrer [États-Unis] ; Sarah Lincoln [États-Unis] | Clinical, 18F-dopa PET, and genetic analysis of an ethnic Chinese kindred with early-onset parkinsonism and parkin gene mutations |
| 002831 |
James H. Bower [États-Unis] ; Dennis W. Dickson [États-Unis] ; Laura Taylor [États-Unis] ; Demetrius M. Maraganore [États-Unis] ; Walter A. Rocca [États-Unis] | Clinical correlates of the pathology underlying parkinsonism: A population perspective |
| 002834 |
Joanne E. Nash [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni] | Characterisation of striatal NMDA receptors involved in the generation of Parkinsonian symptoms: Intrastriatal microinjection studies in the 6-OHDA-lesioned rat |
| 002835 |
Demetrius M. Maraganore [États-Unis] ; Matthew J. Fairer [États-Unis] ; Shannon K. Mcdonnell [États-Unis] ; Alexis Elbaz [États-Unis] ; Daniel J. Schaid [États-Unis] ; John A. Hardy [États-Unis] ; Walter A. Rocca [États-Unis] | Case-control study of estrogen receptor gene polymorphisms in Parkinson's disease |
| 002836 |
John L. Goudreau [États-Unis] ; Demetrius M. Maraganore [États-Unis] ; Matthew J. Farrer [États-Unis] ; Timothy G. Lesnick [États-Unis] ; Andrew B. Singleton [États-Unis] ; James H. Bower [États-Unis] ; John A. Hardy [États-Unis] ; Walter A. Rocca [États-Unis] | Case-control study of dopamine transporter-1, monoamine oxidase-B, and catechol-O-methyl transferase polymorphisms in Parkinson's disease |
| 002837 |
Silke Wunderlich [Allemagne] ; Ilona Csoti [Allemagne] ; Karlheinz Reiners [Allemagne] ; Thomas Günthner-Lengsfeld [Allemagne] ; Christiane Schneider [Allemagne] ; Georg Becker [Allemagne] ; Markus Naumann [Allemagne] | Camptocormia in Parkinson's disease mimicked by focal myositis of the paraspinal muscles |
| 002838 |
Jakob Christensen [Danemark] ; Erik Dupont [Danemark] ; Karen Stergaard [Danemark] | Cabergoline plasma concentration is increased during concomitant treatment with itraconazole |
| 002839 |
| COMT inhibitors |
| 002844 |
Winston D. Byblow [Nouvelle-Zélande] ; Jeffery J. Summers [Australie] ; Gwyn N. Lewis [Nouvelle-Zélande] ; Julie Thomas [Australie] | Bimanual coordination in Parkinson's disease: Deficits in movement frequency, amplitude, and pattern switching |
| 002845 |
Quincy J. Almeida [Canada] ; Laurie R. Wishart [Canada] ; Timothy D. Lee [Canada] | Bimanual coordination deficits with Parkinson's disease: The influence of movement speed and external cueing |
| 002847 |
Francesc Valldeoriola [Espagne] ; Manuela Pilleri [Espagne] ; Eduardo Tolosa [Espagne] ; José L. Molinuevo [Espagne] ; Jordi Rumia [Espagne] ; Enric Ferrer [Espagne] | Bilateral subthalamic stimulation monotherapy in advanced Parkinson's disease: Long-term follow-up of patients |
| 002848 |
Pablo Martinez-Martin [Espagne] ; Francesc Valldeoriola [Espagne] ; Eduardo Tolosa [Espagne] ; Manuela Pilleri [Espagne] ; José Luis Molinuevo [Espagne] ; Jordi Rumia [Espagne] ; Enric Ferrer [Espagne] | Bilateral subthalamic nucleus stimulation and quality of life in advanced Parkinson's disease |
| 002849 |
Rob M. A. De Bie [Pays-Bas] ; P. Richard Schuurman [Pays-Bas] ; Rianne A. J. Esselink [Pays-Bas] ; D. Andries Bosch [Pays-Bas] ; Johannes D. Speelman [Pays-Bas] | Bilateral pallidotomy in Parkinson's disease: A retrospective study |
| 002850 |
David J. Burn [Royaume-Uni] | Beyond the iron mask: Towards better recognition and treatment of depression associated with Parkinson's disease |
| 002851 |
Mikko Kuoppam Ki [Royaume-Uni] ; Ghassan Al-Barghouthy [Royaume-Uni] ; Michael Jackson [Royaume-Uni] ; Lance Smith [Royaume-Uni] ; Bai-Yun Zeng [Royaume-Uni] ; Niall Quinn [Royaume-Uni] ; Peter Jenner [Royaume-Uni] | Beginning-of-dose and rebound worsening in MPTP-treated common marmosets treated with levodopa |
| 002856 |
Masataka Nishimura [Japon] ; Ryuji Kaji [Japon] ; Mitsuhiro Ohta [Japon] ; Ikuko Mizuta [Japon] ; Sadako Kuno [Japon] | Association between dopamine transporter gene polymorphism and susceptibility to Parkinson's disease in Japan |
| 002858 |
Alice J. Manson [Royaume-Uni] ; Kirsten Turner [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease: Long-term follow-up study of 64 patients |
| 002859 |
| Anticholinergic therapies in the treatment of Parkinson's disease |
| 002860 |
ZHIGAO HUANG [États-Unis] ; Michael Jacewicz [États-Unis] ; Ronald F. Pfeiffer [États-Unis] | Anticardiolipin antibody in vascular parkinsonism |
| 002861 |
Maria K. Viitasalo [Finlande] ; Ville Kampman [Finlande] ; Kyösti A. Sotaniemi [Finlande] ; Seppo Lepp Vuori [Finlande] ; Vilho V. Myllyl [Finlande] ; Juha T. Korpelainen [Finlande] | Analysis of sway in Parkinson's disease using a new inclinometry-based method |
| 002862 |
Michele T. M. Hu [Royaume-Uni] ; K. Ray Chaudhuri [Royaume-Uni] ; Jozef Jarosz [Royaume-Uni] ; Lidia Yaguez [Royaume-Uni] ; David J. Brooks [Royaume-Uni] | An imaging study of parkinsonism among African-Caribbean and Indian London communities |
| 002863 |
| Amantadine and other antiglutamate agents |
| 002866 |
Lisa M. Shulman [États-Unis] ; X. Wen [États-Unis] ; William J. Weiner [États-Unis] ; Dinorah Bateman [États-Unis] ; Alireza Minagar [États-Unis] ; Robert Duncan [États-Unis] ; Janet Konefal [États-Unis] | Acupuncture therapy for the symptoms of Parkinson's Disease |
| 002867 |
Marcelo Merello [Argentine] ; Maria I. Nouzeilles [Argentine] ; Gabriel Piran Arce [Argentine] ; Ramon Leiguarda [Argentine] | Accuracy of acute levodopa challenge for clinical prediction of sustained long-term levodopa response as a major criterion for idiopathic Parkinson's disease diagnosis |
| 002869 |
JIAN WANG [République populaire de Chine] ; Chun-Ying Zhao [République populaire de Chine] ; Yan-Mei Si [République populaire de Chine] ; Zhuo-Lin Liu [République populaire de Chine] ; BIAO CHEN [République populaire de Chine] ; LONG YU [République populaire de Chine] | ACT and UCH-L1 polymorphisms in Parkinson's disease and age of onset |
| 002872 |
Andrea Varrone [États-Unis] ; Kenneth L. Marek [États-Unis] ; Danna Jennings [États-Unis] ; Robert B. Innis [États-Unis] ; John P. Seibyl [États-Unis] | [123I]β-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's Disease and multiple system atrophy |
| 002873 |
Tarja H. Haapaniemi [Finlande] ; Aapo Ahonen [Finlande] ; Pentti Tomiainen [Finlande] ; Kyosti A. Sotaniemi [Finlande] ; Vilho V. Myllyl [Finlande] | [123I]β-CIT SPECT demonstrates decreased brain dopamine and serotonin transporter levels in untreated parkinsonian patients |
| 002875 |
Padraig E. Osuilleabhain [États-Unis] ; Richard B. Jr Dewey [États-Unis] | Validation for tremor quantification of an electromagnetic tracking device |
| 002884 |
J. Thomas Hutton [États-Unis] ; Leo Verhagen Metman [États-Unis] ; Thomas N. Chase [États-Unis] ; Jorge L. Juncos [États-Unis] ; William C. Koller [États-Unis] ; Rajesh Pahwa [États-Unis] ; Peter A. Lewitt [États-Unis] ; Ali Samii [Canada] ; Joseph K. C. Tsui [Canada] ; Donald B. Calne [Canada] ; Cheryl H. Waters [États-Unis] ; Vincent P. Calabrese [États-Unis] ; James P. Bennett [États-Unis] ; Richard Barrett [États-Unis] ; Jerry L. Morris [États-Unis] | Transdermal dopaminergic D2 receptor agonist therapy in Parkinson's disease with N-0923 TDS: A double-blind, placebo-controlled study |
| 002886 |
Lawrence I. Golbe [États-Unis] ; Alice M. Lazzarini [États-Unis] ; John R. Spychala [États-Unis] ; William G. Johnson [États-Unis] ; Edward S. Stenroos [États-Unis] ; Margery H. Mark [États-Unis] ; Jacob I. Sage [États-Unis] | The tau A0 allele in Parkinson's disease |
| 002887 |
M. C. Carboneini [Italie] ; D. Manzoni [Italie] ; S. Strambi [Italie] ; U. Bonuccelli [Italie] ; N. Pavese [Italie] ; P. Andre [Italie] ; B. Rossi [Italie] | The relation between EMG activity and kinematic parameters strongly supports a role of the action tremor in Parkinsonian bradykinesia |
| 002889 |
Christopher G. Goetz [États-Unis] ; Teresa A. Chmura [États-Unis] ; Douglas J. Lanska [États-Unis] | The history of Parkinson's disease : Part 2 of the MDS-sponsored history of movement disorders exhibit, Barcelona, june, 2000 |
| 002892 |
Markus Kofler [Autriche] ; Jörg Müller [Espagne] ; Gregor K. Wenning [Espagne] ; Laura Reggiani [Espagne] ; Pia Hollosi [Espagne] ; Sylvia Bösch [Espagne] ; Gerhard Ransmayr [Espagne] ; Josep Valls-Sole [Autriche] ; Werner Poewe [Espagne] | The auditory startle reaction in Parkinsonian disorders |
| 002894 |
William Ondo [États-Unis] ; Kevin Dat Vuong [États-Unis] ; Michael Almaguer [États-Unis] ; Joseph Jankovic [États-Unis] ; Richard K. Simpson [États-Unis] | Thalamic deep brain stimulation: Effects on the nontarget limbs |
| 002897 |
F. Tracik [Allemagne] ; G. Ebersbach [Allemagne] | Sudden daytime Sleep onset in Parkinson's disease: Polysomnographic recordings |
| 002898 |
Arthur Korten [Pays-Bas] ; Jan Lodder [Pays-Bas] ; Fred Vreeling [Pays-Bas] ; Anita Boreas [Pays-Bas] ; Lisette Van Raak [Pays-Bas] ; Fons Kessels [Pays-Bas] | Stroke and idiopathic Parkinson's disease : Does a shortage of dopamine offer protection against stroke? |
| 002902 |
Elan D. Louis [États-Unis] ; Linda Winfield [États-Unis] ; Stanley Fahn [États-Unis] ; Blair Ford [États-Unis] | Speech dysfluency exacerbated by levodopa in Parkinson's disease |
| 002905 |
Virgilio G. H. Evidente [États-Unis] ; John N. Caviness [États-Unis] ; Charles H. Adler [États-Unis] ; Katrina A. Gwinn-Hardy [États-Unis] ; Richard E. Pratley [États-Unis] | Serum leptin concentrations and satiety in Parkinson's disease patients with and without weight loss |
| 002909 |
Christopher G. Goetz [États-Unis] ; Teresa A. Chmura [États-Unis] ; Douglas J. Lanska [États-Unis] | Seminal figures in the history of movement disorders : Sydenham, Parkinson, and Charcot: Part 6 of the MDS-sponsored history of movement disorders exhibit, Barcelona, june 2000 |
| 002910 |
Paul J. Reading [Royaume-Uni] ; Anna K. Luce [Royaume-Uni] ; Ian G. Mckeith [Royaume-Uni] | Rivastigmine in the treatment of Parkinsonian psychosis and cognitive impairment: Preliminary findings from an open trial |
| 002911 |
Oum-Kaltoum Hassani [France] ; Mireille Mouroux [France] ; Georg Andrees Bohme [France] ; Jean-Marie Stutzmann [France] ; Jean Feger [France] | Riluzole reduces hyperactivity of subthalamic neurons induced by unilateral 6-OHDA lesion in the rat brain |
| 002912 |
Ania Winogrodzka [Pays-Bas] ; Robert C. Wagenaar [Pays-Bas] ; Paul Bergmans [Pays-Bas] ; Astrid Vellinga [Pays-Bas] ; Jan Booij [Pays-Bas] ; Eric A. Van Royen [Pays-Bas] ; Richard E. A. Van Emmerik [États-Unis] ; Johannes C. Stoof [Pays-Bas] ; Erik Ch. Wolters [Pays-Bas] | Rigidity decreases resting Tremor intensity in Parkinson's disease: A [123I]β-CIT SPECT study in early, nonmedicated patients |
| 002915 |
Georg Berding [Allemagne] ; Per Odin [Allemagne] ; David J. Brooks [Royaume-Uni] ; Guido Nikkhah [Allemagne] ; Cordula Matthies [Allemagne] ; Thomas Peschel [Allemagne] ; Mona Shing [Allemagne] ; Hans Kolbe [Allemagne] ; Jörg Van Den Hoff [Allemagne] ; Harald Fricke [Allemagne] ; Reinhard Dengler [Allemagne] ; Madjid Samii [Allemagne] ; Wolfram H. Knapp [Allemagne] | Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the Off and On conditions with [18F]FDG-PET |
| 002916 |
G. M. Petzinger [États-Unis] ; M. Quik [États-Unis] ; E. Ivashina [États-Unis] ; M. W. Jakowec [États-Unis] ; M. Jakubiak [États-Unis] ; D. Di Monte [États-Unis] ; J. W. Langston [États-Unis] | Reliability and validity of a new global dyskinesia rating scale in the MPTP-lesioned non-human primate |
| 002917 |
Joohi Shahed [États-Unis] ; Joseph Jankovic [États-Unis] | Re-emergence of Childhood stuttering in Parkinson's disease : A hypothesis |
| 002918 |
Elina Nurmi [Finlande] ; Hanna M. Ruottinen [Finlande] ; Jörgen Bergman [Finlande] ; Merja Haaparanta [Finlande] ; Olof Solin [Finlande] ; Pirkko Sonninen [Finlande] ; Juha O. Rinne [Finlande] | Rate of progression in Parkinson's disease: A 6-[18F]fluoro-L-dopa PET study |
| 002919 |
William Koller [États-Unis] ; Andrew Lees (neurologue) [Royaume-Uni] ; Miroslava Doder [Royaume-Uni] ; Mariese Hely [Australie] | Randomized trial of tolcapone versus pergolide as add-on to levodopa therapy in Parkinson's disease patients with motor fluctuations |
| 002923 |
Hiroshi Ujike [Japon] ; Mitsutoshi Yamamoto [Japon] ; Akihiro Kanzaki [Japon] ; Kazuya Okumura [Japon] ; Manabu Takaki [Japon] ; Shigetoshi Kuroda [Japon] | Prevalence of homozygous deletions of the parkin gene in a cohort of patients with sporadic and familial Parkinson's disease |
| 002925 |
Hubert H. Fernandez [États-Unis] ; Rowena E. J. Tabamo [États-Unis] ; Raymund R. David [États-Unis] ; Joseph H. Friedman [États-Unis] | Predictors of depressive symptoms among spouse caregivers in Parkinson's Disease |
| 002927 |
Anette Schrag [Royaume-Uni] ; Michael Trimble [Royaume-Uni] | Poetic talent unmasked by treatment of Parkinson's disease |
| 002929 |
Marie-Paule Muriel [France] ; Yves Agid [France] ; Etienne Hirsch [France] | Plasticity of afferent fibers to striatal neurons bearing D1 dopamine receptors in Parkinson's disease |
| 002932 |
Anna R. Bentivoglio [Italie] ; Pietro Cortelli [Italie] ; Enza M. Valente [Italie] ; Tamara Ialongo [Italie] ; Alessandro Ferraris [Italie] ; Antonio Elia [Italie] ; Pasquale Montagna [Italie] ; Alberto Albanese [Italie] | Phenotypic characterisation of autosomal recessive PARK6-linked Parkinsonism in three unrelated Italian families |
| 002937 |
Christopher G. Goetz [États-Unis] ; Teresa A. Chmura [États-Unis] ; Douglas J. Lanska [États-Unis] | Parkinsonism-plus syndromes: Part 7 of the MDS-sponsored history of movement disorders exhibit, Barcelona, june 2000 |
| 002939 |
Jasmine M. Henderson [Australie] ; WEI PING GAI [Australie] ; Mariese A. Hely [Australie] ; Wayne G. J. Reid [Australie] ; Grant L. Walker [Australie] ; Glenda M. Halliday [Australie] | Parkinson's disease with late Pick's dementia |
| 002944 |
R. E. Yee [États-Unis] ; I. Irwin [États-Unis] ; C. Milonas [États-Unis] ; D. B. Stout [États-Unis] ; S-C. Huang [États-Unis] ; K. Shoghi-Jadid [États-Unis] ; N. Satyamurthy [États-Unis] ; L. E. Delanney [États-Unis] ; D. M. Togasaki [États-Unis] ; K. F. Farahani [États-Unis] ; K. Delfani [États-Unis] ; A. M. Janson [États-Unis] ; M. E. Phelps [États-Unis] ; J. W. Langston [États-Unis] ; J. R. Barrio [États-Unis] | Novel observations with FDOPA-PET imaging after early nigrostriatal damage |
| 002945 |
G. Pierangeli [Italie] ; F. Provini [Italie] ; P. Maltoni [Italie] ; G. Barletta [Italie] ; M. Contin [Italie] ; E. Lugaresi [Italie] ; P. Montagna [Italie] ; P. Cortelli [Italie] | Nocturnal body core temperature falls in Parkinson's disease but not in multiple-system atrophy |
| 002949 |
P. H. Gordon [États-Unis] ; S. J. Frucht [États-Unis] | Neuroleptic malignant syndrome in advanced Parkinson's disease |
| 002950 |
Georg Becker [Allemagne] ; Daniela Berg [Allemagne] | Neuroimaging in basal ganglia disorders : Perspectives for Transcranial ultrasound |
| 002952 |
Susan H. Fox [Royaume-Uni] ; Brian Henry [Royaume-Uni] ; Micheal P. Hill [Royaume-Uni] ; David Peggs [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni] | Neural mechanisms underlying peak-dose dyskinesia induced by levodopa and apomorphine are distinct : Evidence from the effects of the Alpha2 adrenoceptor antagonist idazoxan |
| 002956 |
R. Cunnington [Australie] ; G. F. Egan [Australie] ; J. D. O'Sullivan [Australie] ; A. J. Hughes [Australie] ; J. L. Bradshaw [Australie] ; J. G. Colebatch [Australie] | Motor imagery in Parkinson's disease: A PET study |
| 002958 |
Paul Krack [France, Allemagne] ; Rajeev Kumar [États-Unis] ; Claire Ardouin [France] ; Patricia Limousin Dowsey [Royaume-Uni] ; John M. Mcvicker [France, États-Unis] ; Alim-Louis Benabid [France] ; Pierre Pollak [France] | Mirthful laughter induced by subthalamic nucleus stimulation |
| 002961 |
Tobias E. Eichhorn [Allemagne] ; Wolfgang H. Oertel [Allemagne] | Macrogol 3350/Electrolyte improves constipation in Parkinson's disease and multiple system atrophy |
| 002962 |
G. Tissingh [Pays-Bas] ; H. W. Berendse [Pays-Bas] ; P. Bergmans [Pays-Bas] ; R. Dewaard [Pays-Bas] ; B. Drukarch [Pays-Bas] ; J. C. Stoof [Pays-Bas] ; E. Ch. Wolters [Pays-Bas] | Loss of olfaction in de novo and treated Parkinson's disease : Possible implications for early diagnosis |
| 002964 |
Jean-Louis Montastruc [France] ; Karine Desboeuf [France] ; Maryse Lapeyre-Mestre [France] ; Jean-Michel Senard [France] ; Olivier Rascol [France] ; Christine Brefel-Courbon [France] | Long-term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease |
| 002966 |
Fabrizio Stocchi [Italie] ; Laura Vacca [Italie] ; Alfredo Berardelli [Italie] ; Francesca De Pandis [Italie] ; Stefano Ruggieri [Italie] | Long-duration effect and the postsynaptic compartment : Study using a dopamine agonist with a short half-life |
| 002973 |
Paolo Del Dotto [Italie] ; Nicola Pavese [Italie] ; Gianna Gambaccini [Italie] ; Silvia Bernardini [Italie] ; Leonard Verhagen Metman [États-Unis] ; Thomas N. Chase [États-Unis] ; Ubaldo Bonuccelli [Italie] | Intravenous amantadine improves levadopa-induced dyskinesias: An acute double-blind placebo-controlled study |
| 002977 |
Thomas C. Wetter [Allemagne] ; Hans Brunner [Allemagne] ; Birgit Högl [Allemagne] ; Alexander Yassouridis [Allemagne] ; Claudia Trenkwalder [Allemagne] ; Elisabeth Friess [Allemagne] | Increased alpha activity in REM sleep in de novo patients with Parkinson's disease |
| 002980 |
Olivier Rascol [France] ; I. Arnulf [France] ; H. Peyro-Saint Paul [France] ; C. Brefel-Courbon [France] ; M. Vidailhet [France] ; C. Thalamas [France] ; A. M. Bonnet [France] ; S. Descombes [France] ; B. Bejjani [France] ; N. Fabre [France] ; J. L. Montastruc [France] ; Yves Agid [France] | Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease |
| 002981 |
Maria D. Benedetti [États-Unis] ; Demetrius M. Maraganore [États-Unis] ; James H. Bower [États-Unis] ; Shannon K. Mcdonnell [États-Unis] ; Brett J. Peterson [États-Unis] ; J. Eric Ahlskog [États-Unis] ; Daniel J. Schaid [États-Unis] ; Walter A. Rocca [États-Unis] | Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: An exploratory case-control study |
| 002991 |
Marwan I. Hariz [Suède] ; Folke Johansson [Suède] | Hardware failure in Parkinsonian patients with chronic subthalamic nucleus stimulation is a medical emergency |
| 002993 |
Federico M. Farin [États-Unis] ; Yolanda Hitosis [États-Unis] ; Sarah E. Hallagan [États-Unis] ; John Kushleika [États-Unis] ; James S. Woods [États-Unis] ; Patricia S. Janssen [États-Unis] ; Terri Smith-Weller [États-Unis] ; Gary M. Franklin [États-Unis] ; Phillip D. Swanson [États-Unis] ; Harvey Checkoway [États-Unis] | Genetic polymorphisms of superoxide dismutase in Parkinson's disease |
| 002994 |
Ruth Hardoff [Israël] ; Michael Sula [Israël] ; Ada Tamir [Israël] ; Adrian Soil [Israël] ; Avi Front [Israël] ; Samich Badarna [Israël] ; Silvia Honigman [Israël] ; Nir Giladi [Israël] | Gastric emptying time and gastric motility in patients with Parkinson's disease |
| 002995 |
Robert Jech [République tchèque] ; Dusan Urgosik [République tchèque] ; Jaroslav Tintera [République tchèque] ; Antonin Nebuzelsky [République tchèque] ; Jan Krasensky [République tchèque] ; Roman Liscak [République tchèque] ; Jan Roth [République tchèque] ; Evzen Ruzicka [République tchèque] | Functional magnetic resonance imaging during deep brain stimulation: A pilot study in four patients with Parkinson's disease |
| 002996 |
Zbigniew K. Wszolek [États-Unis] ; Randy H. Kardon [États-Unis] ; Erik Ch. Wolters [Pays-Bas] ; Ronald F. Pfeiffer [États-Unis] | Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17): PPND family. A longitudinal videotape demonstration |
| 002997 |
J. Eric Ahlskog [États-Unis] ; Manfred D. Muenter [États-Unis] | Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature |
| 002998 |
Neil S. Lava [États-Unis] ; Stewart A. Factor [États-Unis] | Focal myopathy as a cause of anterocollis in Parkinsonism |
| 002999 |
J. H. Friedman [États-Unis] ; H. Friedman [États-Unis] | Fatigue in Parkinson's disease: A nine-year follow-up |
| 002A00 |
E. Apartis [France] ; F. Tison [France] ; P. Arne [France] ; C. P. Jedynak [France] ; M. Vidailhet [France] | Fast orthostatic tremor in Parkinson's disease mimicking primary orthostatic tremor |
| 002A03 |
Jau-Shin Lou [États-Unis] ; Greg Kearns [États-Unis] ; Barry Oken [États-Unis] ; Gary Sexton [États-Unis] ; John Nutt [États-Unis] | Exacerbated physical fatigue and mental fatigue in Parkinson's disease |
| 002A06 |
Andrea S. Winkler [Royaume-Uni] ; Joanne Marsden [Royaume-Uni] ; Matthew Parton [Royaume-Uni] ; Peter J. Watkins [Royaume-Uni] ; K. Ray Chaudhuri [Royaume-Uni] | Erythropoietin deficiency and anaemia in multiple system atrophy |
| 002A10 |
Joseph H. Friedman [États-Unis] | Effects of reviewing DATATOP videotapes on IQ and MMPI in PSG coordinators and investigators, or, whatever happened to tony lang? |
| 002A11 |
N. Allert [Allemagne] ; J. Volkmann [Allemagne] ; S. Dotse [Allemagne] ; H. Hefter [Allemagne] ; V. Sturm [Allemagne] ; H.-J. Freund [Allemagne] | Effects of Bilateral pallidal or subthalamic stimulation on gait in advanced Parkinson's Disease |
| 002A12 |
Birgit Högl [Allemagne] ; Cecilia Peralta [Argentine] ; Thomas C. Wetter [Allemagne] ; Oscar Gershanik [Argentine] ; Claudia Trenkwalder [Allemagne] | Effect of sleep deprivation on motor performance in patients with Parkinson's Disease |
| 002A16 |
L. Alvarez [Cuba] ; R. Macias [Cuba] ; J. Guridi [Espagne] ; G. Lopez [Cuba] ; E. Alvarez [Cuba] ; C. Maragoto [Cuba] ; J. Teijeiro [Cuba] ; A. Torres [Cuba] ; N. Pavon [Cuba] ; M. C. Rodriguez-Oroz [Espagne] ; L. Ochoa [Cuba] ; H. Hetherington [États-Unis] ; J. Juncos [États-Unis] ; M. R. Delong [États-Unis] ; J. A. Obeso [Espagne] | Dorsal subthalamotomy for Parkinson's disease |
| 002A17 |
Y. R. Wu [Taïwan] ; R. Levy [Canada] ; P. Ashby [Canada] ; R. R. Tasker [Canada] ; J. O. Dostrovsky [Canada] | Does stimulation of the GPi control dyskinesia by activating inhibitory axons? |
| 002A18 |
Orhan Barlas [Turquie] ; Hasmet A. Hanagasi [Turquie] ; Murat Imer [Turquie] ; Hüseyin A. Sahin [Turquie] ; Serra Sencer [Turquie] ; Murat Emre [Turquie] | Do unilateral ablative lesions of the subthalamic nucleu in parkinsonian patients lead to hemiballism? |
| 002A19 |
Richard Camicioli [États-Unis] ; Sandra J. Grossmann [États-Unis] ; Peter S. Spencer [États-Unis] ; Ken Hudnell [États-Unis] ; W. Kent Anger [États-Unis] | Discriminating mild Parkinsonism : Methods for epidemiological research |
| 002A23 |
Marcelo Merello [Argentine] ; Angel Cammarota [Argentine] ; Ramon Leiguarda [Argentine] ; Ralph Pikielny [Argentine] | Delayed intracerebral electrode infection after bilateral STN implantation for Parkinson's disease: Case report |
| 002A27 |
Kerstin D. Pfann [États-Unis] ; Aron S. Buchman [États-Unis] ; Cynthia L. Comella [États-Unis] ; Daniel M. Corcos [États-Unis] | Control of movement distance in Parkinson's disease |
| 002A28 |
Alberto Albanese [Italie] ; Ubaldo Bonuccelli [Italie] ; Christine Brefel [France] ; K. Ray Chaudhuri [Royaume-Uni] ; Carlo Colosimo [Italie] ; Tobias Eichhorn [Allemagne] ; Eldad Melamed [Israël] ; Pierre Pollak [France] ; Teus Van Laar [Pays-Bas] ; Mario Zappia [Italie] | Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease |
| 002A32 |
Lisa M. Shulman [États-Unis] ; Robin Leifert Taback [États-Unis] ; Judy Bean [États-Unis] ; William J. Weiner [États-Unis] | Comorbidity of the nonmotor symptoms of Parkinson's disease |
| 002A33 |
Stewart A. Factor [États-Unis] ; Joseph H. Friedman [États-Unis] ; Margaret C. Lannon [États-Unis] ; David Oakes [États-Unis] ; Keith Bourgeois [États-Unis] | Clozapine for the treatment of drug-induced psychosis in Parkinson's disease : Results of the 12 week open label extension in the PSYCLOPS trial |
| 002A34 |
S. Bostantjopoulou [Grèce] ; Z. Katsarou [Grèce] ; A. Papadimitriou [Grèce] ; V. Veletza [Grèce] ; G. Hatzigeorgiou [Grèce] ; A. Lees [Royaume-Uni] | Clinical features of parkinsonian patients with the α-synuclein (G209A) mutation |
| 002A35 |
C.-S. Lu [Taïwan] ; J.-C. Wu [Taïwan] ; C.-H. Tsai [Taïwan] ; R.-S. Chen [Taïwan] ; Y.-H. Wu Chou [Taïwan] ; N. Hattori [Japon] ; H. Yoshino [Japon] ; Y. Mizuno [Japon] | Clinical and genetic studies on familial parkinsonism : The first report on a Parkin gene mutation in a Taiwanese family |
| 002A36 |
Krishna P. Datla [Royaume-Uni] ; Stavia B. Blunt [Royaume-Uni] ; David T. Dexter [Royaume-Uni] | Chronic L-DOPA administration is not toxic to the remaining dopaminergic nigrostriatal neurons, but instead may promote their functional recovery, in rats with partial 6-OHDA or FeCl3 nigrostriatal lesions |
| 002A37 |
Lorraine O. Ramig [États-Unis] ; Shimon Sapir [États-Unis] ; Cynthia Fox [États-Unis] ; Stefanie Countryman [États-Unis] | Changes in vocal loudness following intensive voice Treatment (LSVT®) in individuals with Parkinson's disease : A comparison with untreated patients and normal age-matched controls |
| 002A41 |
Hélène Turmel [France] ; Andreas Hartmann [France] ; Karine Parain [France] ; Aicha Doubou [France] ; Anu Srinivasan [États-Unis] ; Yves Agid [France] ; Etienne C. Hirsch [France] | Caspase-3 activation in 1 -methyl-4-phenyl- 1, 2,3,6-tetrahydropyridine (MPTP)-treated mice |
| 002A45 |
Björn Holmberg [Suède] ; Mika Kallio [Finlande] ; Bo Johnels [Suède] ; Mikael Elam [Suède] | Cardiovascular reflex testing contributes to clinical evaluation and differential diagnosis of Parkinsonian syndromes |
| 002A49 |
B. Sanjay Harhangi [Pays-Bas] ; Ben A. Oostra [Pays-Bas] ; Peter Heutink [Pays-Bas] ; Cornelia M. Van Duijn [Pays-Bas] ; Albert Hofman [Pays-Bas] ; Monique M. B. Breteler [Pays-Bas] | CYP2D6 polymorphism in Parkinson's disease : The Rotterdam study |
| 002A55 |
Sasa R. Filipovic [Serbie] ; Nadezda Sternic [Serbie] ; Marina Svetel [Serbie] ; Natasa Dragasevic [Serbie] ; Dusica Lecic [Serbie] ; Vladimir S. Kostic [Serbie] | Bereitschaftspotential in depressed and non-depressed patients with Parkinson's disease |
| 002A58 |
Bradley F. Boeve [États-Unis] ; Michael H. Silber [États-Unis] ; Tanis J. Ferman [États-Unis] ; John A. Lucas [États-Unis] ; Joseph E. Parisi [États-Unis] | Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy |
| 002A59 |
Armin J. Grau [Allemagne] ; Vera Willig [Allemagne] ; Wolfgang Fogel [Allemagne] ; Egon Werle [Allemagne] | Assessment of plasma lactoferrin in Parkinson's disease |
| 002A60 |
Eleni C. Maratos [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Ronald K. B. Pearce [Royaume-Uni] ; Peter Jenner [Royaume-Uni] | Antiparkinsonian activity and dyskinesia risk of ropinirole and L-DOPA combination therapy in drug naïve MPTP-lesioned common marmosets (Callithrix jacchus) |
| 002A61 |
Pau Pastor [Espagne] ; Esteban Munoz [Espagne] ; Mario Ezquerra [Espagne] ; Victor Obach [Espagne] ; Maria José Marti [Espagne] ; Francese Valldeoriola [Espagne] ; Eduard Tolosa [Espagne] ; Rafael Oliva [Espagne] | Analysis of the coding and the 5' flanking regions of the α-synuclein gene in patients with Parkinson's disease |
| 002A65 |
F. Carella [Italie] ; S. Genitrini [Italie] ; M. Bressanelli [Italie] ; P. Soliveri [Italie] ; D. Servello [Italie] ; G. Broggi [Italie] ; S. Piacentini [Italie] ; G. Geminiani [Italie] ; F. Girotti [Italie] | Acute effects of bilateral subthalamic nucleus stimulation on clinical and kinematic parameters in Parkinson's disease |
| 002A67 |
J. I. Hoff [Pays-Bas] ; A. A. V. D. Plas [Pays-Bas] ; E. A. H. Wagemans [Pays-Bas] ; J. J. Van Hilten [Pays-Bas] | Accelerometric assessment of levodopa-induced dyskinesias in Parkinson's disease |
| 002A69 |
Alice Nieuwboer [Belgique] ; René Dom [Belgique] ; Willy De Weerdt [Belgique] ; Kaat Desloovere [Belgique] ; Steffen Fieuws [Belgique] ; Eva Broens-Kaucsik [Belgique] | Abnormalities of the spatiotemporal characteristics of gait at the onset of freezing in Parkinson's disease |
| 002A72 |
Connie Marras [Canada] ; Anthony E. Lang [Canada] ; LEE CYN ANG [Canada] ; Jcm Zijlmans [Royaume-Uni] ; G. K. Wenning [Autriche] | 69-year-old man with gait disturbance and parkinsonism |
| 002A73 |
| |
| 002A75 |
| Abstracts of the sixth international congress of Parkinson's disease and movement disorders, Barcelona, Spain, June 11-15, 2000 |
| 002A77 |
Walter Pirker [Autriche] ; Susanne Asenbaum [Autriche] ; Gerhard Bencsits [Autriche] ; Daniela Prayer [Autriche] ; Willibald Gerschlager [Autriche] ; Lüder Deecke [Autriche] ; Thomas Brücke [Autriche] | [123I]β-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration |
| 002A78 |
C. W. Olanow [États-Unis] ; A. H. V. Schapira [Royaume-Uni] ; T. Roth [États-Unis] | Waking up to sleep episodes in Parkinson's disease |
| 002A80 |
Aileen K. Ho [Australie] ; John L. Bradshaw [Australie] ; Robert Iansek [Australie] | Volume perception in parkinsonian speech |
| 002A81 |
Elka D. Stefanova [Serbie] ; Vladimir S. Kostic [Serbie] ; Ljubomir Ziropadja [Serbie] ; Milan Markovic [Serbie] ; Gordana G. Ocic [Serbie] | Visuomotor skill learning on Serial Reaction Time task in patients with early Parkinson's disease |
| 002A83 |
D. S. Latchman [Royaume-Uni] ; R. S. Coffin [Royaume-Uni] | Viral vectors in the treatment of Parkinson's disease |
| 002A89 |
M. S. Baron [États-Unis] ; J. L. Vitek [États-Unis] ; R. A. E. Bakay [États-Unis] ; J. Green [États-Unis] ; W. M. Mcdonald [États-Unis] ; S. A. Cole [États-Unis] ; M. R. Delong [États-Unis] | Treatment of advanced Parkinson's Disease by unilateral posterior GPi pallidotomy : 4-Year results of a pilot study |
| 002A91 |
Silvana Tesei [Italie] ; Angelo Antonini [Italie] ; Margherita Canesi [Italie] ; Anna Zecchinelli [Italie] ; Claudio B. Mariani [Italie] ; Gianni Pezzoli [Italie] | Tolerability of paroxetine in Parkinson's disease : A prospective study |
| 002A92 |
R. A. Hauser [États-Unis] ; W. C. Koller [États-Unis] ; J. P. Hubble [États-Unis] ; T. Malapira [États-Unis] ; K. Busenbark [États-Unis] ; C. W. Olanow [États-Unis] | Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson's Disease |
| 002A94 |
Albert F. G. Leentjens [Pays-Bas] ; Frans R. J. Verhey [Pays-Bas] ; Gert-Jan Luijckx [Pays-Bas] ; Jaap Troost [Pays-Bas] | The validity of the Beck Depression Inventory as a screening and diagnostic instrument for depression in patients with Parkinson's disease |
| 002A95 |
L. M. Shulman [États-Unis] ; A. Minagar [États-Unis] ; A. Rabinstein [États-Unis] ; W. J. Weiner [États-Unis] | The use of dopamine agonists in very elderly patients with Parkinson's disease |
| 002A96 |
Hasmet A. Hanagasi [Turquie] ; Gülüstü Kaptanoglu [Turquie] ; Hüseyin A. Sahin [Turquie] ; Murat Emre [Turquie] | The use of NMDA antagonist memantine in drug-resistant dyskinesias resulting from L-dopa |
| 002A97 |
Roberta Marchese [Italie] ; Manuela Diverio [Italie] ; Francesca Zucchi [Italie] ; Carmelo Lentino [Italie] ; Giovanni Abbruzzese [Italie] | The role of sensory cues in the rehabilitation of parkinsonian patients : A comparison of two physical therapy protocols |
| 002A98 |
A.-M. Kuopio [Finlande] ; R. J. Marttila [Finlande] ; H. Helenius [Finlande] ; M. Toivonen [Finlande] ; U. K. Rinne [Finlande] | The quality of life in Parkinson's disease |
| 002B03 |
C. Ramaker [Pays-Bas] ; W. J. T. Van De Beek [Pays-Bas] ; M. J. J. Finken [Pays-Bas] ; B. J. J. Van Hilten [Pays-Bas] | The efficacy and safety of adjunct bromocriptine therapy for levodopa-induced motor complications : A systematic review |
| 002B04 |
L. M. Shulman [États-Unis] ; A. Minagar [États-Unis] ; W. J. Weiner [États-Unis] | The effect of pregnancy in Parkinson's disease |
| 002B05 |
I. Reuter [Royaume-Uni] ; S. Harder [Allemagne] ; M. Engelhardt [Allemagne] ; H. Baas [Allemagne] | The effect of exercise on pharmacokinetics and pharmacodynamics of levodopa |
| 002B06 |
R. L. Oliveri [Italie] ; G. Annesi [Italie] ; M. Zappia [Italie] ; D. Civitelli [Italie] ; E. V. De Marco [Italie] ; A. A. Pasqua [Italie] ; F. Annesi [Italie] ; P. Spadafora [Italie] ; A. Gambardella [Italie] ; G. Nicoletti [Italie] ; D. Branca [Italie] ; M. Caracciolo [Italie] ; U. Aguglia [Italie] ; A. Quattrone [Italie] | The dopamine D2 receptor gene is a susceptibility locus for Parkinson's disease |
| 002B08 |
C. N. Homann [Royaume-Uni] ; K. Suppan [Royaume-Uni] ; K. Wenzel [Royaume-Uni] ; G. Giovannoni [Royaume-Uni] ; G. Ivanic [Royaume-Uni] ; S. Horner [Royaume-Uni] ; E. Ott [Royaume-Uni] ; H. P. Hartung [Royaume-Uni] | The bradykinesia akinesia incoordination test (BRAIN TEST©), an objective and user-friendly means to evaluate patients with parkinsonism |
| 002B11 |
M. De Marinis [Italie] ; F. Stocchi [Italie] ; B. Gregori [Italie] ; N. Accornero [Italie] | Sympathetic skin response and cardiovascular autonomic function tests in Parkinson's disease and multiple system atrophy with autonomic failure |
| 002B13 |
S. A. Factor [États-Unis] ; D. L. Brown [États-Unis] ; E. S. Molho [États-Unis] | Subcutaneous apomorphine injections as a treatment for intractable pain in Parkinson's disease |
| 002B16 |
Georg Ebersbach [Allemagne] ; Martin Sojer [Autriche] ; Tjoerg Muller [Autriche] ; Michaela Heijmenberg [Allemagne] ; Werner Poewe [Autriche] | Sociocultural differences in gait |
| 002B17 |
T. A. Zesiewicz [États-Unis] ; M. Helal [États-Unis] ; R. A. Hauser [États-Unis] | Sildenafil citrate (Viagra) for the treatment of erectile dysfunction in men with Parkinson's Disease |
| 002B19 |
M. Miranda [Chili] ; P. Chana [Chili] | Severe off-period facial dystonia in Parkinson's disease |
| 002B20 |
C. Mcrae [États-Unis] ; G. Diem [États-Unis] ; A. Vo [États-Unis] ; C. O'Brien [États-Unis] ; L. Seeberger [États-Unis] | Schwab & England : Standardization of administration |
| 002B21 |
Alessandro Di Rocco [États-Unis] ; John D. Rogers [États-Unis] ; Richard Brown [États-Unis] ; Peter Werner [États-Unis] ; Teodoro Bottiglieri [États-Unis] | S-Adenosyl-methionine improves depression in patients with Parkinson's disease in an open-label clinical trial |
| 002B23 |
Erich Mohr [Canada] ; Tilak Mendis [Canada] ; Kathleen Hildebrand [Canada] ; Peter Paul De Deyn [Belgique] | Risperidone in the treatment of dopamine-induced psychosis in Parkinson's disease: An open pilot trial |
| 002B26 |
D. A. Di Monte [États-Unis] ; A. Mccormack [États-Unis, Suède] ; G. Petzinger [États-Unis] ; A. M. Janson [États-Unis, Suède] ; M. Quik [États-Unis] ; W. J. Langston [États-Unis] | Relationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model |
| 002B29 |
H. M. Bronte-Stewart [États-Unis] ; LONG DING [États-Unis] ; C. Alexander [États-Unis] ; YI ZHOU [États-Unis] ; G. P. Moore [États-Unis] | Quantitative digitography (QDG) : A sensitive measure of digital motor control in idiopathic Parkinson's disease |
| 002B31 |
R. J. Elble [États-Unis] ; K. Leffler [États-Unis] | Pushing and pulling with the upper extremities while standing : The effects of mild Alzheimer dementia and Parkinson's disease |
| 002B36 |
R. A. Hauser [États-Unis] ; L. Gauger [États-Unis] ; W. M. Anderson [États-Unis] ; T. A. Zesiewicz [États-Unis] | Pramipexole-induced somnolence and episodes of daytime sleep |
| 002B39 |
M. Bhatt [Inde] ; J. Desai [Inde] ; A. Mankodi [Inde] ; M. Elias [Inde] ; N. Wadia [Inde] | Posttraumatic akinetic-rigid syndrome resembling Parkinson's disease : A report on three patients |
| 002B44 |
Akinori Hozumi [Japon] ; Koichi Hirata [Japon] ; Hideaki Tanaka [Japon, Suisse] ; Kaoru Yamazaki [Japon] | Perseveration for novel stimuli in Parkinson's disease : An evaluation based on event-related potentials topography |
| 002B48 |
José Antonio Molina [Espagne] ; Maria José Sainz-Artiga [Espagne] ; Talicia Fraile [Espagne] ; Félix Javier Jimenez-Jimenez [Espagne] ; Clara Villanueva [Espagne] ; Miguel Orti-Pareja [Espagne] ; Félix Bermeio-P [Espagne] | Pathologic gambling in Parkinson's disease : A behavioral manifestation of pharmacologic treatment? |
| 002B52 |
P. Martinez-Martin [Espagne] ; F. Valldeoriola [Espagne] ; J. L. Molinuevo [Espagne] ; F. A. Nobbe [Espagne] ; J. Rumia [Espagne] ; E. Tolosa [Espagne] | Pallidotomy and quality of life in patients with Parkinson's disease : An early study |
| 002B54 |
V. S. C. Fung [Australie] ; J. A. Burne [Australie] ; J. G. L. Morris [Australie] | Objective quantification of resting and activated parkinsonian rigidity : A comparison of angular impulse and work scores |
| 002B56 |
JIAN WANG [République populaire de Chine] ; ZHUOLIN LIU [République populaire de Chine] | No association between paraoxonase 1 (PON1) gene polymorphisms and susceptibility to Parkinson's disease in a chinese population |
| 002B59 |
Jean A. Saint-Cyr [Canada] ; Lisa L. Trepanier [Canada] | Neuropsychologic assessment of patients for movement disorder surgery |
| 002B62 |
J. Raethjen [Allemagne] ; M. Lindemann [Allemagne] ; H. Schmaljohann [Allemagne] ; R. Wenzelburger [Allemagne] ; G. Pfister [Allemagne] ; G. Deuschl [Allemagne] | Multiple oscillators are causing parkinsonian and essential tremor |
| 002B67 |
J. N. Caviness [États-Unis] ; B. E. Smith [États-Unis] ; J. C. Stevens [États-Unis] ; C. H. Adler [États-Unis] ; R. J. Caselli [États-Unis] ; C. A. Reiners [États-Unis] ; J. G. Hentz [États-Unis] ; M. D. Muenter [États-Unis] | Motor unit changes in sporadic idiopathic Parkinson's disease |
| 002B68 |
E. B. Jr Montgomery [États-Unis] ; K. B. Baker [États-Unis] ; K. Lyons [États-Unis] ; W. C. Koller [États-Unis] | Motor initiation and execution in essential tremor and Parkinson's disease |
| 002B69 |
Robert A. Hauser [États-Unis] ; Mervat N. Wahba [États-Unis] ; Theresa A. Zesiewicz [États-Unis] ; W. Mcdowell Anderson [États-Unis] | Modafinil treatment of pramipexole-associated somnolence |
| 002B70 |
Ikuko Mizuta [Japon] ; Eiji Mizuta [Japon] ; Shunzou Yamasaki [Japon] ; Sadako Kuno [Japon] ; Minoru Yasuda [Japon] ; Chikako Tanaka [Japon] | Meta-analysis of polymorphism of the catechol-O-methyltransferase gene in relation to the etiology of Parkinson's disease in Japan |
| 002B74 |
Matt Farrer [États-Unis, France] ; Alain Destée [France] ; Estelle Becquet ; Fabienne Wavrant-De Vrieze [États-Unis] ; Vincent Mouroux ; Florence Richard ; Luc Defebvre [France] ; Sarah Lincoln [États-Unis] ; John Hardy [États-Unis] ; Philippe Amouyel ; Marie-Christine Chartier-Harlin | Linkage exclusion in French families with probable Parkinson's disease |
| 002B78 |
Ida Tonolli [France] ; Roselyne Aurenty [France] ; Robert George Lee [France, Canada] ; Francois Viallet [France] ; Jean Massion [France] | Lateral leg raising in patients with Parkinson's disease : Influence of equilibrium constraint |
| 002B79 |
JIAN WANG [République populaire de Chine] ; ZHUOLIN LIU [République populaire de Chine] ; PIU CHAN [États-Unis] | Lack of association between cytochrome P450 2E1 gene polymorphisms and Parkinson's disease in a chinese population |
| 002B80 |
R. Wenzelburger [Allemagne] ; J. Raethjen [Allemagne] ; K. Löffler [Allemagne] ; H. Stolze [Allemagne] ; M. Illert [Allemagne] ; G. Deuschl [Allemagne] | Kinetic tremor in a reach-to-grasp movement in Parkinson's disease |
| 002B82 |
Silvio Aime [Italie] ; Bruno Bergamasco [Italie] ; Mariano Casu [Italie] ; Giuseppe Digilio [Italie] ; Mauro Fasano [Italie] ; Sabrina Giraudo [Italie] ; Leonardo Lopiano [Italie] | Isolation and 13C-NMR characterization of an insoluble proteinaceous fraction from substantia nigra of patients with Parkinson's disease |
| 002B83 |
Doron Merims [Israël] ; Ronit Galili-Mosberg [Israël] ; Eldad Melamed [Israël] | Is there addiction to levodopa in patients with Parkinson's disease? |
| 002B84 |
Boulos Paul Bejjani [France] ; Isabelle Arnulf [France] ; Marie Vidailhet [France] ; Bernard Pidoux [France] ; Philippe Damier [France] ; Savvas Papadopoulos [France] ; Anne-Marie Bonnet [France] ; Philippe Cornu [France] ; Didier Dormont [France] ; Yves Agid [France] | Irregular jerky tremor, myoclonus, and thalamus : A study using low-frequency stimulation |
| 002B89 |
J. M. Hurtado [États-Unis] ; J.-P. Lachaux [États-Unis] ; D. J. Beckley [États-Unis] ; C. M. Gray [États-Unis] ; K. A. Sigvardt [États-Unis] | Inter- and intralimb oscillator coupling in parkinsonian tremor |
| 002B90 |
James H. Bower [États-Unis] ; Demetrius M. Maraganore [États-Unis] ; Shannon K. Mcdonnell [États-Unis] ; Walter A. Rocca [États-Unis] | Influence of strict, intermediate, and broad diagnostic criteria on the age- and sex-specific incidence of Parkinson's disease |
| 002B91 |
T. E. Kimber [Australie] ; P. D. Thompson [Australie] | Increased blink rate in advanced Parkinson's disease : A form of 'off'-period dystonia? |
| 002B93 |
M. D. Welsh [États-Unis] ; T. Dorflinger [États-Unis] ; D. Chernik [États-Unis] ; C. Waters [États-Unis] | Illness Impact and Adjustment to Parkinson's disease : Before and after treatment with tolcapone |
| 002B94 |
A. J. Manson [Royaume-Uni] ; E. Iakovidou [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Idazoxan is ineffective for levodopa-induced dyskinesias in Parkinson's disease |
| 002B96 |
Anette Schrag [Royaume-Uni] ; Marjan Jahanshahi [Royaume-Uni] ; Niall Quinn [Royaume-Uni] | How does Parkinson's Disease affect quality of life? A comparison with quality of life in the general population |
| 002B98 |
P. Hagell [Suède] ; L. Crabb [Royaume-Uni] ; O. Pogarell [Allemagne] ; A. Schrag [Royaume-Uni] ; H. Widner [Suède] ; D. J. Brooks [Royaume-Uni] ; W. H. Oertel [Allemagne] ; N. P. Quinn [Royaume-Uni] ; O. Lindvall [Suède] | Health-related quality of life following bilateral intrastriatal transplantation in Parkinson's disease |
| 002B99 |
H. H. Fernandez [États-Unis] ; K. L. Lapane [États-Unis] ; B. R. Ott [États-Unis] ; J. H. Friedman [États-Unis] | Gender differences in the frequency and treatment of behavior problems in Parkinson's disease |
| 002C05 |
S. Canavero [Italie] ; R. Paolotti [Italie] | Extradural motor cortex stimulation for advanced Parkinson's disease : Case report |
| 002C07 |
Manuel Rodriguez [Espagne] ; Patricio Abdala [Espagne] ; José A. Obeso [Espagne] | Excitatory responses in the 'direct' striatonigral pathway : Effect of nigrostriatal lesion |
| 002C08 |
Hubert H. Fernandez [États-Unis] ; Kate L. Lapane [États-Unis] | Estrogen use among nursing home residents with a diagnosis of Parkinson's disease |
| 002C13 |
E. B. Jr Montgomery [États-Unis] ; K. Lyons [États-Unis] ; W. C. Koller [États-Unis] | Early detection of probable idiopathic Parkinson's disease : II. A prospective application of a diagnostic test battery |
| 002C14 |
E. B. Jr Montgomery [États-Unis] ; W. C. Koller [États-Unis] ; T. J. K. Lamantia [États-Unis] ; M. C. Ii Newman [États-Unis] ; A. W. Kaszniak [États-Unis] ; K. Lyons [États-Unis] | Early detection of probable idiopathic Parkinson's disease : I. Development of a diagnostic test battery |
| 002C19 |
R. Leiguarda [Argentine] ; M. Merello [Argentine] ; J. Balej [Argentine] ; S. Starkstein [Argentine] ; M. Nogues [Argentine] ; C. D. Marsden [Royaume-Uni] | Disruption of spatial organization and interjoint coordination in Parkinson's disease, progressive supranuclear palsy, and multiple system atrophy |
| 002C20 |
Lauri V. Laitinen [Suède] ; Darko Chudy [Croatie] ; Magnus Tengvar [Suède] ; Marwan I. Hariz [Suède] ; A. Tommy Bergenheim [Suède] | Dilated perivascular spaces in the putamen and pallidum in patients with Parkinson's disease scheduled for pallidotomy: A comparison between MRI findings and clinical symptoms and signs |
| 002C21 |
C. G. Goetz [États-Unis] ; G. T. Stebbins [États-Unis] ; L. M. Blasucci [États-Unis] | Differential progression of motor impairment in levodopa-treated Parkinson's Disease |
| 002C22 |
John G. Nutt [États-Unis] ; Eric S. Lea ; Laura Van Houten ; Robert A. Schuff ; Gary J. Sexton | Determinants of tapping speed in normal control subjects and subjects with Parkinson's disease : Differing effects of brief and continued practice |
| 002C23 |
N. L. W. Keijsers [Pays-Bas] ; M. W. I. M. Horstink [Pays-Bas] ; J. J. Van Hilten [Pays-Bas] ; J. I. Hoff [Pays-Bas] ; C. C. A. M. Gielen [Pays-Bas] | Detection and assessment of the severity of levodopa-induced dyskinesia in patients with Parkinson's disease by neural networks |
| 002C24 |
O. Bandmann [Royaume-Uni] ; J. R. Vaughan [Royaume-Uni] ; P. Holmans [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; N. W. Wood [Royaume-Uni] | Detailed genotyping demonstrates association between the slow acetylator genotype for N-acetyltransferase 2 (NAT2) and familial Parkinson's disease |
| 002C27 |
Hiroshi Morita [Japon] ; Masaomi Shindo [Japon] ; Shu-Ichi Ikeda [Japon] ; Nobuo Yanagisawa [Japon] | Decrease in presynaptic inhibition on heteronymous monosynaptic Ia terminals in patients with Parkinson's disease |
| 002C29 |
A. D. Siderowf [États-Unis] ; R. G. Holloway [États-Unis] ; M. B. Stern [États-Unis] | Cost-effectiveness analysis in Parkinson's disease : Determining the value of interventions |
| 002C30 |
H. T. S. Benamer [Royaume-Uni] ; J. Patterson [Royaume-Uni] ; D. J. Wyper [Royaume-Uni] ; D. M. Hadley [Royaume-Uni] ; G. J. A. Macphee [Royaume-Uni] ; D. G. Grosset [Royaume-Uni] | Correlation of Parkinson's disease severity and duration with 123I-FP-CIT SPECT striatal uptake |
| 002C32 |
H. H. Fernandez [États-Unis] ; M. C. Lannon [États-Unis] ; J. H. Friedman [États-Unis] ; B. P. Abbott [États-Unis] | Clozapine replacement by quetiapine for the treatment of drug-induced psychosis in Parkinson's disease |
| 002C34 |
Jan P. Larsen [Norvège] ; Karen Karlsen [Norvège] ; Elise Tandberg [Norvège] | Clinical problems in non-fluctuating patients with Parkinson's disease : A community-based study |
| 002C37 |
J. Kulisevsky [Espagne] ; C. Garcia-Sanchez [Espagne] ; M. L. Berthier [Espagne] ; M. Barbanoj [Espagne] ; B. Pascual-Sedano [Espagne] ; A. Gironell [Espagne] ; A. Estevez-Gonzalez [Espagne] | Chronic effects of dopaminergic replacement on cognitive function in Parkinson's disease : A two-year follow-up study of previously untreated patients |
| 002C41 |
D. M. Maraganore [États-Unis] ; M. J. Farrer [États-Unis] ; J. A. Hardy [États-Unis] ; S. K. Mcdonnell [États-Unis] ; D. J. Schaid [États-Unis] ; W. A. Rocca [États-Unis] | Case-control study of debrisoquine 4-hydroxylase, N-acetyltransferase 2, and apolipoprotein E gene polymorphisms in Parkinson's disease |
| 002C45 |
H. Apaydin [Turquie] ; S. Ertan [Turquie] ; S. Özekmekci [Turquie] | Broad bean (Vicia faba) : A natural source of L-dopa : Prolongs "on" periods in patients with Parkinson's disease who have "on-off" fluctuations |
| 002C48 |
M. I. Hariz [Suède] ; F. Johansson [Suède] ; P. Shamsgovara [Suède] ; E. Johansson [Suède] ; G.-M. Hariz [Suède] ; M. Fagerlund [Suède] | Bilateral subthalamic nucleus stimulation in a parkinsonian patient with preoperative deficits in speech and cognition : Persistent improvement in mobility but increased dependency : A case study |
| 002C52 |
E. Luginger [Autriche] ; G. K. Wenning [Autriche] ; S. Bosch [Autriche] ; Werner Poewe [Autriche] | Beneficial effects of amantadine on L-dopa-induced dyskinesias in Parkinson's Disease |
| 002C53 |
K. Ray Chaudhuri [Royaume-Uni] ; M. T. M. Hu [Royaume-Uni] ; D. J. Brooks [Royaume-Uni] | Atypical parkinsonism in Afro-Caribbean and Indian origin immigrants to the UK |
| 002C54 |
J. H. Friedman [États-Unis] ; S. A. Factor | Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease |
| 002C57 |
Werner Poewe [Autriche] ; Gregor K. Wenning [Autriche] | Apomorphine : An underutilized therapy for Parkinson's disease |
| 002C58 |
M. Shiba [États-Unis] ; J. H. Bower [États-Unis] ; D. M. Maraganore [États-Unis] ; S. K. Mcdonnell [États-Unis] ; B. J. Peterson [États-Unis] ; J. E. Ahlskog [États-Unis] ; D. J. Schaid [États-Unis] ; W. A. Rocca [États-Unis] | Anxiety disorders and depressive disorders preceding Parkinson's disease : A case-control study |
| 002C59 |
F. Stocchi [Italie] ; D. Badiali [Italie] ; L. Vacca [Italie] ; L. D'Alba [Italie] ; F. Bracci [Italie] ; S. Ruggieri [Italie] ; M. Torti [Italie] ; A. Berardelli [Italie] ; E. Corazziari [Italie] | Anorectal function in multiple system atrophy and Parkinson's disease |
| 002C64 |
Christopher Dromey [Canada] ; Rajeev Kumar [Canada] ; Anthony E. Lang [Canada] ; Andres M. Lozano [Canada] | An investigation of the effects of subthalamic nucleus stimulation on acoustic measures of voice |
| 002C65 |
G. K. Wenning [Autriche] ; K. J. Jellinger [Autriche] ; N. P. Quinn [Royaume-Uni] ; Werner Poewe [Autriche] | An early report of striatonigral degeneration |
| 002C69 |
L. Grevle [Norvège] ; C. Güzey [Norvège] ; H. Hadidi [Norvège] ; R. Brennersted [Norvège] ; J. R. Idle [Norvège] ; J. Aasly [Norvège] | Allelic association between the DRD2 TaqI A polymorphism and Parkinson's disease |
| 002C70 |
Silvia Buervenich [Suède] ; Olof Sydow [Suède] ; Andrea Carmine [Suède] ; ZHIPING ZHANG [Suède] ; Maria Anvret [Suède] ; Lars Olson [Suède] | Alcohol dehydrogenase alleles in Parkinson's disease |
| 002C72 |
H. Forssberg [Suède] ; P. E. Ingvarsson [Suède] ; N. Iwasaki [Suède] ; R. S. Johansson [Suède] ; A. M. Gordon [États-Unis] | Action tremor during object manipulation in Parkinson's disease |
| 002C80 |
Susan H. Fox [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni] | 5-HT2C receptor binding is increased in the substantia nigra pars reticulata in Parkinson's disease |
| 002C82 |
K. Kompoliti [États-Unis] ; C. G. Goetz [États-Unis] ; S. Leurgans [États-Unis] ; M. Morrissey [États-Unis] ; I. M. Siegel [États-Unis] | "On" freezing in Parkinson's disease : Resistance to visual cue walking devices |
| 002C85 |
M. Neystat [États-Unis] ; T. Lynch [États-Unis] ; S. Przedborski [États-Unis] ; N. Kholodilov [États-Unis] ; M. Rzhetskaya [États-Unis] ; R. E. Burke [États-Unis] | α-Synuclein expression in substantia nigra and cortex in Parkinson's disease |
| 002C86 |
G. Ebersbach [Autriche] ; M. Stöck [Autriche] ; J. Müller [Autriche] ; G. Wenning [Autriche] ; J. Wissel [Autriche] ; Werner Poewe [Autriche] | Worsening of motor performance in patients with Parkinson's disease following transdermal nicotine administration |
| 002C87 |
E. S. Molho [États-Unis] ; S. A. Factor [États-Unis] | Worsening of motor features of Parkinsonism with olanzapine |
| 002C88 |
F. Durif [France] ; M. Vidailhet [France] ; B. Debilly [France] ; Yves Agid [France] | Worsening of levodopa-induced dyskinesias by motor and mental tasks |
| 002C91 |
G. D. Mellick [Australie] ; D. D. Buchanan [Australie] ; S. J. Mccann [Australie] ; K. M. James [Australie] ; A. G. Johnson [Australie] ; D. R. Davis [Australie] ; N. Liyou [Australie] ; D. Chan [Australie] ; D. G. Le Couteur [Australie] | Variations in the monoamine oxidase B (MAOB) gene are associated with Parkinson's disease |
| 002C94 |
R. M. A. De Bie [Pays-Bas] ; P. R. Schuurman [Pays-Bas] ; P. S. De Haan [Pays-Bas] ; D. A. Bosch [Pays-Bas] ; J. D. Speelman [Pays-Bas] | Unilateral pallidotomy in advanced Parkinson's disease : A retrospective study of 26 patients |
| 002C97 |
J. L. Montastruc [France] ; Olivier Rascol [France] ; J.-M. Senard [France] | Treatment of Parkinson's disease should begin with a dopamine agonist |
| 002C98 |
S. A. Factor [États-Unis] ; E. S. Molho [États-Unis] | Transient benefit of amantadine in Parkinson's disease : The facts about the myth |
| 002D01 |
B. Henry [Royaume-Uni] ; S. H. Fox [Royaume-Uni] ; D. Peggs [Royaume-Uni] ; A. R. Crossman [Royaume-Uni] ; J. M. Brotchie [Royaume-Uni] | The α2-adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti-Parkinsonian actions of L-dopa in the MPTP-lesioned primate model of Parkinson's disease |
| 002D02 |
A. E. Kingsbury [Royaume-Uni] ; D. Marsden [Royaume-Uni] ; O. J. F. Foster [Royaume-Uni] | The vulnerability of nigral neurons to Parkinson's disease is unrelated to their intrinsic capacity for dopamine synthesis : An in situ hybridization study |
| 002D03 |
M. Vidailhet [France] ; A. M. Bonnet [France] ; R. Marconi [France] ; F. Durif [France] ; Yves Agid [France] | The phenomenology of L-dopa-induced dyskinesias in Parkinson's disease |
| 002D04 |
W. J. Weiner [États-Unis] | The initial treatment of Parkinson's disease should begin with levodopa |
| 002D06 |
C. D. Hardman [Australie] ; G. M. Halliday [Australie] | The external globus pallidus in patients with Parkinson's disease and progressive supranuclear palsy |
| 002D07 |
J. E. Ahlskog [États-Unis] ; R. J. Uitti [États-Unis] ; M. K. O'Connor [États-Unis] ; D. M. Maraganore [États-Unis] ; J. Y. Matsumoto [États-Unis] ; K. F. Stark [États-Unis] ; M. F. Turk [États-Unis] ; O. L. Burnett [États-Unis] | The effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease |
| 002D09 |
S. Spieker [Allemagne] ; P.-A. Löschmann [Allemagne] ; T. Klockgether [Allemagne] | The NMDA antagonist budipine can alleviate levodopa-induced motor fluctuations |
| 002D13 |
C. Dentresangle [France] ; L. Veyre [France] ; D. Le Bars [France] ; C. Pierre [France] ; F. Lavenne [France] ; Pierre Pollak [France] ; J. Guerin [France] ; J.-C. Froment [France] ; E. Brousolle [France] | Striatal D2 dopamine receptor status in Parkinson's disease : An [18F]dopa and [11C]raclopride PET study |
| 002D15 |
A. Dalvi [États-Unis] ; L. Winfield [États-Unis] ; QIPING YU [États-Unis] ; L. Cote [États-Unis] ; R. R. Goodman [États-Unis] ; S. L. Pullman [États-Unis] | Stereotactic posteroventral pallidotomy : Clinical methods and results at 1-year follow up |
| 002D22 |
A. Churchyard [Royaume-Uni] ; C. J. Mathias [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Selegiline-induced postural hypotension in Parkinson's disease : A longitudinal study on the effects of drug withdrawal |
| 002D31 |
S. Shaunak [Royaume-Uni] ; E. O'Sullivan [Royaume-Uni] ; S. Blunt [Royaume-Uni] ; M. Lawden [Royaume-Uni] ; T. Crawford [Royaume-Uni] ; L. Henderson [Royaume-Uni] ; C. Kennard [Royaume-Uni] | Remembered saccades with variable delay in Parkinson's disease |
| 002D32 |
A. Schrag [Royaume-Uni] ; L. Schelosky [Allemagne] ; U. Scholz [Allemagne] ; Werner Poewe [Autriche] | Reduction of parkinsonian signs in patients with parkinson's disease by dopaminergic versus anticholinergic single-dose challenges |
| 002D33 |
C. G. Goetz [États-Unis] | Rating scales for dyskinesias in Parkinson's disease |
| 002D34 |
H. H. Fernandez [États-Unis] ; J. H. Friedman [États-Unis] ; C. Jacques [États-Unis] ; M. Rosenfeld [États-Unis] | Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease |
| 002D36 |
P. R. Burkhard [États-Unis] ; H. Shale [États-Unis] ; J. W. Langston [États-Unis] ; J. W. Tetrud [États-Unis] | Quantification of dyskinesia in Parkinson's disease : Validation of a novel instrumental method |
| 002D37 |
H. H. Fernandez [États-Unis] ; J. H. Friedman [États-Unis] | Punding on L-dopa |
| 002D39 |
G. K. Wenning [Autriche] ; G. Ebersbach [Autriche] ; M. Verny [France] ; K. Ray Chaudhuri [Royaume-Uni] ; K. Jellinger [Autriche] ; A. Mckee [États-Unis] ; Werner Poewe [États-Unis] ; I. Litvan [États-Unis] | Progression of falls in postmortem-confirmed Parkinsonian disorders |
| 002D42 |
J. M. Errea [Espagne] ; J. R. Ara [Espagne] ; C. Aibar [Espagne] ; J. De Pedro-Cuesta [Espagne, Suède] | Prevalence of Parkinson's disease in Lower Aragon, Spain |
| 002D43 |
A. G. E. M. De Boer [Pays-Bas] ; M. A. G. Sprangers [Pays-Bas] ; H. D. Speelman [Pays-Bas] ; H. C. J. M. De Haes [Pays-Bas] | Predictors of health care use in patients with Parkinson's disease : A longitudinal study |
| 002D47 |
M. Gentilucci [Italie] ; A. Negrotti [Italie] | Planning and executing an action in Parkinson's disease |
| 002D49 |
B. Barbiroli [Italie] ; P. Martinelli [Italie] ; A. Patuelli [Italie] ; R. Lodi [Italie] ; S. Iotti [Italie] ; P. Cortelli [Italie] ; P. Montagna [Italie] | Phosphorus magnetic resonance spectroscopy in multiple system atrophy and Parkinson's disease |
| 002D68 |
A. Brashear [États-Unis] ; G. K. Mulholland [États-Unis] ; Q.-H. Zheng [États-Unis] ; M. R. Farlow [États-Unis] ; E. R. Siemers [États-Unis] ; G. D. Hutchins [États-Unis] | PET imaging of the pre-synaptic dopamine uptake sites in rapid-onset dystonia-parkinsonism (RDP) |
| 002D70 |
P.-A. Fall [Suède] ; M. Fredrikson [Suède] ; O. Axelson [Suède] ; A.-K. Granerus [Suède] | Nutritional and occupational factors influencing the risk of parkinson's disease : A case-control study in southeastern Sweden |
| 002D71 |
T. Müller [Allemagne] ; H. Przuntek [Allemagne] ; W. Kuhn [Allemagne] ; S. S. Baum [Allemagne] ; H. Rommelspacher [Allemagne] | No increase of synthesis of (R)salsolinol in Parkinson's disease |
| 002D78 |
R. Cunnington [Australie] ; R. Iansek [Australie] ; J. L. Bradshaw [Australie] | Movement-related potentials in Parkinson's disease : External cues and attentional strategies |
| 002D81 |
Joseph Jankovic [États-Unis] ; L. Ben-Arie [États-Unis] ; K. Schwartz [États-Unis] ; KIM CHEN [États-Unis] ; M. Khan [États-Unis] ; E. C. Lai [États-Unis] ; J. K. Krauss [États-Unis] ; R. Grossman [États-Unis] | Movement and reaction times and fine coordination tasks following pallidotomy |
| 002D82 |
L. J. P. Defebvre [France] ; P. Derambure [France] ; J.-L. Bourriez [France] ; F. Cassim [France] ; J. D. Guieu [France] ; A. Destee [France] | Motor programming is more affected in progressive supranuclear palsy than in Parkinson's disease : A spatiotemporal study of event-related desynchronization |
| 002D84 |
P. Praamstra [Pays-Bas] ; E. M. Plat [Pays-Bas] ; A. S. Meyer [Pays-Bas] ; M. W. I. M. Horstink [Pays-Bas] | Motor cortex activation in Parkinson's disease : Dissociation of electrocortical and peripheral measures of response generation |
| 002D91 |
L. Baum [Hong Kong] ; Z.-Y. Dong [République populaire de Chine] ; H.-K. Ng [Hong Kong] ; L. K. Law [Hong Kong] ; J. Woo [Hong Kong] ; CHI PUI PANG [Hong Kong] | Low-density lipoprotein receptor-related protein (LRP) gene 766T polymorphism and Parkinson's disease |
| 002D95 |
D. C. C. Wan [Hong Kong] ; L. K. Law [Hong Kong] ; D. T. M. Ip [Hong Kong] ; W. T. Cheung [Hong Kong] ; W. K. K. Ho [Hong Kong] ; K. W. K. Tsim [Hong Kong] ; R. Kay [Hong Kong] ; J. Woo [Hong Kong] ; C. P. Pang [Hong Kong] | Lack of allelic association of dopamine D4 receptor gene polymorphisms with Parkinson's disease in a chinese population |
| 002D96 |
Olivier Rascol [France] | L-dopa-induced peak-dose dyskinesias in patients with Parkinson's disease : A clinical pharmacologic approach |
| 002E00 |
G. Ebersbach [Allemagne] ; M. Heijmenberg [Allemagne] ; L. Kindermann [Allemagne] ; T. Trottenberg [Allemagne] ; J. Wissel [Autriche] ; Werner Poewe [Autriche] | Interference of rhythmic constraint on gait in healthy subjects and patients with early Parkinson's disease : Evidence for impaired locomotor pattern generation in early Parkinson's disease |
| 002E01 |
P. Barbanti [Italie] ; G. Fabbrini [Italie] ; A. Ricci [Italie] ; R. Cerbo [Italie] ; E. Bronzetti [Italie] ; B. Caronti [Italie] ; C. Calderaro [Italie] ; L. Felici [Italie] ; F. Stocchi [Italie] ; G. Meco [Italie] ; F. Amenta [Italie] ; G. L. Lenzi [Italie] | Increased expression of dopamine receptors on lymphocytes in Parkinson's disease |
| 002E02 |
F. Stocchi [Italie] ; C. Farina [Italie] ; G. Nordera [Italie] ; S. Ruggieri [Italie] | Implantable venous access system for apomorphine infusion in complicated Parkinson's disease |
| 002E07 |
H. Miwa [Japon] ; A. Yoritaka [Japon] ; Y. Mizuno [Japon] | Hemifacial spasm in Parkinson's disease |
| 002E10 |
E. J. Pappert [États-Unis] ; C. G. Goetz [États-Unis] ; F. G. Niederman [États-Unis] ; R. Raman [États-Unis] ; S. Leurgans [États-Unis] | Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson's disease |
| 002E11 |
M. Merello [Argentine] ; Andrew Lees (neurologue) [Royaume-Uni] ; J. Balej [Argentine] ; A. Cammarota [Argentine] ; R. Leiguarda [Argentine] | GPi firing rate modification during beginning-of-dose motor deterioration following acute administration of apomorphine |
| 002E16 |
K. Karlsen [Norvège] ; J. P. Larsen [Norvège] ; E. Tandberg [Norvège] ; K. J Rgensen [Norvège] | Fatigue in patients with Parkinson's disease |
| 002E17 |
G. T. Stebbins [Canada] ; C. G. Goetz [Canada] ; A. E. Lang [Canada] ; E. Cubo [Canada] | Factor analysis of the motor section of the unified Parkinson's disease rating scale during the off-state |
| 002E18 |
E. Tandberg [Norvège] ; J. P. Larsen [Norvège] ; K. Karlsen [Norvège] | Excessive daytime sleepiness and sleep benefit in Parkinson's disease : A community-based study |
| 002E19 |
K. A. Reardon [Australie] ; M. Shiff [Australie] ; P. A. Kempster [Australie] | Evolution of motor fluctuations in Parkinson's disease : A longitudinal study over 6 years |
| 002E22 |
A.-M. Kuopio [Finlande] ; R. J. Marttila [Finlande] ; H. Helenius [Finlande] ; U. K. Rinne [Finlande] | Environmental risk factors in Parkinson's disease |
| 002E24 |
| Efficacy and tolerability of tolcapone compared with bromocriptine in levodopa-treated Parkinsonian patients |
| 002E25 |
R. B. Innis [États-Unis] ; K. L. Marek [États-Unis] ; K. Sheff [États-Unis] ; S. Zoghbi [États-Unis] ; J. Castronuovo [États-Unis] ; A. Feigin [États-Unis] ; J. P. Seibyl [États-Unis] | Effect of treatment with L-dopa/carbidopa or L-selegiline on striatal dopamine transporter SPECT imaging with [123I]β-CIT |
| 002E30 |
P. Damier [France] ; C. Jaillon [France] ; I. Clavier [France] ; I. Arnulf [France] ; A.-M. Bonnet [France] ; B.-P. Bejjani [France] ; Yves Agid [France] | Dyskinesias assessment in phase II studies |
| 002E31 |
P. Brown [Royaume-Uni] ; A. Manson [Royaume-Uni] | Dyskinesias assessment and ambulatory devices |
| 002E32 |
H. Widner [Suède] ; G.-L. Defer [France] | Dyskinesias assessment : From CAPIT to CAPSIT |
| 002E34 |
M. M. Pinter [Autriche] ; M. Murg [Autriche] ; F. Alesch [Autriche] ; B. Freundl [Autriche] ; R. J. Helscher [Autriche] ; H. Binder [Autriche] | Does deep brain stimulation of the nucleus ventralis intermedius affect postural control and locomotion in Parkinson's disease? |
| 002E36 |
I. H. Richard [États-Unis] ; A. Maughn [États-Unis] ; R. Kurlan [États-Unis] | Do serotonin reuptake inhibitor antidepressants worsen Parkinson's disease? A retrospective case series |
| 002E39 |
C. Anderson [États-Unis] ; H. Checkoway [États-Unis] ; G. M. Franklin [États-Unis] ; S. Beresford [États-Unis] ; T. Smith-Weller [États-Unis] ; P. D. Swanson [États-Unis] | Dietary factors in Parkinson's disease : The role of food groups and specific foods |
| 002E41 |
I. Vermes [Pays-Bas] ; E. N. H. J. Steur [Pays-Bas] ; C. Reutelingsperger [Pays-Bas] ; C. Haanen [Pays-Bas] | Decreased concentration of annexin v in parkinsonian cerebrospinal fluid : Speculation on the underlying cause |
| 002E43 |
G.-L. Defer [France] ; H. Widner [Suède] ; R.-M. Marie [France] ; P. Remy [France] ; M. Levivier [Belgique] | Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD) |
| 002E47 |
C. Junque [Suède] ; M. Alegret [Suède] ; F. A. Nobbe [Espagne] ; F. Valldeoriola [Espagne] ; R. Pueyo [Suède] ; P. Vendrell [Suède] ; E. Tolosa [Espagne] ; J. Rumia [Espagne] ; J. M. Mercader [Espagne] | Cognitive and behavioral changes after unilateral posteroventral pallidotomy : Relationship with lesional data from MRI |
| 002E48 |
P. Hagell [Suède] ; H. Widner [Suède] | Clinical rating of dyskinesias in Parkinson's disease : Use and reliability of a new rating scale |
| 002E51 |
H. R. Siebner [Allemagne] ; A. Ceballos-Baumann [Allemagne] ; H. Standhardt [Autriche] ; C. Auer [Allemagne] ; B. Conrad [Allemagne] ; F. Alesch [Autriche] | Changes in handwriting resulting from bilateral high-frequency stimulation of the subthalamic nucleus in Parkinson's disease |
| 002E52 |
O. Lindvall [Suède] | Cerebral implantation in movement disorders : State of the art |
| 002E56 |
R. Djaldetti [Israël] ; R. Mosberg-Galili ; H. Sroka ; D. Merims ; E. Melamed | Camptocormia (bent spine) in patients with Parkinson's disease: Characterization and possible pathogenesis of an unusual phenomenon |
| 002E57 |
N. Sabbagh [France] ; A. Brice [France] ; D. Marez [France] ; A. Dürr [France] ; M. Legrand [France] ; J.-M. Lo Guidice [France] ; A. Destee [France] ; Yves Agid [France] ; F. Broly [France] | CYP2D6 polymorphism and Parkinson's disease susceptibility |
| 002E59 |
P. Brown [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Bradykinesia and impairment of EEG desynchronization in Parkinson's disease |
| 002E65 |
E. Grünblatt [Israël] ; S. Mandel [Israël] ; T. Berkuzki [Israël] ; M. B. H. Youdim [Israël] | Apomorphine protects against MPTP-induced neurotoxicity in mice |
| 002E66 |
M. Merello [Argentine] ; J. Balej [Argentine] ; M. Delfino [Argentine] ; A. Cammarota [Argentine] ; O. Betti [Argentine] ; R. Leiguarda [Argentine] | Apomorphine induces changes in GPi spontaneous outflow in patients with Parkinson's disease |
| 002E75 |
O. Joost [États-Unis] ; C. A. Taylor [États-Unis] ; C. A. Thomas [États-Unis] ; L. A. Cupples [États-Unis] ; M. H. Saint-Hilaire [États-Unis] ; R. G. Feldman [États-Unis] ; C. T. Baldwin [États-Unis] ; R. H. Myers [États-Unis] | Absence of effect of seven functional mutations in the CYP2D6 gene in Parkinson's disease |
| 002E77 |
J. I. Hoff [Pays-Bas] ; B. J. Van Hilten [Pays-Bas] ; R. A. C. Roos [Pays-Bas] | A review of the assessment of dyskinesias |
| 002E78 |
J.-L. Montastruc [France] ; M. Ziegler [France] ; Olivier Rascol [France] ; M. Malbezin [France] | A randomized, double-blind study of a skin patch of a dopaminergic agonist, piribedil, in Parkinson's disease |
| 002E80 |
W. Ondo [États-Unis] ; C. Hunter [États-Unis] ; M. Almaguer [États-Unis] ; Joseph Jankovic [États-Unis] | A novel sublingual apomorphine treatment for patients with fluctuating Parkinson's disease |
| 002E84 |
J. M. Graham [Royaume-Uni] ; BSC [Royaume-Uni] ; H. J. Sagar [Royaume-Uni] ; DM [Royaume-Uni] | A data-driven approach to the study of heterogeneity in idiopathic Parkinson's disease : Identification of three distinct subtypes |
| 002E91 |
A. Schrag [Royaume-Uni] ; Y. Ben-Shlomo [Royaume-Uni] ; R. Brown [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; N. Quinn [Royaume-Uni] | Young-onset Parkinson's disease revisited : Clinical features, natural history, and mortality |
| 002E93 |
I. Shoulson [États-Unis] | Where do we stand on neuroprotection? Where do we go from here? |
| 002E98 |
O. Lindvall [Suède] | Update on fetal transplantation : The Swedish experience |
| 002F02 |
P. Krack [France] ; A. Benazzouz [France] ; Pierre Pollak [France] ; P. Limousin [France] ; B. Piallat [France] ; D. Hoffmann [France] ; JING XIE [France] ; Alim-Louis Benabid [France] | Treatment of tremor in Parkinson's disease by subthalamic nucleus stimulation |
| 002F08 |
M. C. Rodriguez [Espagne] ; O. J. Guridi [Espagne] ; L. Alvarez [Cuba] ; K. Mewes [États-Unis] ; R. Macias [Cuba] ; J. Vitek [États-Unis] ; M. R. Delong [États-Unis] ; J. A. Obeso [Espagne] | The subthalamic nucleus and tremor in Parkinson's disease |
| 002F09 |
S. Hua [États-Unis] ; S. G. Reich ; A. T. Zirh ; V. Perry ; P. M. Dougherty ; F. A. Lenz | The role of the thalamus and basal ganglia in parkinsonian tremor |
| 002F10 |
T. Van Laar [Pays-Bas] ; B. Van Hilten [Pays-Bas] ; C. Neef [Pays-Bas] ; A. W. F. Rutgers [Pays-Bas] ; S. Pavel [Pays-Bas] ; J. A. Bruijn [Pays-Bas] | The role of EDTA in provoking allergic reactions to subcutaneous infusion of apomorphine in patients with Parkinson's disease : A histologic study |
| 002F12 |
E. A. Chrischilles [États-Unis] ; L. M. Rubenstein [États-Unis] ; M. D. Voelker [États-Unis] ; R. B. Wallace [États-Unis] ; R. L. Rodnitzky [États-Unis] | The health burdens of Parkinson's disease |
| 002F15 |
N. Syed [États-Unis] ; J. Murphy [États-Unis] ; T. Jr Zimmerman [États-Unis] ; M. H. Mark [États-Unis] ; J. I. Sage [États-Unis] | Ten years' experience with enteral levodopa infusions for motor fluctuations in Parkinson's disease |
| 002F21 |
P. Van Den Munckhof [États-Unis] ; F. A. Lenz [États-Unis] ; T. N. Chase [États-Unis] ; L. V. Metman [États-Unis] | Square-wave action dystonia in Parkinson's disease |
| 002F24 |
A. Kupsch [Allemagne] ; W. H. Oertel [Allemagne] | Selegiline, pregnancy, and Parkinson's disease |
| 002F25 |
A. D. Korczyn [Israël] ; D. J. Brooks [Royaume-Uni] ; E. R. Brunt [Pays-Bas] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; F. Stocchi [Italie] | Ropinirole versus bromocriptine in the treatment of early Parkinson's disease : A 6-month interim report of a 3-year study |
| 002F26 |
Olivier Rascol [France] ; D. J. Brooks [Royaume-Uni] ; E. R. Brunt [Pays-Bas] ; A. D. Korczyn [Israël] ; Werner Poewe [Autriche] ; F. Stocchi [Italie] | Ropinirole in the treatment of early Parkinson's disease : A 6-month interim report of a 5-year levodopa-controlled study |
| 002F27 |
R. C. Duvoisin [États-Unis] | Role of genetics in the cause of Parkinson's disease |
| 002F28 |
I. Ziv [Israël] ; E. Melamed | Role of apoptosis in the pathogenesis of Parkinson's disease : A novel therapeutic opportunity? |
| 002F30 |
J. D. Speelman [Pays-Bas] ; D. A. Bosch [Pays-Bas] | Resurgence of functional neurosurgery for Parkinson's disease : A historical perspective |
| 002F33 |
C. P. Pang [Hong Kong] ; JUN ZHANG [Hong Kong] ; T. Woo [Hong Kong] ; D. Chan [Hong Kong] ; L. K. Law [Hong Kong] ; S. F. Tong [Hong Kong] ; T. Kwok [Hong Kong] ; T. Kay [Hong Kong] | Rarity of debrisoquine hydroxylase gene polymorphism in chinese patients with Parkinson's disease |
| 002F34 |
F. Blandini [Italie] ; G. Nappi [Italie] ; J. T. Greenamyre [États-Unis] | Quantitative study of mitochondrial complex I in platelets of parkinsonian patients |
| 002F38 |
R. E. Burke [États-Unis] | Programmed cell death and Parkinson's disease |
| 002F39 |
A. Chio [Italie] ; C. Magnani [Italie] ; D. Schiffer [Italie] | Prevalence of Parkinson's disease in Northwestern Italy : Comparison of tracer methodology and clinical ascertainment of cases |
| 002F41 |
P. Hagell [Suède] ; P. Odin [Allemagne] ; E. Vinge [Suède] | Pregnancy in Parkinson's disease : A review of the literature and a case report |
| 002F42 |
UN JUNG KANG [États-Unis] | Potential of gene therapy for Parkinson's disease : Neurobiologic issues and new developments in gene transfer methodologies |
| 002F49 |
H. Bergman [Israël] ; A. Raz [Israël] ; A. Feingold [Israël] ; A. Nini [Israël] ; I. Nelken [Israël] ; D. Hansel [France] ; H. Ben-Pazi [Israël] ; A. Reches [Israël] | Physiology of MPTP tremor |
| 002F51 |
P. G. Wasielewski [États-Unis] ; J. M. Burns [États-Unis] ; W. C. Koller [États-Unis] | Pharmacologic treatment of tremor |
| 002F55 |
H. R. Morris [Royaume-Uni] ; Neville F. Moriabadi [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; D. J. Dick [États-Unis] ; Nora F. Moriabadi [Royaume-Uni] ; D. Turjanski [Royaume-Uni] | Parkinsonism following electrical injury to the hand |
| 002F57 |
E. J. Skalabrin [États-Unis] ; E. R. Jr Laws [États-Unis] ; J. P. Jr Bennett [États-Unis] | Pallidotomy improves motor responses and widens the levodopa therapeutic window in Parkinson's disease |
| 002F58 |
A. M. Lozano [Canada] ; A. E. Lang [Canada] ; W. D. Hutchison [Canada] | Pallidotomy for tremor |
| 002F60 |
R. Kumar [Canada] ; A. M. Lozano [Canada] ; E. Montgomery [États-Unis] ; A. E. Lang [Canada] | Pallidotomy and deep brain stimulation of the pallidum and subthalamic nucleus in advanced Parkinson's disease |
| 002F61 |
A. G. Riedl [Royaume-Uni] ; P. M. Watts [Royaume-Uni] ; P. Jenner [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | P450 enzymes and Parkinson's disease : The story so far |
| 002F62 |
P. Jenner [Royaume-Uni] | Oxidative mechanisms in nigral cell death in Parkinson's disease |
| 002F66 |
C. H. Adler [États-Unis] ; K. A. Gwinn [États-Unis] ; S. Newman [États-Unis] | Olfactory function in restless legs syndrome |
| 002F67 |
N. Fabre [France] ; C. Brefel [France] ; U. Sabatini [Italie] ; P. Celsis [France] ; J. L. Montastruc [France] ; F. Chollet [France] ; Olivier Rascol [France] | Normal frontal perfusion in patients with frozen gait |
| 002F71 |
J. H. Kordower [États-Unis] ; T. B. Freeman [États-Unis] ; C. W. Olanow [États-Unis] | Neuropathology of fetal nigral grafts in patients with Parkinson's disease |
| 002F73 |
O. Pogarell [Allemagne] ; W. H. Oertel [Allemagne] | Neural transplantation in Parkinson's disease and its effects on rest tremor : A review of the literature |
| 002F74 |
V. P. Calabrese [Canada] ; K. A. Lloyd [Canada] ; P. Brancazio [Canada] ; E. Cefali [États-Unis] ; P. Martin [États-Unis] ; J. Jr Wall [États-Unis] ; D. Sica [États-Unis] | N-0923, a novel soluble dopamine D2 agonist in the treatment of parkinsonism |
| 002F79 |
S. Przedborski [États-Unis] ; V. Jackson-Lewis [États-Unis] | Mechanisms of MPTP toxicity |
| 002F80 |
S. Spieker [Allemagne] ; A. Boose [Allemagne] ; S. Breit [Allemagne] ; J. Dichgans [Allemagne] | Long-term measurement of tremor |
| 002F81 |
Alim-Louis Benabid [France] ; A. Benazzouz [France] ; D. Hoffmann [France] ; P. Limousin [France] ; P. Krack [France] ; Pierre Pollak [France] | Long-term electrical inhibition of deep brain targets in movement disorders |
| 002F82 |
J. H. Carter [États-Unis] ; B. J. Stewart [États-Unis] ; P. G. Archbold [États-Unis] ; I. Inoue [États-Unis] ; J. Jaglin [États-Unis] ; M. Lannon [États-Unis] ; E. Rost-Ruffner [États-Unis] ; M. Tennis [États-Unis] ; M. P. Mcdermott [États-Unis] ; D. Amyot [Canada] ; R. Barter [États-Unis] ; L. Cornelius [États-Unis] ; C. Demong [Canada] ; J. Dobson [États-Unis] ; J. Duff [Canada] ; J. Erickson [États-Unis] ; N. Gardiner [États-Unis] ; L. Gauger [États-Unis] ; P. Gray [Canada] ; B. Kanigan [Canada] ; B. Kiryluk [États-Unis] ; P. Lewis [États-Unis] ; K. Mistura [États-Unis] ; T. Malapira [États-Unis] ; M. Pay [États-Unis] ; C. Sheldon [États-Unis] ; L. Winfield [États-Unis] ; K. Wolfington-Shallow [États-Unis] ; K. Zoog [États-Unis] | Living with a person who has Parkinson's disease : The spouse's perspective by stage of disease |
| 002F85 |
J. Lagopoulos [Australie] ; P. Clouston [Australie] ; H. Barhamali [Australie] ; E. Gordon [Australie] ; W. M. Li [Australie] ; J. Lesley [Australie] ; J. G. L. Morris [Australie] | Late components of the event-related potentials and their topography in Parkinson's disease |
| 002F86 |
N. R. Hughes [Royaume-Uni] ; A. T. Mcknight [Royaume-Uni] ; G. N. Woodruff [Royaume-Uni] ; M. P. Hill [Royaume-Uni] ; A. R. Crossman [Royaume-Uni] ; J. M. Brotchie [Royaume-Uni] | Kappa-opioid receptor agonists increase locomotor activity in the monoamine-depleted rat model of parkinsonism |
| 002F87 |
E. C. Hirsch [France] ; B. A. Faucheux [France] | Iron metabolism and Parkinson's disease |
| 002F89 |
P. Krack [France] ; Pierre Pollak [France] ; P. Limousin [France] ; D. Hoffmann [France] ; A. Benazzouz [France] ; Alim-Louis Benabid [France] | Inhibition of levodopa effects by internal pallidal stimulation |
| 002F90 |
V. Dietz [Suisse] ; G. Colombo [Suisse] | Influence of body load on the gait pattern in Parkinson's disease |
| 002F92 |
B. Holmberg [Suède] ; L. Rosengren [Suède] ; J.-E. Karlsson [Suède] ; B. Johnels [Suède] | Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease |
| 002F98 |
R. M. Oliveira [Royaume-Uni, Brésil] ; J. M. Gurd [Royaume-Uni] ; P. Nixon ; J. C. Marshall [Royaume-Uni] ; R. E. Passingham [Royaume-Uni] | Hypometria in Parkinson's disease : Automatic versus controlled processing |
| 003003 |
S. Fahn [États-Unis] ; R. Elliott [États-Unis] | Highlights of the Parkinson's Disease Foundation |
| 003004 |
R. B. Banati [Royaume-Uni] ; S. E. Daniel [Royaume-Uni] ; S. B. Blunt [Royaume-Uni] | Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease |
| 003006 |
O. Bandmann [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; N. W. Wood [Royaume-Uni] | Genetic aspects of Parkinson's disease |
| 003008 |
J. M. Hausdorff [États-Unis] ; M. E. Cudkowicz [États-Unis] ; R. Firtion [États-Unis] ; J. Y. Wei [États-Unis] ; A. L. Goldberger [États-Unis] | Gait variability and basal ganglia disorders : Stride-to-stride variations of gait cycle timing in Parkinson's disease and Huntington's disease |
| 003011 |
J. D. O'Sullivan [Australie] ; C. M. Said [Australie] ; L. C. Dillon [Australie] ; M. Hoffman [Australie] ; A. J. Hughes [Australie] | Gait analysis in patients with Parkinson's disease and motor fluctuations : Influence of levodopa and comparison with other measures of motor function |
| 003012 |
S.-L. Ho [Hong Kong] ; M. H. W. Kung [Hong Kong] | G209A mutation in the α-synuclein gene is rare and not associated with sporadic Parkinson's disease |
| 003013 |
J. A. Loeb [États-Unis] | Functional improvement in a patient with cerebral calcinosis using a bisphosphonate |
| 003016 |
J. H. Kordower [États-Unis] ; T. B. Freeman [États-Unis] ; E.-Y. Chen [États-Unis] ; E. J. Mufson [États-Unis] ; P. R. Sanberg [États-Unis] ; R. A. Hauser [États-Unis] ; B. Snow [Canada] ; C. W. Olanow [États-Unis] | Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease |
| 003018 |
G. T. Stebbins [États-Unis] ; C. G. Goetz [États-Unis] | Factor structure of the Unified Parkinson's Disease Rating Scale : Motor examination section |
| 003019 |
R. Djaldetti [Israël] ; I. Ziv ; E. Melamed | Extreme anticipation in young-onset Parkinson's disease |
| 003023 |
G. Magnani [Italie] ; M. Cursi [Italie] ; L. Leocani [Italie] ; M. A. Volonte [Italie] ; T. Locatelli [Italie] ; A. Elia [Italie] ; G. Comi [Italie] | Event-related desynchronization to contingent negative variation and self-paced movement paradigms in Parkinson's disease |
| 003036 |
H. L. Ryoo [États-Unis] ; D. Pierrotti [États-Unis] ; J. N. Joyce [États-Unis] | Dopamine D3 receptor is decreased and D2 receptor is elevated in the striatum of Parkinson's disease |
| 003037 |
I. Delalande [France] ; J. C. Hache [France] ; G. Forzy [France] ; M. Bughin [France] ; J. Benhadjali [France] ; A. Destee [France] | Do visual-evoked potentials and spatiotemporal contrast sensitivity help to distinguish idiopathic Parkinson's disease and multiple system atrophy? |
| 003039 |
A. Antonini [États-Unis] ; K. Kazumata [États-Unis] ; A. Feigin [États-Unis] ; F. Mandel [États-Unis] ; V. Dhawan [États-Unis] ; C. Margouleff [États-Unis] ; D. Eidelberg [États-Unis] | Differential diagnosis of parkinsonism with [18F]fluorodeoxyglucose and PET |
| 003040 |
G. Logroscino [États-Unis, Italie] ; K. Marder [États-Unis] ; J. Graziano [États-Unis] ; G. Freyer [États-Unis] ; V. Slavkovich [États-Unis] ; N. Lojacono [États-Unis] ; L. Cote [États-Unis] ; R. Mayeux [États-Unis] | Dietary iron, animal fats, and risk of Parkinson's disease |
| 003042 |
S. E. Starkstein [Argentine] ; G. Petracca [Argentine] ; E. Chemerinski [Argentine] ; A. Teson [Argentine] ; L. Sabe [Argentine] ; T. Merello [Argentine] ; T. Leiguarda [Argentine] | Depression in classic versus akinetic-rigid Parkinson's disease |
| 003043 |
B.-P. Bejjani [France] ; P. Damier [France] ; I. Arnulf [France] ; S. Papadopoulos [France] ; A.-M. Bonnet [France] ; M. Vidailhet [France] ; Yves Agid [France] ; B. Pidoux [France] ; P. Cornu [France] ; D. Dormont [France] ; C. Marsault [France] | Deep brain stimulation in Parkinson's disease : Opposite effects of stimulation in the pallidum |
| 003044 |
R. K. B. Pearce [Royaume-Uni] ; T. Banerji ; P. Jenner ; C. D. Marsden | De novo administration of ropinirole and bromocriptine induces less dyskinesia than L-dopa in the MPTP-treated marmoset |
| 003045 |
A. E. Kingsbury [Royaume-Uni] ; C. D. Mardsen [Royaume-Uni] ; O. J. F. Foster [Royaume-Uni] | DNA fragmentation in human substantia nigra : Apoptosis or perimortem effect? |
| 003046 |
C. W. Olanow [États-Unis] ; C. Mytilineou [États-Unis] ; W. Tatton [États-Unis] | Current status of selegiline as a neuroprotective agent in Parkinson's disease |
| 003047 |
R. C. Dodel [Allemagne] ; K. M. Eggert [Allemagne] ; M. S. Singer [Allemagne] ; T. E. Eichhorn [Allemagne] ; O. Pogarell [Allemagne] ; W. H. Oertel [Allemagne] | Costs of drug treatment in Parkinson's disease |
| 003048 |
J. N. Caviness [États-Unis] ; C. H. Adler [États-Unis] ; S. Newman [États-Unis] ; R. J. Caselli [États-Unis] ; M. D. Muenter [États-Unis] | Cortical myoclonus in levodopa-responsive Parkinsonism |
| 003052 |
P. A. Lewitt [États-Unis] | Conjugate eye deviations as dyskinesias induced by levodopa in Parkinson's disease |
| 003053 |
M. Merello [Argentine] ; A. Cammarota [Argentine] ; M. I. Nouzeilles [Argentine] ; O. Betti [Argentine] ; R. Leiguarda [Argentine] | Confirmation of the antidyskinetic effect of posteroventral pallidotomy by means of an intraoperative apomorphine test |
| 003057 |
R. M. Trosch [États-Unis] ; J. H. Friedman [États-Unis] ; M. C. Lannon [États-Unis] ; R. Pahwa [États-Unis] ; D. Smith [États-Unis] ; L. C. Seeberger [États-Unis] ; C. F. O'Brien [États-Unis] ; P. A. Lewitt [États-Unis] ; W. C. Koller [États-Unis] | Clozapine use in Parkinson's disease : A retrospective analysis of a large multicentered clinical experience |
| 003059 |
H. H. Fernandez [États-Unis] ; R. Durso [États-Unis] | Clozapine for dopaminergic-induced paraphilias in Parkinson's disease |
| 003061 |
R. Agostino [Italie] ; A. Berardelli ; A. Curra ; N. Accornero ; M. Manfredi | Clinical impairment of sequential finger movements in Parkinson's disease |
| 003064 |
C. Potagas [France] ; G. Dellatolas [France] ; M. Ziegler [France] ; J. Leveteau [France] ; N. Bathien [France] ; P. Macleod [France] ; P. Rondot [France] | Clinical assessment of olfactory dysfunction in Parkinson's disease |
| 003070 |
D. W. Anderson [États-Unis] ; W. A. Rocca [États-Unis] ; M. C. De Rijk [Pays-Bas] ; F. Grigoletto [Italie] ; M. O. Melcon [Argentine] ; M. B. Breteler [Pays-Bas] ; D. M. Maraganore [États-Unis] | Case ascertainment uncertainties in prevalence surveys of Parkinson's disease |
| 003075 |
S. Dethy [Belgique] ; N. Van Blercom [Belgique] ; P. Damhaut [Belgique] ; D. Wikler [Belgique] ; J. Hildebrand [Belgique] ; S. Goldman [Belgique] | Asymmetry of basal ganglia glucose metabolism and dopa responsiveness in parkinsonism |
| 003077 |
G.-M. Hariz [Suède] ; A. T. Bergenheim [Suède] ; M. I. Hariz [Suède] ; M. Lindberg [Suède] | Assessment of ability/disability in patients treated with chronic thalamic stimulation for tremor |
| 003079 |
J. D. O'Sullivan [Australie] ; A. J. Hughes [Australie] | Apomorphine-induced penile erections in Parkinson's disease |
| 003080 |
M. Gassen [Allemagne] ; A. Gross [Israël] ; M. B. H. Youdim [Israël] | Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2 and 6-hydroxydopamine |
| 003081 |
M. Gassen [Israël] ; A. Gross [Israël] ; M. B. H. Youdim [Israël] | Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2 and 6-hydroxydopamine |
| 003082 |
T. Van Laar [Pays-Bas] ; G.-J. Lammers [Pays-Bas] ; R. A. C. Roos [Pays-Bas] ; J. J. Gerritsen [Pays-Bas] ; A. E. Meinders [Pays-Bas] | Antiparkinsonian drugs causing inappropriate antidiuretic hormone secretion |
| 003085 |
P. J. Blanchet [États-Unis] ; S. Konitsiotis [États-Unis] ; T. N. Chase [États-Unis] | Amantadine reduces levodopa-induced dyskinesias in Parkinsonian monkeys |
| 003088 |
J. M. Brotchie [Royaume-Uni] | Adjuncts to dopamine replacement : A pragmatic approach to reducing the problem of dyskinesia in Parkinson's disease |
| 003091 |
P. Brown [Royaume-Uni] ; D. M. Corcos [Royaume-Uni, États-Unis] ; J. C. Rothwell [Royaume-Uni] | Action tremor and weakness in Parkinson's disease : A study of the elbow extensors |
| 003093 |
M. Morris [Australie] ; R. Iansek [Australie] ; T. Matyas [Australie] ; J. Summers [Australie] | Abnormalities in the stride length-cadence relation in parkinsonian gait |
| 003094 |
L. V. Metman [États-Unis] ; P. J. Blanchet [États-Unis] ; P. Van Den Munckhof [États-Unis] ; P. Del Dotto [États-Unis] ; R. Natte [États-Unis] ; T. N. Chase [États-Unis] | A trial of dextromethorphan in Parkinsonian patients with motor response complications |
| 003095 |
P. A. Lapchak [États-Unis] | A preclinical development strategy designed to optimize the use of glial cell line-derived neurotrophic factor in the treatment of Parkinson's disease |
| 003096 |
R. A. Hauser [États-Unis] ; E. Molho [États-Unis] ; H. Shale [États-Unis] ; S. Pedder [États-Unis] ; E. E. Dorflinger [États-Unis] | A pilot evaluation of the tolerability, safety, and efficacy of tolcapone alone and in combination with oral selegiline in untreated Parkinson's disease patients |
| 003097 |
R. B. Jr Dewey [États-Unis] ; D. M. Maraganore [États-Unis] ; J. E. Ahlskog [États-Unis] ; J. Y. Matsumoto [États-Unis] | A double-blind, placebo-controlled study of intranasal apomorphine spray as a rescue agent for off-states in Parkinson's disease |
| 003098 |
E. Tandberg [Norvège] ; J. P. Larsen [Norvège] ; K. Karlsen [Norvège] | A community-based study of sleep disorders in patients with Parkinson's disease |
| 003101 |
G. K. Wenning [Autriche] ; E. Donnemiller [Autriche] ; R. Granata [Autriche] ; G. Riccabona [Autriche] ; Werner Poewe [Autriche] | 123I-β-CIT and 123I-IBZM-SPECT scanning in levodopa-naive Parkinson's disease |
| 003102 |
J. Schwarz [Allemagne] ; K. Tatsch [Allemagne] ; T. Gasser [Allemagne] ; G. Arnold [Allemagne] ; O. Pogarell [Allemagne] ; G. Künig [Allemagne] ; W. H. Oertel [Allemagne] | 123I-IBZM binding compared with long-term clinical follow up in patients with de novo parkinsonism |
| 003103 |
| |
| 003104 |
| |
| 003105 |
| |
| 003106 |
J. Schwarz [Allemagne] ; K. Tatsch [Allemagne] ; T. Gasser ; G. Arnold ; W. H. Oertel | [123]IBZM binding predicts dopaminergic responsiveness in patients with parkinsonism and previous dopaminomimetic therapy |
| 003111 |
A. M. Bonnet [France] ; J. Pichon [France] ; M. Vidailhet [France] ; N. Gouider-Khouja [France] ; G. Robain [France] ; M. Perrigot [France] ; Yves Agid [France] | Urinary disturbances in striatonigral degeneration and Parkinson's disease: Clinical and urodynamic aspects |
| 003114 |
C. E. Clarke [Royaume-Uni] ; M. Lowry [Royaume-Uni] ; A. Horsman [Royaume-Uni] | Unchanged basal ganglia N-acetylaspartate and glutamate in idiopathic Parkinson's disease measured by proton magnetic resonance spectroscopy |
| 003115 |
P. J. Koehler [Pays-Bas] ; A. Keyser | Tremor in Latin texts of Dutch physicians : 16th-18th centuries |
| 003118 |
E. Dupont [Danemark] ; J.-M. Burgunder [Suisse] ; L. J. Findley [Royaume-Uni] ; J.-E. Olsson [Suède] ; E. Dorflinger [États-Unis] | Tolcapone added to levodopa in stable parkinsonian patients : A double-blind placebo-controlled study |
| 003122 |
E. D. Louis [États-Unis] | The shaking palsy, the first forty-five years : A journey through the British literature |
| 003125 |
P. Lewitt [États-Unis] ; D. Oakes [États-Unis] ; L. Cui [États-Unis] | The need for levodopa as an end point of Parkinson's disease progression in a clinical trial of selegiline and α-tocopherol |
| 003127 |
J. P. Larsen [Norvège] ; J. Boas [Danemark] | The effects of early selegiline therapy on long-term levodopa treatment and parkinsonian disability : An interim analysis of a Norwegian-Danish 5-year study |
| 003128 |
L. Rioux [États-Unis] ; P. A. Frohna [États-Unis] ; J. N. Joyce [États-Unis] ; J. S. Schneider [États-Unis] | The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys |
| 003135 |
S. Kösel [Allemagne] ; R. Egensperger [Allemagne] ; N. M. Schnopp [Allemagne] ; M. B. Graeber [Allemagne] | The 'common deletion' is not increased in parkinsonian substantia nigra as shown by competitive polymerase chain reaction |
| 003136 |
C. Klein [Royaume-Uni] ; R. Brown [Royaume-Uni] ; G. Wenning [Royaume-Uni] ; N. Quinn [Royaume-Uni] | The "cold hands sign" in multiple system atrophy |
| 003141 |
E. G. Gonera [Pays-Bas] ; M. Van'T Hof [Pays-Bas] ; H. J. C. Berger [Pays-Bas] ; C. Van Weel [Pays-Bas] ; M. W. I. M. Horstink [Pays-Bas] | Symptoms and duration of the prodromal phase in Parkinson's disease |
| 003146 |
A. Burleigh-Jacobs [États-Unis] ; F. B. Horak [États-Unis] ; J. G. Nutt [États-Unis] ; J. A. Obeso [Espagne] | Step initiation in Parkinson's disease : Influence of levodopa and external sensory triggers |
| 003150 |
M. Merello [Argentine] ; A. Hughes [Australie] ; C. Colosimo [Argentine] ; M. Hoffman [Australie] ; S. Starkstein [Argentine] ; R. Leiguarda [Argentine] | Sleep benefit in Parkinson's disease |
| 003151 |
J. Lyytinen [Finlande] ; S. Kaakkola [Finlande] ; S. Ahtila [Finlande] ; P. Tuomainen [Finlande] ; H. Ter V Inen [Finlande] | Simultaneous MAO-B and COMT inhibition in L-dopa-treated patients with Parkinson's disease |
| 003152 |
M. Zappia [Italie] ; R. Montesanti [Italie] ; R. Colao [Italie] ; D. Branca [Italie] ; G. Nicoletti [Italie] ; U. Aguglia [Italie] ; A. Quattrone [Italie] | Short-term levodopa test assessed by movement time accurately predicts dopaminergic responsiveness in Parkinson's disease |
| 003153 |
V. Müller [Allemagne] ; B. Mohr [Allemagne] ; R. Rosin [Allemagne] ; F. Pulvermüller [Allemagne] ; F. Müller [Allemagne] ; N. Birbaumer [Allemagne, Italie] | Short-term effects of behavioral treatment on movement initiation and postural control in Parkinson's disease : A controlled clinical study |
| 003154 |
M. Welsh [États-Unis] ; L. Hung [États-Unis] ; C. H. Waters [États-Unis] | Sexuality in women with Parkinson's disease |
| 003156 |
A. Albanese ; G. Maria [Italie] ; A. Bentivoglio ; T. Brisinda [Italie] ; E. Cassetta [Italie] ; P. Tonali | Severe constipation in Parkinson's disease relieved by botulinum toxin |
| 003157 |
R. A. Hauser [États-Unis] ; T. A. Zesiewicz [États-Unis] | Sertraline for the treatment of depression in Parkinson's disease |
| 003158 |
G. Abbruzzese [Italie] ; R. Marchese [Italie] ; C. Trompetto [Italie] | Sensory and motor evoked potentials in multiple system atrophy : A comparative study with Parkinson's disease |
| 003159 |
A. Straube [Allemagne] ; J.-B. Mennicken [Allemagne] ; M. Riedel [Allemagne] ; T. Eggert [Allemagne] ; N. Müller [Allemagne] | Saccades in Gilles de la Tourette's syndrome |
| 003161 |
G. Meco [Italie] ; A. Alessandri [Italie] ; P. Giustini [Italie] ; V. Bonifati [Italie] | Risperidone in levodopa-induced psychosis in advanced Parkinson's disease: An open-label, long-term study |
| 003162 |
L. Derex [France] ; P. Trouillas [France] | Reversible parkinsonism, hypophosphoremia, and hypocalcemia under vitamin D therapy |
| 003165 |
S. Avissar [Israël] ; L. Barki-Harrington [Israël] ; Y. Herishanu [Israël] ; G. Schreiber [Israël] | Reduced Gs protein function and Gαs levels in leukocytes of patients with Parkinson's disease |
| 003168 |
F. Federico [Italie] ; I. L. Simone [Italie] ; V. Lucivero [Italie] ; G. Iliceto [Italie] ; M. De Mari [Italie] ; P. Giannini [Italie] ; D. M. Mezzapesa [Italie] ; A. Tarantino [Italie] ; P. Lamberti [Italie] | Proton magnetic resonance spectroscopy in Parkinson's disease and atypical parkinsonian disorders |
| 003172 |
M. O. Melcon [Argentine] ; D. W. Anderson [États-Unis] ; R. H. Vergara [Argentine] ; W. A. Rocca [États-Unis] | Prevalence of Parkinson's disease in Junín, Buenos Aires Province, Argentina |
| 003174 |
K. Ray Chaudhuri [Royaume-Uni] ; C. Ellis ; S. Love-Jones ; T. Thomaides ; S. Clift ; C. J. Mathias ; J. D. Parkes | Postprandial hypotension and parkinsonian state in Parkinson's disease |
| 003175 |
C. I. Blake [États-Unis] ; E. Spitz [États-Unis] ; M. Leehey [États-Unis] ; B. J. Hoffer [États-Unis] ; S. J. Boyson [États-Unis] | Platelet mitochondrial respiratory chain function in Parkinson's disease |
| 003178 |
A. Curra [Italie] ; A. Berardelli ; R. Agostino ; N. Modugno ; C. Conti Puorger ; N. Accornero ; M. Manfredi | Performance of sequential arm movements with and without advance knowledge of motor pathways in Parkinson's disease |
| 003184 |
P. K. Morrish [Royaume-Uni] | Parkinson's disease is not a long-latency illness |
| 003194 |
J. G. Nutt [États-Unis] ; J. H. Carter [États-Unis] ; E. S. Lea [États-Unis] ; W. R. Woodward [États-Unis] | Motor fluctuations during continuous Levodopa infusions in patients with Parkinson's disease |
| 003198 |
G. Dziewczapolski [Argentine] ; L. B. Menalled [Argentine] ; M. T. Savino [Argentine] ; M. Mora [Argentine] ; F. J. E. Stefano [Argentine] ; O. Gershanik [Argentine] | Mechanism of action of clozapine-induced modification of motor behavior in an animal model of the "super-off" phenomenon |
| 003199 |
A. Prochazka [Canada] ; D. J. Bennett [Canada] ; M. J. Stephens [Canada] ; S. K. Patrick [Canada] ; R. Sears-Duru [Canada] ; T. Roberts [Canada] ; J. H. Jhamandas [Canada] | Measurement of rigidity in Parkinson's disease |
| 003202 |
W. H. Jost [Allemagne] ; K. Schimrigk [Allemagne] | Long-term results with cisapride in Parkinson's disease |
| 003203 |
A. Antonini [Suisse] ; J. Schwarz [Suisse] ; W. H. Oertel [Suisse] ; O. Pogarell [Suisse] ; K. L. Leenders [Suisse, Allemagne] | Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease : A study with positron emission tomography and [11C]raclopride |
| 003205 |
I. Ziv [Israël] ; R. Zilkha-Falb [Israël] ; D. Offen [Israël] ; A. Shirvan [Israël] ; A. Barzilai [Israël] ; E. Melamed [Israël] | Levodopa induces apoptosis in cultured neuronal cells : A possible accelerator of nigrostriatal degeneration in Parkinson's disease? |
| 003208 |
H. Ackermann [Allemagne] ; I. Hertrich [Allemagne] ; I. Daum [Allemagne] ; G. Scharf [Allemagne] ; S. Spieker [Allemagne] | Kinematic analysis of articulatory movements in central motor disorders |
| 003210 |
S. P. Swinnen [Belgique] ; L. Van Langendonk [Belgique] ; S. Verschueren [Belgique] ; G. Peeters [Belgique] ; R. Dom [Belgique] ; W. De Weerdt [Belgique] | Interlimb coordination deficits in patients with Parkinson's disease during the production of two-joint oscillations in the sagittal plane |
| 003213 |
J. K. Krauss [États-Unis] ; R. G. Grossman [États-Unis] ; Joseph Jankovic [États-Unis] | Improvement of Parkinsonian signs after vascular lesions of the basal ganglia circuitry |
| 003219 |
R. Fitzpatrick [Royaume-Uni] ; V. Peto [Royaume-Uni] ; C. Jenkinson [Royaume-Uni] ; R. Greenhall [Royaume-Uni] ; N. Hyman [Royaume-Uni] | Health-related quality of life in Parkinson's disease : A study of outpatient clinic attenders |
| 003222 |
R. Rosin [Allemagne] ; H. Topka [Allemagne] ; J. Dichgans [Allemagne] | Gait initiation in Parkinson's disease |
| 003223 |
P. Chana [Chili] ; A. De Marinis [Chili] ; N. Barrientos [Chili] | Gabapentin and motor fluctuations in Parkinson's disease |
| 003224 |
T. Xie [Hong Kong] ; S. L. Ho [Hong Kong] ; L. S. W. Li [Hong Kong] ; O. C. K. Ma [Hong Kong] | G/A1947 polymorphism in catechol-O-methyltransferase (COMT) gene in Parkinson's disease |
| 003232 |
L. A. Smith [Royaume-Uni] ; A. Gordin [Finlande] ; P. Jenner [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Entacapone enhances levodopa-induced reversal of motor disability in MPTP-treated common marmosets |
| 003234 |
C. G. Goetz [États-Unis] ; G. T. Stebbins [États-Unis] ; L. M. Blasucci [États-Unis] ; M. S. Grobman [États-Unis] | Efficacy of a patient-training videotape on motor fluctuations for on-off diaries in Parkinson's disease |
| 003235 |
J. P. Hubble [États-Unis] ; K. L. Busenbark [États-Unis] ; S. Wilkinson [États-Unis] ; R. Pahwa [États-Unis] ; G. W. Paulson [États-Unis] ; K. Lyons [États-Unis] ; W. C. Koller [États-Unis] | Effects of thalamic deep brain stimulation based on tremor type and diagnosis |
| 003236 |
I. Soykan [États-Unis] ; I. Sarosiek [États-Unis] ; J. Shifflett [États-Unis] ; G. F. Wooten [États-Unis] ; R. W. Mccallum [États-Unis] | Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson's disease |
| 003238 |
A. Rajput [États-Unis] ; A. Kishore [Canada] ; B. Snow [Canada] ; C. F. Bolton [Canada] ; A. H. Rajput [Canada] | Dopa-responsive, nonprogressive, juvenile parkinsonism : Report of a case |
| 003239 |
J. N. Joyce [États-Unis] ; G. Smutzer [États-Unis] ; C. J. Whitty [États-Unis] ; A. Myers [États-Unis] ; M. J. Bannon [États-Unis] | Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease |
| 003240 |
W. L. Scheider [États-Unis] ; L. A. Hershey [États-Unis] ; J. E. Vena [États-Unis] ; T. Holmlund [États-Unis] ; J. R. Marshall [États-Unis] ; J. L. Freudenheim [États-Unis] | Dietary antioxidants and other dietary factors in the etiology of Parkinson's disease |
| 003241 |
F. Tison [France] ; P. Barberger-Gateau [France] ; B. Dubroca [France] ; P. Henry [France] ; J.-F. Dartigues [France] | Dependency in Parkinson's disease : A population-based survey in nondemented elderly subjects |
| 003244 |
K. Itoh [Allemagne] ; S. Weis [Allemagne] ; P. Mehraein [Allemagne] ; J. Müller-Höcker [Allemagne] | Defects of cytochrome c oxidase in the substantia nigra of Parkinson's disease : An immunohistochemical and morphometric study |
| 003245 |
C. Teo [États-Unis] ; L. Rasco [États-Unis] ; K. Al-Mefty [États-Unis] ; T. D. Skinner [États-Unis] ; F. A. Boop [États-Unis] ; E. Garcia-Rill [États-Unis] | Decreased habituation of midlatency auditory evoked responses in Parkinson's disease |
| 003248 |
M. I. Nouzeilles [Argentine] ; M. Merello [Argentine] | Correlation between results of motor section of UPDRS and Webster scale |
| 003249 |
J. Konczak [Allemagne] ; H. Ackermann [Allemagne] ; I. Hertrich [Allemagne] ; S. Spieker [Allemagne] ; J. Dichgans [Allemagne] | Control of repetitive lip and finger movements in Parkinson's disease : Influence of external timing signals and simultaneous execution on motor performance |
| 003250 |
W. Ashraf [États-Unis] ; R. F. Pfeiffer [États-Unis] ; F. Park [États-Unis] ; J. Lof [États-Unis] ; E. M. M. Quigley [États-Unis] | Constipation in Parkinson's disease : Objective assessment and response to psyllium |
| 003251 |
A. H. Rajput [Canada] ; M. E. Fenton [Canada] ; D. George [Canada] ; A. Rajput [États-Unis] ; W. Wilson [Canada] ; L. Mcculloch [Canada] | Concordance of common movement disorders among familial cases |
| 003253 |
B. T. Johnston [États-Unis] ; J. A. Castell [États-Unis] ; S. Stumacher [États-Unis] ; T. Colcher [États-Unis] ; R. M. Gideon [États-Unis] ; Q. Li [États-Unis] ; D. O. Castell [États-Unis] | Comparison of swallowing function in Parkinson's disease and progressive supranuclear palsy |
| 003254 |
R. Pahwa [États-Unis] ; K. Lyons [États-Unis] ; D. Mcguire [États-Unis] ; P. Silverstein [États-Unis] ; F. Zwiebel [États-Unis] ; M. Robischon [États-Unis] ; W. C. Koller [États-Unis] | Comparison of standard carbidopa-levodopa and sustained-release carbidopa-levodopa in Parkinson's disease : Pharmacokinetic and quality-of-life measures |
| 003261 |
G. Gomez Arevalo [Argentine] ; R. Jorge [Argentine] ; S. Garcia [Argentine] ; O. Scipioni [Argentine] ; O. Gershanik [Argentine] | Clinical and pharmacological differences in early- versus late-onset Parkinson's disease |
| 003271 |
N. Giladi [Israël] ; S. Honigman [Israël] | Botulinum toxin injections to one leg alleviate freezing of gait in a patient with Parkinson's disease |
| 003275 |
P. R. Schuurman [Pays-Bas] ; R. M. A. De Bie [Pays-Bas] ; J. D. Speelman [Pays-Bas] ; D. A. Bosch [Pays-Bas] | Bilateral posteroventral pallidotomy in advanced Parkinson's disease in three patients |
| 003276 |
D. G. Le Couteur [Australie] ; P. W. Leighton [Australie] ; S. J. Mccann [Australie] ; S. M. Pond [Australie] | Association of a polymorphism in the dopamine-transporter gene with Parkinson's disease |
| 003294 |
N. Andreu [France] ; C. Damase-Michel [France] ; J.-M. Senard [France] ; Olivier Rascol [France] ; J.-L. Montastruc [France] | A dose-ranging study of selegiline in patients with Parkinson's disease : Effect on platelet monoamine oxidase activity |
| 003300 |
| |
| 003311 |
F. Stocchi [Italie] ; M. F. De Pandis [Italie] ; F. A. Delfino [Italie] ; T. Anselmo [Italie] ; D. Frongillo [Italie] | Transient atrial fibrillation after subcutaneous apomorphine bolus |
| 003315 |
R. Bordet [France] ; J. Benhadjali [France] ; A. Destee [France] ; J. F. Hurtevent [France] ; J. L. Bourriez [France] ; J. D. Guieu [France] | Sympathetic skin response and R-R interval variability in multiple system atrophy and idiopathic Parkinson's disease |
| 003323 |
M. H. Thaut [États-Unis] ; G. C. Mcintosh ; R. R. Rice ; R. A. Miller [États-Unis] ; J. Rathbun [États-Unis] ; J. M. Brault [États-Unis] | Rhythmic auditory stimulation in gait training for Parkinson's disease patients |
| 003326 |
E. D. Louis [États-Unis] ; T. Lynch [États-Unis] ; K. Marder ; S. Fahn [États-Unis] | Reliability of patient completion of the historical section of the Unified Parkinson's Disease Rating Scale |
| 003328 |
A. Tan [États-Unis] ; M. Salgado [États-Unis] ; S. Fahn [États-Unis] | Rapid eye movement sleep behavior disorder preceding Parkinson's disease with therapeutic response to levodopa |
| 003329 |
J. C. M. Zijlmans [Pays-Bas] ; P. J. E. Poels [Pays-Bas] ; J. Duysens [Pays-Bas] ; J. Van Der Straaten [Pays-Bas] ; T. Thien [Pays-Bas] ; M. A. Van'T Hof [Pays-Bas] ; H. O. M. Thijssen [Pays-Bas] ; M. W. I. M. Horstink [Pays-Bas] | Quantitative gait analysis in patients with vascular parkinsonism |
| 003333 |
A. Freese [États-Unis] ; M. Stern [États-Unis] ; M. G. Kaplitt ; W. M. O'Connor [États-Unis] ; M. V. Abbey ; M. J. O'Connor [États-Unis] ; M. J. During [États-Unis] | Prospects for gene therapy in Parkinson's disease |
| 003336 |
R. Pahwa [États-Unis] ; J. Marjama [États-Unis] ; D. Mcguire [États-Unis] ; K. Lyons [États-Unis] ; F. Zwiebel ; P. Silverstein ; R. Ward ; W. C. Koller [États-Unis] | Pharmacokinetic comparison of Sinemet and atamet (generic carbidopa/levodopa) : A single-dose study |
| 003342 |
J. V. H Gglund [Suède] ; S.-M. Aquilonius | Parkinson's disease after open-heart surgery |
| 003344 |
B. Ford [États-Unis] ; E. D. Louis [États-Unis] ; P. Greene [États-Unis] ; S. Fahn [États-Unis] | Oral and genital pain syndromes in Parkinson's disease |
| 003347 |
W. A. Rocca [États-Unis] ; D. W. Anderson ; F. Meneghini ; F. Grigoletto ; L. Morgante ; A. Reggio ; G. Savettieri ; R. Di Perri | Occupation, education, and Parkinson's disease : A case-control study in an Italian population |
| 003348 |
E. M. Gatto [Argentine] ; M. C. Carreras ; G. A. Pargament ; N. A. Riobo ; C. Reides ; M. Repetto ; M. M. Fernandez Pardal [Argentine] ; S. Llesuy ; J. J. Poderoso | Neutrophil function, nitric oxide, and blood oxidative stress in Parkinson's disese |
| 003349 |
M. Grasso [Italie] ; L. Mazzini [Italie] ; M. Schieppati | Muscle relaxation in Parkinson's disease : A reaction time study |
| 003354 |
J. Galazka-Friedman [Pologne] ; E. R. Bauminger ; A. Friedman ; M. Barcikowska ; D. Hechel ; I. Nowik | Iron in parkinsonian and control substantia nigra : a Mössbauer spectroscopy study |
| 003356 |
L. M. Shulman [États-Unis] ; C. Singer [États-Unis] ; J. A. Bean ; W. J. Weiner [États-Unis] | Internal tremor in patients with Parkinson's disease |
| 003357 |
B. R. Bloem [Pays-Bas] ; D. J. Beckley [États-Unis] ; J. G. Van Dijk [Pays-Bas] ; A. H. Zwinderman [Pays-Bas] ; M. P. Remler [États-Unis] ; R. A. C. Roos [Pays-Bas] | Influence of dopaminergic medication on automatic postural responses and balance impairment in Parkinson's disease |
| 003372 |
J. Green [États-Unis] ; J. L. Woodard ; B. E. Sirockman ; G. O. Zakers ; C. L. Maier ; R. C. Green ; R. L. Watts | Event-related potential P3 change in mild Parkinson's disease |
| 003374 |
G. De Michele [Italie] ; A. Filla [Italie] ; G. Volpe [Italie] ; V. De Marco [Italie] ; A. Gogliettino [Italie] ; G. Ambrosio [Italie] ; R. Marconi ; A. E. Castellano ; G. Campanella [Italie] | Environmental and genetic risk factors in Parkinson's disease : a case-control study in southern Italy |
| 003376 |
F. Tison [France] ; L. Wiart [France] ; M. Guatterie [France] ; N. Fouillet [France] ; V. Lozano [France] ; P. Henry [France] ; M. Barat [France] | Effects of central dopaminergic stimulation by apomorphine on swallowing disorders in Parkinson's disease |
| 003377 |
L. V. Metman [États-Unis] ; P. J. Blanchet [États-Unis] ; D. De Jong [États-Unis] ; M. M. Mouradian [États-Unis] ; T. N. Chase [États-Unis] | Effect of the putative dopamine D1 agonist and D2 antagonist FCE 23884 on Parkinson's disease |
| 003378 |
K. D. Pfann [États-Unis] ; R. D. Penn ; K. M. Shannon ; M. B. Shapiro ; D. M. Corcos [États-Unis] | Effect of stimulation in the ventral intermediate nucleus of the thalamus on limb control in Parkinson's disease : A case study |
| 003379 |
P. J. Blanchet [Canada] ; R. Grondin ; P. J. Bedard | Dyskinesia and wearing-off following dopamine D1 agonist treatment in drug-naive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned primates |
| 003384 |
L. J. Born [États-Unis] ; R. H. Harned ; L. F. Fikkers ; R. F. Pfeiffer [États-Unis] ; E. M. M. Quigley [États-Unis] | Cricopharyngeal dysfunction in Parkinson's disease : role in dysphagia and response to myotomy |
| 003386 |
T. E. Eichhorn [Allemagne] ; T. Gasser [Allemagne] ; N. Mai [Allemagne] ; C. Marquardt ; G. Arnold [Allemagne] ; J. Schwarz [Allemagne] ; W. H. Oertel [Allemagne] | Computational analysis of open loop handwriting movements in Parkinson's disease : A rapid method to detect dopamimetic effects |
| 003390 |
R. A. C. Roos [Pays-Bas] ; J. C. F. Jongen [Pays-Bas] ; E. A. Van Der Velde | Clinical course of patients with idiopathic Parkinson's disease |
| 003391 |
I. Daum [Allemagne] ; M. M. Schugens [Allemagne] ; C. Breitenstein [Allemagne] ; H. Topka [Allemagne] ; S. Spieker [Allemagne] | Classical eyeblink conditioning in Parkinson's disease |
| 003397 |
G. Geminiani [Italie] ; V. Fetoni [Italie] ; S. Genitrini [Italie] ; P. Giovannini [Italie] ; F. Tamma [Italie] ; T. Caraceni [Italie] | Cabergoline in Parkinson's disease complicated by motor fluctuations |
| 003408 |
F. Q. Ye [Canada] ; P. S. Allen [Canada] ; W. R. W. Martin | Basal ganglia iron content in Parkinson's disease measured with magnetic resonance |
| 003413 |
L. Smith [Royaume-Uni] ; M. De Salvia [Royaume-Uni] ; P. Jenner [Royaume-Uni] ; C. D. Marsden | An appraisal of the antiparkinsonian activity of piribedil in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmosets |
| 003414 |
K. Jendroska [Allemagne] ; Andrew Lees (neurologue) [Royaume-Uni] ; Werner Poewe [Autriche] ; S. E. Daniel [Royaume-Uni] | Amyloid β-peptide and the dementia of Parkinson's disease |
| 003416 |
P. J. Blanchet [États-Unis] ; L. V. Metman [États-Unis] ; M. M. Mouradian [États-Unis] ; T. N. Chase [États-Unis] | Acute pharmacologic blockade of dyskinesias in Parkinson's disease |
| 003419 |
P. Limousin [France] ; Pierre Pollak [France] ; D. Hoffmann [France] ; ABDELHAMID BENAZZOUZ [France] ; J. E. Perret [France] ; Alim-Louis Benabid [France] | Abnormal involuntary movements induced by subthalamic nucleus stimulation in parkinsonian patients |
| 003421 |
T. Van Laar [Pays-Bas] ; C. Neef [Pays-Bas] ; M. Danhof [Pays-Bas] ; K. I. Roon [Pays-Bas] ; R. A. C. Roos [Pays-Bas] | A new sublingual formulation of apomorphine in the treatment of patients with Parkinson's disease |
| 003425 |
| |
| 003427 |
G. Pezzoli [Italie] ; A. Antonini ; S. Barbieri [Italie] ; M. Canesi [Italie] ; L. Perbellini ; A. Zecchinelli [Italie] ; C. B. Mariani [Italie] ; A. Bonetti [Italie] ; K. L. Leenders | n-Hexane-induced Parkinsonism : pathogenetic hypotheses |
| 003429 |
G. Staude [Allemagne] ; W. Wolf [Allemagne] ; M. Ott ; W. H. Oertel ; R. Dengler | Tremor as a factor in prolonged reaction times of Parkinsonian patients |
| 003434 |
E. Tandberg [Norvège] ; J. P. Larsen [Norvège] ; E. G. Nessler [Norvège] ; T. Riise ; J. A. Aarli | The epidemiology of Parkinson's disease in the county of Rogaland, Norway |
| 003435 |
W. Diaz Neira [Espagne] ; V. Sanchez ; M. A. Mena ; J. G. De Yebenes | The effects of cisapride on plasma L-dopa levels and clinical response in Parkinson's disease |
| 003439 |
R. K. B. Pearce [Royaume-Uni] ; C. H. Hawkes ; S. E. Daniel [Royaume-Uni] | The anterior olfactory nucleus in Parkinson's disease |
| 003440 |
M. Onofrj [Italie] ; T. Fulgente [Italie] ; G. Malatesta [Italie] ; F. Ferracci [Italie] ; A. Thomas [Italie] ; L. Curatola ; F. Bollettini ; M. Ragno | The abnormality of N30 somatosensory evoked potential in idiopathic Parkinson's disease is unrelated to disease stage or clinical scores and insensitive to dopamine manipulations |
| 003441 |
C. G. Goetz [États-Unis] ; G. T. Stebbins [États-Unis] ; T. A. Chmura [États-Unis] ; S. Fahn ; H. L. Klawans [États-Unis] ; C. D. Marsden | Teaching tape for the motor section of the unified Parkinson's disease rating scale |
| 003443 |
F. Valldeoriola [Espagne] ; J. Valls-Sole ; E. S. Tolosa ; M. J. Marti | Striated anal sphincter denervation in patients with progressive supranuclear palsy |
| 003444 |
XIAO-HUI ZHONG [Canada] ; J. W. Haycock ; K. Shannak [Canada] ; Y. Robitaille ; J. Fratkin ; A. H. Koeppen ; O. Hornykiewicz [Canada] ; S. J. Kish [Canada] | Striatal dihydroxyphenylalanine decarboxylase and tyrosine hydroxylase protein in idiopathic Parkinson's disease and dominantly inherited olivopontocerebellar atrophy |
| 003445 |
F. A. Lenz [États-Unis] ; S. L. Normand ; H. C. Kwan ; D. Andrews ; L. H. Rowland [États-Unis] ; M. W. Jones ; M. Seike [États-Unis] ; Y. C. Lin [États-Unis] ; R. R. Tasker ; J. O. Dostrovsky ; Y. E. Lenz [États-Unis] | Statistical prediction of the optimal site for thalamotomy in Parkinsonian tremor |
| 003447 |
C. Stewart [États-Unis] ; L. Winfield ; A. Hunt ; S. B. Bressman ; S. Fahn ; A. Blitzer ; M. F. Brin | Speech dysfunction in early Parkinson's disease |
| 003449 |
J. C. Garcia-Monco [Espagne] ; A. Padierna ; M. G. Beldarrain | Selegiline, fluoxetine, and depression in Parkinson's disease |
| 003450 |
J. Duarte [Espagne] ; L. E. Claveria [Espagne] ; J. De Pedro-Cuesta ; A. P. Sempere [Espagne] ; F. Coria [Espagne] ; D. B. Calne | Screening Parkinson's disease : a validated questionnaire of high specificity and sensitivity |
| 003460 |
S. S. Palmer [États-Unis] ; J. T. Hutton | Postural finger tremor exhibited by Parkinson patients and age-matched subjects |
| 003462 |
T. Van Laar [Pays-Bas] ; E. N. H. Jansen ; C. Neef ; M. Danhof ; R. A. C. Roos | Pharmacokinetics and clinical efficacy of rectal apomorphine in patients with Parkinson's disease : a study of five different suppositories |
| 003464 |
H. S. Markus [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; G. Lennox ; C. D. Marsden ; D. C. Costa | Patterns of regional cerebral blood flow in corticobasal degeneration studies using HMPAO SPECT ; comparison with Parkinson's disease and normal controls |
| 003466 |
E. D. Louis [États-Unis] ; J. E. Goldman ; J. M. Powers ; S. Fahn [États-Unis] | Parkinsonian features of eight pathologically diagnosed cases of diffuse lewy body disease |
| 003468 |
J. E. Ahlskog [États-Unis] ; R. J. Uitti ; P. A. Low [États-Unis] ; G. M. Tyce ; K. K. Nickander [États-Unis] ; R. C. Petersen [États-Unis] ; E. Kokmen [États-Unis] | No evidence for systemic oxidant stress in Parkinson's or Alzheimer's disease |
| 003471 |
H. Nogaki [Japon] ; T. Fukusako ; F. Sasabe ; K. Negoro ; M. Miromatsu | Muscle strength in early Parkinson's disease |
| 003475 |
R. A. Maricle [États-Unis] ; J. G. Nutt ; J. H. Carter | Mood and anxiety fluctuation in Parkinson's disease associated with levodopa infusion : preliminary findings |
| 003477 |
G. Fabbrini [Italie] ; F. Baronti ; S. Ruggieri ; G. L. Lenzi | Meningioma-induced loss of antiparkinsonian response to levodopa |
| 003480 |
R. Inzelberg [Israël] ; P. Nisipeanu ; M. J. Rabey ; A. D. Korczyn | Long-term tolerability and efficacy of cabergoline, a new long-acting dopamine agonist, in Parkinson's disease |
| 003481 |
B. R. Bloem [Pays-Bas] ; D. J. Beckley ; J. P. P. Van Vugt [Pays-Bas] ; J. G. Van Dijk [Pays-Bas] ; M. P. Remler ; J. W. Langston ; R. A. C. Roos [Pays-Bas] | Long latency postural reflexes are under supraspinal dopaminergic control |
| 003484 |
J. M. Cooper [Royaume-Uni] ; S. E. Daniel ; C. D. Marsden ; A. H. V. Schapira [Royaume-Uni] | L-dihyroxyphenalanine and complex I deficiency in Parkinson's disease brain |
| 003485 |
J. Opacka-Juffry [Royaume-Uni] ; D. J. Brooks | L-dihydroxyphenylalanine and its decarboxylase : new ideas on their neuroregulatory roles |
| 003489 |
W. H. Oertel [Allemagne] ; R. C. Dodel | International guide to drugs for Parkinson's disease |
| 003491 |
J. J. Van Hilten [Pays-Bas] ; E. A. M. Braat [Pays-Bas] ; E. A. Van Der Velde ; H. A. M. Middelkoop [Pays-Bas] ; J. G. Van Dijk [Pays-Bas] ; G. J. Ligthart ; R. A. C. Roos [Pays-Bas] | Hypokinesia in Parkinson's disease : influence of age, disease severity, and disease duration |
| 003493 |
A. E. Lang [Canada] | Hemiatrophy, juvenile-onset exertional alternating leg paresis, hypotonia, and hemidystonia and adult-onset hemiparkinsonism : the spectrum of hemiparkinsonism-hemiatrophy syndrome |
| 003497 |
K. Bötzel [Allemagne] ; M. Mayer [Allemagne] ; W. H. Oertel [Allemagne] ; W. Paulus | Frontal and parietal premovement slow brain potentials in Parkinson's disease and aging |
| 003501 |
T. L. Davis [États-Unis] ; M. Roznoski ; R. S. Burns | Effects of tolcapone in Parkinson's patients taking L-dihydroxyphenalalanine/carbidopa and selegiline |
| 003503 |
R. Djaldetti [Israël] ; M. Koren ; ILAN ZIV ; A. Achiron ; ELDAD MELAMED | Effect of cisapride on response fluctuations in Parkinson's disease |
| 003506 |
C. E. Clarke [Royaume-Uni] | Does levodopa therapy delay death in Parkinson's disease ? A review of the evidence |
| 003507 |
J.-L. Montastruc [France] ; N. Fabre [France] ; O. Blin [France] ; J.-M. Senard [France] ; Olivier Rascol [France] ; A. Rascol [France] | Does fluoxetine aggravate Parkinson's disease ? A pilot prospective study |
| 003515 |
V. Plante-Bordeneuve [Royaume-Uni] ; O. Bandmann ; G. Wenning ; N. P. Quinn ; S. E. Daniel ; A. E. Harding | CYP2D6-debrisoquine hydroxylase gene polymorphism in multiple system atrophy |
| 003520 |
P. Limousin [France] ; Pierre Pollak [France] ; ABDELHAMID BENAZZOUZ [France] ; D. Hoffmann [France] ; E. Broussolle [France] ; J. E. Perret [France] ; Alim-Louis Benabid [France] | Bilateral subthalamic nucleus stimulation for severe Parkinson's disease |
| 003521 |
O. Suchowersky [Canada] ; S. Furtado ; G. Rohs | Beneficial effect of intranasal desmopressin for nocturnal polyuria in Parkinson's disease |
| 003525 |
R. Sprengelmeyer [Allemagne] ; A. G. M. Canavan ; H. W. Lange ; V. Hömberg | Associative learning in degenerative neostriatal disorders : contrasts in explicit and implicit remembering between Parkinson's and Huntington's diseases |
| 003527 |
S. T. Gancher [États-Unis] ; J. G. Nutt [États-Unis] ; W. R. Woodward | Apomorphine infusional therapy in Parkinson's disease : clinical utility and lack of tolerance |
| 003528 |
S. Przedborski [États-Unis] ; V. Jackson-Lewis ; S. Fahn | Antiparkinsonian therapies and brain mitochondrial complex I activity |
| 003529 |
WASEEM ASHRAF [États-Unis] ; Z. K. Wszolek ; R. F. Pfeiffer ; M. Normand ; K. Maurer ; F. Srb [États-Unis] ; L. L. Edwards ; E. M. M. Quigley [États-Unis] | Anorectal function in fluctuating (on-off) Parkinson's disease : evaluation by combined anorectal manometry and electromyography |
| 003533 |
A. Hufschmidt [Allemagne] ; C.-H. Lücking | Abnormalities of tracking behavior in Parkinson's disease |
| 003534 |
Olivier Rascol [France] ; U. Sabatini ; N. Fabre [France] ; J. M. Senard [France] ; M. Simonetta-Moreau [France] ; J. L. Montrastruc [France] ; M. Clanet [France] ; A. Rascol [France] | Abnormal vestibuloocular reflex cancellation in multiple system atrophy and progressive supranuclear palsy but not in Parkinson's disease |
| 003535 |
C. Nahmias [Canada] ; L. Wahl ; R. Chirakal ; G. Firnau ; E. S. Garnett | A probe for intracerebral aromatic amino-acid decarboxylase activity : distribution and kinetics of [18F]6-fluoro-L-m-tyrosine in the human brain |
| 003536 |
A. Ishikawa [Japon] ; T. Miyatake | A family with hereditary juvenile dystonia-parkinsonism |
| 003537 |
T. Klockgether [Allemagne] ; M. Borutta ; H. Rapp ; S. Spieker ; J. Dichgans | A defect of kinesthesia in Parkinson's disease |
| 003538 |
G. Glosser [États-Unis] ; C. Clark ; B. Freundlich ; L. Kliner-Krenzel ; P. Flaherty ; M. Stern | A controlled investigation of current and premorbid personality : characteristics of Parkinson's disease patients |
| 003539 |
G. K. Wenning [Royaume-Uni] ; M. T. O'Connell ; P. N. Patsalos ; N. P. Quinn | A clinical and pharmacokinetic case study of an interaction of levodopa and antituberculous therapy in Parkinson's disease |
| 003540 |
A. M. Bonnet [France] ; I. Serre [France] ; R. Marconi [France] ; Yves Agid [France] ; B. Dubois [France] | A "combined" levodopa test as a useful method for evaluating the efficacy of dopamine agonists : application to pergolide and bromocriptine |
| 003542 |
N. Gouider-Khouja [France] ; M. Vidailhet [France] ; A.-M. Bonnet [France] ; J. Pichon [France] ; Yves Agid [France] | "Pure" striatonigral degeneration and Parkinson's disease : a comparative clinical study |
| 003543 |
C. Pacchetti [Italie] ; G. Albani ; E. Martignoni ; L. Godi ; E. Alfonsi ; G. Nappi | "Off" painful dystonia in Parkinson's disease treated with botulinum toxin |
| 003545 |
| |
| 003550 |
B. A. Haug [Allemagne] ; C. Trenkwalder [Allemagne] ; G. B. Arden ; W. H. Oertel ; W. Paulus | Visual thresholds to low-contrast pattern displacement, color contrast, and luminance contrast stimuli in Parkinson's disease |
| 003551 |
T. Klockgether [Allemagne] ; J. Dichgans | Visual control of arm movement in Parkinson's disease |
| 003554 |
C. G. Goetz [États-Unis] ; G. T. Stebbins ; H. M. Shale ; A. E. Lang ; D. A. Chernik ; T. A. Xhmura ; J. E. Ahlskog ; E. E. Dorflinger | Utility of an objective dyskinesia rating scale for Parkinson's disease: inter- and intrarater reliability assessment |
| 003557 |
P. Martinez-Martin [Espagne] ; A. Gil-Nagel [Espagne] ; L. Morlan Gracia [Espagne] ; J. Balseiro Gomez [Espagne] ; J. Martinez-Sarries [Espagne] ; F. Bermejo | Unified Parkinson's disease rating scale characteristics and structure |
| 003558 |
V. Plante-Bordeneuve [Royaume-Uni] ; M. B. Davis ; D. M. Maraganore ; C. D. Marsden ; A. E. Harding | Tyrosine hydroxylase polymorphism in familial and sporadic Parkinson's disease |
| 003564 |
R. J. Vermeulen [Pays-Bas] ; B. Drukarch [Pays-Bas] ; M. C. R. Sahadat ; C. Goosen ; E. C. Wolters [Pays-Bas] ; J. C. Stoof [Pays-Bas] | The dopamine D1 agonist SKF 81297 and the dopamine D2 agonist LY 171555 act synergistically to stimulate motor behavior of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned parkinsonian rhesus monkeys |
| 003566 |
K. Nakashima [Japon] ; M. Shimoda ; N. Kuno ; K. Takahashi | Temporary symptom worsening caused by manidipine hydrochloride in two patients with Parkinson's disease |
| 003568 |
T. Mendis [Canada] ; E. Mohr [Canada] ; A. George ; I. N. Rusk [Canada] ; P. Gray ; J. D. Grimes | Symptomatic relief from treatment-induced psychosis in Parkinson's disease: an open-label pilot study with remoxipride |
| 003570 |
J. P. Jr Bennett [États-Unis] ; E. R. Landow ; S. Dietrich ; L. A. Schuh | Suppression of dyskinesias in advanced Parkinson's disease: moderate daily clozapine doses provide long-term dyskinesia reduction |
| 003575 |
R. Mayeux [États-Unis] ; MING-XIN TANG [États-Unis] ; K. Marder [États-Unis] ; L. J. Cote ; Y. Stern [États-Unis] | Smoking and Parkinson's disease |
| 003576 |
T. R. Jr Zimmerman [États-Unis] ; J. I. Sage ; A. E. Lang ; M. H. Mark | Severe evening dyskinesias in advanced Parkinson's disease: clinical description, relation to plasma levodopa, and treatment |
| 003579 |
M. Richards [États-Unis] ; K. Marder [États-Unis] ; L. Cote ; R. Mayeux [États-Unis] | Reliability of symptom onset assessment in Parkinson's disease |
| 003581 |
J. J. Van Hilten [Pays-Bas] ; A. D. Van Der Zwan [Pays-Bas] ; A. H. Zwinderman ; R. A. C. Roos [Pays-Bas] | Rating impairment and disability in Parkinson's Disease: evaluation of the Unified Parkinson's Disease rating Scale |
| 003582 |
R. K. Mosewich [Canada] ; A. H. Rajput [Canada] ; A. Shuaib [Canada] ; B. Rozdilsky ; L. Ang | Pulmonary embolism: an under-recognized yet frequent cause of death in Parkinsonism |
| 003585 |
M. P. Caligiuri [États-Unis] | Portable device for quantifying parkinsonian wrist rigidity |
| 003587 |
M. Scarpa [Italie] ; U. Castiello | Perturbation of a prehension movement in Parkinson's disease |
| 003588 |
G. Pezzoli [Italie] ; E. Martignoni ; C. Pacchetti ; V. A. Angeleri ; P. Lamberti ; A. Muratorio ; U. Bonuccelli ; M. De Mari ; N. Foschi ; E. Cossutta ; F. Nicoletti ; F. Giammona ; M. Cansei [Italie] ; G. Scarlato [Italie] ; T. Caraceni ; E. Moscarelli | Pergolide compared with bromocriptine in Parkinson's disease: a multicenter, crossover, controlled study |
| 003589 |
A. P. Sempere [Espagne] ; J. Duarte [Espagne] ; J. M. Palomares ; F. Coria ; L. E. Claveria | Parkinsonism and tardive dyskinesia after chronic use of clebopride |
| 003591 |
A. T. M. Hageman [Pays-Bas] ; M. W. I. M. Horstink | Parkinson due to a subdural hematoma |
| 003594 |
Olivier Rascol [France] ; N. Fabre [France] ; O. Blin ; J. Poulik [France] ; U. Sabatini [France] ; J.-M. Senard [France] ; M. Ane [France] ; J.-L. Montastruc [France] ; A. Rascol | Naltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinson's disease |
| 003595 |
J. D. Belluzzi [États-Unis] ; E. F. Domino ; J. M. May ; K. S. Bankiewicz ; D. A. Mcafee | N-0923, a selective dopamine D2 receptor agonist, is efficacious in rat and monkey models of Parkinson's disease |
| 003597 |
R. J. Labutta [États-Unis] ; R. B. Miles [États-Unis] ; J. N. Sanes ; M. Hallett [États-Unis] | Motor program memory storage in Parkinson's disease patients tested with a delayed response task |
| 003598 |
L. V. Metman [États-Unis] ; V. H. Sethy ; J. R. Roberts ; D. Bravi ; J. I. Hoff ; M. M. Mouradian ; T. N. Chase | Motor effects of the partial dopamine agonist (-)-3-(3-hydroxyphenyl)-N-n-propylpiperidine (Preclamol) in Parkinson's disease |
| 003599 |
J. M. Olive [Espagne] ; L. Masana ; J. Gonzalez | Meperidine and reversible parkinsonism |
| 003602 |
R. Marconi [France] ; D. Lefebvre-Caparros ; A.-M. Bonnet [France] ; M. Vidailhet [France] ; B. Dubois [France] ; Yves Agid [France] | Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology |
| 003606 |
G. K. Wenning [Royaume-Uni] ; R. J Ger [Royaume-Uni] ; B. Kendall ; D. Kingsley [Royaume-Uni] ; S. E. Daniel ; N. P. Quinn [Royaume-Uni] | Is cranial computerized tomography useful in the diagnosis of multiple system atrophy? |
| 003607 |
M. Richards [États-Unis] ; K. Marder ; L. Cote ; R. Mayeux | Interrater reliability of the Unified Parkinson's Disease Rating Scale motor examination |
| 003609 |
D. T. Dexter [Royaume-Uni] ; A. E. Holley ; W. D. Flitter ; T. F. Slater ; F. R. Wells ; S. E. Daniel ; Andrew Lees (neurologue) [Royaume-Uni] ; P. Jenner [Royaume-Uni] ; C. D. Marsden | Increated levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study |
| 003611 |
G. S. Hotamisligil [États-Unis] ; A. S. Girmen [États-Unis] ; J. S. Fink [États-Unis] ; E. Tivol [États-Unis] ; C. Shalish [États-Unis] ; J. Trofatter [États-Unis] ; J. Baenziger ; S. Diamond ; C. Markham ; J. Sullivan ; J. Growdon [États-Unis] ; X. O. Breakefield [États-Unis] | Hereditary variations in monoamine oxidase as a risk factor for Parkinson's disease |
| 003612 |
F. Tison ; C. Coutelle [France] ; P. Henry [France] ; A. Cassaigne | Glutathion S-transferase (class μ) phenotype in Parkinson's disease |
| 003614 |
L. Verhagen Metman [États-Unis] ; J. Hoff ; M. M. Mouradian ; T. N. Chase | Fluctuations in plasma levodopa and motor responses with liquid and tablet levodopa/carbidopa |
| 003621 |
A. H. V. Schapira [Royaume-Uni] | Evidence for mitochondrial dysfunction in Parkinson's disease: a critical appraisal |
| 003624 |
U. B. Muthane [Inde] ; H. S. Swamy [Inde] ; P. Satishchandra [Inde] ; M. N. Subhash ; S. Rao ; D. Subbakrishna | Early onset Parkinson's disease: are juvenile- and young-onset different? |
| 003633 |
S. Rose [Royaume-Uni] ; P. Jenner ; C. D. Marsden | Chronic administration does not alter the accumulation of L-dopa into muscle |
| 003636 |
M. F. Gordon [États-Unis] ; W. J. Weiner ; W. C. Koller ; T. H. Rao [États-Unis] ; V. Chehebar [États-Unis] ; D. W. Diskson | Case 2, 1994 : parkinsonism and cognitive impairment |
| 003639 |
J. Kulisevsky [Espagne] ; M. Lima De Freitas ; L. Barraquer-Bordas | Bilateral akinesia in drug-induced parkinsonism after a subthalamic lesion |
| 003643 |
W. Ashraf [États-Unis] ; R. F. Pfeiffer ; E. M. M. Quigley [États-Unis] | Anorectal manometry in the assessment of anorectal function in parkinson's disease : a comparison with chronic idiopathic constipation |
| 003644 |
R. Agostino [Italie] ; A. Berardelli ; A. Formica ; F. Stocchi ; N. Accornero ; M. Manfredi | Analysis of repetitive and nonrepetitive sequential arm movements in patients with Parkinson's disease |
| 003645 |
C. L. Comella [États-Unis] ; C. G. Goetz | Akathisia in Parkinson's disease |
| 003648 |
C. W. Olanow [États-Unis] ; S. Fahn ; M. Muenter ; H. Klawans ; H. Hurtig ; M. Stern ; I. Shoulson ; R. Kurlan ; J. D. Grimes ; Joseph Jankovic [États-Unis] ; M. Hoehn ; C. H. Markham ; R. Duvoisin ; O. Reinmuth ; H. A. Leonard ; E. Ahlskog ; R. Feldman ; L. Hershey ; M. D. Yahr | A multicenter double-blind placebo-controlled trial of pergolide as an adjunct to Sinemet® in Parkinson's disease |
| 003649 |
C. Hertzman [Canada] ; M. Wiens ; B. Snow ; S. Kelly ; D. Calne | A case-control study of Parkinson's disease in a horticultural region of British Columbia |
| 003653 |
| |
| 003654 |
| |
| 003655 |
R. A. Hauser [États-Unis] ; C. W. Olanow | orobuccal dyskinesia associated with trihexyphenidyl therapy in a patient with Parkinson's disease |
| 003656 |
Joseph Jankovic [États-Unis] ; A. H. Rajput [États-Unis] ; L. I. Golbe [États-Unis] ; J. C. Goodman | What is it? Case 1. 1993: Parkinsonism, dysautonomia, and ophthalmoparesis |
| 003657 |
U. B. Muthane [Inde] ; P. Satishchandra [Inde] ; M. N. Subhash | Visual and auditory evoked potentials in early onset Parkinson's disease and their relationship to cerebrospinal fluid monoamine metabolites |
| 003662 |
D. Bravi [États-Unis] ; T. L. Davis ; M. M. Mouradian ; T. N. Chase | Treatment of Parkinson's disease with the partial dopamine agonist EMD 49980 |
| 003666 |
J. Guridi [Espagne] ; M. R. Luquin ; M. T. Herrero ; J. A. Obeso | The subthalamic nucleus: a possible target for stereotaxic surgery in Parkinson's disease |
| 003667 |
M. B. H. Youdim [Israël] ; P. Riederer | The relevance of glial monoamine oxidase-B and polyamines to the action of selegiline in Parkinson's disease |
| 003668 |
M. B. H. Youdim [Israël] ; D. Ben-Shachar [Israël] ; P. Riederer | The possible role of iron in the etiopathology of Parkinson's disease |
| 003670 |
G. V. Sawle [Royaume-Uni] | The detection of preclinical Parkinson's disease: what is the role of positron emission tomography? |
| 003672 |
C. Pacchetti [Italie] ; E. Martignoni [Italie] ; P. Bruggi [Italie] ; L. Godi [Italie] ; B. Aufdembrinke ; C. Miltenburger ; B. Voet ; G. Nappi [Italie] | Terguride in fluctuating Parkinsonian patients: a double-blind study versus placebo |
| 003674 |
H. Allain [France] ; Pierre Pollak [France] ; H. C. Neukirch [France] | Symptomatic effect of selegiline in De Novo Parkinsonian patients |
| 003675 |
SHUU JIUN WANG [Taïwan] ; JONG LING FUH ; D. E. Shan ; KWONG KUM LIAO ; KON PING LIN ; CHING PIAO TSAI ; ZIN AN WU | Sympathetic skin response and R-R interval variation in Parkinson's disease |
| 003676 |
S. B. Blunt [Royaume-Uni] ; P. Jenner [Royaume-Uni] ; C. D. Marsden | Suppressive effect of L-dopa on dopamine cells remaining in the ventral tegmental area of rats previously exposed to the neurotoxin 6-hydroxydopamine |
| 003677 |
A. J. Hughes [Royaume-Uni] ; S. Bishop ; B. Kleedorfer ; N. Turjanski ; W. Fernandez ; Andrew Lees (neurologue) [Royaume-Uni] ; G. M. Stern | Subcateneous apomorphine in Parkinson's disease: response to chronic administration for up to five years |
| 003680 |
B. Johnels [Suède] ; P. E. Ingvarsson [Suède] ; B. Holmberg ; M. Matousek [Suède] ; G. Steg [Suède] | Single-dose L-dopa response in early parkinson's disease : measurements with optoelectronic recording technique |
| 003682 |
V. V. Myllyl [Finlande] ; K. A. Sotaniemi ; J. A. Vuorinen ; E. H. Heinonen | Selegiline in De Novo Parkinsonian patients: the finnish study |
| 003686 |
E. Broussolle [France] ; L. Cinotti [France] ; Pierre Pollak [France] ; P. Landais [France] ; D. Le Bars [France] ; G. Galy [France] ; F. Lavenne [France] ; Y. Khalfallah ; G. Chazot [France] ; F. Mauguiere [France] | Relief of akinesia by apomorphine and cerebral metabolic changes in Parkinson's disease |
| 003687 |
M. A. Hely [Australie] ; T. Chey [Australie] ; A. Wilson ; P. M. Williamson ; D. J. O'Sullivan ; D. Rail ; J. G. L. Morris [Australie] | Reliability of the Columbia scale for assessing signs of Parkinson's disease |
| 003688 |
F. Ishizaki [Japon] ; T. Harada ; S. Katayama ; H. Abe ; S. Nakamura | Relationship between osteopenia and clinical characteristics of Parkinson's disease |
| 003693 |
M. M. Schugens [Allemagne] ; I. Daum ; S. Richter ; E. Scholz ; A. G. M. Canavan | Proximal and distal reaction times (RTs) are not differentially affected in Parkinson's disease |
| 003694 |
A. Achiron [Israël] ; I. Ziv ; M. Goren ; H. Goldberg ; Y. Zoldan ; H. Sroka ; E. Melamed | Primary progressive freezing gait |
| 003701 |
B. A. Rybicki [États-Unis] ; C. Cole Johnson [États-Unis] ; J. Uman [États-Unis] ; J. M. Gorell | Parkinson's disease mortality and the industrial use of heavy metals in Michigan |
| 003703 |
J. O. Rinne [Finlande] ; A. Laihinen [Finlande] ; U. K. Rinne [Finlande] ; K. Nagren ; J. Bergman ; U. Ruotsalainen | PET study on striatal dopamine D2 receptor changes during the progression of early Parkinson's disease |
| 003704 |
M. S. Sandy [États-Unis] ; J. W. Langston [États-Unis] ; M. T. Smith ; D. A. Di Monte [États-Unis] | PCR analysis of platelet mtDNA : lack of specific changes in parkinson's disease |
| 003706 |
G. Linazasoro [Espagne] ; J. F. Marti Masso ; J. A. Suarez | Nocturnal akathisia in Parkinson's disease: treatment with clozapine |
| 003707 |
J. O. Rinne [Finlande] | Nigral degeneration in Parkinson's disease |
| 003708 |
K. T. Finnegan [États-Unis] | Neurotoxins and monoamine oxidase inhibition: new aspects |
| 003709 |
S. E. Starkstein [Argentine] ; R. Leiguarda | Neuropsychological correlates of brain atrophy in parkinson's disease : a CT-scan study |
| 003713 |
G. J. Gomez Arevalo [Argentine] ; O. S. Gershanik | Modulator effect of clozapine on levodopa response in Parkinson's disease: a preliminary study |
| 003714 |
M. E. Giuffra [États-Unis] ; V. H. Sethy ; T. L. Davis ; M. M. Mouradian ; T. N. Chase | Milacemide therapy for Parkinson's disease |
| 003717 |
H. P. H. Kremer [Pays-Bas] ; G. T. A. M. Bots | Lewy bodies in the lateral hypothalamus: do they imply neuronal loss ? |
| 003719 |
JONG SUNG KIM [Corée du Sud] ; MYOUNG CHONG LEE | Leg tremor mimicking orthostatic tremor as an initial manifestation of Parkinson's disease |
| 003722 |
J. P. Hubble [États-Unis] ; R. Pahwa [États-Unis] ; D. K. Michalek [États-Unis] ; C. Thomas ; W. C. Koller [États-Unis] | Interactive video conferencing: a means of providing interim care to Parkinson's disease patients |
| 003723 |
W. S. Metzer [États-Unis] ; S. R. Paige ; J. E. O. Newton | Inefficacy of propranolol in attenuation of drug-induced parkinsonian tremor |
| 003728 |
L. Edwards [États-Unis] ; E. M. M. Quigley ; R. Hofman [États-Unis] ; R. F. Pfeiffer [États-Unis] | Gastrointestinal symptoms in parkinson disease : 18-month follow-up study |
| 003729 |
V. S. Kostic [Serbie] ; Z. Marinkovic ; S. Filipovic ; D. Momcilovic | Function of dopamine receptors in young-onset Parkinson's disease: prolactin response |
| 003731 |
A. L. Burleigh [États-Unis] ; F. B. Horak [États-Unis] ; K. J. Burchiel ; J. G. Nutt | Effects of thalamic stimulation on tremor, balance, and step initiation: a single subject study |
| 003733 |
B. Gomez-Mancilla [Canada] ; R. Boucher ; C. Gagnon ; T. Di Paolo ; R. Markstein ; P. J. Bedard | Effect of adding the D1 agonist CY 208-243 to chronic bromocriptine treatment. I: Evaluation of motor parameters in relation to striatal catecholamine content and dopamine receptors |
| 003735 |
S. A. Factor [États-Unis] ; W. J. Weiner | Early combination therapy with bromocriptine and levodopa in Parkinson's disease |
| 003736 |
P. G. Strange [Royaume-Uni] | Dopamine receptors in the basal ganglia: relevance to Parkinson's disease |
| 003737 |
J. G. Nutt [États-Unis] ; J. H. Carter ; W. Woodward ; J. P. Hammerstad ; S. T. Gancher | Does tolerance develop to levodopa? Comparison of 2- and 21-H levodopa infusions |
| 003739 |
L. Schelosky [Allemagne] ; J. Hierholzer ; J. Wissel ; M. Cordes ; Werner Poewe [Autriche] | Correlation of clinical response in apomorphine test with D2-receptor status as demonstrated by 123I IBZM-SPECT |
| 003742 |
W. H. Jost [Allemagne] ; K. Schimrigk | Cisapride treatment of constipation in Parkinson's disease |
| 003745 |
S. Przedborski [Belgique] ; S. Goldman ; M. Levivier ; N. Giladi ; L. M. Bidaut ; J. Hildebrand [Belgique] ; E. Stanus ; D. Labar ; A. Luxen | Brain glucose metabolism and dopamine D2 receptor analysis in a patient with hemiparkinsonism-hemiatrophy syndrome |
| 003754 |
U. Bonuccelli [Italie] ; P. Piccini [Italie] ; P. Del Dotto [Italie] ; G. Rossi ; G. U. Corsini ; A. Muratorio [Italie] | Apomorphine test for dopaminergic responsiveness: a dose assessment study |
| 003755 |
E. R. Siemers [États-Unis] ; A. Shekhar ; K. Quaid ; H. Dickson | Anxiety and motor performance in Parkinson's disease |
| 003759 |
M. Guttman [Canada] ; G. Leger ; A. Reches ; A. Evans ; H. Kuwabara ; J. M. Cedarbaum ; A. Gjedde | Administration of the new COMT inhibitor OR-611 increases striatal uptake of fluorodopa |
| 003762 |
S. A. Factor [États-Unis] | Acetazolamide therapy of menstrual-related fluctuations in Parkinson's disease |
| 003763 |
C. W. Olanow [États-Unis] | A rationale for monoamine oxidase inhibition as neuroprotective therapy for Parkinson's disease |
| 003768 |
| |
| 003769 |
Andrew Lees (neurologue) [Royaume-Uni] | When did Ray Kennedy's Parkinson's disease begin? |
| 003773 |
W. Fernandez [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Temporary deterioration in Parkinsonian signs after modest alcohol intake |
| 003783 |
F. J. Jimenez-Jimenez [Espagne] ; D. Mateo ; S. Gimenez-Roldan | Premorbid smoking, alcohol consumption, and coffee drinking habits in Parkinson's disease: a case-control study |
| 003792 |
R. Djaldetti [Israël] ; I. Ziv ; A. Achiron ; E. Melamed | Parkinson's disease in a patient with mitochondrial myopathy: is there a causative relationship? |
| 003799 |
M. R. Luquin [Espagne] ; O. Scipioni ; J. Vaamonde ; O. Gershanik ; J. A. Obeso | Levopoda-induced dyskinesias in Parkinson's disease : clinical and pharmacological classification |
| 003801 |
M Contin [Italie] ; R. Riva ; P. Martinelli ; A. Baruzzi | Kinetic-dynamic relationship of oral levopoda : possible biphasic response after sequential doses in Parkinson's disease |
| 003804 |
F. Stocchi [Italie] ; S. Ruggieri ; A. Carta ; J. Ryatt ; N. Quinn ; P. Jenner ; C. D. Marsden ; A. Agnoli | Intravenous boluses and continuous infusions of L-DOPA methyl ester in fluctuating patients with Parkinson's disease |
| 003805 |
J.-A. C. Lazarus [États-Unis] ; G. E. Stelmach | Interlimb coordination in Parkinson's disease |
| 003807 |
S. Przedborski [Belgique] ; A. Liard ; J. Hildebrand | Induction of mania by apomorphine in a depressed Parkinsonian patient |
| 003808 |
R. D. Jones [Nouvelle-Zélande] ; I. M. Donaldson ; P. L. Timming | Impairment of high-constrast visual acuity in Parkinson's disease |
| 003812 |
M. J. Steiger [Royaume-Uni] ; M. Pires ; F. Scaravilli ; N. P. Quinn ; C. D. Marsden | Hemiballism and chorea in a patient with parkinsonism due to a multisystem degeneration |
| 003815 |
F. Javier Jimenez-Jimenez [Espagne] ; D. Mateo ; S. Gimenez-Roldan | Exposure to well water and pesticides in Parkinson's disease : a case-control study in the Madrid area |
| 003816 |
E. Pourcher [Canada] ; B. Gomez-Mancilla ; P. J. Bedard | Ethosuximide and tremor in Parkinson's disease : a pilot study |
| 003817 |
L. Christenson [États-Unis] ; D. F. Emerich ; P. R. Sanberg | Encapsulated cell implatation for Parkinson's disease |
| 003818 |
M. Emre [Suisse] ; U. K. Rinne ; A. Rascol ; A. Lees ; Yves Agid [France] ; X. Lataste | Effects of a selective partial D1 agonist, CY 208-243, in De Novo patients with Parkinson disease |
| 003819 |
B. Gomez-Mancilla [Canada] ; J.-F. Latulippe ; R. Boucher ; P. J. Bedard | Effect of ethosuximide on rest tremor in the MPTP monkey model |
| 003820 |
D. Bravi [États-Unis] ; J. J. Anderson ; F. Dagani ; T. L. Davis ; R. Feerari ; M. Gillespie ; T. N. Chase | Effect of aging and dopaminomimetic therapy on mitochondrial respiratory function in Parkinson's disease |
| 003821 |
B. Gomez-Mancilla [Canada] ; R. Boucher ; P. J. Bedard | Effect of LY 171555 and CY 208-243 on tremor suppression in the MPTP monkey model of Parkinsonism |
| 003825 |
P. J. Morrison [Royaume-Uni] ; V. H. Patterson | Cranial dystonia (Meige syndrome) in postencephalitic Parkinsonism |
| 003828 |
J. William Langston [États-Unis] ; H. Widner ; C. G. Goetz ; D. Brooks ; S. Fahn ; T. Freeman ; R. Watts | Core assessment program for intracerebral transplantations (CAPIT) |
| 003829 |
S. A. Factor [États-Unis] ; D. Brown | Clozapine prevents recurrence of psychosis in Parkinson's disease |
| 003831 |
E. Fazzini [États-Unis] ; J. Fleming ; S. Fahn | Cerebrospinal fluid antibodies to coronavirus in patients with Parkinson's disease |
| 003838 |
| |
| 003839 |
| |
| 003841 |
F. Micheli [Argentine] ; M. Fernandez Pardal ; R. Giannaula ; S. Fahn | What it it? case 3, 1991 : moaning in a man with parkinsonian signs |
| 003849 |
S. Rittig ; J. Arentsen ; K. Soêrensen ; T. Matthiesen ; E. Dupont | The hemodynamic effects of triglycyl-lysine-vasopressin (glypressin) in patients with parkinsonism and orthostatic hypotension |
| 003852 |
M. J. Steiger ; N. P. Quinn ; C. D. Marsden | Sickness due to levodopa-induced neck dyskinesias in Parkinson's disease |
| 003859 |
S. A. Factor ; W. J. Weiner | Prior history of head trauma in Parkinson's disease |
| 003862 |
V. P. Calabrese ; M. G. Hadfield | Parkinsonism and extraocular motor abnormalities with unusual neuropathological findings |
| 003864 |
R. Kurlan [États-Unis] ; M. H. Kim ; D. M. Gash | Oral levodopa dose-response study in MPTP-induced hemiparkinsonian monkeys : assessment with a new rating scale for monkey parkinsonism |
| 003865 |
M. J. Steiger ; N. P. Quinn ; B. Toone ; C. D. Marsden | Off-period screaming accompanying motor fluctuations in Parkinson's disease |
| 003866 |
W. R. G. Gibb ; T. Scott ; Andrew Lees (neurologue) [Royaume-Uni] | Neuronal inclusions of Parkinson's disease |
| 003870 |
T. Z. Aziz [Royaume-Uni] ; D. Peggs ; M. A. Sambrook ; A. R. Crossman | Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonims in the primate |
| 003875 |
G. Pezzoli [Italie] ; A. Zecchinelli ; S. Ricciardi ; R. E. Burke ; S. Fahn ; G. Scarlato ; A. Carenzi | Intraventricular infusion of epidermal growth factor restores dopaminergic pathway in hemiparkinsonian rats |
| 003877 |
G. Geminiani [Italie] ; B. M. Cesana ; F. Tamma ; P. Contri ; C. Pacchetti ; F. Carella ; R. Piolti ; E. Martignoni ; P. Giovannini ; F. Girotti ; T. Caraceni | Interobserver reliability between neurologists in training of Parkinson's disease rating scales : A multicenter study |
| 003881 |
A. J. Hughes [Royaume-Uni] ; S. E. Daniel ; Andrew Lees (neurologue) [Royaume-Uni] | Idiopathic Parkinson's disease combined with multiple system atrophy : A clinicopathological report |
| 003884 |
M. B. Stern | Head trauma as a risk factor for Parkinson's disease |
| 003885 |
L. L. Edwards ; R. F. Pfeiffer ; E. M. M. Quigley ; R. Hofman ; M. Balluff | Gastrointestinal symptoms in Parkinson's disease |
| 003889 |
M. B. Stern | Electroconvulsive therapy in untreated Parkinson's disease |
| 003890 |
R. Faber [États-Unis] ; M. R. Trimble | Electroconvulsive therapy in Parkinson's disease and other movement disorders |
| 003891 |
P. Giovannini ; I. Piccolo ; S. Genitrini ; P. Soliveri ; F. Girotti ; G. Geminiani ; G. Scigliano ; T. Caraceni | Early-onset Parkinson's disease |
| 003903 |
J. M. Brotchie ; I. J. Mitchell ; M. A. Sambrook ; A. R. Crossman | Alleviation of Parkinsonism by antagonism of excitatory amino acid transmission in the medial segment of the globus pallidus in rat and primate |
| 003904 |
S. T. Gancher ; J. G. Nutt ; W. R. Woodward | Absorption of apomorphine by various routes in parkinsonism |
| 003908 |
D. M. Maraganore ; A. E. Harding ; C. D. Marsden | A clinical and genetic study of familial Parkinson's disease |
| 003911 |
| First international congress of movement disorders: abstracts, Washington DC, April 25-27, 1990 |
| 003912 |
A. J. Lewis ; M. J. Gawel | diffuse lewy body disease with dementia and oculomotor dysfunction |
| 003913 |
J. Rivest ; N. Quinn ; J. Gibbs ; C. D. Marsden | Unilateral abolition of extrapyramidal rigidity after ipsilateral cerebellar infarction |
| 003914 |
C. J. Hunker ; J. H. Abbs | Uniform frequency of Parkinsonian resting tremor in the lips, jaw, tongue, and index finger |
| 003915 |
W. G. Johnson ; S. E. Hodge ; R. Duvoisin | Twin studies and the genetics of Parkinson's disease ― a reappraisal |
| 003917 |
D. Eidelberg ; J. R. Moeller ; V. Dhawan ; J. J. Sidtis ; J. Z. Ginos ; S. C. Strother ; J. Cedarbaum ; P. Greene ; S. Fahn ; D. A. Rottenberg | The metabolic anatomy of Parkinson's disease : complementary [18F]fluorodeoxyglucose and [18F]fluorodopa positron emission tomographic studies |
| 003920 |
J. M. Cedarbaum ; M. Clark ; L. H. Toy ; A. Green-Parsons | Sustained-release (+)-PHNO [MK-458 (HPMC)] in the treatment of Parkinson's disease : evidence for tolerance to a selective D2-receptor agonist administered as a long-acting formulation |
| 003923 |
S. A. Factor ; T. Mcalarney ; J. R. Sanchez-Ramos ; W. J. Weiner | Sleep disorders and sleep effect in Parkinson's disease |
| 003929 |
U. K. Rinne ; A. Laihinen ; J. O. Rinne ; K. Nagren ; J. Bergman ; U. Ruotsalainen | Positron emission tomography demonstrates dopamine D2 receptor supersensitivity in the striatum of patients with early Parkinson's disease |
| 003933 |
B. V. Manyam | Paralysis agitans and levodopa in "Ayurveda": ancient Indian medical treatise |
| 003939 |
M. A. Menza ; J. Sage ; E. Marshall ; R. Cody ; R. Duvoisin | Mood changes and on-off phenomena in Parkinson's disease |
| 003940 |
A. H. V. Schapira ; I. J. Holt ; M. Sweeney ; A. E. Harding ; P. Jenner ; C. D. Marsden | Mitochondrial DNA analysis in Parkinson's disease |
| 003948 |
L. W. Svenson | Geographic distribution of deaths due to Parkinson's disease in Canada : 1979-1986 |
| 003951 |
L. I. Golbe ; T. M. Farrell ; P. H. Davis | Follow-up study of early-life protective and risk factors in Parkinson's disease |
| 003953 |
M. A. Dietz ; C. G. Goetz ; G. T. Stebbins | Evaluation of a modified inverted walking stick as a treatment for Parkinsonian freezing episodes |
| 003955 |
J. Vaamonde ; M. R. Luquin ; J. A. Obeso | Dopaminergic responsiveness to apomorphine after chronic treatment with subcutaneous lisuride infusion in Parkinson's disease |
| 003958 |
V. S. Kostic ; N. Covickovic-Sternic ; L. Beslac-Bumbasirevic ; G. Ocic ; D. Pavlovic ; M. Nikolic | Dexamethasone suppression test in patients with Parkinson's disease |
| 003961 |
J. H. Friedman ; M. C. Lannon | Clozapine-responsive tremor in Parkinson's disease |
| 003962 |
R. F. Pfeiffer ; J. Kang ; B. Graber ; R. Hofman ; J. Wilson | Clozapine for psychosis in Parkinson's disease |
| 003966 |
Werner Poewe [Autriche] ; G. Luef ; B. Kleedorfer ; M. Emre | Antiparkinsonian activity of a non-ergot dopamine agonist, CV 205-502, in patients with fluctuating Parkinson's disease |
| 003967 |
L. Herzberg | An essay on the shaking palsy: reviews and notes on the journals in which they appeared |
| 003969 |
C. Waters ; H. H. Itabashi ; M. L. J. Apuzzo ; L. P. Weiner | Adrenal to caudate transplantation - Postmortem study |
| 003970 |
K. Marder ; P. Flood ; L. Cote ; R. Mayeux | A pilot study of risk factors for dementia in Parkinson's disease |
| 003972 |
A. R. Crossman | A hypothesis on the pathophysiological mechanisms that underlie levodopa- or dopamine agonist-induced dyskinesia in Parkinson's disease: implications for future strategies in treatment |
| 003973 |
M. Sano ; Y. Stern ; K. Marder ; R. Mayeux | A controlled trial of piracetam in intellectually impaired patients with Parkinson's disease |
| 003976 |
| Parkinson's Disease Foundation symposium, New York City, 1987 |
| 003985 |
W. R. G. Gibb ; M. Terruli ; Andrew Lees (neurologue) [Royaume-Uni] ; P. Jenner ; C. D. Marsden | The evolution and distribution of morphological changes in the nervous system of the common marmoset following the acute administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
| 003986 |
R. J. Coleman ; K. W. Lange ; N. P. Quinn ; A. E. Loper ; J. V. Bondi ; M. Hitchens ; S. M. Stahl ; C. D. Marsden | The antiparkinsonian actions and pharmacokinetics of transdermal (+)-4-propyl-9-hydroxynaphthoxazine (+ PHNO): preliminary results |
| 003988 |
M. Gresty | Stability of the head in pitch (neck flexion-extension): studies in normal subjects and patients with axial rigidity |
| 003992 |
N. P. Quinn ; P. Luthert ; M. Honavar ; C. D. Marsden | Pure akinesia due to Lewy body Parkinson's disease: a case with pathology |
| 003994 |
C. H. Adler ; M. B. Stern ; M. L. Brooks | Parkinsonism secondary to bilateral striatal fungal abscesses |
| 003995 |
L. I. Golbe ; D. C. Miller ; R. C. Duvoisin | Paraneoplastic degeneration of the substantia nigra with dystonia and parkinsonism |
| 003997 |
P. A. Kempster ; Andrew Lees (neurologue) [Royaume-Uni] ; P. Crichton ; J. P. Fkankel ; P. Shorvon | Off-period belching due to a reversible disturbance of oesophageal motility in Parkinson's disease and its treatment with apomorphine |
| 003999 |
P. M. Fitzgerald ; Joseph Jankovic [États-Unis] | Lower body Parkinsonism: evidence for vascular etiology |
| 003A04 |
W. S. Metzer ; J. E. O. Newton ; R. W. Steele ; M. Claybrook ; S. R. Paige ; D. E. Mcmillan ; S. Hays | HLA Antigens in drug-induced Parkinsonism |
| 003A07 |
E. Pourcher ; A.-M. Bonnet ; J. Kefalos ; B. Dubois ; Yves Agid [France] | Effects of etybenzatropine and diazepam on Levodopa-induced diphasic dyskinesias in Parkinson's disease |
| 003A08 |
E. Mohr ; G. Fabbrini ; J. Williams ; J. Schlegel ; C. Cox ; P. Fedio ; T. N. Chase | Dopamine and memory function in Parkinson's disease |
| 003A09 |
Joseph Jankovic [États-Unis] ; K. Schwartz ; C. Vander Linden | Comparison of Sinemet CR4 and standars Sinemet: double blind and long-term open trial in Parkinsonian patients with fluctuations |
| 003A10 |
F. Grandas ; J. Artieda ; J. A. Obeso | Clinical and CT scan findings in a case of cyanide intoxication |
| 003A13 |
U. J. Kang ; S. Fahn ; H. Schwarz ; I. Shoulson ; H. Vallejos ; J. Goldman | Case 1, 1989: Juvenile-onset Parkinsonism, dystonia, and pyramidal tract signs |
| 003A14 |
R. F. Pfeiffer ; L. H. Herrera ; C. S. Glaeske ; R. E. Hofman | CQP A01-403 in Parkinson's disease: an open-label pilot study |
| 003A18 |
J. A. Temlett ; N. P. Quinn ; P. G. Jenner ; C. D. Marsden ; E. Pourcher ; A.-M. Bonnet ; Y. Acid ; R. Markstein ; X. Lataste | Antiparkinsonian activity of CY 208-243, a partial D-1 dopamine receptor agonist, in MPTP-treated marmosets and patients with Parkinson's disease |
| 003A25 |
L. I. Golbe ; J. Pae | Validity of a mailed epidemiological questionnaire and physical self-assessment in Parkinson's disease |
| 003A26 |
S. A. Factor ; J. Sanchez-Ramos ; W. J. Weiner | Trauma as an etiology of Parkinsonism: a historical review of the concept |
| 003A28 |
R. Mayeux ; Y. Stern ; M. Sano ; J. B. W. Williams ; L. J. Cote | The relationship of serotonin to depression in Parkinson's disease |
| 003A41 |
CHI-CHEN MAO ; S. T. Gancher ; R. M. Herndon | Movement disorders in multiple sclerosis |
| 003A43 |
G. Pezzoli ; S. Tesei ; C. Ferrante ; E. Cossutta ; A. Zecchinelli ; G. Scarlato | Madopar HBS in fluctuating Parkinsonian patients: two-year treatment |
| 003A44 |
F. Viallet ; D. Gambarelli ; B. Alonzo ; R. Sedan ; R. Khalil | Long-term follow-up after stereotaxic basal ganglia surgery in Parkinsonism: a neuroanatomical study of a case showing unusual postural disorders |
| 003A45 |
O. S. Gershanik ; M. R. Luquin ; O. Scipioni ; J. A. Obeso | Isoniazid therapy in Parkinson's disease |
| 003A50 |
M. Hietanen ; H. Teravainen | Dementia and treatment with L-dopa in Parkinson's disease |
| 003A53 |
J. M. Maloteaux ; E. C. Laterre ; P. M. Laduron ; F. Javoy-Agid ; Yves Agid [France] | Decrease of serotonin-S2 receptors in temporal cortex of patients with Parkinson's disease and progressive supranuclear palsy |
| 003A58 |
S. Ruggieri ; F. Stocchi ; A. Carta ; D. Bravi ; M. Bragoni ; L. Giorgi ; A. Agnoli | Comparison between L-dopa and lisuride intravenous infusions: a clinical study |
| 003A63 |
R. G. Brown ; C. D. Marsden | An investigation of the phenomenon of "set" in Parkinson's disease |
| 003A65 |
N. Quinn ; P. Critchley ; C. D. Marsden | Young onset Parkinson's disease |
| 003A66 |
H. Shale ; S. Fahn ; W. C. Koller ; A. E. Lang | What is it? Case I, 1987: Unusual tremors, bradykinesia, and cerebral lucencies |
| 003A68 |
J. G. De Yebenes ; S. Fahn ; V. Jackson-Lewis ; M.-A. Mena | The effect of intracerebroventricular infusion of (+)-4-propyl-9-hydroxynapthoxacine (PHNO) through a totally implanted drug delivery system in rats with dopamine deficiency |
| 003A73 |
F. A. Luque ; J. B. Selhorst ; P. Petruska | Parkinsonism induced by high-dose cytosine arabinoside |
| 003A74 |
W. Koller ; G. Herbster ; J. Gordon | PHNO, a novel dopamine agonist, in animal models of parkinsonism |
| 003A78 |
J. L. Montastruc ; P. Celsis ; A. Agniel ; J. F. Demonet ; B. Doyon ; M. Puel ; J. P. Marc-Vergnes ; A. Rascol | Levodopa-induced regional cerebral blood flow changes in normal volunteers and patients with Parkinson's disease: lack of correlation with clinical or neuropsychological improvements |
| 003A80 |
C. Diener ; E. Scholz ; B. Guschlbauer ; J. Dichgans | Increased shortening reaction in parkinson's disease reflects a difficulty in modulating long loop reflexes |
| 003A81 |
J. C. Krusz ; W. C. Koller ; D. K. Ziegler | Historical review: abnormal movements associated with epidemic encephalitis lethargica |
| 003A89 |
R. Agostino ; A. Berardelli ; G. Cruccu ; F. Stocchi ; M. Manfredi | Corneal and blink reflexes in Parkinson's disease with "on-off" fluctuations |
| 003A90 |
J. G. De Yebenes ; S. Fahn ; S. Lovelle ; V. Jackson-Lewis ; P. Jorge ; M. A. Mena ; J. Reiriz ; J. C. Bustos ; C. Magarinos ; A. Martinez | Continuous intracerebroventricular infusion of dopamine and dopamine agonists through a totally implanted drug delivery system in animal models of Parkinson's disease |
| 003A92 |
A. M. Bonnet ; G. Tell ; P. J. Schechter ; J. Grove ; M. H. Saint-Hilaire ; Y. De Smet ; Yves Agid [France] | Cerebrospinal fluid GABA and homocarnosine concentrations in patients with Friedreich's ataxia, Parkinson's disease, and Huntington's chorea |
| 003A96 |
F. Grandas ; N. Quinn ; P. Critchley ; A. Rohan ; C. D. Marsden ; S. M. Stahl | Antiparkinsonian activity of a single oral dose of PHNO |
| 003A97 |
N. Nomoto ; S. Stahl ; P. Jenner ; C. D. Marsden | Antiparkinsonian activity of (+)-PHNO in the MPTP-treated common marmoset |
| 003B02 |
W. J. Weiner ; S. A. Factor ; J. Sanchez-Ramos ; J. Berger | A double-blind evaluation of ciladopa in Parkinson's disease |
